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Abstract 
 
The body of this thesis is comprised of four scientific articles and is preceded by an 
overview that contextualises all of this submitted/published work. 
 
The first major part of this thesis is comprised of Publication 1. This details work 
concerned with establishing the true structure of the sorbicillinoid-derived isolate 
rezishanone C by total synthesis. Specifically, the enantiomer, B, of what proved to be 
the true structure, C, of the sorbicillinoid rezishanone C (sorbivinetone) was synthesized 
from the homochiral cis-1,2-dihydrocatechol A that is itself generated through the 
whole-cell biotransformation of toluene. These studies and dispersion-corrected DFT 
calculations support the proposal that rezishanone C is an artefact of the isolation 
process and arises through a Diels-Alder cycloaddition reaction between ethyl vinyl 
ether and sorbicillinol (D). 
 
 
 
The second major part of the thesis is comprised of Publication 2. This is concerned 
with the synthesis and photochemical rearrangements of enantiomerically pure, 
polysubstituted and, in some cases, variously annulated bicyclo[2.2.2]octenones. 
Specifically, then, a series of bicyclo[2.2.2]octenones has been prepared by engaging 
the enzymatically-derived and enantiomerically pure cis-1,2-dihydrocatechol A in either 
inter- or intra-molecular Diels-Alder cycloaddition reactions with various dienophiles. 
These polycyclic adducts or simple derivatives thereof were shown to readily participate 
in both photochemically promoted 1,3-acyl migration and oxa-di-π-methane 
rearrangement processes to give products such as E and F, respectively. 
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The third major part of the thesis is comprised of Publication 3. This details the 
establishment of a palladium-catalyzed Ullmann cross-coupling/reductive cyclization 
route to the carbazole natural products 3-methyl-9H-carbazole, glycoborine, 
glycozoline, clausazoline K, mukonine and karapinchamine A. These were prepared by 
reductive cyclisation of the relevant 2-arylcyclohex-2-en-1-one (e.g. G) to the 
corresponding tetrahydrocarbazole (e.g. H) and dehydrogenation of this to give the 
target carbazole (e.g. I). Compounds such as G were themselves prepared using a 
palladium-catalyzed Ullmann cross-coupling reaction that served to link the appropriate 
2-iodocyclohex-2-en-1-one and o-halonitrobenzene.
The fourth and final part of the thesis is comprised of Publication 4. This details a 
unified approach to the isomeric α-, β-, γ- and δ-carbolines via their 6,7,8,9-tetrahydro 
counterparts. Specifically, then, a cross-coupling/reductive cyclisation protocol has been 
employed in preparing all four carbolines. So, for example, the 2-nitropyridine (L), 
which is readily generated through an efficient palladium-catalyzed Ullmann cross-
coupling reaction, is reductively cyclized under conventional conditions to give 6,7,8,9-
tetrahydro-α-carboline (M) that is itself readily aromatized to give α-carboline (N). 
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Thesis Overview 
Publication 1: Establishing the True Structure of the Sorbicillinoid-derived Isolate 
Rezishanone C by Total Synthesis 
The sorbicillins are an ever-expanding class of polyketide-derived fungal metabolite1 
that display significant structural diversity and (sometimes) unusual biological 
activities.2 Rezishanone C3 is a representative member of the sub-type2c of sorbicillins 
that arise through a Diels-Alder reaction between sorbicillinol and various non-
sorbicillinoid-derived compounds containing a dienophilic residue. In particular, 
rezishanone C is thought to arise through reaction between ethyl vinyl ether (a common 
contaminant in ethyl acetate, the solvent used to isolate this material) but precisely 
which one of eight possible adducts represents the true structure of this artefact remains 
unclear. Given the uncertainty regarding the structure of rezishanone C and informed by 
theoretical calculations, the author developed a total synthesis of what proved to be ent-
rezishanone C. 
Figure 1. Structures of rezishanone C, ent-rezishanone C and sorbicillinol 
Thus, this publication details a twenty-three step total synthesis of ent-rezishanone C 
(Scheme 1). Starting from cis-1,2-dihydrocatechol 1, and through the application of 
intermolecular Diels-Alder and retro-aldol/aldol sequences, trans-diol 2 was formed. 
Over nine steps this last compound was converted into ethyl ether 3 that was itself 
subjected to cis-dihydroxylation under conditions defined by Bäckvall4 and so affording 
diol 4. A Barton-McCombie deoxygenation reaction5 then a DMP (Dess-Martin 
periodinane)-mediated oxidation followed and compound 4 was thereby transformed 
into ketone 5. When the potassium enolate derived from compound 5 was treated with 
(3E,5E)-2-oxo-3,5-heptadienenitrile6,7 then the desired C-acylated product 6 was formed. 
Hydrolysis of the acetonide residue within compound 6 and oxidation of the resulting 
sorbicillinol
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diol then gave ent-rezishanone C. All the spectral data derived from this material 
matched those reported for the isolate. Furthermore, the specific rotation of the 
synthetic material was of the same magnitude but opposite sign to that reported for the 
isolate and so definitively establishing the structure of rezishanone C as that shown in 
Figure 1. 
Scheme 1. Key steps involved in the synthesis of ent-rezishanone C 
Publication 2: Studies on the Photochemical Rearrangements of Enantiomerically 
Pure, Polysubstituted and Variously Annulated Bicyclo[2.2.2]octenones 
Bicyclo[2.2.2]octenones including the parent system 7 (Scheme 2) are excellent 
substrates for certain photochemically promoted rearrangement reactions.8 Specifically, 
on irradiation in the presence of photosensitizers such as acetophenone they participate 
in oxa-di-π-methane rearrangements and so affording, via a triplet pathway, 
cyclopropannulated diquinanes such as 8. In contrast, on direct irradiation they engage, 
now via a singlet pathway, in a 1,3-acyl migration reaction (Givens rearrangement) to 
give bicyclo[4.2.0]oct-4-en-7-ones such as 9. Upon sustained irradiation photoproduct 9 
and many of its derivatives can undergo decarbonylation to give the corresponding Δ2-
norcarene, e.g. 10. 
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Scheme 2. Photochemical rearrangement reactions of bicyclo[2.2.2]octenone (7) 
By way of example, then, Publication 2 describes methods for the synthesis of 
enantiomerically pure bicyclo[2.2.2]octenones such as 11-14 (Figure 2)9 and the 
engagement of these systems in the above-mentioned photochemical processes. As a 
result a suite of novel diquinanes, bicyclo[4.2.0]octenones and/or  bicyclo[4.1.0]octenes 
was produced. A number of these photoproducts are potential precursors to a range of 
terpenoid-type natural products.	
Figure 2. Examples of enantiomerically pure bicyclo[2.2.2]octenones 
Publication 3: A Palladium-Catalyzed Ullmann Cross-Coupling/Reductive 
Cyclization Route to the Carbazole Natural Products 3-Methyl-9H-carbazole, 
Glycoborine, Glycozoline, Clausazoline K, Mukonine and Karapinchamine A 
9H-Carbazole and its various derivatives continue to fascinate organic chemists because 
of their value in both medicine and materials science.10 Many biologically active natural 
products embodying this framework have also been isolated, particularly from higher 
plants.10d,10e,11 Accordingly, this publication details the development of a two-step 
process leading to 1,2,3,4-tetrahydro-9H-carbazoles (formally 2,3,4,9-tetrahydro-1H-
carbazoles)12 that can then be oxidized (directly) to the corresponding carbazoles.13 A 
relevant example leading to the natural product glycozoline is shown in Scheme 3. 
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Scheme 3. The synthesis of glycozoline 
By such means the author has been able to realize syntheses of the parent carbazole as 
well as the natural products 3-methyl-9H-carbazole,14 glycoborine (a.k.a.
glycrophylamine),11a,15 glycozoline,11a,16 clauszoline K,17 mukonine18 and 
karapinchamine A19 together with their mono-methoxylated congener 2-methoxy-9H-
carbazole (Figure 3). 
Figure 3. Structures of certain carbazole-based natural products and a mono-
methoxylated congener 
Publication 4: A Unified Approach to the Isomeric α-, β-, γ- and δ-Carbolines via 
their 6,7,8,9-Tetrahydro Counterparts 
The isomeric α-, β-, γ- and δ-carbolines (Figure 4) are important heterocyclic ring 
systems20 encountered, albeit to varying extents, as key structural motifs in various 
biologically active natural products.  
Figure 4. The isomeric α-, β-, γ- and δ-carbolines (17-20, respectively) 
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This publication reports on the development of a unified approach (perhaps the first to 
have been developed) to the carbolines involving palladium-catalyzed Ullmann cross-
coupling,21 reductive cyclization and dehydrogenation reactions as key steps,  the last 
being employed to convert tetrahydro-carbolines into their fully aromatic counterparts 
(viz. the carbolines). The synthesis of α-carboline, as shown in Scheme 4, is illustrative 
of the reaction sequence used. 
Scheme 4. The synthesis of α-carboline 
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Natural Product Synthesis
Establishing the True Structure of the Sorbicillinoid-Derived
Isolate Rezishanone C by Total Synthesis
Qiao Yan,[a] Martin G. Banwell,*[a] Michelle L. Coote,[a, b] Richmond Lee,[a, b] and
Anthony C. Willis[a]
Abstract: The enantiomer, ent-4, of the true structure, 4,
of the sorbicillinoid rezishanone C (sorbivinetone) has
been synthesized from a homochiral cis-1,2-dihydrocate-
chol that is itself generated through the whole-cell bio-
transformation of toluene. These studies together with
dispersion-corrected DFT calculations support the propos-
al that rezishanone C is an artefact of the isolation process
and arises through a Diels–Alder reaction between ethyl
vinyl ether and sorbicillinol (3).
The sorbicillins are an ever-expanding class of polyketide-de-
rived fungal metabolite[1] that display significant structural di-
versity and (sometimes) unusual biological activities.[2] Rezisha-
none C (sorbivinetone, Figure 1),[3] for which both structures
1 and 2 have been suggested, can be classified as a member
of the so-called hybrid sub-type[2a] of sorbicillins that arise
through a Diels–Alder reaction between sorbicillinol (3) and
various non-sorbicillinoid-derived compounds containing a di-
enophilic residue. In the case of rezishanone C, it has been
suggested[3a] that ethyl vinyl ether is the dienophile involved.
Since this ether is a contaminant often found in ethyl acetate,
the solvent used in extracting rezishanone C from various
fungal sources, it is quite possible that this compound is an ar-
tefact of the isolation process rather than a true natural prod-
uct. Some support for this argument follows from the report[3a]
that the acetate of the racemic modification of compound 3
(i.e. (:)-sorbicillinol acetate) reacts with ethyl vinyl ether under
ambient conditions to give a Diels–Alder adduct designated O-
acetylrezishanone C. On this basis, Bringmann proposed[3a]
structure 1 for rezishanone C (a compound that would arise
through a-face addition of ethyl vinyl ether to diene 3).
Others who have isolated what we now confirm to be the
same material have suggested that it may be one or other of
the C7 epimeric forms of compound 2 (that would arise if the
same dienophile added, depending on the C7 stereochemistry,
in either an exo or endo mode to the b face of diene 3).[3b–d] It
should be noted that each of the four research groups who
have reported isolating rezishanone C used a different solvent
to acquire their 1H and 13C NMR spectral data sets and thus
preventing direct comparisons between them.3
Rezishanone C, in any of its structurally proposed or plausi-
ble alternate forms,[4] embodies a polyfunctionalized and ho-
mochiral bicyclo[2.2.2]octane core bearing a bridgehead
methyl group, a structural motif that we have been able to as-
semble by chemoenzymatic means during the course of our
studies on the total synthesis of various terpenoids.[5] Accord-
ingly, and given the absence of any prior studies[6] as well as
the ambiguities associated with its structure, we were attract-
ed to rezishanone C as a synthetic target. As a prelude to un-
dertaking synthetic studies, we carried out dispersion-correct-
ed DFT calculations to determine the transition state energies
associated with the various possible modes of Diels–Alder cy-
cloaddition that could take place between sorbicillinol (2) and
ethyl vinyl ether. These suggested that the reaction pathway
leading to compound 4 (rather than congener 1 or the 7R epi-
meric form of 2) is the most energetically favorable one (see
the Supporting Information). As such, and given the nature of
the homochiral starting material available to us, we pursued
the total synthesis of ent-rezishanone C (ent-4, Figure 2), and
thereby established that the illustrated structure 4 is the cor-
rect one for rezishanone C.
The opening stages of the synthesis are shown in Scheme 1
and involved converting, under standard conditions, the readi-
Figure 1. The two possible structures, 1 and 2, originally proposed for re-
zishanone C (sorbivinetone) and its likely biogenetic precursor sorbicillinol
(3).
[a] Q. Yan, Prof. M. G. Banwell, Prof. M. L. Coote, Dr. R. Lee, Dr. A. C. Willis
Research School of Chemistry
Institute of Advanced Studies
The Australian National University
Canberra, ACT 2601 (Australia)
E-mail : martin.banwell@anu.edu.au
[b] Prof. M. L. Coote, Dr. R. Lee
ARC Centre of Excellence for Electromaterials Science
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ly available, enzymatically derived and homochiral cis-1,2-dihy-
drocatechol 5[7] into the corresponding and previously report-
ed acetonide 6.[5,8] Compound 6 was itself engaged in a ther-
mally induced Diels–Alder cycloaddition reaction with a-chlor-
oacrylonitrile,[9] and the epimeric mixture of ortho adducts thus
obtained were hydrolyzed using potassium hydroxide in tert-
butanol to give the known[5, 10] bicyclo[2.2.2]octenone 7 (53%
from 5). Cleavage of the acetonide moiety within the last com-
pound was achieved using acidified AG-50W-X8 resin in hot
aqueous methanol, but this process was accompanied by
a retro-aldol/aldol sequence that led to the production of the
trans-diol 8 (86%). The structure of compound 8 was con-
firmed via single-crystal X-ray analysis (see the Supporting In-
formation). The propensity for retro-aldol reactions to take
place within this framework was further emphasized on at-
tempting to convert the ketone moiety within compound 8
into the corresponding ethylene ketal. Thus, on treating this
substrate with ethylene glycol in benzene under reflux, the un-
expected, ring-cleaved and crystalline cyclohexenone 9[10]
(48%) was obtained.
Progress towards the bicyclo[2.2.2]octane core of target ent-
4 could be made (Scheme 2) by selectively converting the hy-
droxyl residue remote from the bridgehead methyl group
within compound 8 into the corresponding TBS ether 10
(88%). Reduction of the ketone moiety associated with com-
pound 10 was achieved stereoselectively using DIBAL-H, and
so affording a chromatographically separable mixture of epi-
mers 11[10] (15%) and 12 (83%). Two-fold acetylation of diol 12
under standard conditions gave the diester 13 (98%), and
treatment of the latter with tetra-n-butylammonium fluoride
(TBAF) then gave alcohol 14[10] (91%) that could be oxidized to
the corresponding ketone 15 (95%) using Dess–Martin periodi-
nane (DMP).[11] Reaction of compound 15 with methyl magne-
sium bromide at 0 8C for a brief period gave the cis diol 16[10]
(85%) through selective si-face addition of the nucleophile to
the ketone carbonyl and as a result of the a-acetoxy group
hindering the corresponding re face. After saponification of the
remaining acetate residue within compound 16, the triol 17[10]
(79%) was converted, by standard methods, into the acetonide
Figure 2. The theoretically favored Diels–Alder adduct, 4, arising from the re-
action of sorbicillinol (3) with ethyl vinyl ether and the structure of its enan-
tiomer (ent-4) targeted for synthesis in the present study.
Scheme 1. Assembling the bicyclo[2.2.2]octane core of ent-rezishanone C
(ent-4).
Scheme 2. Elaborating the bicyclo[2.2.2]octane core of ent-rezishanone C
(ent-4).
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18 (91%). Finally, compound 18 was treated with sodium hy-
dride and ethyl iodide and so generating the ethyl ether 19
(86%) that embodies a number of the key structural features
of the core of ent-rezishanone C.
Our proposed conversion of compound 19 into target 1 re-
quired that the double bond within the former compound be
manipulated such that a ketone carbonyl group is introduced
adjacent to (rather than remote from) the bridgehead methyl
group. In one of a number of attempts to achieve such an out-
come alkene 19 (Scheme 3) was treated with meta-chloroper-
benzoic acid (mCPBA) and a single epoxide 20 (86%) was ob-
tained. The high degree of selectivity associated with this elec-
trophilic addition reaction may be the result of hydrogen
bonding between the epoxidizing agent and the oxygen of
the pendant ethoxy group. Disappointingly, all efforts to effect
the reductive cleavage of this compound with the desired re-
gioselectivity failed. So, for example, on reaction of com-
pound 20 with lithium triethylborohydride the undesired alco-
hol 21 (84%) was obtained, perhaps as a result of electronic ef-
fects exerted by the pendant ethoxy group and/or steric ones
arising from the methyl group at the junction between dioxo-
lane and bicyclo[2.2.2]octane frameworks. The structure of
compound 21 (and, therefore, the precursor epoxide 20) fol-
lowed from a single-crystal X-ray analysis of the crystalline triol
22[10] (59% or 84%, based on recovered starting material) pro-
duced through hydrolysis of the acetonide group using acidi-
fied AG-50W-X8 resin.
The above-mentioned difficulties were overcome by the
means outlined in Scheme 4. Thus, alkene 19 was subjected to
dihydroxylation under conditions defined by B-ckvall,[12] afford-
ing a chromatographically separable mixture of products 23
(22%) and 24 (68%). Presumably, the facial selectivity of this
oxidation process, which is essentially opposite to that ob-
served in the conversion 19!20, is now dictated, to some
extent at least, by the steric demands of the pendant ethoxy
group. Treatment of the latter with para-methoxybenzalde-
hyde dimethylacetal (PMBDMA) in the presence of para-tolue-
nesulfonic acid monohydrate (pTsOH·H2O) afforded the epimer-
ically pure acetal 25 (89%) that was reductively cleaved with
diisobutylaluminum hydride (DIBAL-H) in CH2Cl2 and so giving
the diol mono-ether 26[10] in 95% yield.[13] As a prelude to con-
ducting a Barton–McCombie deoxygenation reaction,[14] com-
pound 26 was converted into the corresponding xanthate 27
(96%) under standard conditions and on treatment of this
with tris(trimethylsilyl)silane (TTMSS)[15] and azobisisobutyroni-
trile (AIBN) reduction took place to give the anticipated ether
28 (79%). 2,3-Dichloro-5,6-dicyanobenzoquinone (DDQ)[16] was
used to effect the oxidative cleavage of compound 28, afford-
ing alcohol 29 (89%) that was converted into the target
ketone 30[10,17] (79%) using DMP in pyridine. Disappointingly,
when the enolate anion derived from ketone 30 [obtained by
treating it with potassium hexamethyl disilazide (KHMDS)] was
quenched with sorbyl chloride in THF at @78 8C, O-acylation
Scheme 3. An unwanted regiochemical outcome associated with manipulat-
ing the olefinic residue in compound 19.
Scheme 4. Regiocontrolled manipulation of the olefinic residue within com-
pound 19 and an O-acylation reaction.
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rather than C-acylation took place, leading to the unstable
enol ester 31 (84%) as the exclusive product of reaction.
The difficulties detailed immediately above were overcome
in the same manner as used by Harned and co-workers[6a]
during the course of their synthesis of sorbicillactone A. Thus,
the potassium enolate derived from deprotonation of ketone
30 (Scheme 5) was treated with (3E,5E)-2-oxo-3,5-heptadieneni-
trile[6a,18] in THF at @78 8C, and now the desired C-acylated
product 32 (55%) was obtained as a crystalline solid, the struc-
ture of which was confirmed by single-crystal X-ray analysis.
The completion of the target compound ent-4 from this point
involved hydrolysis[19] of the acetonide residue within com-
pound 32 using acidified AG-50W-X8 resin then pyridinium
para-toluenesulfonate (PPTS).[20] Oxidation of the resulting diol
33 (63% or 82%, based on recovered starting material) with
the Ley–Griffith reagent[21] then gave compound ent-4 (52%).
All the spectral data acquired on compound ent-4 were in
complete accord with the assigned structure. In addition, the
specific rotation of this material was of similar magnitude but
opposite sign to that reported for rezishanone C[22] while the
1H and 13C NMR data recorded on the synthetic material
matched those reported by Bringmann,[3a] Lee,[3b] Laatsch,[3c]
and Kçnig[3d] for the title isolate (see the Supporting Informa-
tion for tabulated comparisons). The studies detailed above
clearly indicate that rezishanone C has the illustrated structure
and not that originally depicted by Bringmann (structure 1).[3a]
Furthermore, the materials subsequently isolated by others are
one and the same compound (and not, for example, the 7R-
epimeric form of 2). This outcome, when considered in con-
junction with the theoretical calculations described above,
adds weight to the hypothesis that rezishanone C is an artefact
of the isolation process and arises as detailed above.[3a] The
present work also emphasizes the unique capacity of total syn-
thesis to definitively establish/re-assign the structures of com-
pounds isolated from natural sources.[23]
Experimental Section
All computational methods, the derived data and the ensuing anal-
yses are provided in the Supporting Information, as are the proce-
dures for the preparation of all new compounds and the associat-
ed spectroscopic and analytical data. Copies of the NMR spectra of
new compounds, and X-ray plots and data for compounds 7, 8, 9,
11, 14, 16, 17, 22, 26, 30 and 32 are also included in the SI.
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Part A: Computational Studies 
1. General Approach and Outcomes
All quantum chemical calculations were carried out with Gaussian 09.1 The activation
free energy barriers in solution (ΔG‡) are reported relative to the individual free
starting materials: the diene and dienophile. The [4+2]-cycloaddition transition state
(TS) electronic structures were optimized with the meta-hybrid functional M06-2X2
in conjunction with Grimme’s empirical dispersion correction D3 (zero damping),3
herein termed M06-2X(D3), using Pople’s4 6-31G(d,p) basis set and the SMD5
polarizable continuum solvent model under ethyl acetate (EA) parameters. The
ultrafine integral grid was selected during the optimization calculations to ensure
accuracy in the computed vibrational frequencies. Frequency calculations at 298K
based on harmonic oscillator approximation were performed at the same level of
theory to verify that all TSs had one imaginary frequency and to compute the
vibrational contributions to the entropies.
Figure S1 shows the various possible transition structures for the [4+2]-cycloaddition
reaction between sorbicillinol (3) and ethyl vinyl ether. We also endeavored to search
for a step-wise [4+2] pathway but only the concerted one was found. From Figure S1
it is seen that the lowest energy transition structure (designated here as TScDA-1aS)
is that leading to ent-rezishanone C (ent-4). The next lowest transition structure is
some 2.5 kcal mol–1 higher in energy and would thus not contribute significantly to
the reaction. As shown in Figure S1, the reason for this preference is predominantly
steric. 
! S3!
Figure S1. Structures and computed Gibbs free energy barriers for possible 
transition states associated with the addition of ethyl vinyl ether to sorbicillinol 
(3). 
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2. Total Energies of Species
Table S1. Energies and corrections
Species Ee Gcorrection Hcorrection ZPE G H Ee + ZPE 
Diene + 
dienophile -1075.98901 0.31310 0.41684 0.39008 -1075.67592 -1075.57217 -1075.59894
TScDA-1aS -1075.99632 0.33880 0.41802 0.39268 -1075.65751 -1075.57829 -1075.60363
TScDA-1aR -1075.99202 0.33845 0.41780 0.39233 -1075.65357 -1075.57422 -1075.59969
TScDA-2aS -1075.96614 0.33732 0.41765 0.39216 -1075.62882 -1075.54848 -1075.57398
TScDA-2aR -1075.97559 0.33967 0.41762 0.39249 -1075.63592 -1075.55797 -1075.58310
TScDA-1bS -1075.97955 0.33837 0.41799 0.39237 -1075.64118 -1075.56156 -1075.58718
TScDA-1bR -1075.98234 0.33910 0.41848 0.39305 -1075.64324 -1075.56386 -1075.58929
All energy values are in hatrees. Ee is the electronic energy of the species. The energy corrections Gcorrection and 
Hcorrection and Zero Point Energy (ZPE) are added to Ee to constitute Gibb’s free energy (G), enthalpy (H) and the 
Ee + ZPE respectively.
3. Gaussian Archive Entries for All Species
diene 
 1\1\GINC-CA139\FOpt\RM062X\6-31G(d,p)\C14H16O4\ROOT\25-Nov-2015\0\\# m 
 062x/6-31G** opt=(maxcyc=200) scf=maxcyc=200 int=ultrafine freq # empi 
 ricaldispersion=gd3 scrf=(smd,solvent=EthylEthanoate)\\Diene\\0,1\H,0. 
 9118471652,0.7607602863,1.7283129434\C,0.1551268325,0.1116187999,1.298 
 5048231\C,0.4098413776,-0.7043179035,0.2609841291\C,-0.6843127873,-1.5 
 701009665,-0.2593218829\C,-1.8943788889,-1.6900160766,0.362866934\C,1. 
 7561279323,-0.7650692082,-0.3825210329\C,2.905566831,-0.1254867215,0.2 
 649600274\H,2.7976888363,0.3088998433,1.2514618313\C,4.1004276879,-0.1 
 013309942,-0.3578786624\H,4.1782986604,-0.5525737361,-1.3464052082\C,5 
 .2976098793,0.4889509388,0.2007347235\H,5.229474379,0.9362420702,1.191 
 5679964\C,6.4637859718,0.4956193515,-0.4638072003\H,6.498005103,0.0395 
 895755,-1.4535924069\O,1.8887362015,-1.3599686844,-1.4605970159\C,-1.2 
 191827129,0.2671202915,1.86026615\C,-2.134988324,-0.9245279383,1.56506 
 37885\O,-3.0760467599,-1.1068489135,2.3323034454\O,-1.1434422387,0.476 
 8534779,3.2488645514\H,-1.9821446651,0.1243791629,3.5914649959\C,-1.86 
 69261517,1.4924337158,1.1722677981\H,-1.9374648635,1.3558912191,0.0902 
 926179\H,-2.871920573,1.621884268,1.5846551066\H,-1.2744295152,2.38401 
 02505,1.3903003518\O,-0.4522564725,-2.2990532726,-1.3471090501\H,0.467 
 6303633,-2.0846847507,-1.6565792445\C,-2.9195900933,-2.6763413524,-0.1 
 148552616\H,-3.8697935749,-2.49169118,0.3888882417\H,-3.065313454,-2.5 
 956258926,-1.1954655369\H,-2.6185656121,-3.7083702328,0.0950921827\C,7 
 .733296543,1.0848245403,0.0507555614\H,8.0961179432,1.8667433365,-0.62 
 55489385\H,7.6030492583,1.5154443712,1.0461209855\H,8.5191257616,0.322 
 7423047,0.0969522558\\Version=AS64L-G09RevD.01\State=1-A\HF=-843.66271 
 3\RMSD=4.198e-09\RMSF=2.771e-06\Dipole=2.8977284,1.4239484,-0.4058954\ 
 Quadrupole=10.8581703,-2.6167901,-8.2413802,0.8479145,2.6773196,-0.781 
 7147\PG=C01 [X(C14H16O4)]\\@ 
dienophile 
 1\1\GINC-CA138\FOpt\RM062X\6-31G(d,p)\C4H8O1\ROOT\25-Nov-2015\0\\# m06 
 2x/6-31G** opt=(maxcyc=200) scf=maxcyc=200 int=ultrafine freq # empiri 
 caldispersion=gd3 scrf=(smd,solvent=EthylEthanoate)\\Dienophile\\0,1\C 
 ,-1.403718679,1.3926371956,-1.4945288669\C,-0.3521507403,1.6984085923, 
-0.7397477275\O,-1.3479173941,0.4578558643,-2.4731676641\C,-2.56845370
44,0.2581938115,-3.1845290428\H,-3.3561482552,-0.0500943017,-2.4846590
767\H,-2.8799109149,1.2010179362,-3.6529290445\C,-2.3302387688,-0.8078
496772,-4.2290837283\H,-3.2476550637,-0.9873588261,-4.7954533259\H,-1.
5478534861,-0.4953426323,-4.925270607\H,-2.0237957624,-1.7452903641,-3
.7581671996\H,-0.4453472634,2.4529434227,0.0308176543\H,0.603549061,1.
205139319,-0.8799616079\H,-2.3703590188,1.8807396697,-1.3643197731\\Ve
rsion=AS64L-G09RevD.01\State=1-A\HF=-232.3263002\RMSD=5.907e-09\RMSF=4
.863e-06\Dipole=-0.8227371,0.0521043,-0.2791994\Quadrupole=0.4241394,-
0.363871,-0.0602684,-0.2959503,0.5605454,1.3506336\PG=C01 [X(C4H8O1)]\
\@
TScDA-1aS 
 1\1\GINC-CA043\FTS\RM062X\6-31G(d,p)\C18H24O5\ROOT\24-Nov-2015\0\\# m0 
 62x/6-31G** opt=(ts,calcfc,noeigen,maxcyc=200) scf=maxcyc=200 int=ultr 
 afine freq # empiricaldispersion=gd3 scrf=(smd,solvent=EthylEthanoate) 
! S5!
 \\TS Diels-Alder concerted to product regio 1a (top) - S isomer\\0,1\H 
 ,-0.3360018093,0.8635709343,1.0759069627\C,0.3938925775,0.2155934066,0 
 .5985407536\C,-0.0302969441,-1.0181731854,0.0757697514\C,0.9988445727, 
 -1.9403480819,-0.3773111648\C,2.3525674673,-1.6506332187,-0.30483666\C 
 ,-1.4138960889,-1.3000677958,-0.2562124002\C,-2.4535020226,-0.27950286 
 17,-0.029928811\H,-2.1789082757,0.6896542077,0.3720740718\C,-3.7386000 
 503,-0.5364427277,-0.3336660389\H,-3.9853950902,-1.5181452884,-0.73591 
 82707\C,-4.8233184446,0.4100083431,-0.1607059355\H,-4.577119261,1.3932 
 385886,0.2398286956\C,-6.0932857188,0.1139683683,-0.4741801392\H,-6.31 
 07825326,-0.877337855,-0.8728796928\O,-1.7465676254,-2.4062449777,-0.7 
 482651432\C,1.7499303742,0.2550906319,1.2606334497\C,2.7849324833,-0.4 
 873395465,0.4144272336\O,3.9499276272,-0.0799709649,0.462343303\O,2.19 
 09793816,1.5695963025,1.4857945363\H,3.1520872146,1.5183398354,1.33196 
 12769\C,1.6414725157,-0.4687950078,2.6207392488\H,1.31961288,-1.505997 
 9784,2.5097698247\H,0.9311303507,0.0654526961,3.2571071766\H,2.6251905 
 501,-0.4460030627,3.0982863918\O,0.6226342871,-3.0722984239,-0.9693841 
 267\H,-0.3899407908,-3.055988901,-0.9682497922\C,3.4015376009,-2.52430 
 18452,-0.9316563425\H,4.0188434557,-3.0137160319,-0.1696728965\H,4.081 
 5649454,-1.9272542069,-1.5478671207\H,2.9493113419,-3.2993322879,-1.55 
 20671276\C,-7.2492185457,1.0454423795,-0.3187862649\H,-7.7441581538,1. 
 2113575223,-1.2821760798\H,-6.9354354221,2.0118206408,0.0830407281\H,- 
 8.0039301011,0.6174711349,0.3504318918\C,1.2353286636,0.7503347251,-1. 
 9263227994\H,2.3083574265,0.6917451197,-2.1077327896\C,0.6597459832,1. 
 5533288143,-0.9758682852\O,0.4523494839,-0.064879729,-2.6032150334\C,1 
 .0817363568,-1.0116392029,-3.4920610542\H,1.7964137338,-1.6047701963,- 
 2.9120832566\H,1.6206483805,-0.4548574138,-4.2653637952\C,-0.014409887 
 2,-1.8714911824,-4.0707156754\H,0.4210562706,-2.6381152325,-4.71585566 
 23\H,-0.7097691065,-1.2700838291,-4.6611719414\H,-0.5664258695,-2.3630 
 492839,-3.2661015286\H,1.2661312121,2.305271334,-0.4886372151\H,-0.408 
 2653969,1.730495334,-1.061762253\\Version=AS64L-G09RevD.01\State=1-A\H 
 F=-1075.9963159\RMSD=6.982e-09\RMSF=2.996e-06\Dipole=-1.8882506,1.2712 
 682,-1.1050708\Quadrupole=3.3414481,-6.9803872,3.6389391,-5.527101,-7. 
 4171643,-0.2596998\PG=C01 [X(C18H24O5)]\\@ 
 
TScDA-1aR 
 1\1\GINC-CA075\FTS\RM062X\6-31G(d,p)\C18H24O5\ROOT\24-Nov-2015\0\\# m0 
 62x/6-31G** opt=(ts,calcfc,noeigen,maxcyc=200) scf=maxcyc=200 int=ultr 
 afine freq # empiricaldispersion=gd3 scrf=(smd,solvent=EthylEthanoate) 
 \\TS Diels-Alder concerted to product regio 1a (top) - R isomer\\0,1\H 
 ,-0.2808218816,0.8374100752,0.7161396023\C,0.3629562437,0.0518649679,0 
 .3299677469\C,-0.1661440944,-1.2353008761,0.1515860946\C,0.7650918749, 
 -2.2875177723,-0.2051919477\C,2.132700073,-2.0830851502,-0.3348617485\ 
 C,-1.5921883209,-1.5034036526,0.0834644974\C,-2.5633616348,-0.40482929 
 6,0.2380700857\H,-2.2136868132,0.6042260823,0.4264809322\C,-3.88360922 
 24,-0.6435438637,0.1346435052\H,-4.2090702284,-1.6653847484,-0.0564565 
 338\C,-4.9090022107,0.3731204319,0.2634742715\H,-4.5865010347,1.395376 
 9065,0.4602248406\C,-6.2158433915,0.0919435032,0.1536531602\H,-6.50840 
 26487,-0.9400206716,-0.0426851032\O,-2.0149226526,-2.6655880801,-0.120 
 1286165\C,1.7899481358,0.1640155324,0.8032240334\C,2.7032452102,-0.841 
 1004296,0.0924966945\O,3.8956796206,-0.5283229877,-0.0112956045\O,2.28 
 97202989,1.463300294,0.6289455461\H,3.192358417,1.3296259233,0.2887736 
 006\C,1.814356583,-0.1802669627,2.3092648361\H,1.4424582254,-1.1875938 
 018,2.5079077284\H,1.2085048245,0.5454840458,2.8581833293\H,2.84982711 
 83,-0.104059475,2.6520878896\O,0.2943572623,-3.4972155654,-0.488335685 
 9\H,-0.7071510333,-3.4324578576,-0.3824197428\C,3.0176249211,-3.187075 
 0138,-0.840886778\H,4.0543731655,-2.8450869077,-0.8532723121\H,2.73846 
 00094,-3.5045033044,-1.8511335719\H,2.9522512998,-4.0738124709,-0.2013 
 591944\C,-7.317194298,1.0906908614,0.2824848953\H,-7.9163063488,1.1264 
 797116,-0.6342725816\H,-6.9299831593,2.0920804841,0.4851209509\H,-8.00 
 07502954,0.8097215858,1.0913599749\C,1.4364324964,0.3877920328,-2.2308 
 100552\C,0.4475393615,1.0262397564,-1.5269095603\O,2.6712568123,0.8553 
 901418,-2.2743281685\C,3.6296393969,0.0224989552,-2.9593464361\H,3.314 
 8714589,-0.071011439,-4.0047430794\H,3.6232836737,-0.9665153267,-2.489 
 7711368\C,4.9803788662,0.6812685738,-2.8372391453\H,5.7289906779,0.077 
 6707991,-3.3562879375\H,5.2598008612,0.7591360097,-1.784676422\H,4.967 
 6106593,1.6782597053,-3.2847079468\H,0.6574894312,2.0163438988,-1.1387 
 795272\H,-0.5764666662,0.7747136602,-1.7743612085\H,1.2421989559,-0.52 
 99582853,-2.7872941712\\Version=AS64L-G09RevD.01\State=1-A\HF=-1075.99 
 20184\RMSD=7.657e-09\RMSF=1.702e-06\Dipole=-1.65978,1.4327332,-1.07215 
 62\Quadrupole=10.922113,-12.7958623,1.8737493,-7.4666513,-8.841663,0.4 
 559919\PG=C01 [X(C18H24O5)]\\@ 
 
TScDA-2aS 
 1\1\GINC-CA043\FTS\RM062X\6-31G(d,p)\C18H24O5\ROOT\24-Nov-2015\0\\# m0 
 62x/6-31G** opt=(ts,calcfc,noeigen,maxcyc=200) scf=maxcyc=200 int=ultr 
 afine freq # empiricaldispersion=gd3 scrf=(smd,solvent=EthylEthanoate) 
 \\TS Diels-Alder concerted to product regio 2a (top) - R isomer\\0,1\H 
! S6!
 ,-0.2334157103,0.984924462,0.9043012491\C,0.4617064942,0.2140744917,0. 
 5836421072\C,-0.0237956745,-1.0603561504,0.256765379\C,0.9513705982,-2 
 .0163415054,-0.1500611421\C,2.2946418905,-1.6430314449,-0.2913488788\C 
 ,-1.4449709658,-1.3666993089,0.0573863635\C,-2.4563781931,-0.309229151 
 ,0.2193882952\H,-2.1471283642,0.693266668,0.4927604145\C,-3.7605361133 
 ,-0.579852946,0.0249531255\H,-4.0404863313,-1.5969398597,-0.2472674486 
 \C,-4.8249603005,0.3936995115,0.1596881191\H,-4.5499864824,1.410906895 
 4,0.4372553821\C,-6.113407585,0.0775990238,-0.0395567645\H,-6.35794903 
 ,-0.948515975,-0.3158699645\O,-1.7982740502,-2.519559097,-0.2564522708 
 \C,1.8076410291,0.2914755529,1.2775913548\C,2.8376584666,-0.5323045893 
 ,0.5031129324\O,4.026930742,-0.2699600356,0.5737712011\O,2.2440106931, 
 1.6059661505,1.5051138394\H,2.5692902531,1.9445704665,0.6580757112\C,1 
 .6805890131,-0.3425213551,2.6774987344\H,1.3701430259,-1.387044887,2.6 
 294482273\H,0.9506091682,0.2243635089,3.2608181359\H,2.6557603494,-0.2 
 726933582,3.1656820331\O,0.5964548791,-3.221163262,-0.6067327839\H,-0. 
 3979106636,-3.2497957958,-0.5425318801\C,3.2564302843,-2.5684717373,-0 
 .9721970097\H,4.2287028812,-2.0831955028,-1.0683577055\H,2.8919597365, 
 -2.8570124023,-1.9623716985\H,3.3873596396,-3.4901836394,-0.3948170609 
 \C,-7.2543513399,1.0298763453,0.0913279926\H,-7.8008775108,1.110854010 
 1,-0.8549315914\H,-6.9151149899,2.0260487239,0.3849013215\H,-7.9726582 
 998,0.6707150982,0.8366173075\H,2.8873572777,0.1717019714,-2.067858516 
 4\C,1.8312132541,0.0096936124,-1.8757463856\H,1.3431592576,-0.78491151 
 09,-2.4243688178\C,1.0690155919,1.043233894,-1.3589254951\H,0.01855610 
 88,1.1482023892,-1.6214774957\O,1.7244507577,2.2240381248,-1.082364266 
 3\C,0.8681924524,3.3012930383,-0.6999317985\H,0.3073454364,3.023988349 
 5,0.2011037351\H,0.1515757817,3.4909595323,-1.509393998\C,1.7328741804 
 ,4.5141253271,-0.4418950185\H,1.1038684593,5.3711833628,-0.1890844363\ 
 H,2.3213034466,4.7624721966,-1.3283797674\H,2.4157124558,4.3342248069, 
 0.3933622333\\Version=AS64L-G09RevD.01\State=1-A\HF=-1075.9661372\RMSD 
 =6.439e-09\RMSF=7.305e-07\Dipole=-3.1134839,1.7603694,-0.6959952\Quadr 
 upole=3.1253256,-1.1532915,-1.9720342,-5.6372889,-4.5842957,-2.613618\ 
 PG=C01 [X(C18H24O5)]\\@ 
 
TScDA-2aR 
 1\1\GINC-CA137\FTS\RM062X\6-31G(d,p)\C18H24O5\ROOT\25-Nov-2015\0\\# m0 
 62x/6-31G** opt=(ts,calcfc,noeigen,maxcyc=200) scf=(novaracc,maxcyc=20 
 0) int=ultrafine freq # empiricaldispersion=gd3 scrf=(smd,solvent=Ethy 
 lEthanoate) iop(1/8=1)\\TS Diels-Alder concerted to product regio 2a ( 
 top) - R isomer\\0,1\H,-0.0180103034,-1.5682696255,0.564218462\C,0.778 
 0838345,-0.9332659451,0.1835552758\C,0.4685524271,0.0558675286,-0.7629 
 918252\C,1.5441448639,0.8957167772,-1.1758998934\C,2.8512051615,0.6654 
 349331,-0.7256978845\C,-0.9070874712,0.4477426406,-1.093546517\C,-2.03 
 13190961,-0.4280717448,-0.7174307424\H,-1.8275099462,-1.4273754948,-0. 
 3479185352\C,-3.3004414421,0.0062687658,-0.8291709962\H,-3.4690911787, 
 1.013464643,-1.2094381019\C,-4.4642846376,-0.7733984945,-0.4572436682\ 
 H,-4.2971794632,-1.7830934807,-0.0830067768\C,-5.7122239374,-0.2900971 
 896,-0.5509094579\H,-5.8478908027,0.7236679927,-0.9286954238\O,-1.1309 
 77351,1.5013832054,-1.7198106878\C,2.0972685434,-1.6401992659,0.053742 
 547\C,3.2234812779,-0.659419549,-0.2640621421\O,4.3798904086,-1.036051 
 3916,-0.0889662642\O,2.409517802,-2.302326085,1.261689286\H,3.37181420 
 44,-2.4315282289,1.2299877623\C,2.0200428532,-2.6563317827,-1.09954498 
 86\H,1.8036023705,-2.1646279376,-2.0514700744\H,1.2416953873,-3.394226 
 0437,-0.8895913164\H,2.9845936731,-3.1668296321,-1.1776310047\O,1.3233 
 72414,1.9971003136,-1.8952288212\H,0.3304151036,2.0669257621,-1.980564 
 1925\C,3.9422397938,1.6530584377,-1.0043494189\H,4.3392819473,1.525946 
 9583,-2.0180976504\H,4.7674993411,1.5001402909,-0.3057190349\H,3.57336 
 46719,2.6771389724,-0.9193815518\C,-6.946799277,-1.0381877637,-0.17300 
 81827\H,-7.5021824247,-0.4975260643,0.6014334492\H,-6.7139199226,-2.03 
 87519193,0.1987567056\H,-7.6206855954,-1.132052987,-1.0317589386\H,2.4 
 690243224,1.8624639471,1.4918273068\C,2.3616235413,0.7953848817,1.6514 
 27164\H,3.2401646869,0.2363705924,1.9478127073\C,1.1067199935,0.259428 
 9233,1.8793619793\O,0.0623441918,1.1447307193,1.8642393377\C,-1.164030 
 8669,0.630426579,2.3706064223\H,-1.0445533031,0.3804807166,3.433822967 
 \H,-1.4325856451,-0.2917290732,1.8379644963\C,-2.2262277772,1.68789014 
 15,2.1733299993\H,-3.1990273622,1.3113245893,2.5002679909\H,-2.2951498 
 303,1.9606647489,1.116556026\H,-1.9871105178,2.5867617495,2.7471146332 
 \H,1.0057113368,-0.6263721111,2.5055675737\\Version=AS64L-G09RevD.01\S 
 tate=1-A\HF=-1075.9755891\RMSD=9.470e-09\RMSF=2.574e-06\Dipole=-2.6951 
 235,-0.9435248,1.0622776\Quadrupole=7.7660361,-4.0201536,-3.7458825,4. 
 5393899,-0.174139,3.2361566\PG=C01 [X(C18H24O5)]\\@ 
 
TScDA-1bS 
 1\1\GINC-CA040\FTS\RM062X\6-31G(d,p)\C18H24O5\ROOT\24-Nov-2015\0\\# m0 
 62x/6-31G** opt=(ts,calcfc,noeigen,maxcyc=200) scf=maxcyc=200 int=ultr 
 afine freq # empiricaldispersion=gd3 scrf=(smd,solvent=EthylEthanoate) 
 \\TS Diels-Alder concerted to product regio 1b (bottom) - S isomer\\0, 
 1\H,-0.3078639866,0.9212968229,-0.6614787015\C,0.346327319,0.129665527 
! S7!
 8,-0.3068050617\C,-0.1667809998,-1.1662038922,-0.179004716\C,0.7822571 
 492,-2.2197921041,0.146271712\C,2.1428342735,-2.0032191959,0.272067407 
 2\C,-1.5908352518,-1.4559943421,-0.1335403755\C,-2.5755158501,-0.36838 
 13315,-0.2799838837\H,-2.2390271304,0.6429325154,-0.4788120119\C,-3.89 
 2095816,-0.6200857982,-0.1614546254\H,-4.2056000855,-1.643923471,0.038 
 7719098\C,-4.9282655554,0.3862528834,-0.2850178562\H,-4.6171505354,1.4 
 101533764,-0.4913308099\C,-6.2313340251,0.094117881,-0.1601776528\H,-6 
 .5126585838,-0.9391941033,0.0452683836\O,-1.9997765032,-2.6271405933,0 
 .040749567\C,1.7794612898,0.2790415889,-0.799453148\C,2.7190383003,-0. 
 7341351494,-0.115990555\O,3.9145217434,-0.4681053299,-0.0123994427\O,1 
 .7369777076,-0.0380556199,-2.1965840837\H,1.4001214317,-0.9423564126,- 
 2.2824330102\C,2.3312880523,1.6887560741,-0.7267563719\H,2.5819050933, 
 1.9693034578,0.2958541803\H,3.2450130398,1.727120327,-1.3208678944\H,1 
 .6069484127,2.3957259506,-1.1417668994\O,0.323743201,-3.4455679812,0.3 
 894179514\H,-0.6764548547,-3.3897012087,0.2876353667\C,3.0412961135,-3 
 .1244485497,0.7133883517\H,4.0720394769,-2.7679282799,0.7556076849\H,2 
 .7578252221,-3.5101785409,1.6983676243\H,2.995387401,-3.9705760393,0.0 
 189788962\C,-7.3428042518,1.0822507333,-0.2842019741\H,-7.9332041825,1 
 .118373204,0.6381783833\H,-6.966582747,2.0857891165,-0.4967347502\H,-8 
 .0316139683,0.7902779777,-1.0846653462\C,1.4018607191,0.3160062581,2.2 
 894913703\C,0.4010543782,0.986820406,1.6317885072\O,2.6131679321,0.827 
 5330258,2.4088620558\C,3.6135730474,-0.0336608,2.9945546946\H,3.342666 
 7688,-0.2031916854,4.0424064808\H,3.603672339,-0.9876111238,2.45775450 
 17\C,4.945191205,0.6603784208,2.8587852385\H,5.7281085507,0.0376624046 
 ,3.2986751924\H,5.169605698,0.8165267009,1.8017691994\H,4.9355475738,1 
 .6230841456,3.3759934378\H,0.5598354566,2.027733703,1.3684201019\H,-0. 
 6171055261,0.677059521,1.8290744046\H,1.2371197578,-0.6636164103,2.738 
 6785169\\Version=AS64L-G09RevD.01\State=1-A\HF=-1075.9795462\RMSD=6.42 
 0e-09\RMSF=7.828e-06\Dipole=-2.1053653,1.6209969,1.5705496\Quadrupole= 
 8.2193915,-7.5404825,-0.6789089,-7.3337323,10.9378237,0.1989229\PG=C01 
  [X(C18H24O5)]\\@ 
 
TScDA-1bR 
 1\1\GINC-CA134\FTS\RM062X\6-31G(d,p)\C18H24O5\ROOT\25-Nov-2015\0\\# m0 
 62x/6-31G** opt=(ts,calcfc,noeigen,maxcyc=200) scf=maxcyc=200 int=ultr 
 afine freq # empiricaldispersion=gd3 scrf=(smd,solvent=EthylEthanoate) 
 \\TS Diels-Alder concerted to product regio 1b (bottom) - R isomer\\0, 
 1\H,0.648741236,0.9206698462,1.4398249904\C,-0.1227036707,0.3654075069 
 ,0.9127535266\C,0.246031723,-0.7823900162,0.2002493568\C,-0.8207376588 
 ,-1.673083453,-0.2412368707\C,-2.1591893075,-1.4476564118,0.012528868\ 
 C,1.6064225369,-1.0348099093,-0.2403276845\C,2.6784819885,-0.069112784 
 1,0.067607522\H,2.4575165342,0.8152205469,0.6554994789\C,3.9277863214, 
 -0.2710362697,-0.3892739531\H,4.1208742986,-1.1657189228,-0.9798240368 
 \C,5.040549773,0.6273951995,-0.150994881\H,4.8511204859,1.5214212801,0 
 .4427582557\C,6.269610412,0.3917206434,-0.6334495888\H,6.4291940197,-0 
 .5109414537,-1.2239606381\O,1.8893391324,-2.0645588213,-0.8967164803\C 
 ,-1.4439230073,0.3385703645,1.6749836996\C,-2.5625631954,-0.3560315485 
 ,0.8682600844\O,-3.7325731761,-0.0339170681,1.0640176287\O,-1.18876925 
 99,-0.4549287528,2.8404929838\H,-0.9385331112,-1.3414612845,2.54021990 
 61\C,-1.905845668,1.6827008765,2.2036437851\H,-2.3247368131,2.30828222 
 77,1.4140637987\H,-2.692088494,1.5058930541,2.9379985775\H,-1.07571619 
 43,2.2068396816,2.6860748954\O,-0.4921393248,-2.7510123225,-0.95272221 
 76\H,0.5106146836,-2.7071292895,-1.0700425263\C,-3.2061501579,-2.35208 
 81419,-0.5746825774\H,-4.1813507729,-1.8651985264,-0.5113892264\H,-2.9 
 895317705,-2.5911360035,-1.6207194314\H,-3.2709639727,-3.3056079571,-0 
 .037350349\C,7.4522195496,1.2782745345,-0.4262046548\H,7.8563307482,1. 
 6146982944,-1.387478721\H,7.1960497283,2.1568485046,0.1707493697\H,8.2 
 587248625,0.7355768502,0.0792997611\C,-1.2887971706,1.4403472798,-1.26 
 44221993\C,-0.3153778657,1.9480525362,-0.4468198474\O,-0.9484935791,0. 
 6320533017,-2.2463998591\C,-2.036094532,0.0566459815,-3.003783507\H,-2 
 .8065607109,-0.275065665,-2.2998326527\H,-2.449422039,0.8416841198,-3. 
 645013324\C,-1.4844635054,-1.0941471397,-3.8081972453\H,-2.2901216279, 
 -1.54443046,-4.3939518863\H,-0.7083222533,-0.749298436,-4.4960343522\H 
 ,-1.0635495611,-1.8543233509,-3.1456622\H,-0.5712175715,2.7558274146,0 
 .2263330179\H,0.7141797497,1.8859123524,-0.7845953505\H,-2.3528518116, 
 1.6240415913,-1.108273245\\Version=AS64L-G09RevD.01\State=1-A\HF=-1075 
 .9823391\RMSD=7.808e-09\RMSF=2.441e-06\Dipole=2.0783348,2.2219918,-1.3 
 505933\Quadrupole=3.7475697,-0.4740664,-3.2735033,2.4713957,12.1393436 
 ,-0.610344\PG=C01 [X(C18H24O5)]\\@ 
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Part B: Experimental Studies  
4. General Experimental Procedures 
Unless otherwise specified, proton (1H) and carbon (13C) NMR spectra were recorded 
at 18 °C in base-filtered CDCl3 on a spectrometer operating at 400 MHz for proton 
and 100 MHz for carbon nuclei. 1H NMR data are recorded as follows: chemical shift 
(δ) [multiplicity, coupling constant(s) J (Hz), relative integral] where multiplicity is 
defined as s = singlet; d = doublet; t = triplet; q = quartet; m = multiplet or 
combinations of the above. In relevant cases, the signal due to residual CHCl3 
appearing at δH 7.26 and the central resonance of the CDCl3 “triplet” appearing at δC 
77.0 were used to reference 1H and 13C NMR spectra, respectively. Samples were 
analyzed by infrared spectroscopy (νmax) as thin films on KBr plates. Optical rotations 
were recorded using the sodium D-line (589 nm) in a cell with a path length of 1 dm, 
at the concentrations indicated and in the specified solvent at 22 °C. Specific rotations 
were then calculated in the usual manner. Low- and high-resolution electron impact 
(EI) mass spectra were recorded on a double focusing, triple sector machine. Low- 
and high-resolution ESI mass spectra were recorded on a triple-quadrupole mass 
spectrometer operating in positive ion mode. Melting points are uncorrected. 
Analytical thin layer chromatography (TLC) was performed on aluminum-backed 0.2 
mm thick silica gel 60 F254 plates. Eluted plates were visualized using a 254 nm UV 
lamp and/or by treatment with a suitable dip followed by heating. These dips included 
phosphomolybdic acid/ceric sulfate/sulfuric acid (conc.)/water (37.5 g : 7.5 g : 37.5 g 
: 720 mL), potassium permanganate/potassium carbonate/5% sodium hydroxide 
aqueous solution/water (3 g : 20 g : 5 mL : 300 mL), and p-anisaldehyde or 
vanillin/sulfuric acid (conc.)/ethanol (15 g : 2.5 mL : 250 mL). Flash chromatographic 
separations were carried out following protocols defined by Still et al.6 with silica gel 
60 (40-63 µm) as the stationary phase and using the AR- or HPLC-grade solvents 
indicated. The melting points of solids purified by such means were recorded directly 
(ie after they had crystallized from the concentrated chromatographic fractions). 
Starting materials, reagents, drying agents, and other inorganic salts were generally 
commercially available and were used as supplied. Tetrahydrofuran (THF), methanol 
and dichloromethane were dried using a solvent purification system that is based upon 
a technology originally described by Grubbs et al.7 Where necessary, reactions were 
performed under a nitrogen atmosphere.  
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5. Specific Chemical Transformations 
 
(3aR,7aS)-2,2,4-Trimethyl-3a,7a-dihydrobenzo[d][1,3]dioxole (6) 
 
 
 
A magnetically stirred solution of commercially available diol 5 (10.00 g, 79.3 mmol) 
in 2,2-dimethoxypropane (320 mL) was cooled to −10 °C then treated with p-
toluenesulfonic acid monohydrate (1.60 g, 8.0 mmol). The ensuing mixture was 
stirred at −10 °C for 0.40 h then treated with triethylamine (4.0 mL, 28.6 mmol) 
before being concentrated under reduced pressure (no heating) to provide a brown oil. 
This oil was dissolved in diethyl ether (400 mL) and the resulting solution washed 
with NaOH (1 × 200 mL of a 1 M aqueous solution). The separated aqueous phase 
was extracted with diethyl ether (1 × 200 mL) and the combined organic extracts 
washed with water (2 × 200 mL) before being dried (MgSO4), filtered then 
concentrated under reduced pressure to afford diene 6 (10.60 g, 80%) as a pale-yellow 
oil. This material, the spectral data for which matched these reported previously,8 was 
used immediately in the next step of the reaction sequence. 
 
(3aS,4R,7S)-2,2,7-Trimethyl-3a,4,7,7a-tetrahydro-4,7-ethanobenzo[d][1,3]dioxol-
8-one (7) 
 
 
 
Step i: A magnetically stirred solution of diene 6 (5.29 g, 31.8 mmol) and α-
chloroacrylonitrile (7.62 mL, 95.4 mmol) in benzene (62 mL) maintained under a 
nitrogen atmosphere was heated under reflux for 18 h then cooled and concentrated 
under reduced pressure. The residue thus obtained was subjected to flash column 
chromatography (silica, 0:1 → 1:24 v/v ethyl acetate/40-60 petroleum ether gradient 
O
O
6
O
O
O
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elution) to give a 4:1 mixture of epimeric and previously reported Diels-Alder 
adducts.9  
Step ii: A magnetically stirred solution of the mixture of adducts (3.98 g, 15.7 mmol) 
obtained from Step i in t-BuOH (120 mL) was treated with potassium hydroxide (3.52 
g of pellets, 62.7 mmol) and the resulting mixture heated under reflux for 15 h before 
being cooled then concentrated under reduced pressure. The residue thus obtained 
was diluted with ethyl acetate (200 mL) and the ensuing mixture washed with water 
(1 × 200 mL). The separated aqueous phase was treated with potassium carbonate 
(1.47 g, 10.6 mmol) and extracted with ethyl acetate (2 × 100 mL) then the combined 
organic phases were dried (MgSO4), filtered, and concentrated under reduced 
pressure. The orange oil thus obtained was subjected to flash chromatography (silica, 
0:1 → 1:9 v/v ethyl acetate/40-60 petroleum ether gradient elution) to afford, after 
concentration of the appropriate fractions (Rf  = 0.5 in 1:4 v/v ethyl acetate/40-60 
petroleum ether), ketone 79 (2.91 g, 89%) as a colorless, crystalline solid, mp = 79-80 
°C (lit.9 mp = 81-82 °C). 
1H NMR (400 MHz, CDCl3) δ 6.34 (t, J = 7.1 Hz, 1H), 5.72 (d, J = 8.0 Hz, 1H), 4.49 
(m, 1H), 4.05 (d, J = 7.1 Hz, 1H), 3.17 (m, 1H), 2.12 (dd, J = 18.7 and 3.9 Hz, 1H), 
1.88 (d, J = 18.7 Hz, 1H), 1.37 (s, 3H), 1.30 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ 210.5, 133.7, 131.6, 110.9, 79.9, 79.3, 54.8, 35.6, 
35.3, 25.5, 25.1, 14.5. 
IR (KBr) νmax 2977, 2935, 2887, 1731, 1374, 1208, 1093, 1070 cm–1. 
MS (EI, 70 eV) m/z 208 (M+•, 30%), 193 [(M−CH3•)+, 40], 150 (60), 121 (70), 108 
(100), 105 (72), 100 (70). 
HRMS M+• calcd for C12H16O3 208.1099, found 208.1095.  
Specific rotation [α]D = +313.5 (c = 0.8, CHCl3). 
 
(1S,4R,7S,8S)-7,8-Dihydroxy-1-methylbicyclo[2.2.2]oct-5-en-2-one (8) 
 
 
 
A magnetically stirred solution of compound 7 (2.40 g, 11.5 mmol) in methanol/water 
(126 mL of a 105:21 v/v mixture) was treated with AG-50W-X8 resin (2.86 g of H+ 
OH
O
OH
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form). The ensuing mixture was heated at 65 °C for 16 h then cooled and filtered. The 
retained solids were washed with methanol (40 mL) and the combined filtrates 
concentrated under reduced pressure. The residue thus obtained was diluted with ethyl 
acetate (40 mL) and the separated aqueous phase extracted with ethyl acetate (2 × 40 
mL). The combined organic extracts were dried (MgSO4), filtered and concentrated 
under reduced pressure and the residue thus obtained subjected to flash column 
chromatography (silica, 1:1 → 1:0 v/v ethyl acetate/40-60 petroleum ether gradient 
elution) to give, after concentration of the appropriate fractions (Rf = 0.2 in ethyl 
acetate), diol 8 (1.67 g, 86%) as a colorless, crystalline solid, mp = 122-125 °C. 
1H NMR (400 MHz, CD3OD) δ 6.45 (m, 1H), 5.82 (dd, J = 7.8 and 1.1 Hz, 1H), 3.91 
(s, 1H), 3.45 (s, 1H), 2.93 (broad s, 1H), 2.07 (m, 2H), 1.23 (s, 3H) (signals due to 
hydroxyl group protons not observed). 
13C NMR (100 MHz, CD3OD) δ 213.1, 136.9, 132.6, 82.8, 80.0, 57.2, 40.5, 36.9, 
14.8. 
IR (KBr) νmax 3388, 1714, 1366, 1097, 1033, 744 cm–1. 
MS (ESI, +ve) m/z 191 [(M+Na)+, 100%]. 
HRMS (M+Na)+ calcd for C9H12NaO3 191.0684, found 191.0687. 
Specific rotation [α]D = +487.8 (c = 0.6, CH3OH). 
 
(5S)-5-((1,3-Dioxolan-2-yl)(hydroxy)methyl)-2-methylcyclohex-2-en-1-one (9) 
 
 
 
A magnetically stirred solution of diol 8 (60 mg, 0.36 mmol) in benzene (5 mL) was 
treated with ethylene glycol (240 µL, 4.30 mmol) and p-toluenesulfonic acid 
monohydrate (12 mg, 0.06 mmol). The ensuing mixture was heated under reflux for 
1.5 h then cooled and concentrated under reduced pressure to give a pale-yellow oil. 
This oil was dissolved in ethyl acetate (50 mL) and the solution thus obtained washed 
with NaHCO3 (1 × 50 mL of a saturated aqueous solution). The separated aqueous 
phase was extracted with ethyl acetate (1 × 50 mL) and the combined organic phases 
were then dried (MgSO4), filtered, and concentrated under reduced pressure. The 
O
HO
O
O
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residue thus obtained was subjected to flash column chromatography (silica, 2:3 → 
1:1 v/v ethyl acetate/40-60 petroleum ether elution) to give, after concentration of the 
appropriate fractions (Rf = 0.5 in ethyl acetate), compound 9 (37 mg, 48%) as a 
colorless, crystalline solid, mp = 112-114 °C. 
1H NMR (400 MHz, CDCl3) δ 6.72 (m, 1H), 4.86 (d, J = 4.0 Hz, 1H), 4.10-3.85 
(complex m, 4H), 3.53 (broad s, 1H), 2.70 (m, 1H), 2.45-2.32 (complex m, 4H), 1.93 
(broad s, 1H), 1.77 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 199.8, 144.4, 135.7, 103.6, 73.9, 65.6, 65.4, 39.2, 
37.7, 29.1, 15.9. 
IR (KBr) νmax 3452, 2966, 2923, 2891, 1668, 1152, 1090, 1074, 963 cm–1. 
MS (ESI, +ve) m/z 235 [(M+Na)+, 100%]. 
HRMS (M+Na)+ calcd for C11H16NaO4 235.0946, found 235.0939. 
Specific rotation [α]D = +34.0 (c = 0.5, CHCl3). 
 
(1S,4R,7S,8S)-8-((tert-Butyldimethylsilyl)oxy)-7-hydroxy-1-methylbicyclo[2.2.2]-
oct-5-en-2-one (10) 
 
 
 
A magnetically stirred solution of diol 8 (700 mg, 4.16 mmol) in dry dichloromethane 
(45 mL) maintained under an atmosphere of nitrogen was treated with imidazole (1.13 
g, 16.6 mmol), DMAP (51 mg, 0.42 mmol) and then TBSCl (1.88 g, 12.5 mmol). The 
ensuing mixture was heated under reflux for 16 h then cooled to room temperature 
before bring poured into NH4Cl (100 mL, a saturated aqueous solution) and extracted 
with dichloromethane (3 × 100 mL). The combined organic phases were then dried 
(MgSO4) filtered, and concentrated under reduced pressure. The residue thus obtained 
was subjected to flash column chromatography (silica, 0:1 → 1:4 v/v ethyl acetate/40-
60 petroleum ether elution) to give, after concentration of the appropriate fractions (Rf 
= 0.7 in ethyl acetate), compound 10 (1.04 g, 88%) as a colorless, crystalline solid, 
mp = 71-73 °C. 
OTBS
O
OH
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1H NMR (400 MHz, CDCl3) δ 6.42 (dd, J = 7.7 and 6.3 Hz, 1H), 5.77 (dd, J = 7.7 and 
1.7 Hz, 1H), 3.96 (d, J = 3.2 Hz, 1H), 3.52 (d, J = 3.8 Hz, 1H), 2.86 (broad s, 1H) 
2.14-2.03 (complex m, 2H), 1.96 (m, 1H), 1.27 (s, 3H), 0.89 (s, 9H), 0.11 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ 210.3, 136.0, 130.6, 83.3, 79.8, 55.7, 39.8, 35.9, 25.9, 
18.2, 14.4, −4.5(7), −4.6(1). 
IR (KBr) νmax 3458, 2955, 2930, 2858, 1720, 1256, 1116, 1087, 838, 777 cm–1. 
MS (ESI, +ve) m/z 305 [(M+Na)+, 100%]. 
HRMS (M+Na)+ calcd for C15H26NaO3Si 305.1549, found 305.1549. 
Specific rotation [α]D = +331.2 (c = 0.8, CHCl3). 
 
(1R,2S,3S,4R,6S)-3-((tert-Butyldimethylsilyl)oxy)-1-methylbicyclo[2.2.2]oct-7-en-
e-2,6-diol (11) and (1R,2S,3S,4R,6R)-3-((tert-Butyldimethylsilyl)oxy)-1-
methylbicyclo[2.2.2]oct-7-ene-2,6-diol (12) 
 
 
 
A magnetically stirred solution of ketone 10 (2.82 g, 10.0 mmol) in dry THF (140 
mL) maintained under an atmosphere of nitrogen was cooled to −78 °C then treated, 
dropwise over 1 h, with DIBAL-H (60 mL of a 1 M solution in THF, 60.0 mmol). The 
ensuing mixture was stirred at −78 °C for 1 h before being warmed to 0 °C and 
quenched by the slow addition of ice (CAUTION! EXOTHERMIC REACTION). 
The ensuing mixture was poured into HCl (40 mL of a 1 M aqueous solution) and 
extracted with ethyl acetate (3 × 200 mL). The combined organic phases were then 
dried (MgSO4), filtered and concentrated under reduced pressure. The residue thus 
obtained was subjected to flash column chromatography (silica, 1:19 → 3:7 v/v ethyl 
acetate/40-60 petroleum ether gradient elution) to give two fractions, A and B.  
Concentration of fraction A (Rf = 0.5 in 1:4 v/v ethyl acetate/40-60 petroleum 
ether) afforded compound 11 (470 mg, 15%) as a colorless, crystalline solid, mp = 
83-85 °C. 
1H NMR (400 MHz, CDCl3) δ 6.14 (dd, J = 8.0 and 6.2 Hz, 1H), 5.75 (dd, J = 8.0 and 
1.2 Hz, 1H), 3.85 (m, 1H), 3.63 (m, 1H), 3.32 (m, 1H), 3.06 (m, 1H), 2.62 (t, J = 6.8 
OTBS
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Hz, 1H), 2.48 (broads s, 1H), 2.10 (m, 1H), 1.55 (s, 1H), 1.39 (s, 3H), 0.88 (s, 9H), 
0.10 (s, 3H), 0.09 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 134.3, 134.2, 85.8, 80.6, 74.2, 43.3, 38.3, 35.2, 26.0, 
18.5, 18.3, −4.4(9), −4.5(4). 
IR (KBr) νmax 3325, 2953, 2929, 2857, 1463, 1257, 1112, 1083, 1060, 836, 776 cm–1. 
MS (ESI, +ve) m/z 307 [(M+Na)+, 100%]. 
HRMS (M+Na)+ calcd for C15H28NaO3Si 307.1705, found 307.1705. 
Specific rotation [α]D = +89.2 (c = 1.3, CHCl3). 
Concentration of fraction B (Rf = 0.1 in 1:4 v/v ethyl acetate/40-60 petroleum 
ether) afforded compound 12 (2.31 g, 83%) as a clear, colorless oil.  
1H NMR (400 MHz, CDCl3) δ 6.33 (m, 1H), 5.76 (d, J = 8.1 Hz, 1H), 3.93 (d, J = 7.2 
Hz, 1H), 3.54 (s, 1H), 3.25 (s, 1H), 2.49 (broad s, 1H), 2.15-2.03 (complex m, 1H), 
1.30 (s, 3H), 1.22 (m, 1H), 0.86 (s, 9H), 0.05 (s, 6H) (signals due to hydroxyl group 
protons not observed). 
13C NMR (100 MHz, CDCl3) δ 134.8, 132.4, 83.2, 79.8, 68.4, 45.5, 39.2, 36.8, 26.0, 
18.2, 18.0, −4.5, −4.6. 
IR (KBr) νmax 3413, 2955, 2929, 2857, 1252, 1111, 1092, 1055, 934, 859, 836, 775, 
718 cm–1. 
MS (EI, 70 eV) m/z 284 (M+•, 3%), 227 (35), 165 (56), 135 (55), 117 (82), 75 (100). 
HRMS M+• calcd for C15H28O3Si 284.1808, found 284.1807. 
Specific rotation [α]D = +80.3 (c = 0.6, CHCl3). 
 
(1R,2S,3S,4R,6R)-3-((tert-Butyldimethylsilyl)oxy)-1-methylbicyclo[2.2.2]oct-7-
ene-2,6-diyl Diacetate (13) 
 
 
 
A magnetically stirred solution of compound 12 (1.70 g, 6.0 mmol) in dry 
dichloromethane (212 mL) maintained at 0 °C under an atmosphere of nitrogen was 
treated with DMAP (58 mg, 0.5 mmol), pyridine (10 mL, 123.6 mmol) and acetic 
anhydride (5.5 mL, 58.6 mmol). After a further 1 h at 0 °C the reaction mixture was 
warmed to 22 °C and then allowed to stir at this temperature for 16 h before being 
OTBS
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poured into water (200 mL) and extracted with dichloromethane (3 × 200 mL). The 
combined organic phases were dried (MgSO4), filtered and concentrated under 
reduced pressure. The residue thus obtained was subjected to flash column 
chromatography (silica, 0:1 → 1:9 v/v ethyl acetate/40-60 petroleum ether gradient 
elution) to give, after concentration of the appropriate fractions (Rf = 0.5 in 3:7 v/v 
ethyl acetate/40-60 petroleum ether), compound 13 (2.16 g, 98%) as a clear, colorless 
oil. 
1H NMR (400 MHz, CDCl3) δ 6.33 (m, 1H), 5.83 (d, J = 8.2 Hz, 1H), 4.97 (dd, J = 
8.2 and 2.6 Hz, 1H), 4.60 (d, J = 1.6 Hz, 1H), 3.60 (m, 1H), 2.52 (m, 1H), 2.21 (m, 
1H), 2.08 (s, 3H), 2.00 (s, 3H), 1.24 (m, 1H), 1.09 (s, 3H), 0.84 (s, 9H), 0.00 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ 171.3, 170.3, 133.6, 132.2, 82.9, 77.3, 71.8, 42.6, 
38.8, 34.4, 25.8, 21.3, 21.1, 18.1, 17.7, −4.8, −4.9. 
IR (KBr) νmax 2955, 2858, 1743, 1372, 1228, 1114, 1096, 1061, 858, 838, 777 cm–1. 
MS (EI, 70 eV) m/z 368 (M+•, <1%), 311 (16), 269 (22), 251 (24), 209 (30), 174 (33), 
159 (32), 135 (65), 117 (100), 93 (60), 75 (53), 73 (45). 
HRMS M+• calcd for C19H32O5Si 368.2019, found 368.2026. 
Specific rotation [α]D = +22.1 (c = 0.4, CHCl3). 
 
(1R,2S,3S,4R,6R)-3-Hydroxy-1-methylbicyclo[2.2.2]oct-7-ene-2,6-diyl Diacetate 
(14) 
 
 
 
A magnetically stirred solution of compound 13 (2.13 g, 5.8 mmol) in dry THF (187 
mL) maintained at 0 °C under an atmosphere of nitrogen was treated, dropwise over 
0.33 h, with TBAF (14.4 mL of a 1 M solution in THF, 14.4 mmol). After a further 
0.66 h at 0 °C the reaction mixture was warmed to 22 °C and allowed to stir at this 
temperature for 1 h then re-cooled to 0 °C and treated with NaHCO3 (200 mL of a 
saturated aqueous solution). The ensuing mixture was extracted with ethyl acetate (3 
× 200 mL) and the combined organic phases dried (MgSO4), filtered, and 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
column chromatography (silica, 3:7 v/v ethyl acetate/40-60 petroleum ether elution) 
OH
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to give, after concentration of the appropriate fractions (Rf = 0.5 in ethyl acetate), 
compound 14 (1.34 g, 91%) as a colorless, crystalline solid, mp = 82-86 °C. 
1H NMR (400 MHz, CDCl3) δ 6.37 (m, 1H), 5.81 (d, J = 8.2 Hz, 1H), 4.98 (dd, J = 
8.2 and 2.9 Hz, 1H), 3.90 (s, 1H), 3.48 (s, 1H), 3.18 (s, 1H), 2.66 (broad s, 1H), 2.18 
(m, 1H), 2.09 (s, 3H), 1.98 (s, 3H), 1.23 (d, J = 14.2 Hz, 1H), 1.17 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 172.8, 171.1, 133.5, 132.3, 85.6, 76.9, 71.2, 41.4, 
36.5, 34.5, 21.2, 21.0, 17.7. 
IR (KBr) νmax 3493, 2975, 1733, 1374, 1249, 1055, 1028, 728 cm–1. 
MS (EI, 70 eV) m/z 254 (M+•, 5%), 134 (32), 108 (100), 93 (60), 92 (43). 
HRMS M+• calcd for C13H18O5 254.1154, found 254.1155. 
Specific rotation [α]D = −99.2 (c = 0.3, CHCl3). 
 
 (1R,2S,4R,6R)-1-Methyl-3-oxobicyclo[2.2.2]oct-7-ene-2,6-diyl Diacetate (15) 
 
 
 
A magnetically stirred solution of alcohol 14 (2.00 g, 7.9 mmol) in dry 
dichloromethane (200 mL) maintained at 0 °C under an atmosphere of nitrogen was 
treated with pyridine (4 mL, 49.5 mmol) then the Dess-Martin periodinane (6.00 g, 
14.1 mmol). After a further 0.66 h at 0 °C the reaction mixture was warmed to 22 °C, 
stirred at this temperature for 3 h then poured into water (200 mL) and extracted with 
dichloromethane (3 × 200 mL). The combined organic phases were washed with 
NaOH (100 mL of a 1 M aqueous solution) and HCl (100 mL of a 1 M aqueous 
solution) before being dried (MgSO4), filtered, and concentrated under reduced 
pressure. The residue thus obtained was subjected to flash column chromatography 
(silica, 3:17 v/v ethyl acetate/40-60 petroleum ether elution) to give, after 
concentration of the appropriate fractions (Rf = 0.3 in 3:7 v/v ethyl acetate/40-60 
petroleum ether), ketone 15 (1.89 g, 95%) as a colorless, crystalline solid, mp = 101-
104 °C. 
1H NMR (400 MHz, CDCl3) δ 6.38 (m, 1H), 6.07 (dd, J = 8.2 and 0.7 Hz, 1H), 5.15 
(dd, J = 8.2 and 3.0 Hz, 1H), 4.90 (s, 1H), 3.14 (broad s, 1H), 2.52 (m, 1H), 2.13 (s, 
3H), 2.02 (s, 3H), 1.59 (m, 1H), 1.20 (s, 3H). 
OAc
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13C NMR (100 MHz, CDCl3) δ 204.0, 170.8, 170.1, 136.6, 129.6, 72.1, 71.4, 46.8, 
45.4, 35.5, 21.1, 20.7, 17.2. 
IR (KBr) νmax 2917, 1737, 1372, 1223, 1037, 744 cm–1. 
MS (ESI, +ve) m/z 275 [(M+Na)+, 45%], 249 (100), 231 (98), 133 (20). 
HRMS m/z (M+Na)+ calcd for C13H16NaO5 275.0895, found 275.0895. 
Specific rotation [α]D = +0.9 (c = 0.9, CHCl3). 
 
 (1S,2R,4R,7S,8R)-7,8-Dihydroxy-1,8-dimethylbicyclo[2.2.2]oct-5-en-2-yl Acetate 
(16) 
 
 
 
A magnetically stirred solution of ketone 15 (2.50 g, 9.9 mmol) in dry THF (200 mL) 
maintained at 0 °C under an atmosphere of nitrogen was treated, in one portion, with 
methylmagnesium bromide solution (10.7 mL of a 3 M solution in diethyl ether, 32.2 
mmol). The ensuing mixture was stirred at 0 °C for 0.33 h then quenched by the slow 
addition of ice (CAUTION! EXOTHERMIC REACTION). The ensuing mixture was 
poured into NH4Cl (200 mL of a saturated aqueous solution) and extracted with ethyl 
acetate (3 × 200 mL). The combined organic phases were then dried (MgSO4), filtered, 
and concentrated under reduced pressure. The residue thus obtained was subjected to 
flash column chromatography (silica, 1:4 v/v ethyl acetate/40-60 petroleum ether 
elution) to give, after concentration of the appropriate fractions (Rf = 0.3 in 1:1 v/v 
ethyl acetate/40-60 petroleum ether), compound 16 (1.90 mg, 85%) as a colorless, 
crystalline solid, mp = 124-126 °C. 
1H NMR (400 MHz, CDCl3) δ 6.32 (dd, J = 8.2 and 6.7 Hz, 1H), 5.74 (d, J = 8.2 Hz, 
1H), 5.07 (dd, J = 8.2 and 3.5 Hz, 1H), 3.05 (s, 1H), 2.71 (m, 1H), 2.48 (m, 1H), 2.31 
(broad s, 2H), 2.00 (s, 3H), 1.24 (s, 6H), 1.00 (m, 1H). 
13C NMR (100 MHz, CDCl3) δ 171.4, 134.5, 134.2, 77.4, 71.7, 69.7, 44.1, 43.0, 32.2, 
30.6, 21.3, 18.0. 
IR (KBr) νmax 3418, 2967, 1735, 1712, 1369, 1248, 1146, 1051, 1033, 937, 730 cm–1. 
MS (ESI, +ve) m/z 475 [(2M+Na)+, 30%], 249 [(M+Na)+, 100]. 
HRMS (M+Na)+ calcd for C12H18NaO4 249.1103, found 249.1105. 
OH
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Specific rotation [α]D = −60.3 (c = 0.6, CHCl3). 
 
(1R,2R,3S,4R,5R)-2,4-Dimethylbicyclo[2.2.2]oct-7-ene-2,3,5-triol (17) 
 
 
 
A magnetically stirred solution of diol 16 (960 mg, 4.2 mmol) in methanol (97 mL) 
was treated with potassium carbonate (586 mg, 4.2 mmol). The ensuing mixture was 
heated under reflux for 16 h then cooled and concentrated under reduced pressure. 
The residue thus obtained was treated with water (30 mL) and extracted with ethyl 
acetate (3 × 100 mL). The combined organic phases were then dried (MgSO4), filtered 
and concentrated under reduced pressure and the residue thus obtained was subjected 
to flash column chromatography (silica, 7:3 v/v ethyl acetate/40-60 petroleum ether 
elution). Concentration of the appropriate fractions (Rf = 0.4 in ethyl acetate) then 
gave triol 17 (620 mg, 79%) as a white, crystalline solid, mp = 180-183 °C. 
1H NMR (400 MHz, CD3OD) δ 6.30 (m, 1H), 5.67 (d, J = 8.2 Hz, 1H), 3.91 (m, 1H), 
2.94 (s, 1H), 2.58 (m, 1H), 2.38 (m, 1H), 1.26 (s, 3H), 1.15 (s, 3H), 0.96 (dt, J = 13.2 
and 3.2 Hz, 1H) (signals due to hydroxyl group protons not observed). 
13C NMR (100 MHz, CD3OD) δ 135.6, 135.4, 78.6, 70.3, 68.2, 46.7, 44.6, 34.9, 30.7, 
18.6. 
IR (KBr) νmax 3362, 3246, 2955, 1372, 1286, 1140, 1064, 1030, 967, 919, 729 cm–1. 
MS (ESI, +ve) m/z 265 (100%), 207 [(M+Na)+, 95]. 
HRMS (M+Na)+ calcd for C10H16NaO3 207.0997, found 207.0996. 
Specific rotation [α]D = −10.8 (c = 0.1, CHCl3). 
 
(3aS,4R,7R,9R)-2,2,4,7a-Tetramethyl-3a,4,7,7a-tetrahydro-4,7-ethanobenzo[d]- 
[1,3]dioxol-9-ol (18) 
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A magnetically stirred solution of triol 17 (1.40 g, 7.6 mmol) and p-toluenesulfonic 
acid monohydrate (217 mg, 1.1 mmol) in dichloromethane (370 mL) maintained at 0 
°C was treated with 2,2-dimethoxypropane (4.7 mL, 38.0 mmol). The ensuing 
mixture was stirred at 0 °C for 2 h then warmed to 22 °C, stirred at this temperature 
for 1 h then quenched with triethylamine (57 µL, 4.1 mmol). The ensuing mixture 
was concentrated under reduced pressure and the residue thus obtained poured into 
water (100 mL) and extracted with ethyl acetate (3 × 200 mL). The combined organic 
phases were then dried (MgSO4), filtered, and concentrated under reduced pressure. 
The residue thus obtained was subjected to flash column chromatography (silica, 1:4 
v/v ethyl acetate/40-60 petroleum ether elution) to give, after concentration of the 
appropriate fractions (Rf = 0.4 in 1:1 v/v ethyl acetate/40-60 petroleum ether), alcohol 
18 (1.55 g, 91%) as a white, crystalline solid, mp = 122-124 °C. 
1H NMR (400 MHz, CDCl3) δ 6.42 (t, J = 8.0 Hz, 1H), 5.68 (d, J = 8.0 Hz, 1H), 4.05 
(d, J = 8.0 Hz, 1H), 3.60 (s, 1H), 2.63 (dd, J = 14.0 and 8.1 Hz, 1H), 2.51 (broad s, 
1H), 1.45 (s, 3H), 1.39 (s, 3H), 1.38 (s, 3H), 1.35 (s, 3H), 1.26 (broad s, 1H), 1.01 (d, 
J = 14.1 Hz, 1H). 
13C NMR (100 MHz, CDCl3) δ 136.6, 133.2, 111.3, 87.3, 83.9, 69.6, 45.5, 42.8, 34.0, 
28.9, 27.2(8), 27.2(5), 19.1. 
IR (KBr) νmax 3388, 2967, 2945, 1368, 1207, 1121, 1040, 730 cm–1. 
MS (EI) m/z 224 (M+•, <1%), 209 [(M−CH3•)+, 10], 166 (38), 123 (77), 114 (100), 
107 (53), 95 (51). 
HRMS (M−CH3•)+ calcd for C12H17O3 209.1178, found 209.1180. 
Specific rotation [α]D = −3.4 (c = 0.4, CHCl3). 
 
(3aS,4R,7R,9R)-9-Ethoxy-2,2,4,7a-tetramethyl-3a,4,7,7a-tetrahydro-4,7-ethano- 
benzo[d][1,3]dioxole (19) 
 
 
 
Sodium hydride (936 mg of a 60% dispersion in mineral oil, 23.4 mmol) was added to 
a magnetically stirred solution of alcohol 18 (350 mg, 1.6 mmol) in THF (18 mL) 
O
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maintained at room temperature under an atmosphere of nitrogen. The resulting 
mixture was treated with iodoethane (753 µL, 9.4 mmol) then stirred at 22 °C for 18 h 
before being cooled to 0 °C then quenched by the slow addition of ice (CAUTION! 
EXOTHERMIC REACTION AND POSSIBILITY OF HYDROGEN EVOLUTION). 
The ensuing mixture was poured into water (100 mL) and extracted with ethyl acetate 
(3 × 100 mL). The combined organic phases were then dried (MgSO4), filtered, and 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
column chromatography (silica, 1:19 v/v ethyl acetate/40-60 petroleum ether elution) 
to give, after concentration of the appropriate fractions (Rf = 0.6 in 3:7 v/v ethyl 
acetate/40-60 petroleum ether), alcohol 19 (358 mg, 91%) as a clear, colorless oil. 
1H NMR (400 MHz, CDCl3) δ 6.32 (m, 1H), 5.70 (d, J = 8.1 Hz, 1H), 3.72 (m, 1H), 
3.54 (m, 2H), 3.34 (m, 1H), 2.51 (m, 1H), 2.44 (m, 1H), 1.46 (s, 3H), 1.39 (s, 3H), 
1.34 (s, 3H), 1.33 (s, 3H), 1.17-1.10 (complex m, 4H). 
13C NMR (100 MHz, CDCl3) δ 134.6, 134.1, 111.1, 87.5, 83.8, 77.0, 64.9, 44.7, 42.7, 
31.1, 29.0, 27.5, 27.4, 19.1, 15.6. 
IR (KBr) νmax 2975, 2933, 2874, 1372, 1243, 1207, 1120, 1095, 1054, 872, 715 cm–1. 
MS (ESI, +ve) m/z 275 [(M+Na)+, 85%], 209 (100). 
HRMS (M+Na)+ calcd for C15H24NaO3 275.1623, found 275.1624. 
Specific rotation [α]D = −35.4 (c = 0.3, CHCl3). 
 
(1aR,2S,2aS,6R,6aS,8R)-8-Ethoxy-2,4,4,5a-tetramethylhexahydro-2,6-ethano- 
oxireno[2',3':4,5]benzo[1,2-d][1,3]dioxole (20) 
 
 
 
A magnetically stirred solution of compound 19 (1.06 g, 4.2 mmol) in 
dichloromethane (289 mL) maintained at 22 °C was treated with m-chloroperbenzoic 
acid (6.20 g of approx. 77% - technical grade - material, 25.2 mmol). The resulting 
mixture was stirred at 22 °C for 16 h then poured into water (200 mL) and extracted 
with ethyl acetate (3 × 200 mL). The combined organic phases were washed with 
NaOH (1 × 50 mL of a 1 M aqueous solution) before being dried (MgSO4), filtered 
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and concentrated under reduced pressure. The residue thus obtained was subjected to 
flash column chromatography (silica, 3:17 v/v ethyl acetate/40-60 petroleum ether 
elution) to give, after concentration of the appropriate fractions (Rf = 0.3 in 3:7 v/v 
ethyl acetate/40-60 petroleum ether), epoxide 20 (970 mg, 86%) as a white, 
crystalline solid, mp = 57-59 °C. 
1H NMR (400 MHz, CDCl3) δ 3.81 (s, 1H), 3.57 (m, 1H), 3.41 (m, 2H), 3.25 (m, 1H), 
2.83 (m, 1H), 2.30 (m, 1H), 2.09 (m, 1H), 1.54 (m, 1H), 1.50 (s, 3H), 1.44 (s, 6H), 
1.29 (s, 3H), 1.18 (t, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 111.1, 86.6, 82.6, 74.8, 66.2, 54.6, 53.2, 42.7, 40.7, 
28.2, 28.1, 27.3, 26.6, 19.2, 15.7. 
IR (KBr) νmax 2977, 2936, 2871, 1375, 1208, 1121, 1100, 1069, 1019, 869 cm–1. 
MS (ESI, +ve) m/z 559 [(2M+Na)+, 40%], 291 [(M+Na)+, 100]. 
HRMS (M+Na)+ calcd for C15H24NaO4 291.1572, found 291.1572. 
Specific rotation [α]D = −76.7 (c = 0.6, CHCl3). 
 
(3aS,4R,6R,7R,9R)-9-Ethoxy-2,2,4,7a-tetramethylhexahydro-4,7-ethanobenzo- 
[d][1,3]dioxol-6-ol (21) 
 
 
 
A magnetically stirred solution of epoxide 20 (1.00 g, 3.7 mmol) in THF (48 mL) 
maintained under nitrogen was cooled to 0 °C then treated, dropwise over 0.25 h, with 
LiEt3BH (37 mL of a 1 M solution in THF, 37 mmol). The ensuing mixture was 
stirred at 0 °C for 0.5 h before being warmed to 22 °C and stirred at this temperature 
for 16 h. The resulting mixture was re-cooled to 0 °C then quenched by the slow 
addition of ice (CAUTION! EXOTHERMIC REACTION AND POSSIBILITY OF 
HYDROGEN EVOLUTION) before being diluted with ethyl acetate (20 mL). The 
ensuing mixture was poured into water (200 mL) and extracted with ethyl acetate (3 × 
200 mL). The combined organic phases were then dried (MgSO4), filtered and 
concentrated under reduced pressure and the ensuing light-yellow oil subjected to 
flash chromatography (silica, 1:9 → 3:17 v/v ethyl acetate/40-60 petroleum ether 
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gradient elution). Concentration of the appropriate fractions (Rf = 0.6 in 3:7 v/v ethyl 
acetate/40-60 petroleum ether) then gave alcohol 21 (840 mg, 84%) as a clear, 
colorless oil. 
1H NMR (400 MHz, CDCl3) δ 3.84 (m, 1H), 3.69 (m, 1H), 3.51 (s, 1H), 3.43-3.34 
(complex m, 2H), 2.14 (m, 1H), 1.95 (m, 1H), 1.75 (dd, J = 15.0 and 4.3 Hz, 1H), 
1.61-1.57 (complex m, 2H), 1.48-1.42 (complex m, 4H), 1.39 (s, 3H), 1.37 (s, 3H), 
1.20 (t, J = 7.0 Hz, 3H), 1.07 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 108.5, 86.8, 80.7, 75.6, 65.7, 64.9, 43.0, 38.1, 35.4, 
26.8, 26.5, 26.3, 23.1, 22.0, 15.6. 
IR (KBr) νmax 3501, 2975, 2871, 1378, 1206, 1056, 1011, 1081, 870 cm–1. 
MS (ESI, +ve) m/z 293 [(M+Na)+, 100%]. 
HRMS (M+Na)+ calcd for C15H26NaO4 293.1729, found 293.1725. 
Specific rotation [α]D = +4.6 (c = 0.7, CHCl3). 
 
 (1S,2S,3R,4R,5R,7R)-7-Ethoxy-1,3-dimethylbicyclo[2.2.2]octane-2,3,5-triol (22) 
 
 
 
A magnetically stirred solution of compound 21 (250 mg, 0.9 mmol) in 
methanol/water (9.5 mL of an 4:1 v/v mixture) maintained at 22 °C was treated with 
AG-50W-X8 resin (212 mg of H+ form) and the ensuing mixture heated at 65 °C for 
40 h then cooled and filtered. The solids thus retained were washed with methanol (20 
mL) and the combined filtrates concentrated under reduced pressure to give a light-
yellow oil. This material was subjected to flash column chromatography (silica, 
1:1→1:0 v/v ethyl acetate/40-60 petroleum ether gradient elution) and thus affording 
two fractions, A and B.  
Concentration of the fraction A (Rf = 0.7 in 1:1 v/v ethyl acetate/40-60 
petroleum ether) gave compound 21 (75 mg, 30% recovery) as a clear, colorless oil 
that was identical, in all respects, with an authentic sample. 
Concentration of the fraction B (Rf = 0.1 in 1:1 v/v ethyl acetate/40-60 
petroleum ether) gave compound 22 (126 mg, 59% or 84% brsm) as a colorless, 
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crystalline solid, mp = 87-90 °C. 
1H NMR (400 MHz, CDCl3) δ 3.89 (broad s, 1H), 3.68 (m, 1H), 3.40 (m, 2H), 3.10 
(m, 1H), 3.06 (s, 1H), 2.89 (d, J = 4.1 Hz, 1H), 2.57 (s, 1H), 2.14 (m, 1H), 1.81 (m, 
2H), 1.63-1.50 (complex m, 2H), 1.31 (s, 3H), 1.19 (t, J = 7.0 Hz, 3H), 1.03 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 79.4, 74.9, 69.9, 65.6, 65.0, 44.6, 39.6, 36.3, 28.9, 
23.0, 21.1, 15.6. 
IR (KBr) νmax 3351, 2969, 2929, 1455, 1371, 1068, 1047, 1007, 973 cm–1. 
MS (ESI, +ve) m/z 253 [(M+Na)+, 100%], 167 (20). 
HRMS (M+Na)+ calcd for C12H22NaO4 253.1416, found 253.1412. 
Specific rotation [α]D = −123.3 (c = 1.1, MeOH). 
 
(3aS,4R,5R,6S,7R,9R)-9-Ethoxy-2,2,4,7a-tetramethylhexahydro-4,7-ethanobenzo- 
[d][1,3]dioxole-5,6-diol (23) and (3aS,4R,5S,6R,7R,9R)-9-Ethoxy-2,2,4,7a-tetra 
methylhexahydro-4,7-ethanobenzo[d][1,3]dioxole-5,6-diol (24) 
 
 
 
A magnetically stirred solution of compound 19 (1.10 g, 4.4 mmol) in 
acetonitrile/water (44 mL of a 4:1 v/v mixture) maintained at 22 °C was treated with 
4-methylmorpholine N-oxide (1.02 g, 8.7 mmol), citric acid (2.50 g, 13.0 mmol) and 
potassium osmate dihydrate (77 mg, 0.2 mmol). The ensuing mixture was stirred at 22 
°C for 14 h then quenched with Na2SO3 (10 mL of a saturated aqueous solution) 
before being poured into water (50 mL) and extracted with ethyl acetate (3 × 50 mL). 
The combined organic phases were then dried (MgSO4) filtered, and concentrated 
under reduced pressure. The residue thus obtained was subjected to flash column 
chromatography (silica, 1:9→3:7 v/v ethyl acetate/40-60 petroleum ether gradient 
elution) to give two fractions, A and B. 
Concentration of fraction A (Rf = 0.4 in 3:7 v/v ethyl acetate/petroleum ether) 
afforded diol 24 (849 mg, 68%) as a white, crystalline solid, mp = 98-101 °C.  
1H NMR (400 MHz, CDCl3) δ 4.20 (m, 1H), 4.06-4.02 (complex m, 2H), 3.54 (m, 
1H), 3.38 (d, J = 8.3 Hz, 1H), 3.26 (m, 1H), 2.52 (m, 1H), 2.35 (complex m, 1H), 2.25 
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(m, 1H), 1.87 (s, 1H), 1.58 (s, 3H), 1.43 (s, 3H), 1.41 (s, 3H), 1.28 (s, 3H), 1.25 (m, 
1H), 1.12 (t, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 107.4, 82.5, 80.0, 75.3, 70.1, 68.6, 64.7, 44.2, 42.2, 
29.6, 27.9, 26.8, 26.7, 18.8, 15.6. 
IR (KBr) νmax 3406, 2975, 2936, 1379, 1206, 1183, 1097, 1051 cm–1. 
MS (ESI, +ve) m/z 309 [(M+Na)+, 100%], 307 (60). 
HRMS (M+Na)+ calcd for C15H26NaO5 309.1678, found 309.1679. 
Specific rotation [α]D = −58.1 (c = 0.2, CHCl3). 
Concentration of fraction B (Rf = 0.2 in 3:7 v/v ethyl acetate/petroleum ether) 
afforded diol 23 (270 mg, 22%) as a clear, pale-yellow oil. 
1H NMR (400 MHz, CDCl3) δ 3.98 (m, 1H), 3.66 (m, 1H), 3.52 (d, J = 8.7 Hz, 1H), 
3.48 (s, 1H), 3.33-3.26 (complex m, 2H), 2.14-2.02 (complex m, 2H), 1.87 (broad d, J 
= 14.2 Hz, 1H), 1.42 (s, 3H), 1.38 (s, 6H), 1.20 (s, 3H), 1.16 (t, J = 7.0 Hz, 3H) 
(signals due to hydroxyl group protons not observed). 
13C NMR (100 MHz, CDCl3) δ 109.1, 85.9, 79.5, 76.9, 69.9, 65.3, 65.1, 42.2, 41.1, 
26.8, 26.7, 26.6, 22.0, 18.3, 15.5. 
IR (KBr) νmax 3471, 2980, 1451, 1378, 1244, 1209, 1177, 1075, 1044, 874 cm–1. 
MS (ESI, +ve) m/z 309 [(M+Na)+, 100%]. 
HRMS (M+Na)+ calcd for C15H26NaO5 309.1678, found 309.1678. 
Specific rotation [α]D = −42.9 (c = 0.1, CHCl3). 
 
(3aS,4S,4aS,6S,7aR,8R,10R)-10-Ethoxy-6-(4-methoxyphenyl)-2,2,4,8a-tetra- 
methylhexahydro-4,8-ethanobenzo[1,2-d:4,5-d']bis([1,3]dioxole) (25) 
 
 
 
A magnetically stirred solution of diol 24 (560 mg, 2.0 mmol) and p-
methoxybenzaldehyde dimethyl acetal (400 µL, 2.1 mmol) in THF (18 mL) 
maintained under a nitrogen atmosphere was cooled to 0 °C then treated with p-
toluenesulfonic acid monohydrate (14 mg, 0.08 mmol). The ensuing mixture was 
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stirred at 0 °C for 4 h then quenched with triethylamine (40 µL) before being 
concentrated under reduced pressure. The residue thus obtained was dissolved in ethyl 
acetate (50 mL) and the resulting solution washed with water (1 × 50 mL). The 
separated aqueous phase was extracted with ethyl acetate (3 × 50 mL) and the 
combined organic phases were then dried (MgSO4), filtered and concentrated under 
reduced pressure to afford a light-yellow oil. Subjection of this material to flash 
chromatography (silica, 1:19→1:9 v/v ethyl acetate/40-60 petroleum ether gradient 
elution) and concentration of the appropriate fractions (Rf = 0.6 in 3:7 v/v ethyl 
acetate/40-60 petroleum ether) gave compound 25 (704 mg, 89%) as a clear, colorless 
oil. 
1H NMR (400 MHz, CDCl3) δ 7.43 (d, J = 8.7 Hz, 2H), 6.90 (d, J = 8.7 Hz, 2H), 5.60 
(s, 1H), 4.37-4.30 (complex m, 2H), 4.07 (s, 1H), 3.81 (s, 3H), 3.61-3.49 (complex m, 
2H), 3.33 (m, 1H), 2.48 (m, 1H), 2.25 (m, 1H), 1.48 (s, 3H), 1.43 (s, 3H), 1.42 (s, 
3H), 1.35 (s, 3H), 1.16 (t, J = 7.0 Hz, 3H), 1.10 (m, 1H). 
13C NMR (100 MHz, CDCl3) δ 160.2, 128.2, 128.0, 113.7, 107.8, 101.6, 82.6, 80.0, 
77.9, 76.1, 74.2, 65.2, 55.4, 41.5, 41.4, 29.2, 28.0, 27.2, 17.6, 15.6 (one signal 
obscured or overlapping). 
IR (KBr) νmax 2975, 2933, 1616, 1518, 1248, 1172, 1151, 1054, 1033, 827 cm–1. 
MS (ESI, +ve) m/z 427 [(M+Na)+, 100%], 405 [(M+H)+, 35], 309 (50), 177 (30), 61 
(90). 
HRMS (M+Na)+ calcd for C23H32NaO6 427.2097, found 427.2098. 
Specific rotation [α]D = −110.3 (c = 1.9, CHCl3). 
 
(3aS,4S,5S,6R,7R,9R)-9-Ethoxy-5-((4-methoxybenzyl)oxy)-2,2,4,7a-tetramethyl- 
hexahydro-4,7-ethanobenzo[d][1,3]dioxol-6-ol (26) 
 
!
 
A magnetically stirred solution of acetal 25 (1.60 g, 4.0 mmol) in dichloromethane 
(42 mL) maintained under a nitrogen atmosphere was cooled to −78 °C then treated 
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with DIBAL-H (29.7 mL of a 1 M solution in hexane, 29.7 mmol). The resulting 
mixture was stirred at −78 °C for 1 h then at 0 °C for 1 h and after which time it was 
quenched with iced-water (50 mL)  (CAUTION! EXOTHERMIC REACTION AND 
POSSIBILITY OF HYDROGEN EVOLUTION). The mixture thus obtained was 
poured into HCl (50 mL of a 1 M aqueous solution) and extracted with ethyl acetate 
(3 × 200 mL). The combined organic phases were then dried (MgSO4), filtered, and 
concentrated under reduced pressure. The residue so produced was subjected to flash 
column chromatography (silica, 0:1→1:9 v/v ethyl acetate/40-60 petroleum ether 
gradient elution) and concentration of the appropriate fractions (Rf = 0.4 in 3:7 v/v 
ethyl acetate/40-60 petroleum ether) gave compound 26 (1.53 g, 95%) as a colorless, 
crystalline solid, mp = 110-113 °C. 
1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.4 Hz, 2H), 6.90 (d, J = 8.4 Hz, 2H), 4.58 
(ABq, J = 10.8 Hz, 2H), 4.18 (m, 1H), 3.99 (s, 1H), 3.88 (d, J = 8.2 Hz, 1H), 3.81 (s, 
3H), 3.56 (m, 1H), 3.37 (d, J = 8.2 Hz, 1H), 3.28 (m, 1H), 2.20 (m, 1H), 1.90 (s, 1H), 
1.49 (s, 3H), 1.42 (s, 3H), 1.39 (s, 3H), 1.29 (s, 3H), 1.26 (m, 1H), 1.14 (t, J = 7.0 Hz, 
3H) (signal due to hydroxyl group proton not observed). 
13C NMR (100 MHz, CDCl3) δ 159.6, 130.2, 129.4, 114.1, 107.6, 82.9, 79.9, 79.2, 
76.6, 75.2, 68.5, 64.6, 55.4, 44.3, 42.7, 29.4, 28.1, 26.8, 26.7, 19.1, 15.6. 
IR (KBr) νmax 3494, 2974, 2935, 1613, 1515, 1379, 1247, 1206, 1182, 1094, 1054, 
872 cm–1. 
MS (ESI, +ve) m/z 429 [(M+Na)+, 100%]. 
HRMS (M+Na)+ calcd for C23H34NaO6 429.2253, found 429.2259. 
Specific rotation [α]D = −62.6 (c = 0.3, CHCl3). 
 
O-((3aS,4S,5S,6R,7R,9R)-9-Ethoxy-5-((4-methoxybenzyl)oxy)-2,2,4,7a-tetrameth- 
ylhexahydro-4,7-ethanobenzo[d][1,3]dioxol-6-yl) S-methyl Carbonodithioate (27) 
 
!
 
A magnetically stirred solution of alcohol 26 (150 mg, 0.37 mmol) in dry THF (6 mL) 
maintained under a nitrogen atmosphere at 22 °C was treated with sodium hydride (74 
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mg of a 60% dispersion in mineral oil, 3.1 mmol). After 1.5 h carbon disulfide (330 
µL, 5.5 mmol) was added to the reaction mixture that was then heated under reflux 
for 2 h. The ensuing mixture was cooled to 22 °C then methyl iodide (120 µL, 1.9 
mmol) added and stirring continued for 5 h. After this time, the reaction mixture was 
cooled to 0 °C and quenched with iced water (12 mL) (CAUTION! EXOTHERMIC 
REACTION AND POSSIBILITY OF HYDROGEN EVOLUTION). The ensuing 
mixture was diluted with ethyl acetate (50 mL) then water (24 mL). The separated 
aqueous phase was extracted with ethyl acetate (3 × 50 mL) and the combined organic 
phases then dried (MgSO4), filtered, and concentrated under reduced pressure. The 
residue thus obtained was subjected to flash column chromatography (silica, 1:19 v/v 
ethyl acetate/40-60 petroleum ether elution) to give, after concentration of the 
relevant fractions (Rf = 0.6), xanthate 27 (176 mg, 96%) as a clear, pale-yellow oil. 
1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.2 Hz, 2H), 6.87 (d, J = 8.2 Hz, 2H), 5.99 
(m, 1H), 4.59 (d, J = 10.5 Hz, 1H), 4.32 (d, J = 10.5 Hz, 1H), 4.07 (s, 1H), 4.00 (d, J 
= 7.6 Hz, 1H), 3.81 (s, 3H), 360 (m, 1H), 3.41 (d, J = 8.0 Hz, 1H), 3.29 (m, 1H), 2.54 
(s, 3H), 2.26 (m, 1H), 2.14 (broad s, 1H), 1.58 (s, 3H), 1.45-1.41 (complex m, 4H), 
1.38 (s, 3H), 1.27 (s, 3H), 1.16 (t, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 215.4, 159.2, 131.1, 129.4, 113.7, 107.6, 82.6, 80.4, 
79.7, 77.1, 75.7, 74.7, 64.6, 55.4, 43.3, 41.8, 28.9, 27.1, 26.6, 26.5, 19.2, 18.7, 15.6. 
IR (KBr) νmax 2972, 2935, 1515, 1248, 1206, 1062 cm–1. 
MS (ESI, +ve) m/z 519 [(M+Na)+, 100%]. 
HRMS (M+Na)+ calcd for C25H36NaO6S2 519.1851, found 519.1851. 
Specific rotation [α]D = −9.0 (c = 0.6, CHCl3). 
 
(3aS,4S,5R,7R,9R)-5-Ethoxy-9-((4-methoxybenzyl)oxy)-2,2,4,7a-tetramethyl-
hexahydro-4,7-ethanobenzo[d][1,3]dioxole (28) 
 
!!
A magnetically stirred and de-oxygenated solution of xanthate 27 (468 mg, 0.94 
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mmol) in toluene (84 mL) maintained under an atmosphere of nitrogen at 22 °C was 
treated with AIBN (47 mg, 0.28 mmol) then (Me3Si)3SiH (840 µL, 2.72 mmol). The 
ensuing mixture was heated at 100 °C for 1 h then cooled and concentrated under 
reduced pressure. The residue thus obtained was subjected to flash column 
chromatography (silica, 1:37.5:350 v/v ethyl acetate/dichloromethane/40-60 
petroleum ether elution) to give, after concentration of the appropriate fractions (Rf = 
0.6 twice in 1:2.5:8.5 v/v ethyl acetate/dichloromethane/40-60 petroleum ether), 
compound 28 (291 mg, 79%) as a white, crystalline solid, mp = 80-84 °C. 
1H NMR (400 MHz, CDCl3) δ 7.24 (d, J = 8.4 Hz, 2H), 6.87 (d, J = 8.4 Hz, 2H), 4.50 
(d, J = 11.2 Hz, 1H), 4.25 (d, J = 11.2 Hz, 1H), 4.00 (s, 1H), 3.81 (s, 3H), 3.68 (d, J = 
8.3 Hz, 1H), 3.56 (complex m, 1H), 3.46 (d, J = 8.3 Hz, 1H), 3.30 (m, 1H), 2.23 (m, 
1H), 1.88 (m, 1H), 1.80-1.73 (complex m, 2H), 1.50 (s, 3H), 1.43 (s, 3H), 1.38 (s, 
3H), 1.24 (s, 3H), 1.21 (m, 1H), 1.14 (t, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 159.0, 131.4, 129.0, 113.8, 107.0, 82.7, 80.7, 76.1, 
75.2, 70.9, 64.7, 55.4, 42.1, 37.6, 30.2, 30.1, 26.7, 26.5, 25.9, 18.6, 15.6. 
IR (KBr) νmax 2973, 2934, 1614, 1514, 1377, 1247, 1094, 1053, 821 cm–1. 
MS (EI, 70 eV) m/z 390 (M+•, 10%), 375 [(M−CH3•)+, 75], 211 (75), 165 (90), 122 
(95), 121 (100). 
HRMS M+• calcd for C23H34O5 390.2406, found 390.2410. 
Specific rotation [α]D = −84.1 (c = 0.4, CHCl3). 
 
(3aS,4R,5R,7S,9R)-9-Ethoxy-2,2,4,7a-tetramethylhexahydro-4,7-ethanobenzo- 
[d][1,3]dioxol-5-ol (29) 
 
!!!A magnetically stirred solution of ether 28 (109 mg, 0.28 mmol) in dichloromethane 
(3.5 mL) maintained at 22 °C was treated with water (400 µL) then 2,3-dichloro-5,6-
dicyano-1,4-benzoquinone (95 mg, 0.42 mmol) and the resulting deep-green mixture 
stirred for 0.25 h then quenched with NaHCO3 (20 mL of a saturated aqueous 
solution). The mixture thus formed was extracted with dichloromethane (3 × 30 mL) 
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and the combined organic extracts were then dried (MgSO4), filtered and concentrated 
under reduced pressure. The residue thus obtained was subjected to flash column 
chromatography (silica, 1:9 v/v ethyl acetate/40-60 petroleum ether elution) to give, 
after concentration of the appropriate fractions (Rf = 0.4 in 3:7 v/v ethyl acetate/40-60 
petroleum ether), alcohol 29 (67 mg, 89%) as a clear, colorless oil. 
1H NMR (400 MHz, CDCl3) δ 4.02 (d, J = 9.2 Hz, 1H), 3.98 (s, 1H), 3.52 (m, 1H), 
3.46 (d, J = 8.6 Hz, 1H), 3.28 (m, 1H), 2.23 (m, 1H), 2.05 (m, 1H), 1.81 (broad s, 
1H), 1.59 (m, 1H), 1.53 (s, 3H), 1.48 (s, 1H), 1.44 (s, 3H), 1.41 (s, 3H), 1.22 (s, 3H), 
1.19 (m, 1H), 1.13 (t, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 107.2, 82.6, 80.7, 75.3, 68.7, 64.7, 42.3, 37.8, 33.5, 
30.1, 26.7, 26.6, 25.8, 18.3, 15.6. 
IR (KBr) νmax 3493, 2973, 2938, 1377, 1247, 1207, 1096, 1052 cm–1. 
MS (EI, 70 eV) m/z 255 [(M−CH3•)+, 100%], 195 (45), 194 (40), 151 (85), 149 (40), 
123 (70). 
HRMS (M−CH3•)+ calcd for C14H23O4 255.1596, found 255.1602. 
Specific rotation [α]D = −74.5 (c = 0.4, CHCl3). 
 
(3aS,4R,7R,9R)-9-Ethoxy-2,2,4,7a-tetramethyltetrahydro-4,7-ethanobenzo- 
[d][1,3]dioxol-5(4H)-one (30) 
 
!
 
A magnetically stirred solution of alcohol 29 (120 mg, 0.44 mmol) in dry 
dichloromethane (12 mL) maintained at 0 °C under an atmosphere of nitrogen was 
treated with pyridine (240 µL, 2.97 mmol) then the Dess-Martin periodinane (DMP) 
(339 mg, 0.80 mmol). After being maintained at 0 °C for a further 0.66 h the reaction 
mixture was warmed to 22 °C, kept at this temperature for 0.5 h then poured into 
water (30 mL) and extracted with dichloromethane (3 × 50 mL). The combined 
organic phases were then dried (MgSO4), filtered and concentrated under reduced 
pressure and the residue so formed subjected to flash column chromatography (silica, 
1:9 v/v ethyl acetate/40-60 petroleum ether elution) to give, after concentration of the 
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appropriate fractions (Rf = 0.5 in 3:7 v/v ethyl acetate/40-60 petroleum ether), 
compound 30 (94 mg, 79%) as a colorless, crystalline solid, mp = 62-64 °C. 
1H NMR (400 MHz, CDCl3) δ 3.66 (d, J = 7.8 Hz, 1H), 3.62-3.58 (complex m, 1H), 
3.56 (s, 1H), 3.29 (m, 1H), 2.49 (m, 1H), 2.35 (m, 1H), 2.21 (m, 2H), 1.60 (m, 1H), 
1.50 (s, 3H), 1.39 (s, 3H), 1.34 (s, 3H), 1.22 (s, 3H), 1.09 (t, J = 7.0 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 212.0, 110.0, 84.6, 80.6, 75.4, 64.9, 54.5, 39.4, 38.4, 
29.0, 26.5, 26.3, 25.7, 15.4, 14.8. 
IR (KBr) νmax 2977, 2936, 2875, 1733, 1380, 1244, 1205, 1092, 1054, 890 cm–1. 
MS (ESI, +ve) m/z 291 [(M+Na)+, 100%]. 
HRMS (M+Na)+ calcd for C15H24NaO4 291.1572, found 291.1574. 
Specific rotation [α]D = −27.2 (c = 0.3, CHCl3). !
(3aS,4R,7R,9R)-9-Ethoxy-2,2,4,7a-tetramethyl-3a,4,7,7a-tetrahydro-4,7-ethano- 
benzo[d][1,3]dioxol-5-yl (2E,4E)-hexa-2,4-dienoate (31) 
 
!
 
A magnetically stirred solution of ketone 30 (49 mg, 0.18 mmol) in THF (5 mL) 
maintained under a nitrogen atmosphere was cooled to −78 °C then treated with 
KHMDS (540 µL of a 0.5 M solution in toluene, 0.27 mmol). The resulting mixture 
was stirred at −78 °C for 1 h then sorbic chloride10 (27 µL, 0.22 mmol) was added 
dropwise over 0.16 h. The ensuing mixture was stirred at −78 °C for 2 h then warmed 
to 0 °C, quenched with NH4Cl (1 × 5 mL, a saturated aqueous solution) and extracted 
with ethyl acetate (3 × 20 mL). The combined organic phases were washed with 
NaHCO3 (1 × 20 mL of a saturated aqueous solution) before being dried (MgSO4), 
filtered and concentrated under reduced pressure. The light-yellow oil thus obtained 
was subjected to flash column chromatography (silica, 1:19→1:9 v/v ethyl acetate/40-
60 petroleum ether gradient elution) to give, after concentration of the appropriate 
fractions (Rf = 0.6 in 3:7 v/v ethyl acetate/40-60 petroleum ether), the O-acylation 
product 31 (55 mg, 84%) as a clear, colorless but unstable oil. 
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1H NMR (400 MHz, CDCl3) δ 7.32 (m, 1H), 6.25-6.12 (complex m, 2H), 5.84 (m, 
2H), 3.90 (s, 1H), 3.77 (d, J = 6.6 Hz, 1H), 3.57 (m, 1H), 3.39 (m, 1H), 2.57 (complex 
m, 1H), 2,46 (m, 1H), 1.86 (d, J = 5.6 Hz, 3H), 1.48 (s, 3H), 1.46 (s, 3H), 1.40 (s, 
3H), 1.24 (m, 1H), 1.22 (s, 3H), 1.14 (t, J = 6.9 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 166.7, 151.0, 146.8, 140.6, 129.9, 117.8, 116.8, 112.0, 
86.5, 84.5, 77.5, 65.0, 48.0, 41.8, 30.3, 28.6, 27.3, 27.2, 18.8, 15.5, 14.5. 
 
 (3aS,4R,7R,9R,Z)-9-Ethoxy-6-((2E,4E)-1-hydroxyhexa-2,4-dien-1-ylidene)-
2,2,4,7a-tetramethyltetrahydro-4,7-ethanobenzo[d][1,3]dioxol-5(4H)-one (32) 
 
!
 
A magnetically stirred solution of ketone 30 (89 mg, 0.33 mmol) in THF (20 mL) 
maintained at −78 °C under a nitrogen atmosphere was treated, dropwise over 0.08 h, 
with KHMDS (1.33 mL of a 0.5 M solution in toluene, 0.66 mmol). The resulting 
mixture was stirred at −78 °C for 0.75 h then a solution of sorbyl cyanide10,11 (60 mg, 
0.50 mmol) in THF (6 mL) was added dropwise over 0.16 h. The ensuing mixture 
was stirred at −78 °C for 2 h, warmed to 0 °C, quenched at this temperature with 
NH4Cl (30 mL of a saturated aqueous solution) and then extracted with ethyl acetate 
(3 × 50 mL). The combined organic phases were then dried (MgSO4), filtered and 
concentrated under reduced pressure to give a light-yellow oil that was subjected to 
flash column chromatography (silica, 1:19 v/v ethyl acetate/40-60 petroleum ether 
elution) and thereby affording two fractions, A and B.  
Concentration of fraction A (Rf = 0.6, in 3:7 v/v ethyl acetate/40-60 petroleum 
ether) gave compound 32 (66 mg, 55% or 81% brsm) as a pale-yellow, crystalline 
solid, mp = 92-94 °C. 
1H NMR (400 MHz, CDCl3) δ 14.12 (s, 1H), 7.21 (dd, J = 15.0 and 10.9 Hz, 1H), 
6.24 (m, 1H), 6.10 (m, 2H), 3.74 (d, J = 6.9 Hz, 1H), 3.66 (s, 1H), 3.52 (m, 1H), 3.30 
(m, 1H), 2.85 (broad s, 1H), 2.57 (m, 1H), 1.86 (d, J = 6.7 Hz, 3H), 1.50 (s, 3H), 1.44 
(m, 1H), 1.41 (s, 3H), 1.30 (s, 6H), 1.09 (t, J = 7.0 Hz, 3H). 
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13C NMR (100 MHz, CDCl3) δ 203.1, 165.9, 140.6, 138.1, 131.1, 118.7, 110.9, 109.9, 
85.0, 82.2, 75.5, 65.0, 53.8, 40.3, 29.9, 27.1, 26.9(4), 26.8(6), 18.9, 15.3, 14.0. 
IR (KBr) νmax 3463, 2977, 2934, 1737, 1607, 1569, 1446, 1378, 1239, 1096, 1053, 
873 cm–1. 
MS (ESI, +ve) m/z 385 [(M+Na)+, 100%]. 
HRMS (M+Na)+ calcd for C21H30NaO5 385.1991, found 385.1994. 
Specific rotation [α]D = +116.6 (c = 0.2, CHCl3). 
Concentration of the fraction B (Rf = 0.2, in 3:7 v/v ethyl acetate/40-60 
petroleum ether) gave compound 30 (29 mg, 33% recovery) as a clear, colorless solid 
that was identical, in all respects, with an authentic sample. !
(1S,4R,5R,6S,7R,Z)-7-Ethoxy-5,6-dihydroxy-3-((2E,4E)-1-hydroxyhexa-2,4-dien-
1-ylidene)-1,5-dimethylbicyclo[2.2.2]octan-2-one (33) 
 
!!
A magnetically stirred mixture of compound 32 (63 mg, 0.17 mmol) in acetic 
acid/water (7.0 mL of a 4:1 v/v mixture) maintained at 22 °C was treated with AG-
50W-X8 resin (151 mg of H+ form) and the ensuing mixture was heated at 70 °C for 
24 h before being cooled to 22 °C and treated with pyridinium p-toluenesulfonate (43 
mg, 0.17 mmol). The ensuing mixture was stirred at 70 °C for 24 h then cooled and 
filtered. The solid thus retained was washed with ethyl acetate (20 mL) and the 
combined filtrates washed with water (1 x 20 mL). The separated aqueous phase was 
extracted with ethyl acetate (1 x 50 mL) and the combined organic phases 
concentrated under reduced pressure to give a light-yellow oil. Subjection of this 
material to flash column chromatography (silica, 1:19 → 3:7 v/v ethyl acetate/40-60 
petroleum ether elution) afforded two fractions, A and B.  
Concentration of the fraction A (Rf = 0.6, in 3:7 v/v ethyl acetate/40-60 
petroleum ether) gave compound 32 (15 mg, 24% recovery) as a light-yellow solid 
that was identical, in all respects, with an authentic sample. 
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Concentration of the fraction B (Rf = 0.2, in 3:7 v/v ethyl acetate/40-60 
petroleum ether) gave diol 33 (35 mg, 63% or 82% brsm) as a white, amorphous 
powder, mp = 51-54 °C. 
1H NMR (600 MHz, CDCl3) δ 14.20 (s, 1H), 7.22 (dd, J = 14.9 and 11.0 Hz, 1H), 
6.25 (m, 1H), 6.20-6.08 (complex m, 2H), 3.70 (m, 1H), 3.52 (m, 1H), 3.31 (m, 1H), 
3.19 (s, 1H), 2.86 (m, 1H), 2.68 (m, 1H), 1.87 (d, J = 6.8 Hz, 3H), 1.38 (m, 1H), 1.27 
(s, 3H), 1.22 (s, 3H), 1.10 (t, J = 7.0 Hz, 3H) (signals due to hydroxyl group protons 
not observed). 
13C NMR (150 MHz, CDCl3) δ 203.5, 165.9, 140.8, 138.3, 131.1, 118.7, 110.8, 76.1, 
73.9, 70.8, 65.0, 54.9, 41.1, 31.0, 29.3, 18.9, 15.4, 12.9. 
1H NMR (600 MHz, CD3OD) δ 7.20 (dd, J = 15.0 and 11.0 Hz, 1H), 6.43-6.26 
(complex m, 2H), 6.14 (m, 1H), 3.75 (dd, J = 8.6 and 3.4 Hz, 1H), 3.53 (m, 1H), 3.29 
(m, 1H), 3.05 (s, 1H), 2.88 (t, J = 2.0 Hz, 1H), 2.72 (m, 1H), 1.87 (dd, J = 6.9 and 1.5 
Hz, 3H), 1.29 (m, 1H), 1.18 (s, 3H), 1.11 (s, 3H), 1.09 (t, J = 7.0 Hz, 3H). 
13C NMR (150 MHz, CD3OD) δ 205.8, 166.3, 141.7, 138.8, 132.4, 119.9, 112.4, 77.0, 
75.6, 71.0, 65.8, 56.2, 42.2, 32.0, 29.1, 18.8, 15.6, 13.4. 
IR (KBr) νmax 3391, 2971, 2931, 1631, 1602, 1562, 1389, 1144, 1091, 991, 920, 732 
cm–1. 
MS (ESI, +ve) m/z 345 [(M+Na)+, 100%]. 
HRMS (M+Na)+ calcd for C18H26NaO5 345.1678, found 345.1680. 
Specific rotation [α]D = +16.0 (c = 0.8, CHCl3). 
 
(1S,3R,4R,7R,Z)-7-Ethoxy-3-hydroxy-5-((2E,4E)-1-hydroxyhexa-2,4-dien-1-
ylidene)-1,3-dimethylbicyclo[2.2.2]octane-2,6-dione (ent-4) 
 
 
 
A magnetically stirred solution of diol 33 (50 mg, 0.16 mmol) in dichloromethane (19 
mL) was treated with 4-methylmorpholine N-oxide (49 mg, 0.418 mmol) and 
molecular sieves (39 mg of powdered 4 Å material) then tetra-n-propylammonium 
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perruthenate (11 mg, 0.031 mmol). The resulting mixture was stirred at 22 °C for 0.75 
h then filtered through a pad of TLC-grade silica. The filtrate was concentrated under 
reduced pressure to give a light-yellow oil and subjection of this material to flash 
chromatography (silica, 1:19 → 1:9 v/v ethyl acetate/30-40 petroleum ether gradient 
elution) afforded two fractions, A and B. 
Concentration of the fraction A (Rf = 0.2 in 3:7 v/v ethyl acetate/40-60 
petroleum ether) gave compound 33 (6 mg, 12% recovery) as a light-yellow, 
amorphous powder that was identical with an authentic sample. 
Concentration of the fraction B (Rf = 0.5 in 3:7 v/v ethyl acetate/40-60 
petroleum ether) gave an oil that was subjected to flash chromatography (silica, 
6:15:100 → 6:15:80 v/v ethyl acetate/dichloromethane/30-40 petroleum ether 
gradient elution) to give, after concentration of the appropriate fractions (Rf = 0.5 in 
3:7 v/v ethyl acetate/40-60 petroleum ether), compound ent-4 (26 mg, 52% or 59% 
brsm) as a light-yellow, amorphous powder, mp = 83-85 °C. 
1H NMR (600 MHz, CDCl3) δ 13.95 (s, 1H), 7.29 (dd, J = 14.9 and 10.9 Hz, 1H), 
6.28 (m, 1H), 6.20-6.13 (complex m, 2H), 3.55 (m, 2H), 3.37 (m, 1H), 3.15 (m, 1H), 
2.78 (m, 1H), 2.56 (broad s, 1H), 1.89 (dd, J = 6.8 and 1.3 Hz, 3H), 1.68 (m, 1H), 
1.31 (s, 3H), 1.20 (s, 3H), 1.11 (t, J = 7.0 Hz, 3H). 
13C NMR (150 MHz, CDCl3) δ 211.1, 196.5, 166.5, 141.9, 139.3, 131.0, 118.2, 110.5, 
79.3, 74.7, 67.2, 65.8, 39.9, 30.8, 24.5, 19.0, 15.2, 9.1. 
1H NMR (600 MHz, CD3OD) δ 7.27 (dd, J = 14.9 and 11.0 Hz, 1H), 6.38 (m, 2H), 
6.18 (m, 1H), 3.61 (m, 1H), 3.58 (m, 1H), 3.34 (m, 1H), 3.16 (m, 1H), 2.83 (m, 1H), 
1.87 (dd, J = 6.9 and 1.3 Hz, 3H), 1.63 (m, 1H), 1.20 (s, 3H), 1.14 (s, 3H), 1.10 (t, J = 
7.0 Hz, 3H) (signals due to hydroxyl group protons not observed). 
13C NMR (150 MHz, CD3OD) δ 210.3, 198.3, 167.2, 142.9, 139.8, 132.3, 119.5, 
112.3, 79.9, 74.9, 68.7, 66.3, 41.7, 31.8, 24.0, 18.8, 15.5, 9.6. 
1H NMR (600 MHz, C6D6) δ 14.65 (s, 1H), 7.33 (dd, J = 14.9 and 11.1 Hz, 1H), 5.97-
5.90 (complex m, 2H), 5.58 (m, 1H), 3.33 (m, 1H), 3.14 (m, 1H), 3.00 (m, 1H), 2.92 
(m, 1H), 2.76 (m, 1H), 2.28 (s, 1H), 1.65 (s, 3H), 1.56 (m, 1H), 1.46 (dd, J = 6.9 and 
1.4 Hz, 3H), 0.96 (s, 3H), 0.84 (t, J = 7.0 Hz, 3H). 
13C NMR (150 MHz, C6D6) δ 210.2, 197.1, 166.4, 141.7, 138.3, 131.2, 118.7, 111.0, 
79.4, 74.6, 67.6, 65.5, 40.2, 31.0, 24.1, 18.6, 15.2, 9.7. 
1H NMR [600 MHz, (CD3)2CO] δ 14.08 (s, 1H), 7.26 (dd, J = 14.9 and 11.1 Hz, 1H), 
6.53 (d, J = 10.0 Hz, 1H), 6.41 (m, 1H), 6.23 (m, 1H), 4.81 (s, 1H), 3.64 (m, 1H), 
! S35!
3.58 (m, 1H), 3.35 (m, 1H), 3.25 (m, 1H), 2.89 (m, 1H), 1.86 (d, J = 4.2 Hz, 3H), 1.64 
(m, 1H), 1.20 (s, 3H), 1.16 (s, 3H), 1.07 (t, J = 7.0 Hz, 3H). 
13C NMR [150 MHz, (CD3)2CO] δ 209.5, 198.0, 166.9, 142.0, 139.2, 132.0, 119.8, 
112.2, 79.2, 74.3, 68.0, 65.6, 41.0, 31.5, 24.0, 18.8, 15.5, 9.5. 
IR (KBr) νmax 3456, 2976, 2936, 2874, 1731, 1632, 1605, 1563, 1446, 1373, 1094, 
1023, 998 cm–1. 
MS (ESI, +ve) m/z 343 [(M+Na)+, 100%]. 
HRMS (M+Na)+ calcd for C18H24NaO5 343.1521, found 343.1521. 
Specific rotation [α]D = −234.0 (c = 0.1, MeOH) {lit.12 value (for 1) [α]D20 = +219 (c 
0.1, methanol)} 
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Scheme S1: Reaction Sequence Used for the Conversion of Diol 23 into Ketone 30 
 
 
 
Experimental Protocols for the Conversion of Diol 23 into Ketone 30 
 
 (3aS,4R,5R,6S,7R,9R)-6-((tert-Butyldimethylsilyl)oxy)-9-ethoxy-2,2,4,7a-tetra 
methylhexahydro-4,7-ethanobenzo[d][1,3]dioxol-5-ol (34) 
  
 
 
Sodium hydride (370 mg of a 60% dispersion in mineral oil, 9.17 mmol) was added, 
in one portion, to a magnetically stirred solution of diol 23 (530 mg, 1.85 mmol) in 
THF (27 mL) maintained at 0 °C under an atmosphere of nitrogen. The ensuing 
mixture was stirred at 0 °C for 0.5 h, warmed to 22 °C and then maintained at this 
temperature for another 0.5 h before being re-cooled 0 °C then treated, dropwise over 
0.16 h, with a solution of TBSCl (310 mg, 2.06 mmol) in THF (20 mL). The ensuing 
mixture was stirred at 0 °C for 0.25 h then quenched with ice water (50 mL) 
(CAUTION! EXOTHERMIC REACTION AND POSSIBILITY OF HYDROGEN 
EVOLUTION) and extracted with ethyl acetate (3 × 100 mL). The combined organic 
phases were then dried (MgSO4), filtered and concentrated under reduced pressure 
and the residue thus obtained subjected to flash column chromatography (silica, 
1:19→1:9 v/v ethyl acetate/40-60 petroleum ether gradient elution) to afford, after 
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concentration of the appropriate fractions (Rf = 0.5 in 1:4 v/v ethyl acetate/40-60 
petroleum ether), alcohol 34 (452 mg, 61%) as a colorless, crystalline solid, mp = 78-
80 °C. 
1H NMR (800 MHz, CDCl3) δ 4.04 (dd, J = 7.5 and 4.3 Hz, 1H), 3.61 (m, 1H), 3.47 
(s, 1H), 3.46 (s, 1H), 3.21-3.13 (complex m, 3H), 1.95 (m, 2H), 1.85 (s, 1H), 1.43 (s, 
3H), 1.39 (s, 3H), 1.37 (s, 3H), 1.18 (s, 3H), 1.14 (t, J = 7.0 Hz, 3H), 0.91 (s, 9H), 
0.08 (s, 3H), 0.06 (s, 3H). 
13C NMR (200 MHz, CDCl3) δ 109.0, 86.3, 79.3, 76.1, 69.7, 66.6, 64.6, 43.9, 41.6, 
27.1, 26.6, 25.9, 21.7, 18.4(9), 18.4(7), 15.6, −4.8, −5.1 (one signal obscured or 
overlapping). 
IR (KBr) νmax 3538, 2957, 2935, 2858, 1739, 1376, 1253, 1211, 1093, 1048, 895, 840, 
778 cm–1. 
MS (ESI, +ve) m/z 423 [(M+Na)+, 100%]. 
HRMS (M+Na)+ calcd for C21H40NaO5Si 423.2543, found 423.2547. 
Specific rotation [α]D = −16.2 (c = 0.4, CHCl3). 
 
(3aS,4R,6S,7R,9R)-6-((tert-Butyldimethylsilyl)oxy)-9-ethoxy-2,2,4,7a-tetramethyl- 
tetrahydro-4,7-ethanobenzo[d][1,3]dioxol-5(4H)-one (35) 
 
 
 
A magnetically stirred solution of alcohol 34 (350 mg, 0.88 mmol) in dry 
dichloromethane (45 mL) maintained at 0 °C under an atmosphere of nitrogen was 
treated with pyridine (420 µL, 5.19 mmol) then the Dess-Martin periodinane (DMP) 
(669 mg, 1.65 mmol). After stirring the reaction mixture at 0 °C for a further 0.66 h it 
was warmed to 22 °C and maintained at this temperature for 1 h then poured into 
water (100 mL) and extracted with dichloromethane (3 × 100 mL). The combined 
organic phases were then dried (MgSO4), filtered and concentrated under reduced 
pressure. The residue thus obtained was subjected to flash column chromatography 
(silica, 1:19 v/v ethyl acetate/40-60 petroleum ether elution) and gave, after 
concentration of the appropriate fractions (Rf = 0.7 in 3:7 v/v ethyl acetate/40-60 
O
OTBSO
O
35
O
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petroleum ether), ketone 35 (311 mg, 89%) as a colorless, crystalline solid, mp = 61-
63 °C. 
1H NMR (400 MHz, CDCl3) δ 3.72-3.69 (complex m, 2H), 3.60 (s, 1H), 3.55 (m, 1H), 
3.23 (m, 1H), 2.26 (m, 1H), 2.15 (m, 1H), 2.03 (m, 1H), 1.50 (s, 3H), 1.42 (s, 3H), 
1.40 (s, 3H), 1.18 (s, 3H), 1.08 (t, J = 7.0 Hz, 3H), 0.87 (s, 9H), 0.10 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ 210.6, 110.2, 84.5, 79.5, 75.2, 70.5, 64.3, 54.8, 46.4, 
26.9, 26.7, 26.4, 25.8, 22.6, 18.3, 15.4, 14.4, −4.4, −5.1. 
IR (KBr) νmax 2933, 2858, 1740, 1249, 1150, 1103, 1035, 837, 779 cm–1. 
MS (ESI, +ve) m/z 421 [(M+Na)+, 100%]. 
HRMS (M+Na)+ calcd for C21H38NaO5Si 421.2386, found 421.2377. 
Specific rotation [α]D = −60.0 (c = 0.4, CHCl3). 
 
(3aS,4R,7R,9R)-9-Ethoxy-2,2,4,7a-tetramethyltetrahydro-4,7-ethanobenzo- 
[d][1,3]dioxol-5(4H)-one (30) 
 
 
 
A magnetically stirred solution of compound 35 (265 mg, 0.67 mmol) in 
THF/methanol (40 mL of a 2:1 v/v mixture) maintained under an atmosphere of 
nitrogen at 0 °C was treated, dropwise, with samarium diiodide (a 0.07-0.12 M 
solution in THF, about 4.90 mmol) until the reaction mixture maintained a pale-
green/blue color for 0.16 h. At this point, the reaction mixture was poured into 
NaHCO3 (100 mL of a saturated aqueous solution) and extracted with ethyl acetate (3 
× 200 mL). The combined organic phases were then dried (MgSO4), filtered and 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
column chromatography (silica, 3:17 v/v ethyl acetate/40-60 petroleum ether elution) 
and gave, after concentration of the appropriate fractions (Rf = 0.5 in 3:7 v/v ethyl 
acetate/40-60 petroleum ether), ketone 30 (166 mg, 93%) as a colorless, crystalline 
solid that was identical with an authentic sample. !
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Table S1. Comparison of the 13C NMR Spectral Data Sets Derived From 
Rezishanone C and ent-Rezishanone C in Various Solvents 
CD3OD CDCl3 C6D6 (CD3)2CO 
δca δcb △δ δcc δcb △δ δcd δcb △δ δce δcb △δ 
210.4 210.3 −0.1 210.9 211.1 +0.2 210.5 210.2 −0.3 209.5 209.5 0 
198.3 198.3 0 196.4 196.5 +0.1 197.0 197.1 +0.1 197.9 198.0 +0.1 
167.3 167.2 −0.1 166.4 166.5 +0.1 166.4 166.4 0 166.9 16.9 0 
142.9 142.9 0 141.8 141.9 +0.1 141.7 141.7 0 142.0 142.0 0 
139.7 139.8 +0.1 139.2 139.3 +0.1 138.2 138.3 +0.1 139.2 139.2 0 
132.3 132.3 0 130.9 131.0 +0.1 131.2 131.2 0 132.0 132.0 0 
119.5 119.5 0 118.0 118.2 +0.2 118.6 118.7 +0.1 119.8 119.8 0 
112.3 112.3 0 110.4 110.5 +0.1 111.0 111.0 0 112.1 122.2 +0.1 
79.9 79.9 0 79.1 79.3 +0.2 79.3 79.4 +0.1 79.2 79.2 0 
74.9 74.9 0 74.6 74.7 +0.1 74.3 74.6 +0.3 74.3 74.3 0 
68.7 68.7 0 67.0 67.2 +0.2 67.6 67.6 0 68.0 68.0 0 
66.3 66.3 0 65.6 65.8 +0.2 65.5 65.5 0 65.6 65.6 0 
41.7 41.7 0 39.7 39.9 +0.2 40.2 40.2 0 40.9 41.0 +0.1 
31.8 31.8 0 30.6 30.8 +0.2 30.9 31.0 +0.1 31.4 31.5 +0.1 
24.0 24.0 0 24.3 24.5 +0.2 24.1 24.1 0 24.0 24.0 0 
18.8 18.8 0 18.8 19.0 +0.2 18.6 18.6 0 18.8 18.8 0 
15.4 15.5 +0.1 15.1 15.2 +0.1 15.2 15.2 0 15.5 15.5 0 
9.6 9.6 0 8.9 9.1 +0.2 9.6 9.7 +0.1 9.5 9.5 0 
aData obtained from reference 12 - recorded in CD3OD. bData obtained from present work-recorded at 150 MHz in CD3OD, 
CDCl3, C6D6, (CD3)2CO, respectively. cData obtained from reference 13 - recorded in CDCl3. dData obtained from reference 14 -
recorded in C6D6 at 75 MHz. eData obtained from reference 15 - recorded in (CD3)2CO at 75 MHz. 
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X-ray Crystallographic Studies 
Crystallographic Data.  
Compound 7. C12H16O3, M = 208.26, T = 150 K, trigonal, space group P3221, Z = 6, a 
= 10.5437(1) Å, c = 17.0184(1) Å; V = 1638.46(2) Å3, Dx = 1.266 g cm–3, 2160 
unique data (2θmax = 144.8°), R = 0.024 [for 2139 reflections with I > 2.0σ(I)]; Rw = 
0.064 (all data), S = 1.01. 
 
Compound 8. C9H12O3, M = 168.19, T = 150 K, orthorhombic, space group P212121, Z 
= 4, a = 6.9885(1) Å, b = 7.9474(1) Å, c = 14.4684(1) Å; V = 803.58(2) Å3, Dx = 
1.390 g cm–3, 1583 unique data (2θmax = 144.6°), R = 0.056 [for 1574 reflections with 
I > 2.0σ(I)]; Rw = 0.056 (all data), S = 1.01. !
Compound 9. C11H16O4, M = 212.25, T = 200 K, orthorhombic, space group P212121, 
Z = 4, a = 5.2471(3) Å, b = 10.1800(4) Å, c = 19.7165(9) Å; V = 1053.17(9) Å3, Dx = 
1.339 g cm–3, 1121 unique data (2θmax = 50.0°), R = 0.47 [for 886 reflections with I > 
2.0σ(I)]; Rw = 0.111 (all data), S = 0.95. 
 
Compound 11. C15H28O3Si, M = 284.47, T = 150 K, monoclinic, space group C2, Z = 
8, a = 31.7863(3) Å, b = 6.3670(1) Å, c = 18.8067(2) Å; β = 117.7194(12) °; V = 
3369.35(8) Å3, Dx = 1.122 g cm–3, 5835 unique data (2θmax = 144.8°), R = 0.027 [for 
5748 reflections with I > 2.0σ(I)]; Rw = 0.073 (all data), S = 1.00. 
 
Compound 14. C13H18O5, M = 254.28, T = 150 K, orthorhombic, space group P212121, 
Z = 4, a = 7.0640(1) Å, b = 8.5640(1) Å, c = 21.1355(2) Å; V = 1278.62(3) Å3, Dx = 
1.321 g cm–3, 2534 unique data (2θmax = 144.8°), R = 0.025 [for 2492 reflections with 
I > 2.0σ(I)]; Rw = 0.065 (all data), S = 1.00. 
 
Compound 16. C12H18O4, M = 226.27, T = 150 K, orthorhombic, space group P212121, 
Z = 4, a = 8.2169(1) Å, b = 10.8611(1) Å, c = 13.4792(1) Å; V = 1202.95(2) Å3, Dx = 
1.249 g cm–3, 2380 unique data (2θmax = 144.8°), R = 0.026 [for 2350 reflections with 
I > 2.0σ(I)]; Rw = 0.072 (all data), S = 1.00. 
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Compound 17. C10H16O3, M = 184.24, T = 150 K, orthorhombic, space group P212121, 
Z = 4, a = 6.4980(1) Å, b = 11.4064(1) Å, c = 12.4797(1) Å; V = 924.98(2) Å3, Dx = 
1.323 g cm–3, 1733 unique data (2θmax = 139.6°), R = 0.025 [for 1723 reflections with 
I > 2.0σ(I)]; Rw = 0.067 (all data), S = 1.01. 
 
Compound 22. C12H22O4, M = 230.30, T = 150 K, orthorhombic, space group P212121, 
Z = 12, a = 12.6340(1) Å, b = 13.4519(1) Å, c = 21.7470(1) Å; V = 3695.93(4) Å3, Dx 
= 1.242 g cm–3, 7216 unique data (2θmax = 144.0°), R = 0.025 [for 7015 reflections 
with I > 2.0σ(I)]; Rw = 0.062 (all data), S = 1.00. 
 
Compound 26. C23H34O6, M = 406.52, T = 150 K, orthorhombic, space group P212121, 
Z = 4, a = 7.9838(1) Å, b = 14.1145(1) Å, c = 18.8516(1) Å; V = 2124.34(3) Å3, Dx = 
1.271 g cm–3, 4199 unique data (2θmax = 144.8°), R = 0.024 [for 4133 reflections with 
I > 2.0σ(I)]; Rw = 0.061 (all data), S = 1.00. 
 
Compound 30. C15H24O4, M = 268.35, T = 150 K, orthorhombic, space group P212121, 
Z = 4, a = 7.6721(1) Å, b = 9.3354(2) Å, c = 20.5773(3) Å; V = 1473.79(4) Å3, Dx = 
1.209 g cm–3, 2911 unique data (2θmax = 144.8°), R = 0.025 [for 2839 reflections with 
I > 2.0σ(I)]; Rw = 0.063 (all data), S = 1.00. 
 
Compound 32. C21H30O5, M = 362.47, T = 150 K, orthorhombic, space group P212121, 
Z = 4, a = 7.3104(2) Å, b = 8.4083(2) Å, c = 33.0483(10) Å; V = 2031.41(10) Å3, Dx 
= 1.185 g cm–3, 3805 unique data (2θmax = 144.6°), R = 0.036 [for 3624 reflections 
with I > 2.0σ(I)]; Rw = 0.093 (all data), S = 1.01. 
 
Structure Determination. The image for compound 9 was measured on a 
diffractometer (Mo Kα, graphite monochromator, λ = 0.71073 Å) fitted with an area 
detector and the data extracted using the DENZO/Scalepack package.16 Images for 
compounds 7, 8, 11, 14, 16, 17, 22, 26, 30 and 32 were measured on a diffractometer 
(Cu Kα, mirror monochromator, λ = 1.54184 Å) fitted with an area detector and the 
data extracted using the CrysAlis package.17 The structure solutions for all eleven 
compounds were solved by direct methods (SIR92)18 then refined using the 
CRYSTALS program package.19 Atomic coordinates, bond lengths and angles, and 
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displacement parameters have been deposited at the Cambridge Crystallographic Data 
Centre (CCDC nos. 1526109-1526119). These data can be obtained free-of-charge via 
www.ccdc.cam.ac.uk/data_request/cif, by emailing data_request@ccdc.cam.ac.uk, or 
by contacting The Cambridge Crystallographic Data Centre, 12 Union Road, 
Cambridge CB2 1EZ, UK; fax: +44 1223 336033. 
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Figure S2: Structure of compound 7 (CCDC 1526109) with labeling of selected 
atoms. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen 
atoms are drawn as circles with small radii. 
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Figure S3: Structure of compound 8 (CCDC 1526110) with labeling of selected 
atoms. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen 
atoms are drawn as circles with small radii. 
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Figure S4: Structure of compound 9 (CCDC 1526111) with labeling of selected 
atoms. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen 
atoms are drawn as circles with small radii.!!!!!!!!!
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Figure S5: Structure of compound 11 (CCDC 1526112) with labeling of selected 
atoms. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen 
atoms are drawn as circles with small radii.!!!
! S49!
 
 
 
 
 
 
 
Figure S6: Structure of compound 14 (CCDC 1526113) with labeling of selected 
atoms. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen 
atoms are drawn as circles with small radii.!!
! S50!
!
 
 
 
 
 
 
Figure S7: Structure of compound 16 (CCDC 1526114) with labeling of selected 
atoms. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen 
atoms are drawn as circles with small radii.!!
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Figure S8: Structure of compound 17 (CCDC 1526115) with labeling of selected 
atoms. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen 
atoms are drawn as circles with small radii.!!!
! S52!
 
 
 
 
 
 
 
 
Figure S9: Structure of compound 22 (CCDC 1526116) with labeling of selected 
atoms. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen 
atoms are drawn as circles with small radii. 
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Figure S10: Structure of compound 26 (CCDC 1526117) with labeling of selected 
atoms. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen 
atoms are drawn as circles with small radii. 
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Figure S11: Structure of compound 30 (CCDC 1526118) with labeling of selected 
atoms. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen 
atoms are drawn as circles with small radii. 
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Figure S12: Structure of compound 32 (CCDC 1526119) with labeling of selected 
atoms. Anisotropic displacement ellipsoids show 30% probability levels. Hydrogen 
atoms are drawn as circles with small radii.!!!
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ABSTRACT: A series of enantiomerically pure bicyclo[2.2.2]octenones, including the lactone-annulated system 26, has been
prepared by engaging derivatives of an enzymatically derived and homochiral cis-1,2-dihydrocatechol in inter- or intra-molecular
Diels−Alder reactions. Systems such as 26 readily participate in photochemically promoted oxa-di-π-methane rearrangement or
1,3-acyl migration processes to give products such as diquinane 34 or mixtures of cyclobutanone 36 and cyclopropane 38,
respectively.
■ INTRODUCTION
Bicyclo[2.2.2]octenones including the parent system 1
(Scheme 1) are excellent substrates for certain photochemically
promoted rearrangement reactions.1 Speciﬁcally, on irradiation
in the presence of photosensitizers such as acetophenone they
participate in oxa-di-π-methane rearrangements and, so
aﬀording, via a triplet pathway, cyclopropannulated diquinanes
such as 2. In contrast, on direct irradiation they engage, now via
a singlet pathway, in a 1,3-acyl migration reaction (Givens
rearrangement) to give bicyclo[4.2.0]oct-4-en-7-ones such as 3.
Upon sustained irradiation, photoproduct 3 and many of its
derivatives can undergo decarbonylation to give the corre-
sponding Δ2-norcarene, e.g. 4.
The capacity to eﬀectively exploit these valuable trans-
formations is contingent on having ready access to
bicyclo[2.2.2]octenones, especially enantiomerically pure
ones. While various methods are available for the synthesis of
such systems,2 a particularly useful approach involves the
facially selective intermolecular cycloaddition of dienophiles to
enantiomerically pure cis-1,2-dihydrocatechols such as 5
(Figure 1) that are readily obtained through the whole-cell
biotransformation of the corresponding arene (toluene in the
case of compound 5).3 Indeed, we have exploited such adducts
in the photochemically mediated total synthesis of a range of
sesquiterpenoid natural products including various triquinanes,4
protoilludanes,5 and the structure assigned to a sterpurene.6 In
seeking to extend such studies for the purposes of preparing
new molecular scaﬀolds, including those of use in drug
discovery, we became interested in establishing the degree to
which the bicyclo[2.2.2]octenone framework could be sub-
stituted and/or annulated and continue to engage in the above-
Received: May 21, 2017
Published: July 3, 2017
Scheme 1. Oxa-di-π-methane, 1,3-Acyl Migration, and
Photodecarbonylation Reactions of the Parent
Bicyclo[2.2.2]octenone (1)
Figure 1. Homochiral cis-1,2-dihydrocatechol 5 and the derived
bicyclo[2.2.2]octenone-based photosubstrates 6 and 7.
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mentioned photochemical processes. Herein, we detail research
that serves to emphasize the remarkable extent to which these
processes can be applied in a reliable fashion.
In connection with our recently reported studies7 on the
synthesis of the sorbicillinoid-derived isolate rezishanone C, we
prepared,7 using intermolecular Diels−Alder cycloaddition
processes, the oxygenated bicyclo[2.2.2]octenones 6 and 7 in
gram quantities from cis-1,2-dihydrocatechol 5. Accordingly,
compounds 6 and 7 became the substrates used in the opening
stages of the present work.
■ RESULTS AND DISCUSSION
Independent irradiation (using a medium-pressure mercury
lamp) of an acetone solution of each of compounds 6 and 7
held in a round-bottomed ﬂask made from borosilicate glass
and containing ca. 1.4 molar equiv of acetophenone (Scheme
2) aﬀorded the anticipated oxa-di-π-methane rearrangement
products 8 (87% or 98% brsm) and 9 (90% or 99% brsm),
respectively. All of the spectral data acquired on compounds 8
and 9 were entirely consistent with the assigned structures, but
ﬁnal conﬁrmation of these followed from single-crystal X-ray
analyses (see the Experimental Section and Supporting
Information for details).
When dichloromethane solutions of substrates 6 and 7 were
subjected to direct irradiation for brief periods (less than 1 h)
with the same type of lamp then the anticipated Givens
rearrangement products 10 (70% or 84% brsm) and 11 (67%),
respectively, were obtained. Upon sustained irradiation (5 h) of
the same substrates, signiﬁcant quantities of the corresponding
decarbonylated systems 12 (32%) and 13 (33%) were obtained
along with reduced amounts of the corresponding and
chromatographically separable cyclobutenones. Once again, all
of the spectroscopic data acquired on compounds 10−13 were
in accord with the assigned structures, but those of the ﬁrst and
the last of these were conﬁrmed by single-crystal X-ray analysis.
Establishing the impact of various modes of ring-fusion on
the capacity of bicyclo[2.2.2]octenones to engage in oxa-di-π-
methane and 1,3-acyl migration reactions was another topic of
interest. Therefore, building upon our earlier studies8 on the
assembly of the relevant frameworks through the intramolecular
Diels−Alder (IMDA) reactions of crotonate esters derived
from cis-1,2-dihydrocatechols, compound 5 was converted
(Scheme 3) into the diesters 14 (81%) and 15 (74%) under
previously established8 conditions. When each of compounds
14 and 15 was heated in reﬂuxing toluene they engaged in the
two possible modes of cycloaddition and thus giving rise to the
corresponding pair of adducts, viz. lactones 16 (40% from 14),
17 (41% from 15), 18 (26% from 14), and 19 (12% from 15),
that could be separated from one another by conventional
chromatographic means. The remaining ester residues within
each of adducts 18 and 19 were cleaved by standard methods
and the resulting alcohols 20 (74%) and 21 (76%) oxidized to
the corresponding ketones 22 (86%) and 23 (82%),
respectively, using the Dess−Martin periodinane.9 Similarly,
esters 16 and 17 were cleaved using potassium carbonate in
methanol and the product alcohols 24 (79%) and 25 (94%),
respectively, oxidized to the corresponding ketones, namely,
compounds 26 (94%) and 27 (78%). Single-crystal X-ray
analyses were conducted on compounds 23 and 27, details of
which are presented in the Experimental Section and SI.
The oxa-di-π-methane rearrangement of the lactone-annu-
lated bicyclo[2.2.2]octenones 22 and 23 took place readily
when acetone solutions of each of these was irradiated in the
presence of acetophenone (Scheme 4). By such means the
cyclopropane-annulated oxatriquinanes 28 (40%) and 29
(43%) were obtained. In contrast, direct irradiation of
substrates 22 and 23 led to the corresponding mixtures of
cyclobutanones 30 (up to 75%) and 31 (up to 73%),
respectively, as well as their decarbonylated counterparts 32
(up to 37%) and 33 (up to 52%), respectively. The structures
of compounds 30 and 32 were conﬁrmed by single-crystal X-
ray analyses.
Equivalent studies on the photochemical behaviors of the
isomeric lactone annulated bicyclo[2.2.2]octenones 26 and 27
(Scheme 5) led to analogous outcomes. Speciﬁcally, the
anticipated oxatriquinanes 34 (45%) and 35 (49%) were
obtained on photosensitized irradiation of these substrates
while direct irradiation aﬀorded mixtures of cyclobutanones 36
(up to 70%) and 37 (up to 71%) as well as their decarbonylated
congeners 38 (up to 35%) and 39 (up to 40%), respectively.
The structures of compounds 34, 35, 36, and 38 were each
conﬁrmed by single-crystal X-ray analyses.
It is worth noting that both the substrates and the
photoproducts shown in Scheme 5 are pseudoenantiomers of
their counterparts shown in Scheme 4. Thus, for example, if
each of compounds 30 (Scheme 4) and 36 (Scheme 5) lacked
the two methyl groups then they would be enantiomers.
Accordingly, the protocols just described provide a means by
which the single enantiomeric form of starting material 5 can be
converted into either enantiomeric form of a range of relatively
complex molecular frameworks.
In seeking to establish the eﬀects of alternate modes of ring
fusion and other substituents on the capacity of bicyclo[2.2.2]-
octenones to engage in photochemically promoted rearrange-
ments, the behaviors of various polyhydro-4,7-ethanoindenone
derivatives were explored. The routes shown in Scheme 6 were
used to prepare these cyclopentannulated systems. Thus, the
previously described4d tricyclic system 40, prepared by a
reaction sequence involving an initial Diels−Alder cyclo-
addition reaction between 2-cyclopenten-1-one and the
Scheme 2. Photochemical Behaviors of
Bicyclo[2.2.2]octenones 6 and 7 under Either Direct
Irradiation or Photosensitized Conditions
The Journal of Organic Chemistry Article
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acetonide derived from cis-diol 5, was reduced with LiAlH4, and
the previously reported4d,5b alcohol 41 (39%) obtained in pure
form after chromatographic separation from its coproduced
epimer.4d,5b Compound 41, the structure of which was
conﬁrmed by single-crystal X-ray analysis, was acetylated
under standard conditions to give ester 42 (97%), and the
acetonide moiety associated with this last compound was
hydrolyzed by treating a methanol/water solution of it with
acidiﬁed AG-50W-X8 resin. The product diol 43 (97%) was
selectively oxidized using the sterically demanding oxammo-
nium salt derived from p-TsOH·H2O-promoted disproportio-
nation of 4-acetamido-TEMPO,10 and thus producing acyloin
44 (97%) that was also subjected to single-crystal X-ray
analysis. Compound 44 was converted into derivatives 45
(91%), 46 (77%), 47 (82%), and 48 (93%) by standard
methods, while samarium iodide mediated deoxygenation of
benzoate 48 also allowed for the preparation of bicyclo[2.2.2]-
octenone 49 (85%). Once again, the structures of compounds
45, 47, and 48 were conﬁrmed by single-crystal X-ray analyses.
Scheme 3. Synthesis of Lactone-Annulated Bicyclo[2.2.2]octenones 22, 23, 26, and 27
Scheme 4. Photochemical Behaviors of
Bicyclo[2.2.2]octenones 22 and 23 under Either Direct
Irradiation or Sensitized Conditions
Scheme 5. Photochemical Behaviors of
Bicyclo[2.2.2]octenones 26 and 27 under Either Direct
Irradiation or Sensitized Conditions
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On direct irradiation of dichloromethane solutions of each of
compounds 45−49 they engaged in 1,3-acyl migration
reactions to give the cyclobutanones 50 (43% or 99% brsm),
51 (27% or 98% brsm), 52 (18% or 99% brsm), 53 (17% or
quant brsm), and 54 (23% or 92% brsm), respectively.
Irradiation of compounds 50 and 47 led to cyclopropanes 55
(98%) and 56 (80%), respectively. The structures of all of these
photoproducts were determined through comprehensive
spectroscopic analyses. In particular, the infrared spectrum of
each of cyclobutanones 50−54 exhibited a characteristic
carbonyl absorption band in the range 1778−1792 cm−1 as
well as a carbonyl carbon resonance above δ 200 ppm in the
corresponding 13C NMR spectrum. The structure of compound
53 was conﬁrmed by single-crystal X-ray analysis.
Given our extensive earlier studies4 on the oxa-di-π-methane
rearrangements of substrates very closely related to compounds
45−49, we have not subjected these to photosensitized
irradiation but would fully expect them to behave in a similar
manner and thus leading to the corresponding cyclopropannu-
lated triquinanes.
In contrast to outcomes noted above (Scheme 6), when the
mesylate 57 (Scheme 7), which was readily prepared in 56%
yield from acyloin 44, was subjected (as a solution in
dichloromethane) to direct irradiation it engaged in an oxa-
di-π-methane rearrangement reaction rather than a 1,3-acyl
migration reaction and so aﬀording the cyclopentannulated and
stereochemically pure triquinane 58 in 48% yield (or 98% yield
brsm). The conﬁguration at the carbon bearing the mesyloxy
group is tentatively assigned as illustrated although the alternate
one cannot be discounted as a result of the intervention of a
photoepimerization process.4b−d The precise origins of this
seemingly anomalous behavior of sulfonate ester 57 remain
unclear at the present time and serve to highlight the very
limited understanding of the photochemical properties of such
systems.11 These matters are the subject of ongoing studies in
our laboratories.
■ CONCLUSIONS
The studies reported here have established that a wide range of
extensively substituted and variously annulated bicyclo[2.2.2]-
octenones are capable of engaging in either oxa-di-π-methane
or 1,3-acyl migration reactions depending upon the mode of
photoactivation (sensitized vs direct irradiation). The 1,3-acyl
migration reactions leading to the isomeric cyclobutanones can
be followed by rapid photodecarbonylation processes to
Scheme 6. Synthesis of Cyclopentannulated
Bicyclo[2.2.2]octenones 45−49 and Their Photochemical
Behaviors under Direct Irradiation Conditions
Scheme 7. Synthesis and Anomalous Photochemical
Behavior of the Mesyloxy-Substituted
Bicyclo[2.2.2]octenone 57
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.7b01243
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coproduce the corresponding (but normally readily separable)
cyclopropanes. A noteworthy feature of the photochemical
behaviors of the annulated bicyclo[2.2.2]octenones studied
here is that the mode of ring fusion (annulation) can have a
signiﬁcant impact on the rates of both types of processes. Thus,
for example, the lactone-annulated systems 22, 23, 26, and 27
appear to engage in more rapid 1,3-acyl migration reactions
than their cyclopentannulated counterparts 45−49. The same
could be said of the corresponding oxa-di-π-methane process,
especially when the outcomes of our earlier studies4 are taken
into account. That is to say, the lactone annulated compounds
just mentioned also appear to participate in more rapid triplet-
sensitized rearrangement reactions than their cyclopentannu-
lated counterparts. The origins of these variations are the
subject of ongoing studies, the outcomes of which will be
reported in due course.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Unless otherwise speciﬁed,
proton (1H) and carbon (13C) NMR spectra were recorded at 18 °C
in base-ﬁltered CDCl3 on a spectrometer operating at 400 MHz for
proton and 100 MHz for carbon nuclei. 1H NMR data are recorded as
follows: chemical shift (δ) [multiplicity, coupling constant(s) J (Hz),
relative integral] where multiplicity is deﬁned as s = singlet; d =
doublet; t = triplet; q = quartet; m = multiplet or combinations of the
above. In relevant cases, the signal due to residual CHCl3 appearing at
δH 7.26 and the central resonance of the CDCl3 “triplet” appearing at
δC 77.0 were used to reference
1H and 13C NMR spectra, respectively.
Samples were analyzed by infrared spectroscopy (νmax) as thin ﬁlms on
KBr plates. Optical rotations were recorded using the sodium D-line
(589 nm) in a cell with a path length of 1 dm, at the concentrations
indicated and in the speciﬁed solvent at 22 °C. Speciﬁc rotations were
then calculated in the usual manner. Low- and high-resolution electron
impact (EI) mass spectra were recorded on a double focusing, triple
sector machine. Low- and high-resolution ESI mass spectra were
recorded on a triple-quadrupole mass spectrometer operating in
positive ion mode. Melting points are uncorrected. Analytical thin
layer chromatography (TLC) was performed on aluminum-backed 0.2
mm thick silica gel 60 F254 plates. Eluted plates were visualized using a
254 nm UV lamp and/or by treatment with a suitable dip followed by
heating. These dips included phosphomolybdic acid/ceric sulfate/
sulfuric acid (conc)/water (37.5 g: 7.5 g: 37.5 g: 720 mL), potassium
permanganate/potassium carbonate/5% sodium hydroxide aqueous
solution/water (3 g: 20 g: 5 mL: 300 mL), and p-anisaldehyde or
vanillin/sulfuric acid (conc)/ethanol (15 g: 2.5 mL: 250 mL). Flash
chromatographic separations were carried out following protocols
deﬁned by Still et al.12 with silica gel 60 (40−63 μm) as the stationary
phase and using the AR- or HPLC-grade solvents indicated. The
melting points of solids puriﬁed by such means were recorded directly
(ie after they had crystallized from the concentrated chromatographic
fractions). Starting materials, reagents, drying agents, and other
inorganic salts were generally commercially available and were used as
supplied. Tetrahydrofuran (THF), methanol, and dichloromethane
were dried using a solvent puriﬁcation system that is based upon a
technology originally described by Grubbs et al.13 Where necessary,
reactions were performed under a nitrogen atmosphere.
Speciﬁc Chemical Transformations. (2a′R,3S,4S,4aR)-3,4-Dihy-
droxy-2b-methylhexahydrocyclopropa[cd]pentalen-2(1H)-one (8).
A deoxygenated solution of compound 67 (94 mg, 0.56 mmol) and
acetophenone (90 μL, 0.77 mmol) in acetone (100 mL) maintained
under nitrogen was subjected to irradiation with a Hanovia 450 W
medium-pressure mercury-vapor lamp for 2.5 h and then cooled and
concentrated under reduced pressure to give a yellow oil. This material
was subjected to ﬂash column chromatography (silica, 1:1 → 1:0 v/v
ethyl acetate/40−60 petroleum ether gradient elution) to aﬀord two
fractions, A and B.
Concentration of fraction A (Rf = 0.3 in ethyl acetate) aﬀorded the
starting compound 6 (10 mg, 11% recovery) as a colorless, crystalline
solid that was identical, in all respects, with an authentic sample.
Concentration of fraction B (Rf = 0.1 in ethyl acetate) aﬀorded
compound 8 (82 mg, 87% or 98% brsm) as a white, crystalline solid:
mp = 169−171 °C; [α]D = +71.4 (c 1.0, methanol); 1H NMR (400
MHz, CD3OD) δ 4.15 (d, J = 2.6 Hz, 1H), 3.74 (s, 1H), 2.81 (t, J =
5.0 Hz, 1H), 2.72 (m, 1H), 2.42 (m, 1H), 2.08 (m, 1H), 1.82 (d, J =
5.0 Hz, 1H), 1.37 (s, 3H) (signals due to O−H group protons not
observed); 13C NMR (100 MHz, CD3OD) δ 217.3, 88.2, 86.3, 47.8,
47.0, 46.3(0), 46.2(8), 44.2, 21.5; IR νmax 3356, 2962, 2904, 1706,
1693, 1290, 1040, 898 cm−1; MS (ESI, + ve) m/z 191 [(M + Na)+,
100]; HRMS m/z (M + Na)+ calcd for C9H12O3Na 191.0684, found
191.0685.
(2a′R,3S,4S,4aR)-4-((tert-Butyldimethylsilyl)oxy)-3-hydroxy-2b-
methylhexahydrocyclopropa[cd]pentalen-2(1H)-one (9). A deoxy-
genated solution of compound 77 (158 mg, 0.56 mmol) and
acetophenone (90 μL, 0.77 mmol) in acetone (100 mL) maintained
under nitrogen was subjected to irradiation with a Hanovia 450 W
medium-pressure mercury-vapor lamp for 2.5 h. The cooled reaction
mixture was concentrated under reduced pressure to give a clear,
yellow oil, and this was subjected to ﬂash column chromatography
(silica, 1:9 → 3:7 v/v ethyl acetate/40−60 petroleum ether gradient
elution) to aﬀord two fractions, A and B.
Concentration of fraction A (Rf = 0.4 in 3:7 v/v ethyl acetate/40−
60 petroleum ether) aﬀorded compound 7 (13 mg, 8% recovery) as a
colorless crystalline solid that was identical, in all respects, with an
authentic sample.
Concentration of fraction B (Rf = 0.2 in 3:7 v/v ethyl acetate/40−
60 petroleum ether) aﬀorded compound 9 (143 mg, 90% or 99%
brsm) as a white, crystalline solid: mp = 99−100 °C; [α]D = +41.8 (c
1.0, CHCl3);
1H NMR (800 MHz, CDCl3) δ 4.20 (d, J = 2.5 Hz, 1H),
3.81 (s, 1H), 2.76 (t, J = 5.1 Hz, 1H), 2.66 (m, 1H), 2.38 (m, 1H),
2.13 (d, J = 17.9 Hz, 1H), 1.86 (d, J = 5.0 Hz, 1H), 1.79 (broad s, 1H),
1.35 (s, 3H), 0.90 (s, 9H), 0.08 (s, 6H); 13C NMR (200 MHz, CDCl3)
δ 213.3, 86.8, 85.8, 45.3, 45.0(4), 44.9(8), 44.4, 42.2, 24.9, 20.4, 17.2,
− 5.6; IR νmax 3351, 2957, 2929, 2886, 2857, 1719, 1254, 1092, 867,
836, 771 cm−1; MS (ESI, + ve) m/z 305 [(M + Na)+, 100], 283 [(M +
H)+, 30]; HRMS m/z (M + Na)+ calcd for C15H26O3SiNa 305.1549,
found 305.1548.
(1R,2S,3S,6R)-2,3-Dihydroxy-4-methylbicyclo[4.2.0]oct-4-en-7-
one (10). A magnetically stirred and deoxygenated solution of
compound 6 (100 mg, 0.59 mmol) in dichloromethane (100 mL)
maintained under nitrogen was subjected to direct irradiation with a
Hanovia 450 W medium-pressure mercury-vapor lamp for 0.83 h. The
cooled reaction mixture was concentrated under reduced pressure to
give a yellow solid that was subjected to ﬂash column chromatography
(silica, 2:3 → 1:0 v/v ethyl acetate/40−60 petroleum ether gradient
elution) to aﬀord two fractions, A and B.
Concentration of fraction A (Rf = 0.4 in ethyl acetate) aﬀorded
compound 10 (70 mg, 70% or 84% brsm) as a white, crystalline solid:
mp = 83−85 °C; [α]D = −234.4 (c 1.0, MeOH); 1H NMR (400 MHz,
CD3OD) δ 5.40 (m, 1H), 3.96 (d, J = 6.9 Hz, 1H), 3.88 (m, 1H), 3.47
(t, J = 7.5 Hz, 1H), 3.24 (m, 1H), 2.98 (m, 1H), 2.57 (m, 1H), 1.81 (s,
3H) (signals due to O−H group protons not observed); 13C NMR
(100 MHz, CD3OD) δ 209.0, 140.2, 116.7, 76.2, 73.6, 61.0, 50.1, 30.2,
20.0; IR νmax 3391, 2882, 1769, 1066, 1047, 1014, 884 cm
−1; MS (ESI,
+ ve) m/z 223 [(M + MeOH + Na)+, 40], 191 [(M + Na)+, 100];
HRMS m/z (M + Na)+ calcd for C9H12O3Na 191.0684, found
191.0684.
Concentration of fraction B (Rf = 0.3 in ethyl acetate) aﬀorded
compound 6 (14 mg, 14% recovery) as a colorless, crystalline solid
that was identical, in all respects, with an authentic sample.
(1R,2S,3S,6R)-2-((tert-Butyldimethylsilyl)oxy)-3-hydroxy-4-
methylbicyclo[4.2.0]oct-4-en-7-one (11). A magnetically stirred and
deoxygenated solution of compound 7 (100 mg, 0.35 mmol) in
dichloromethane (100 mL) maintained under nitrogen was subjected
to direct irradiation with a Hanovia 450 W medium-pressure mercury-
vapor lamp for 0.67 h. The cooled reaction mixture was concentrated
under reduced pressure to give a pale-yellow oil. This was subjected to
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ﬂash column chromatography (silica, 1:9 v/v ethyl acetate/40−60
petroleum ether elution) to give, after concentration of the appropriate
fractions (Rf = 0.6 in 3:7 v/v ethyl acetate/40−60 petroleum ether),
compound 11 (67 mg, 67%) as a white, crystalline solid: mp = 67−69
°C; [α]D = −139.6 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ
5.38 (m, 1H), 4.04 (d, J = 7.0 Hz, 1H), 3.86 (m, 1H), 3.57 (t, J = 7.7
Hz, 1H), 3.24 (m, 1H), 2.94 (m, 1H), 2.57 (m, 1H), 2.18 (broad s,
1H), 1.82 (s, 3H), 0.90 (s, 9H), 0.13 (s, 3H), 0.10 (s, 3H); 13C NMR
(100 MHz, CDCl3) δ 207.0, 138.4, 115.1, 77.9, 73.4, 60.6, 50.2, 29.9,
25.9, 19.1, 18.3, − 3.8, − 4.2; IR νmax 3499, 2954, 2930, 2857, 1779,
1126, 1087, 836 cm−1; MS (ESI, + ve) m/z 337 [(M + MeOH + Na)+,
30], 305 [(M + Na)+, 100]; HRMS m/z (M + Na)+ calcd for
C15H26O3SiNa 305.1549, found 305.1554.
(1R,2S,3S,6R)-4-Methylbicyclo[4.1.0]hept-4-ene-2,3-diol (12). A
magnetically stirred and deoxygenated solution of compound 6 (100
mg, 0.59 mmol) in dichloromethane (100 mL) maintained under a
nitrogen atmosphere was subjected to direct irradiation with a Hanovia
450 W medium-pressure mercury-vapor lamp for 5 h. The cooled
reaction mixture was concentrated under reduced pressure to give a
brown oil that was subjected to ﬂash column chromatography (silica,
1:4 → 1:1 v/v ethyl acetate/40−60 petroleum ether gradient elution)
to aﬀord two fractions, A and B.
Concentration of fraction A (Rf = 0.6 in ethyl acetate) aﬀorded
compound 12 (27 mg, 32%) as a pale-yellow oil: [α]D = +93.2 (c 0.8,
CHCl3);
1H NMR (400 MHz, CDCl3) δ 6.00 (m, 1H), 4.04−3.99
(complex m, 2H), 1.92 (broad s, 2H), 1.76 (s, 3H), 1.48−1.35
(complex m, 2H), 1.03 (m, 1H), 0.64 (m, 1H); 13C NMR (100 MHz,
CDCl3) δ 130.3, 127.8, 73.3, 70.1, 21.4, 19.6, 18.7, 11.0; IR νmax 3367,
2920, 1445, 1260, 1048, 1001, 724 cm−1; MS (EI, 70 eV) m/z 140
(M•+, 30), 122 [(M − H2O)•+, 60], 93 (100), 79 (90), 77 (70), 70
(60), 55 (60); HRMS m/z M•+ calcd for C8H12O2 140.0837, found
140.0842.
Concentration of fraction B (Rf = 0.4 in ethyl acetate) aﬀorded
compound 10 (48 mg, 48%) as a white, crystalline solid that was
identical, in all respects, with an authentic sample.
(1R,2S,3S,6R)-2-((tert-Butyldimethylsilyl)oxy)-4-methylbicyclo-
[4.1.0]hept-4-en-3-ol (13). A magnetically stirred and deoxygenated
solution of compound 7 (100 mg, 0.35 mmol) in dichloromethane
(100 mL) maintained under a nitrogen atmosphere was subjected to
irradiation with a Hanovia 450 W medium-pressure mercury-vapor
lamp for 5 h. The cooled reaction mixture was concentrated under
reduced pressure to give a brown oil that was subjected to ﬂash
column chromatography (silica, 1:9 → 1:4 v/v ethyl acetate/40−60
petroleum ether gradient elution) to aﬀord two fractions, A and B.
Concentration of fraction A (Rf = 0.7 in 3:7 v/v ethyl acetate/40−
60 petroleum ether) aﬀorded compound 13 (30 mg, 33%) as a
colorless, crystalline solid: mp = 32−33 °C; [α]D = +35.3 (c 1.0,
CHCl3).
1H NMR (400 MHz, CDCl3) δ 5.71 (m, 1H), 4.08 (d, J = 5.9
Hz, 1H), 3.59 (m, 1H), 1.97 (broad s, 1H), 1.74 (s, 3H), 1.33−1.17
(complex m, 2H), 0.99−0.94 (complex m, 1H), 0.92 (s, 9H), 0.32 (m,
1H), 0.14 (s, 3H), 0.12 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
134.4, 124.7, 75.1, 74.0, 26.0, 19.6, 19.3, 18.7, 18.3, 12.0, − 4.1, − 4.6;
IR νmax 3458, 2929, 2857, 1254, 1075, 1003, 835, 775 cm
−1; MS (EI,
70 eV) m/z 239 [(M − CH3•)+, 30], 211 (35), 197 [(M − C4H9•)+,
35], 105 (60), 75 (100), 73 (95); HRMS m/z (M − CH3•)+ calcd for
C13H23O2Si 239.1467, found 239.1468.
Concentration of fraction B (Rf = 0.6 in 3:7 v/v ethyl acetate/40−
60 petroleum ether) aﬀorded compound 11 (33 mg, 33%) as a
colorless, crystalline solid that was identical, in all respects, with an
authentic sample.
(1S,2R)-3-Methylcyclohexa-3,5-diene-1,2-diyl (2E,2′E)-Bis(but-2-
enoate) (14). A magnetically stirred solution of (1S,2R)-3-methyl-
cyclohexa-3,5-diene-1,2-diol (5) (2.40 g, 19.0 mmol) in dry THF (284
mL) was cooled to −78 °C and then treated, dropwise over 0.5 h, with
n-BuLi (12.5 mL of a 1.6 M solution in hexane, 20.0 mmol). The
resulting solution was stirred at −78 °C for 0.17 h and then treated
with crotonoyl chloride (1.80 mL, 19.02 mmol) over 0.33 h. The
resulting solution was stirred for 2 h at −78 °C and then treated,
dropwise over 0.5 h, with n-BuLi (12.5 mL of a 1.6 M solution in
hexane, 20.0 mmol). After 0.17 h, another portion of crotonoyl
chloride (1.80 mL, 19.02 mmol) was added over 0.33 h, and then
stirring of the recation mixture was continued at −78 °C for 1 h. The
ensuing mixture was warmed to 22 °C and then quenched with
NaHCO3 (96 mL of a saturated aqueous solution) before being
diluted with diethyl ether (390 mL). The separated organic phase was
washed with NH4Cl (1 × 96 mL of a saturated aqueous solution) and
then dried (MgSO4), ﬁltered, and concentrated under reduced
pressure. The residue thus obtained was subjected to ﬂash column
chromatography to give, after concentration of the appropriate
fractions (Rf = 0.5 in 1:4 v/v ethyl acetate/40−60 petroleum ether),
compound 14 (4.04 g, 81%) as a pale-yellow oil. The spectral data
recorded on this material matched those reported previously.8
(1S,2R)-3-Methylcyclohexa-3,5-diene-1,2-diyl (2E,2′E)-Bis(4-
methylpent-2-enoate) (15). A magnetically stirred solution of
(1S,2R)-3-methylcyclohexa-3,5-diene-1,2-diol (5) (2.40 g, 19.02
mmol) in dry THF (284 mL) was cooled to −78 °C and then
treated, dropwise over 0.5 h, with n-BuLi (12.5 mL of a 1.6 M solution
in hexane, 20.0 mmol). The resulting solution was stirred at −78 °C
for 0.17 h and then treated, dropwise over 0.33 h, with (E)-4-
methylpent-2-enoyl chloride14 (2.50 mL, 19.02 mmol). The ensuing
mixture was stirred at −78 °C for 2 h and again treated, dropwise over
0.5 h, with n-BuLi (12.5 mL of a 1.6 M solution in hexane, 20.0
mmol). After 0.17 h, further (E)-4-methylpent-2-enoyl chloride (1.80
mL, 19.02 mmol) was added, again dropwise over 0.33 h, and stirring
was continued at −78 °C for 1 h. The reaction mixture was then
allowed to warm to 22 °C before being quenched with NaHCO3 (96
mL of a saturated aqueous solution) and diluted with diethyl ether
(390 mL). The separated organic phase was washed with NH4Cl (1 ×
96 mL of a saturated aqueous solution), dried (MgSO4), ﬁltered, and
concentrated under reduced pressure. The residue thus obtained was
subjected to ﬂash column chromatography to give, after concentration
of the appropriate fractions (Rf = 0.6 in 1:4 v/v ethyl acetate/40−60
petroleum ether), compound 15 (4.47 g, 74%) as a pale-yellow oil:
[α]D = +71.6 (c 1.0, CHCl3);
1H NMR (400 MHz, CDCl3) δ 6.98−
6.88 (complex m, 2H), 6.06 (m, 1H), 5.88 (broadened d, J = 5.2 Hz,
1H), 5.81−5.72 (complex m, 3H), 5.62 (s, 2H), 2.43 (m, 2H), 1.84 (s,
3H), 1.05−1.02 (complex m, 12H); 13C NMR (100 MHz, CDCl3) δ
166.5, 166.3, 156.5, 156.2, 134.7, 126.6, 123.0, 121.9, 118.3, 118.1,
69.5, 68.0, 31.1, 31.0, 21.3, 21.2, 19.8 (two signals obscured or
overlapping); IR νmax 2963, 1717, 1651, 1297, 1260, 1157, 982, 859
cm−1; MS (ESI, + ve) m/z 341 [(M + Na)+, 100]; HRMS m/z: (M +
Na)+ calcd for C19H26O4Na 341.1729, found 341.1728.
3a,8-Dimethyl-2-oxo-2,3,3a,6,7,7a-hexahydro-3,6-methanoben-
zofuran-7-yl (E)-But-2-enoate (16) and 6,8-Dimethyl-2-oxo-
2,3,3a,6,7,7a-hexahydro-3,6-methanobenzofuran-7-yl (E)-But-2-
enoate (18). A magnetically stirred solution of compound 14 (4.04
g, 15.40 mmol) in toluene (97 mL) maintained under a nitrogen
atmosphere was heated at reﬂux for 24 h then cooled to 22 °C and
concentrated under reduced pressure. The resulting yellow oil was
subjected to ﬂash chromatography (silica, 1:19 v/v ethyl acetate/40−
60 petroleum ether elution) to give two fractions, A and B.
Concentration of fraction A [Rf = 0.2(5) in 1:4 v/v ethyl acetate/
40−60 petroleum ether] aﬀorded compound 16 (1.62 g, 40%) as a
white, crystalline solid, mp = 45−47 °C. The spectral data recorded on
this material matched those reported previously.8
Concentration of fraction B (Rf = 0.2 in 1:4 v/v ethyl acetate/40−
60 petroleum ether) aﬀorded compound 18 (1.06 g, 26%) as a clear,
colorless oil. The spectral data recorded on this material matched
those reported previously.8
8-Isopropyl-3a-methyl-2-oxo-2,3,3a,6,7,7a-hexahydro-3,6-meth-
anobenzofuran-7-yl (E)-4-Methylpent-2-enoate (17) and 8-Iso-
propyl-6-methyl-2-oxo-2,3,3a,6,7,7a-hexahydro-3,6-methanoben-
zofuran-7-yl (E)-4-Methylpent-2-enoate (19). A magnetically stirred
solution of compound 15 (4.47 g, 14.04 mmol) in toluene (88 mL)
maintained under a nitrogen atmosphere was heated at reﬂux for 72 h
then cooled to 22 °C, and concentrated under reduced pressure. The
resulting yellow oil was subjected to ﬂash chromatography (silica, 1:19
v/v ethyl acetate/40−60 petroleum ether elution) to aﬀord two
fractions, A and B.
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Concentration of fraction A (Rf = 0.4 in 1:4 v/v ethyl acetate/40−
60 petroleum ether) aﬀorded compound 17 (1.83 g, 41%) as a white,
crystalline solid: mp = 69−71 °C; [α]D = −115.4 (c 1.0, CHCl3); 1H
NMR (400 MHz, CDCl3) δ 6.97 (dd, J = 15.7 and 6.5 Hz, 1H), 6.38
(t, J = 7.6 Hz, 1H), 5.84 (m, 2H), 4.37 (dd, J = 6.7 and 2.2 Hz, 1H),
4.24 (d, J = 6.7 Hz, 1H), 2.98 (m, 1H), 2.47 (m, 1H), 1.93−1.88
(complex m, 2H), 1.40 (s, 3H), 1.27 (m, 1H), 1.08 (s, 3H), 1.06 (s,
3H), 0.97 (d, J = 6.5 Hz, 3H), 0.90 (d, J = 6.6 Hz, 3H); 13C NMR
(100 MHz, CDCl3) δ 179.3, 166.5, 156.8, 133.1, 132.2, 117.9, 77.3,
70.6, 49.7, 46.9, 45.1, 38.8, 31.1, 30.5, 21.3, 21.2, 20.9, 20.8, 20.7; IR
νmax 2962, 1783, 1717, 1264, 1160, 1038, 1009, 902 cm
−1; MS (EI, 70
eV) m/z 318 (M•+, 5), 156 (15), 133 (10), 97 (100), 69 (10), 41 (20);
HRMS m/z M•+ calcd for C19H26O4 318.1831, found 318.1834.
Concentration of fraction B [Rf = 0.3(5) in 1:4 v/v ethyl acetate/
40−60 petroleum ether] aﬀorded compound 19 (537 mg, 12%) as a
clear, colorless oil: [α]D = +176.0 (c 1.0, CHCl3);
1H NMR (400
MHz, CDCl3) δ 6.97 (dd, J = 15.7 and 6.5 Hz, 1H), 6.09 (d, J = 8.2
Hz, 1H), 6.00 (dd, J = 8.2 and 6.6 Hz, 1H), 5.83 (dd, J = 15.7 and 1.5
Hz, 1H), 4.57 (m, 1H), 4.05 (d, J = 6.7 Hz, 1H), 3.45 (m, 1H), 2.47
(m, 1H), 2.30 (m, 1H), 2.16 (m, 1H), 2.01 (m, 1H), 1.24 (s, 3H), 1.08
(s, 3H), 1.06 (s, 3H), 0.99 (d, J = 6.9 Hz, 3H), 0.61 (d, J = 6.8 Hz,
3H); 13C NMR (100 MHz, CDCl3) δ 179.7, 166.7, 156.8, 140.3,
124.6, 117.8, 74.4, 72.9, 48.0, 42.2, 40.6, 40.2, 31.1, 27.4, 22.8, 21.3,
21.2, 19.9, 19.1; IR νmax 2961, 1786, 1718, 1264, 1158, 1027, 982, 907
cm−1; MS (EI, 70 eV) m/z 318 (M•+, 5), 205 (5), 97 (100), 69 (15),
41 (25); HRMS m/z M•+ calcd for C19H26O4 318.1831, found
318.1832.
7-Hydroxy-6,8-dimethyl-3a,6,7,7a-tetrahydro-3,6-methanoben-
zofuran-2(3H)-one (20). A magnetically stirred solution of compound
18 (918 mg, 3.50 mmol) in methanol (55 mL) maintained at 0 °C was
treated, in one portion, with potassium carbonate (242 mg, 1.75
mmol). The ensuing mixture was stirred at 0 °C for a further 0.5 h and
then warmed to 22 °C, stirred at this temperature for 1 h, and then
recooled to 0 °C and treated with water (30 mL) before being
concentrated under reduced pressure. The residue thus obtained was
extracted with ethyl acetate (3 × 100 mL), and the combined organic
phases were then dried (MgSO4), ﬁltered, and concentrated under
reduced pressure. The resulting light-yellow oil was subjected to ﬂash
column chromatography (silica, 3:7 → 1:1 v/v ethyl acetate/40−60
petroleum ether gradient elution) to give, after concentration of the
appropriate fractions (Rf = 0.1 in 3:7 v/v ethyl acetate/40−60
petroleum ether), compound 20 (503 mg, 74%) as a white, crystalline
solid: mp = 114−116 °C; [α]D = +67.5 (c 1.0, CHCl3); 1H NMR (400
MHz, CDCl3) δ 6.06−6.00 (complex m, 2H), 4.39 (t, J = 6.0 Hz, 1H),
3.43 (m, 1H), 3.26 (t, J = 6.7 Hz, 1H), 2.23 (d, J = 6.8 Hz, 1H), 2.11
(m, 1H), 2.01 (d, J = 4.5 Hz, 1H), 1.25 (s, 3H), 0.89 (d, J = 7.1 Hz,
3H); 13C NMR (100 MHz, CDCl3) δ 178.9, 141.2, 124.2, 74.9, 71.9,
46.9, 44.1, 40.4, 36.5, 18.8, 17.3; IR νmax 3417, 2968, 1760, 1750, 1184,
1102, 1015, 713 cm−1; MS (ESI, + ve) m/z 217 [(M + Na)+, 100];
HRMS m/z (M + Na)+ calcd for C11H14O3Na 217.0841, found
217.0844.
7-Hydroxy-8-isopropyl-6-methyl-3a,6,7,7a-tetrahydro-3,6-meth-
anobenzofuran-2(3H)-one (21). A magnetically stirred solution of
compound 19 (1.11 g, 3.50 mmol) in methanol (55 mL) maintained
at 0 °C was treated, in one portion, with potassium carbonate (242
mg, 1.75 mmol). After being kept for 0.5 h at 0 °C, the reaction
mixture was warmed to 22 °C, maintained at this temperature for 1 h,
and then recooled to 0 °C and treated with water (30 mL) before
being concentrated under reduced pressure. The residue thus obtained
was extracted with ethyl acetate (3 × 100 mL), and the combined
organic phases were then dried (MgSO4), ﬁltered, and concentrated
under reduced pressure to give a light-yellow oil. This material was
subjected to ﬂash column chromatography (silica, 3:17 → 3:7 v/v
ethyl acetate/40−60 petroleum ether gradient elution) and gave, after
concentration of the appropriate fractions (Rf = 0.3 in 3:7 v/v ethyl
acetate/40−60 petroleum ether), compound 21 (590 mg, 76%) as a
white solid: mp = 120−122 °C; [α]D = +100.7 (c 1.0, CHCl3); 1H
NMR (400 MHz, CDCl3) δ 6.09 (d, J = 8.1 Hz, 1H), 5.93 (m, 1H),
4.35 (m, 1H), 3.43 (m, 1H), 3.12 (d, J = 6.9 Hz, 1H), 2.28 (m, 1H),
2.03−1.95 (complex m, 2H), 1.26 (s, 3H), 0.97 (d, J = 6.7 Hz, 3H),
0.60 (d, J = 6.7 Hz, 3H) (signal due to O−H group proton not
observed); 13C NMR (100 MHz, CDCl3) δ 179.3, 141.8, 123.3, 74.8,
72.9, 47.6, 44.0, 40.2 (3), 40.1 (7), 27.3, 22.7, 19.8, 18.8; IR νmax 3425,
2958, 1765, 1170, 1100, 978, 723 cm−1; MS (ESI, + ve) m/z 467 [(2M
+ Na)+, 30], 245 [(M + Na)+, 100], 223 [(M + H)+, 70]; HRMS m/z
(M + Na)+ calcd for C13H18O3Na 245.1154, found 245.1156.
6,8-Dimethyl-3a,7a-dihydro-3,6-methanobenzofuran-2,7-
(3H,6H)-dione (22). A magnetically stirred solution of compound 20
(466 mg, 2.40 mmol) in dry dichloromethane (78 mL) maintained at
0 °C under an atmosphere of nitrogen was treated with pyridine (1.2
mL, 15.05 mmol) and then Dess−Martin periodinane (1.83 g, 4.32
mmol). After a further 0.5 h, the reaction mixture was warmed to 22
°C, maintained at this temperature for 3 h, and then poured into water
(100 mL) and extracted with dichloromethane (3 × 100 mL). The
combined organic phases were washed with NaOH (1 × 100 mL of a 1
M aqueous solution) and then HCl (1 × 100 mL of a 1 M aqueous
solution) before being dried (MgSO4), ﬁltered, and then concentrated
under reduced pressure. The residue thus obtained was subjected to
ﬂash column chromatography (silica, 1:9 → 3:17 v/v ethyl acetate/
40−60 petroleum ether gradient elution) to give, after concentration
of the appropriate fractions (Rf = 0.3 in 3:7 v/v ethyl acetate/40−60
petroleum ether), compound 22 (397 mg, 86%) as a white, crystalline
solid: mp = 121−124 °C; [α]D = +518.8 (c 1.0, CHCl3); 1H NMR
(400 MHz, CDCl3) δ 6.32 (dd, J = 8.1 and 6.5 Hz, 1H), 6.02 (d, J =
8.1 Hz, 1H), 4.15 (dd, J = 5.0 and 1.0 Hz, 1H), 3.66 (m, 1H), 2.37 (d,
J = 5.0 Hz, 1H), 2.21 (m, 1H), 1.32 (s, 3H), 1.02 (d, J = 7.0 Hz, 3H);
13C NMR (100 MHz, CDCl3) δ 201.5, 177.8, 136.7, 128.3, 73.9, 53.8,
47.1, 41.3, 40.9, 16.1, 15.2; IR νmax 2976, 2937, 1785, 1736, 1159, 989,
837, 713 cm−1; MS (ESI, + ve) m/z 247 [(M + MeOH + Na)+, 100],
215 [(M + Na)+, 20]; HRMS m/z (M + MeOH + Na)+ calcd for
C12H16O4Na 247.0946, found 247.0946.
8-Isopropyl-6-methyl-3a,7a-dihydro-3,6-methanobenzofuran-
2,7(3H,6H)-dione (23). A magnetically stirred solution of compound
21 (533 mg, 2.40 mmol) in dry dichloromethane (78 mL) maintained
at 0 °C under an atmosphere of nitrogen was treated with pyridine
(1.2 mL, 15.05 mmol) and then the Dess−Martin periodinane (1.83 g,
4.32 mmol). After a further 0.5 h the reaction mixture was warmed to
22 °C, stirred at this temperature for 3 h, and then poured into water
(100 mL) and extracted with dichloromethane (3 × 100 mL). The
combined organic phases were washed with NaOH (1 × 100 mL of a 1
M aqueous solution) then HCl (1 × 100 mL of a 1 M aqueous
solution) before being dried (MgSO4), ﬁltered, and concentrated
under reduced pressure. The residue thus obtained was subjected to
ﬂash column chromatography (silica, 3:17 → 3:7 v/v ethyl acetate/
40−60 petroleum ether gradient elution) and gave, after concentration
of the appropriate fractions (Rf = 0.3 in 3:7 v/v ethyl acetate/40−60
petroleum ether), compound 23 (433 mg, 82%) as a white, crystalline
solid: mp = 114−116 °C; [α]D = +396.1 (c 0.8, CHCl3); 1H NMR
(400 MHz, CDCl3) δ 6.19 (dd, J = 8.1 and 6.6 Hz, 1H), 6.04 (m, 1H),
4.12 (dd, J = 5.0 and 1.1 Hz, 1H), 3.67 (m, 1H), 2.64 (m, 1H), 2.11
(m, 1H), 1.99 (m, 1H), 1.36 (s, 3H), 1.01 (d, J = 6.9 Hz, 3H), 0.72 (d,
J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 200.7, 178.5, 136.8,
127.3, 73.9, 53.6, 51.7, 40.9, 40.4, 28.2, 22.8, 20.0, 15.3; IR νmax 2961,
1802, 1786, 1734, 1151, 1002, 981, 899 cm−1; MS (ESI, + ve) m/z 275
[(M + MeOH + Na)+, 100], 243 [(M + Na)+, 40]; HRMS m/z (M +
MeOH + Na)+ calcd for C14H20O3Na 275.1259, found 275.1251.
7-Hydroxy-3a,8-dimethyl-3a,6,7,7a-tetrahydro-3,6-methanoben-
zofuran-2(3H)-one (24). A magnetically stirred solution of compound
16 (918 mg, 3.50 mmol) in methanol (55 mL) maintained at 0 °C
under an atmosphere of nitrogen was treated, in one portion, with
potassium carbonate (242 mg, 1.75 mmol). After a further 0.5 h, the
reaction mixture was warmed to 22 °C, stirred at this temperature for
1 h, and then recooled to 0 °C and treated with water (30 mL) before
being concentrated under reduced pressure. The residue thus obtained
was extracted with ethyl acetate (3 × 100 mL), and the combined
organic phases were then dried (MgSO4), ﬁltered, and concentrated
under reduced pressure to give a light-yellow oil. This material was
subjected to ﬂash column chromatography (silica, 1:4 → 3:7 v/v ethyl
acetate/40−60 petroleum ether gradient elution) and gave, after
concentration of the appropriate fractions (Rf = 0.2 in 3:7 v/v ethyl
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acetate/40−60 petroleum ether), compound 24 (538 mg, 79%) as a
white, crystalline solid: mp = 146−148 °C; [α]D = +15.8 (c 1.0,
CHCl3);
1H NMR (400 MHz, CDCl3) δ 6.36 (t, J = 7.6 Hz, 1H), 5.81
(dd, J = 7.6 and 1.0 Hz, 1H), 3.98 (d, J = 6.9 Hz, 1H), 3.57 (dd, J = 6.9
and 2.2 Hz, 1H), 2.68 (m, 1H), 2.47 (m, 2H), 1.68 (s, 1H), 1.39 (s,
3H), 0.93 (d, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 179.0,
135.4, 130.8, 79.0, 69.0, 52.2, 45.2, 45.0, 33.1, 21.1, 20.1; IR νmax 3402,
2964, 1740, 1347, 1182, 1085, 992, 948, 713, 703 cm−1; MS (ESI, +
ve) m/z 217 [(M + Na)+, 100%]; HRMS m/z (M + Na)+ calcd for
C11H14O3Na 217.0841, found 217.0842.
7-Hydroxy-8-isopropyl-3a-methyl-3a,6,7,7a-tetrahydro-3,6-
methanobenzofuran-2(3H)-one (25). A magnetically stirred solution
of compound 17 (1.11 g, 3.50 mmol) in methanol (55 mL)
maintained at 0 °C under an atmosphere of nitrogen was treated, in
one portion, with potassium carbonate (242 mg, 1.75 mmol). After a
further 0.5 h at 0 °C, the reaction mixture was warmed to 22 °C,
stirred at this temperature for 1 h, and then recooled to 0 °C and
treated with water (30 mL) before being concentrated under reduced
pressure. The ensuing mixture was extracted with ethyl acetate (3 ×
100 mL), and the combined organic phases were dried (MgSO4),
ﬁltered, and concentrated under reduced pressure. The residue thus
obtained was subjected to ﬂash column chromatography (silica, 3:7→
1:1 v/v ethyl acetate/40−60 petroleum ether gradient elution) and
gave, after concentration of the appropriate fractions (Rf = 0.2 in 3:7
v/v ethyl acetate/40−60 petroleum ether), compound 25 (732 mg,
94%) as a white, crystalline solid: mp = 60−61 °C; [α]D = +2.8 (c 0.9,
CHCl3);
1H NMR (400 MHz, CDCl3) δ 6.35 (t, J = 8.3 Hz, 1H), 5.78
(dd, J = 8.3 and 1.2 Hz, 1H), 3.99 (d, J = 6.9 Hz, 1H), 3.54 (dd, J = 6.9
and 2.3 Hz, 1H), 2.89 (m, 1H), 2.48 (broad s, 1H), 1.85 (m, 2H), 1.38
(s, 3H), 1.25 (m, 1H), 0.93 (d, J = 6.5 Hz, 3H), 0.87 (d, J = 6.6 Hz,
3H); 13C NMR (100 MHz, CDCl3) δ 179.1, 134.6, 131.1, 79.3, 68.9,
49.7, 46.4, 44.9, 41.7, 30.7, 21.1, 20.8(0), 20.7(6); IR νmax 3452, 2962,
1778, 1166, 1117, 993, 706 cm−1; MS (ESI, + ve) m/z 245 [(M +
Na)+, 40], 223 [(M + H)+, 100], 205 (50), 159 (100), 109 (90), 90
(70); HRMS m/z (M + H)+ calcd for C13H19O3 223.1334, found
223.1331.
3a,8-Dimethyl-3a,7a-dihydro-3,6-methanobenzofuran-2,7-
(3H,6H)-dione (26). A magnetically stirred solution of compound 24
(466 mg, 2.40 mmol) in dry dichloromethane (78 mL) maintained at
0 °C under an atmosphere of nitrogen was treated with pyridine (1.2
mL, 15.05 mmol) and then the Dess−Martin periodinane (1.83 g, 4.32
mmol). After being kept at 0 °C for a further 0.5 h, the reaction
mixture was warmed to 22 °C and maintained at this temperature for 3
h before being poured into water (100 mL) and extracted with
dichloromethane (3 × 100 mL). The combined organic phases were
washed with NaOH (1 × 100 mL of a 1 M aqueous solution) and HCl
(1 × 100 mL of a 1 M aqueous solution) and then dried (MgSO4),
ﬁltered, and concentrated under reduced pressure. The residue thus
obtained was subjected to ﬂash column chromatography (silica, 1:9→
3:17 v/v ethyl acetate/40−60 petroleum ether gradient elution) and
gave, after concentration of the appropriate fractions (Rf = 0.3 in 3:7
v/v ethyl acetate/40−60 petroleum ether), compound 26 (434 mg,
94%) as a white, crystalline solid: mp = 135−136 °C; [α]D = −445.7
(c 1.0, CHCl3);
1H NMR (400 MHz, CDCl3) δ 6.37 (t, J = 7.5 Hz,
1H), 6.13 (dd, J = 7.5 and 1.0 Hz, 1H), 3.75 (s, 1H), 3.27 (dd, J = 6.7
and 3.1 Hz, 1H), 2.59 (m, 1H), 1.98 (s, 1H), 1.47 (s, 3H), 1.02 (d, J =
7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 200.0, 177.7, 134.5,
130.4, 78.5, 54.0, 51.9, 46.5, 37.2, 19.9, 18.4; IR νmax 2964, 1788, 1742,
1312, 1161, 995, 875, 723 cm−1; MS (ESI, + ve) m/z 247 [(M +
MeOH + Na)+, 100]; HRMS m/z (M + MeOH + Na)+ Calcd for
C12H16O3Na 247.0946, found 247.0943.
8-Isopropyl-3a-methyl-3a,7a-dihydro-3,6-methanobenzofuran-
2,7(3H,6H)-dione (27). A magnetically stirred solution of compound
25 (533 mg, 2.40 mmol) in dry dichloromethane (78 mL) maintained
at 0 °C under an atmosphere of nitrogen was treated with pyridine
(1.2 mL, 15.05 mmol) and then the Dess−Martin periodinane (1.83 g,
4.32 mmol). After a further 0.5 h at 0 °C, the reaction mixture was
warmed to 22 °C and then stirred at this temperature for 3 h before
being poured into water (100 mL) and extracted with dichloro-
methane (3 × 100 mL). The combined organic phases were washed
with NaOH (1 × 100 mL of a 1 M aqueous solution) and HCl (1 ×
100 mL of a 1 M aqueous solution) then dried (MgSO4), ﬁltered, and
concentrated under reduced pressure. The residue thus obtained was
subjected to ﬂash column chromatography (silica, 1:9 → 3:17 v/v
ethyl acetate/40−60 petroleum ether gradient elution) and gave, after
concentration of the appropriate fractions (Rf = 0.5 in 3:7 v/v ethyl
acetate/40−60 petroleum ether), compound 27 (413 mg, 78%) as a
white, crystalline solid: mp = 121−123 °C; [α]D = −332.5 (c 1.0,
CHCl3);
1H NMR (400 MHz, CDCl3) δ 6.37 (t, J = 8.2 Hz, 1H), 6.09
(dd, J = 8.2 and 1.1 Hz, 1H), 3.77 (s, 1H), 3.49 (dd, J = 6.7 and 3.1
Hz, 1H), 2.19 (s, 1H), 1.93 (dd, J = 10.2 and 2.5 Hz, 1H), 1.47 (s,
3H), 1.42 (m, 1H), 1.00 (d, J = 6.5 Hz, 3H), 0.89 (d, J = 6.6 Hz, 3H);
13C NMR (100 MHz, CDCl3) δ 200.4, 177.7, 134.8, 129.8, 78.8, 51.1,
50.2, 49.4, 46.2, 29.2, 20.6, 20.4, 19.9; IR νmax 2968, 17909, 1775, 1741,
1160, 985, 713 cm−1; MS (ESI, + ve) m/z 275 [(M + MeOH + Na)+,
100], 221 [(M + H)+, 10]; HRMS m/z (M + MeOH + Na)+ calcd for
C14H20O3Na 275.1259, found 275.1260.
(1aS,1a′R,3aS,4S,4aR,4a′R)-4,4a-Dimethylhexahydro-1H-
cyclopropa[3,4]pentaleno[1,6-bc]furan-1,3(1aH)-dione (28). A de-
oxygenated and magnetically stirred solution of compound 22 (108
mg, 0.56 mmol) and acetophenone (90 μL, 0.77 mmol) in acetone
(100 mL) maintained under a nitrogen atmosphere was subjected to
irradiation with a Hanovia 450 W medium-pressure mercury-vapor
lamp for 0.83 h. The reaction mixture was then cooled and
concentrated under reduced pressure to give a brown oil that was
subjected to ﬂash column chromatography (silica, 3:17 → 3:7 v/v
ethyl acetate/40−60 petroleum ether gradient elution). Concentration
of the appropriate fractions (Rf = 0.3 in 1:1 v/v ethyl acetate/40−60
petroleum ether) then gave compound 28 (44 mg, 40%) as a pale-
yellow oil: [α]D = +5.1 (c 1.0, CHCl3);
1H NMR (400 MHz, CDCl3)
δ 4.57 (dd, J = 9.0 and 2.2 Hz, 1H), 3.59 (m, 1H), 2.80 (t, J = 8.0 Hz,
1H), 2.60 (m, 1H), 2.45 (m, 1H), 1.98 (m, 1H), 1.30 (d, J = 7.2 Hz,
3H), 1.22 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 206.9, 176.8, 82.4,
57.2, 46.1, 45.1, 45.0, 44.7, 38.1, 19.5, 18.4; IR νmax 2969, 2928, 1779,
1726, 1192, 1152, 1054, 1031, 983 cm−1; MS (ESI, + ve) m/z 215 [(M
+ Na)+, 100]; HRMS m/z (M + Na)+ calcd for C11H12O3Na 215.0684,
found 215.0687.
(1aS,1a′R,3aS,4S,4aS,4a′R)-4-Isopropyl-4a-methylhexahydro-1H-
cyclopropa[3,4]pentaleno[1,6-bc]furan-1,3(1aH)-dione (29). A de-
oxygenated and magnetically stirred solution of compound 23 (123
mg, 0.56 mmol) and acetophenone (90 μL, 0.77 mmol) in acetone
(100 mL) maintained under a nitrogen atmosphere was subjected to
irradiation with a Hanovia 450 W medium-pressure mercury-vapor
lamp for 0.67 h. The reaction mixture thus formed was cooled and
concentrated under reduced pressure to give a yellow oil that was
subjected to ﬂash column chromatography (silica, 3:17 → 1:3 v/v
ethyl acetate/40−60 petroleum ether gradient elution). Concentration
of the appropriate fractions (Rf = 0.4 in 1:1 v/v ethyl acetate/40−60
petroleum ether) then gave compound 29 (53 mg, 43%) as a white,
crystalline solid: mp = 107−109 °C; [α]D = −7.6 (c 1.0, CHCl3). 1H
NMR (400 MHz, CDCl3) δ 4.60 (dd, J = 8.9 and 2.0 Hz, 1H), 3.61
(m, 1H), 3.10 (dd, J = 8.5 and 6.5 Hz, 1H), 2.62 (m, 1H), 2.38 (m,
1H), 2.15 (m, 1H), 1.88 (m, 1H), 1.27 (s, 3H), 1.05 (d, J = 6.9 Hz,
3H), 0.97 (d, J = 6.5 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 206.9,
177.4, 82.5, 55.0, 47.8, 46.6, 45.6, 44.0, 38.3, 29.2, 22.1, 19.5, 17.0; IR
νmax 2963, 1780, 1728, 1196, 1150, 1049, 983 cm
−1; MS (EI, 70 eV)
m/z 220 (M•+, 25), 153 (40), 149 (90), 133 (40), 105 (60), 93 (100),
91 (70), 84 (60), 77 (50), 59 (70); HRMS m/z M•+ calcd for
C13H16O3 220.1099, found 220.1092.
(2aS,2a′R,3aR,6S,6aS)-5,6-Dimethyl-2a1,3a,6,6a-tetrahydro-1H-
cyclobuta[cd]isobenzofuran-1,3(2aH)-dione (30). A deoxygenated
and magnetically stirred solution of compound 22 (100 mg, 0.52
mmol) in dichloromethane (100 mL) maintained under a nitrogen
atmosphere was subjected to irradiation with a Hanovia 450 W
medium-pressure mercury-vapor lamp for 0.5 h. The reaction thus
obtained was then cooled and concentrated under reduced pressure to
give a yellow solid. Subjection of this material to ﬂash column
chromatography (silica, 1:4→ 3:7 v/v ethyl acetate/40−60 petroleum
ether gradient elution) gave, after concentration of the appropriate
fractions (Rf = 0.2 in 3:7 v/v ethyl acetate/40−60 petroleum ether),
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compound 30 (75 mg, 75%) as a white, crystalline solid: mp = 161−
163 °C; [α]D = −344.2 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3)
δ 5.37 (m, 1H), 5.33 (m, 1H), 3.93 (m, 1H), 3.48 (m, 1H), 2.97 (dd, J
= 10.0 and 2.1 Hz, 1H), 2.67 (m, 1H), 1.78 (s, 3H), 1.19 (d, J = 7.2
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 200.3, 177.5, 140.6, 112.9,
89.8, 58.8, 43.3, 33.9, 26.8, 23.0, 19.8; IR νmax 2968, 1782, 1256, 1148,
1141, 1130, 1004 cm−1; MS (ESI, + ve) m/z 247 [(M + MeOH +
Na)+, 100]; HRMS m/z (M + MeOH + Na)+ calcd for C12H16O3Na
247.0946, found 247.0945.
(2aS,2a′R,3aR,6S,6aS)-6-Isopropyl-5-methyl-2a′,3a,6,6a-tetrahy-
dro-1H-cyclobuta[cd]isobenzofuran-1,3(2aH)-dione (31). A deoxy-
genated and magnetically stirred solution of compound 23 (100 mg,
0.45 mmol) in dichloromethane (100 mL) maintained under nitrogen
was subjected to irradiation with a Hanovia 450 W medium-pressure
mercury-vapor lamp for 0.5 h. The reaction mixture thus obtained was
cooled and concentrated under reduced pressure to give a yellow oil.
Subjection of this material to ﬂash column chromatography (silica, 1:4
→ 3:7 v/v ethyl acetate/40−60 petroleum ether gradient elution)
gave, after concentration of the appropriate fractions (Rf = 0.2 in 3:7
v/v ethyl acetate/40−60 petroleum ether), compound 31 (73 mg,
73%) as a clear, colorless oil: [α]D = −163.3 (c 0.7, CHCl3). 1H NMR
(400 MHz, CDCl3) δ 5.47 (s, 1H), 5.27 (dd, J = 6.4 and 4.0 Hz, 1H),
3.88 (m, 1H), 3.43 (m, 1H), 3.08 (dd, J = 10.1 and 1.4 Hz, 1H), 2.45
(d, J = 3.9 Hz, 1H), 1.90 (m, 1H), 1.79 (s, 3H), 1.06 (d, J = 6.8 Hz,
3H), 0.89 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 200.4,
178.7, 138.9, 114.7, 89.1, 59.4, 45.9, 38.1, 30.8, 28.3, 24.5, 21.6, 19.6;
IR νmax 2963, 1782, 1168, 1147, 1131, 1005, 838 cm
−1; MS (ESI, + ve)
m/z 275 [(M + MeOH + Na)+, 100], 221 [(M + H)+, 25]; HRMS m/
z (M + MeOH + Na)+ calcd for C14H20O3Na 275.1259, found
275.1260.
( 2 a S , 2 a ′R , 3 S , 5 aR , 5 bR ) - 3 , 4 -D ime t h y l - 2 a ′ , 3 , 5 a , 5 b -
tetrahydrocyclopropa[cd]isobenzofuran-2(2aH)-one (32). A deoxy-
genated and magnetically stirred solution of compound 22 (100 mg,
0.52 mmol) in dichloromethane (100 mL) maintained under a
nitrogen atmosphere was irradiated with a Hanovia 450 W medium-
pressure mercury-vapor lamp for 5 h. The ensuing reaction mixture
was cooled to ca. 22 °C then concentrated under reduced pressure to
give a brown oil. Subjection of this material to ﬂash column
chromatography (silica, 1:9→ 3:7 v/v ethyl acetate/40−60 petroleum
ether gradient elution) gave two fractions, A and B.
Concentration of fraction A (Rf = 0.5 in 3:7 v/v ethyl acetate/40−
60 petroleum ether) aﬀorded compound 32 (32 mg, 37%) as a
colorless, crystalline solid: mp = 73−75 °C; [α]D = −102.8 (c 0.4,
CHCl3);
1H NMR (400 MHz, CDCl3) δ 5.34 (s, 1H), 4.33 (dd, J =
6.3 and 5.4 Hz, 1H), 2.89 (dd, J = 7.7 and 3.0 Hz, 1H), 2.23 (m, 1H),
1.95 (m, 1H), 1.69 (s, 3H), 1.46 (m, 1H), 1.21 (d, J = 7.0 Hz, 3H);
13C NMR (100 MHz, CDCl3) δ 180.3, 142.7, 112.7, 60.5, 44.7, 35.9,
22.4, 18.7, 17.8, 11.6; IR νmax 2965, 1773, 1453, 1150, 1086, 1074, 922,
794 cm−1; MS (ESI, + ve) m/z 187 [(M + Na)+, 100]; HRMS m/z (M
+ Na)+ calcd for C10H12O2Na 187.0735, found 187.0735.
Concentration of fraction B (Rf = 0.2 in 3:7 v/v ethyl acetate/40−
60 petroleum ether) aﬀorded compound 30 (28 mg, 28%) as a white
solid that was identical with an authentic sample.
(2aS,2a′R,3S,5aR,5bR)-3-Isopropyl-4-methyl-2a′,3,5a,5b-
tetrahydrocyclopropa[cd]isobenzofuran-2(2aH)-one (33). A deoxy-
genated and magnetically stirred solution of compound 23 (100 mg,
0.45 mmol) in dichloromethane (100 mL) maintained under a
nitrogen atmosphere was subjected to irradiation with a Hanovia 450
W medium-pressure mercury-vapor lamp for 1.5 h. The ensuing
mixture was cooled then concentrated under reduced pressure to give
a brown oil. Subjection of this material to ﬂash column
chromatography (silica, 1:9→ 3:7 v/v ethyl acetate/40−60 petroleum
ether gradient elution) aﬀorded two fractions, A and B.
Concentration of fraction A (Rf = 0.6 in 3:7 v/v ethyl acetate/40−
60 petroleum ether) gave compound 33 (45 mg, 52%) as a clear,
colorless oil: [α]D = −29.8 (c 1.0, CHCl3); 1H NMR (400 MHz,
CDCl3) δ 5.45 (s, 1H), 4.33 (m, 1H), 3.03 (dd, J = 7.7 and 2.4 Hz,
1H), 2.02−1.88 (complex m, 3H), 1.71 (s, 3H), 1.45 (m, 1H), 1.06 (d,
J = 6.5 Hz, 3H), 0.98 (d, J = 6.6 Hz, 3H); 13C NMR (100 MHz,
CDCl3) δ 181.1, 141.1, 114.8, 61.4, 47.6, 40.3, 30.7, 24.2, 21.7, 19.9,
18.0, 13.5; IR νmax 2960, 1769, 1149, 1127, 1087, 933, 781 cm
−1; MS
(ESI, + ve) m/z 215 [(M + Na)+, 100]; HRMS m/z (M + Na)+ calcd
for C12H16O2Na 215.1048, found 215.1048.
Concentration of fraction B (Rf = 0.2 in 3:7 v/v ethyl acetate/40−
60 petroleum ether) aﬀorded compound 31 (25 mg, 25%) as a white
solid that was identical with an authentic sample.
(1aR,1a ′S,3aR,4S,4a1R)-1a ′ ,4-Dimethylhexahydro-1H-
cyclopropa[3,4]pentaleno[1,6-bc]furan-1,3(1aH)-dione (34). A de-
oxygenated and magnetically stirred solution of compound 26 (108
mg, 0.56 mmol) and acetophenone (90 μL, 0.77 mmol) in acetone
(100 mL) maintained under nitrogen was subjected to irradiation with
a Hanovia 450 W medium-pressure mercury-vapor lamp for 2.5 h. The
ensuing reaction mixture was cooled then concentrated under reduced
pressure to give a yellow oil. Subjection of this material to ﬂash column
chromatography (silica, 3:17 → 3:7 v/v ethyl acetate/40−60
petroleum ether gradient elution) gave, after concentration of the
appropriate fractions (Rf = 0.3 in 1:1 v/v ethyl acetate/40−60
petroleum ether), compound 34 (49 mg, 45%) as a white, crystalline
solid: mp = 154−156 °C, [α]D = +68.6 (c 1.0, CHCl3). 1H NMR (400
MHz, CDCl3) δ 4.21 (s, 1H), 2.55−2.47 (complex m, 3H), 2.18 (m,
1H), 1.97 (m, 1H), 1.54 (s, 3H), 1.38 (d, J = 6.8 Hz, 3H); 13C NMR
(100 MHz, CDCl3) δ 206.9, 176.5, 87.7, 64.3, 55.0, 42.6, 40.3, 38.0,
35.6, 22.6, 20.8; IR νmax 2970, 1781, 1726, 1238, 1163, 1033, 884, 874
cm−1; MS (ESI, + ve) m/z 247 [(M + MeOH + Na)+, 20], 215 [(M +
Na)+, 100], 193 (30); HRMS m/z (M + Na)+ calcd for C11H12O3Na
215.0684, found 215.0676.
(1aR,1a′S,3aR,4S,4a′R)-4-Isopropyl-1a′-methylhexahydro-1H-
cyclopropa[3,4]pentaleno[1,6-bc]furan-1,3(1aH)-dione (35). A de-
oxygenated and magnetically stirred solution of compound 27 (123
mg, 0.56 mmol) and acetophenone (90 μL, 0.77 mmol) in acetone
(100 mL) maintained under a nitrogen atmosphere was irradiated with
a Hanovia 450 W medium-pressure mercury-vapor lamp for 2.5 h. The
cooled reaction mixture was concentrated under reduced pressure to
give a yellow oil and this subjected to ﬂash column chromatography
(silica, 3:17 → 1:3 v/v ethyl acetate/40−60 petroleum ether gradient
elution). Concentration of the appropriate fractions (Rf = 0.5 in 1:1 v/
v ethyl acetate/40−60 petroleum ether) then gave compound 35 (60
mg, 49%) as a white, crystalline solid: mp = 102−103 °C; [α]D =
+83.8 (c 1.0, CHCl3);
1H NMR (400 MHz, CDCl3) δ 4.22 (s, 1H),
2.72 (d, J = 6.4 Hz, 1H), 2.41 (t, J = 4.0 Hz, 1H), 2.22−2.15 (complex
m, 2H), 2.08 (m, 1H), 1.94 (m, 1H), 1.53 (s, 3H), 1.03 (d, J = 3.0 Hz,
3H), 1.02 (d, J = 3.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 207.1,
176.8, 87.6, 59.1, 54.6, 53.7, 37.4, 37.3, 35.5, 32.9, 20.6, 20.2, 19.4; IR
νmax 2961, 1790, 1781, 1732, 1240, 1160, 1047, 889 cm
−1; MS (ESI, +
ve) m/z 275 [(M + MeOH + Na)+, 20], 243 [(M + Na)+, 100];
HRMS m/z (M + Na)+ calcd for C13H16O3Na 243.0997, found
243.0993.
(2aR,2a′S,3aS,6S,6aR)-2a′,6-Dimethyl-2a′,3a,6,6a-tetrahydro-
1H-cyclobuta[cd]isobenzofuran-1,3(2aH)-dione (36). A deoxygen-
ated and magnetically stirred solution of compound 26 (100 mg, 0.52
mmol) in dichloromethane (100 mL) maintained under a nitrogen
atmosphere was irradiated with a Hanovia 450 W medium-pressure
mercury-vapor lamp for 0.58 h then cooled and concentrated under
reduced pressure to give a yellow solid. Subjection of this material to
ﬂash column chromatography (silica, 1:4→ 3:7 v/v ethyl acetate/40−
60 petroleum ether gradient elution) then gave, after concentration of
the appropriate fractions (Rf = 0.2 in 3:7 v/v ethyl acetate/40−60
petroleum ether), compound 36 (70 mg, 70%) as a white, crystalline
solid: mp = 100−101 °C; [α]D = +220.5 (c 1.0, CHCl3). 1H NMR
(400 MHz, CDCl3) δ 6.02 (m, 1H), 5.69 (dd, J = 10.0 and 4.0 Hz,
1H), 4.82 (d, J = 4.0 Hz, 1H), 3.60 (m, 1H), 2.93 (m, 1H), 2.66 (s,
1H), 1.70 (s, 3H), 1.23 (d, J = 7.3 Hz, 3H); 13C NMR (100 MHz,
CDCl3) δ 200.1, 177.7, 132.6, 119.1, 93.5, 63.8, 48.5, 35.5, 30.1, 24.9,
21.2; IR νmax 2965, 1779, 1191, 1096, 997, 744, 725 cm
−1; MS (ESI, +
ve) m/z 247 [(M + MeOH + Na)+, 100%]; HRMS m/z (M + MeOH
+ Na)+ calcd for C12H16O3Na 247.0946, found 247.0947.
(2aR,2a′S,3aS,6S,6aR)-6-Isopropyl-2a′-methyl-2a′,3a,6,6a-tetra-
hydro-1H-cyclobuta[cd]isobenzofuran-1,3(2aH)-dione (37). A de-
oxygenated and magnetically stirred solution of compound 27 (100
mg, 0.45 mmol) in dichloromethane (100 mL) maintained under a
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nitrogen atmosphere was irradiated with a Hanovia 450 W medium-
pressure mercury-vapor lamp for 0.55 h then cooled and concentrated
under reduced pressure to give a yellow solid. Subjection of this
material to ﬂash column chromatography (silica, 1:4 → 3:7 v/v ethyl
acetate/40−60 petroleum ether gradient elution) then gave, after
concentration of the appropriate fractions (Rf = 0.2 in 3:7 v/v ethyl
acetate/40−60 petroleum ether), compound 37 (71 mg, 71%) as a
white, crystalline solid: mp = 96−98 °C; [α]D = +196.2 (c 1.0,
CHCl3);
1H NMR (400 MHz, CDCl3) δ 6.11 (m, 1H), 5.73 (dd, J =
10.1 and 3.6 Hz, 1H), 4.79 (d, J = 3.6 Hz, 1H), 3.56 (m, 1H), 2.95 (d,
J = 1.7 Hz, 1H), 2.43 (t, J = 8.0 Hz, 1H), 1.68 (s, 3H), 1.66−1.60
(complex m, 1H), 1.09 (d, J = 6.6 Hz, 3H), 1.01 (d, J = 6.6 Hz, 3H);
13C NMR (100 MHz, CDCl3) δ 199.9, 178.5, 131.8, 120.0, 93.5, 64.2,
44.8, 42.6, 35.9, 33.1, 24.1, 21.4, 21.3; IR νmax 2964, 1782, 1471, 1293,
1193, 1000, 722 cm−1; MS (ESI, + ve) m/z 527 [(2M + 2MeOH +
Na)+, 15], 275 [(M + MeOH + Na)+, 100], 221 [(M + H)+, 15];
HRMS m/z (M + MeOH + Na)+ calcd for C14H20O3Na 275.1259,
found 275.1257.
( 2aR ,2a ′S ,3S , 5aS ,5bS ) -2a ′ , 3 -D imethy l - 2a 1 , 3 , 5a ,5b -
tetrahydrocyclopropa[cd]isobenzofuran-2(2aH)-one (38). A deoxy-
genated and magnetically stirred solution of compound 26 (100 mg,
0.52 mmol) in dichloromethane (100 mL) maintained under a
nitrogen atmosphere was irradiated with a Hanovia 450 W medium-
pressure mercury-vapor lamp for 3.1 h then cooled and concentrated
under reduced pressure to give a brown oil. Subjection of this material
to ﬂash column chromatography (silica, 1:9 → 3:7 v/v ethyl acetate/
40−60 petroleum ether gradient elution) then gave two fractions, A
and B.
Concentration of fraction A (Rf = 0.5 in 3:7 v/v ethyl acetate/40−
60 petroleum ether) aﬀorded compound 38 (30 mg, 35%) as a
colorless, crystalline solid: mp = 40−42 °C; [α]D = +152.0 (c 0.5,
CHCl3);
1H NMR (400 MHz, CDCl3) δ 5.95 (dd, J = 9.9 and 6.0 Hz,
1H), 5.66 (dd, J = 9.9 and 4.5 Hz, 1H), 4.03 (d, J = 5.6 Hz, 1H), 2.65
(s, 1H), 2.54 (m, 1H), 1.39 (s, 3H), 1.35 (m, 1H), 1.22 (d, J = 7.1 Hz,
3H); 13C NMR (100 MHz, CDCl3) δ 180.7, 134.8, 119.4, 65.2, 49.3,
31.7, 23.5, 20.6, 19.3, 18.9; IR νmax 2962, 2929, 1783, 1769, 1143,
1090, 846, 750 cm−1; MS (EI, 70 eV) m/z 164 (M+•, 20%), 121 (30),
107 (100), 91 (70), 77 (25), 65 (15); HRMS m/z M•+ calcd for
C10H12O2 164.0837, found 164.0835.
Concentration of fraction B (Rf = 0.2 in 3:7 v/v ethyl acetate/40−
60 petroleum ether) aﬀorded compound 36 (32 mg, 32%) as a white,
crystalline solid that was identical, in all respects, with an authentic
sample.
(2aR,2a′S,3S,5aS,5bS)-3-Isopropyl-2a′-methyl-2a′,3,5a,5b-
tetrahydrocyclopropa[cd]isobenzofuran-2(2aH)-one (39). A deoxy-
genated and magnetically stirred solution of compound 27 (100 mg,
0.45 mmol) in dichloromethane (100 mL) maintained under a
nitrogen atmosphere was irradiated with a Hanovia 450 W medium-
pressure mercury-vapor lamp for 3.1 h then cooled and concentrated
under reduced pressure to give a brown oil. Subjection of this material
to ﬂash column chromatography (silica, 1:9 → 3:7 v/v ethyl acetate/
40−60 petroleum ether elution) then gave two fractions, A and B.
Concentration of fraction A (Rf = 0.6 in 3:7 v/v ethyl acetate/40−
60 petroleum ether) aﬀorded compound 39 (35 mg, 40%) as a yellow
oil, [α]D = +166.7 (c 1.0, CHCl3).
1H NMR (400 MHz, CDCl3) δ 6.02
(dd, J = 9.9 and 6.1 Hz, 1H), 5.70 (dd, J = 9.9 and 4.2 Hz, 1H), 4.02
(d, J = 5.5 Hz, 1H), 2.92 (s, 1H), 2.02 (m, 1H), 1.79 (m, 1H), 1.36 (s,
3H), 1.34 (m, 1H), 1.05 (d, J = 6.6 Hz, 3H), 0.99 (d, J = 6.6 Hz, 3H);
13C NMR (100 MHz, CDCl3) δ 181.2, 134.0, 120.3, 65.5, 46.0, 43.8,
32.3, 23.7, 21.8, 20.9, 20.1, 19.3; IR νmax 2966, 2872, 1778, 1148, 1092,
834, 752 cm−1; MS (ESI, + ve) m/z 215 [(M + Na)+, 100%]; HRMS
m/z (M + Na)+ calcd for C12H16O2Na 215.1048, found 215.1047.
Concentration of fraction B (Rf = 0.2 in 3:7 v/v ethyl acetate/40−
60 petroleum ether) aﬀorded compound 37 (34 mg, 34%) as a white,
crystalline solid that was identical, in all respects, with an authentic
sample.
( 3aR ,4R ,4aR ,5S ,7aR ,8S ,8aS ) -2 ,2 ,4 ,6 ,6 -Pentamethy l -
3a,4a,5,6,7,7a,8,8a-octahydro-4H-4,8-ethenoindeno[5,6-d][1,3]-
dioxol-5-yl Acetate (42). A magnetically stirred solution of compound
414d,5b (5.00 g, 17.96 mmol), acetic anhydride (3.40 mL, 35.97 mmol)
and 4-(N,N-dimethylamino)pyridine (440 mg, 3.60 mmol) in
triethylamine (7.50 mL, 53.8 mmol) was stirred at 0 °C for 2 h and
then warmed to 22 °C and stirred at this temperature for another 2 h.
After this time, NH4Cl (50 mL of a saturated aqueous solution) was
added to the reaction mixture, and the resulting suspension was
extracted with dichloromethane (3 × 50 mL). The combined organic
fractions were washed with water (2 × 50 mL) and brine (1 × 50 mL)
before being dried (MgSO4), ﬁltered, and concentrated under reduced
pressure. The residue thus obtained was subjected to ﬂash column
chromatography (silica, 1:19 v/v ethyl acetate/40−60 petroleum ether
elution) and gave, after concentration of the appropriate fractions (Rf
= 0.3 in 1:9 v/v ethyl acetate/40−60 petroleum ether), compound 42
(5.58 g, 97%) as a white, crystalline solid: mp = 135−137 °C; [α]D =
+7.6 (c 1.0, CHCl3);
1H NMR (400 MHz, CDCl3) δ 5.86−5.80
(complex m, 2H), 4.98 (d, J = 6.1 Hz, 1H), 4.22 (dd, J = 7.2 and 3.1
Hz, 1H), 3.79 (d, J = 7.2 Hz, 1H), 2.75 (m, 1H), 2.22 (m, 1H), 2.07
(m, 1H), 2.04 (s, 3H), 1.37 (m, 2H), 1.32 (s, 3H), 1.27 (s, 3H), 1.14
(s, 3H), 0.95 (s, 3H), 0.82 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
170.4, 137.3, 125.7, 109.1, 84.1, 81.0, 80.1, 49.7, 44.7, 42.0, 40.8, 40.0,
38.0, 25.6 (5), 25.6 (2), 25.2, 22.4, 21.6, 19.9; IR νmax 2961, 2934,
1733, 1370, 1234, 1073, 723 cm−1; MS (ESI, + ve) m/z 343 [(M +
Na)+, 100]; HRMS m/z (M + Na)+ calcd for C19H28O4Na 343.1885,
found 343.1884.
(3S,3aR,4R,7S,7aR,8S,9R)-8,9-Dihydroxy-2,2,4-trimethyl-
2,3,3a,4,7,7a-hexahydro-1H-4,7-ethanoinden-3-yl Acetate (43).
AG-50W-X8 resin (3.32 g of H+ form) was added to a magnetically
stirred solution of compound 42 in methanol/water (72 mL of a 5:1
v/v mixture) and the resulting suspension heated under reﬂux for 67 h
and then cooled to 22 °C before being ﬁltered through a sintered glass
funnel. The ﬁltrate was concentrated under reduced pressure and the
residue thus obtained subjected to ﬂash column chromatography
(silica, 3:7 v/v ethyl acetate/40−60 petroleum ether elution).
Concentration of the appropriate fractions (Rf = 0.1 in 3:7 v/v ethyl
acetate/40−60 petroleum ether) gave compound 43 (1.80 g, 97%) as
a white solid: mp = 73−74 °C; [α]D = −2.3 (c 1.1, CHCl3); 1H NMR
(400 MHz, CDCl3) δ 5.99−5.91 (complex m, 2H), 4.97 (d, J = 6.1 Hz,
1H), 3.88 (dd, J = 7.5 and 2.4 Hz, 1H), 3.40 (d, J = 7.5 Hz, 1H), 2.73
(m, 1H), 2.52 (broad s, 2H), 2.27 (m, 1H), 2.13 (m, 1H), 2.03 (s,
3H), 1.39 (m, 1H), 1.25 (t, J = 11.6 Hz, 1H), 1.15 (s, 3H), 0.93 (s,
3H), 0.80 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 170.4, 138.8,
126.8, 81.6, 75.4, 71.7, 50.4, 44.1, 42.0, 41.5, 41.3, 40.8, 25.5, 22.3,
21.6, 19.6; IR νmax 3394, 2965, 2932, 1732, 1374, 1240, 1057 cm
−1;
MS m/z 583 [(2M + Na)+, 5], 303 [(M + Na)+, 100]; HRMS m/z (M
+ Na)+ calcd for C16H24O4Na 303.1572, found 303.1577.
(3S,3aR,4R,7S,7aS,9R)-9-Hydroxy-2,2,4-trimethyl-8-oxo-
2,3,3a,4,7,7a-hexahydro-1H-4,7-ethanoinden-3-yl Acetate (44). A
magnetically stirred mixture of p-toluenesulfonic acid monohydrate
(448 mg, 2.36 mmol) and 4-acetamido-TEMPO (502 mg, 2.35 mmol)
in dichloromethane (10 mL) was maintained at 0 °C under a nitrogen
atmosphere for 0.5 h and the resulting solution then added, dropwise
over 2 h, to a magnetically stirred solution of compound 43 (300 mg,
1.07 mmol) in dichloromethane (10 mL) maintained at 0 °C. The
ensuing mixture was stirred for a further 2 h at this temperature and
then quenched with NaHCO3 (50 mL of a saturated aqueous
solution). The resulting suspension was extracted with dichloro-
methane (3 × 50 mL), and the combined organic phases were washed
with water (2 × 50 mL) and brine (1 × 50 mL) before being dried
(Na2SO4), ﬁltered, and concentrated under reduced pressure. The
residue thus obtained was subjected to ﬂash column chromatography
(silica, 3:17 v/v ethyl acetate/40−60 petroleum ether elution) to give,
after concentration of the appropriate fractions (Rf = 0.2 in 3:7 v/v
ethyl acetate/40−60 petroleum ether), compound 44 (289 mg, 97%)
as a white, crystalline solid: mp = 147−149 °C; [α]D = +215.0 (c 1.1,
CHCl3);
1H NMR (400 MHz, CDCl3) δ 6.08 (d, J = 7.9 Hz, 1H), 5.92
(t, J = 7.9 Hz, 1H), 5.09 (d, J = 6.0 Hz, 1H), 3.34 (s, 1H), 3.15 (d, J =
6.0 Hz, 1H), 2.72−2.49 (complex m, 3H), 2.06 (s, 3H), 1.52 (dd, J =
12.2 and 7.4 Hz, 1H), 1.40 (t, J = 12.2 Hz, 1H), 1.22 (s, 3H), 1.00 (s,
3H), 0.87 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 211.0, 170.2,
142.2, 121.9, 81.1, 75.2, 51.8, 50.1, 44.8, 43.9, 41.7, 39.3, 25.6, 22.2,
21.6, 18.1; IR νmax 3451, 3239, 2965, 1730, 1374, 1236, 1081, 1039
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cm−1; MS (ESI, + ve) m/z 579 [(2M + Na)+, 10], 301 [(M + Na)+,
100]; HRMS m/z (M + Na)+ calcd for C16H22O4Na 301.1416, found
301.1411.
(3S,3aR,4R,7S,7aS,9R)-2,2,4-Trimethyl-8-oxo-2,3,3a,4,7,7a-hexa-
hydro-1H-4,7-ethanoindene-3,9-diyl Diacetate (45). A magnetically
stirred solution of compound 44 (239 mg, 0.86 mmol), 4-(N,N-
dimethylamino)pyridine (11 mg, 0.09 mmol), and triethylamine (180
μL, 1.29 mmol) in dichloromethane (10 mL) maintained at 0 °C
under a nitrogen atmosphere was treated with acetic anhydride (97 μL,
1.03 mmol). The ensuing mixture was kept at 0 °C for 2 h and then at
22 °C for 16 h before being quenched with NH4Cl (10 mL of a
saturated aqueous solution). The resulting mixture was extracted with
dichloromethane (2 × 20 mL), and the combined organic phases were
washed with water (2 × 20 mL) and brine (1 × 20 mL) before being
dried (Na2SO4), ﬁltered, and concentrated under reduced pressure.
The residue thus obtained was subjected to ﬂash column
chromatography (silica, 3:17 v/v ethyl acetate/40−60 petroleum
ether elution) and gave, after concentration of the appropriate
fractions (Rf = 0.4 in 3:7 v/v ethyl acetate/40−60 petroleum ether),
compound 45 (250 mg, 91%) as a white, crystalline solid: mp = 175−
177 °C; [α]D = +200.0 (c 1.0, CHCl3);
1H NMR (400 MHz, CDCl3)
δ 6.09 (d, J = 8.1 Hz, 1H), 5.97 (t, J = 8.1 Hz, 1H), 5.09 (d, J = 6.0 Hz,
1H), 4.85 (s, 1H), 3.17 (d, J = 6.0 Hz, 1H), 2.74 (m, 1H), 2.64 (dd, J
= 10.6 and 6.0 Hz, 1H), 2.10 (s, 3H), 2.06 (s, 3H), 1.53 (dd, J = 12.2
and 7.3 Hz, 1H), 1.39 (t, J = 12.2 Hz, 1H), 1.05 (s, 3H), 1.01 (s, 3H),
0.86 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 205.2, 170.7, 170.1,
141.4, 122.2, 81.1, 74.2, 51.5, 50.7, 44.9, 42.6, 41.7, 39.6, 25.5, 22.2,
21.5, 20.7, 17.9; IR νmax 2979, 2965, 2932, 1721, 1374, 1230, 1053,
1020 cm−1; MS (ESI, + ve) m/z 663 [(2M + Na)+, 20], 343 [(M +
Na)+, 100], 321 [(M + H)+, 5]; HRMS m/z (M + Na)+ calcd for
C18H24O5Na 343.1521, found 343.1505.
(3S,3aR,4R,7S,7aS,9R)-9-(Methoxymethoxy)-2,2,4-trimethyl-8-
oxo-2,3,3a,4,7,7a-hexahydro-1H-4,7-ethanoinden-3-yl Acetate
(46). A magnetically stirred solution of compound 44 (280 mg, 1.00
mmol), chloromethyl methyl ether (122 μL, 1.60 mmol), tetra-n-
butylammonium iodide (37 mg, 0.10 mmol), and N,N-diisopropyle-
thylamine (348 μL, 2.00 mmol) in dichloromethane (5 mL)
maintained under a nitrogen atmosphere was stirred at 22 °C for 48
h and then treated with NH4Cl (10 mL of a saturated aqueous
solution) and extracted with dichloromethane (2 × 20 mL). The
combined organic phases were washed with water (2 × 20 mL) and
brine (1 × 20 mL) before being dried (Na2SO4), ﬁltered, and
concentrated under reduced pressure. The residue thus obtained was
subjected to ﬂash column chromatography (silica, 1:4 v/v ethyl
acetate/40−60 petroleum ether elution) and gave, after concentration
of the appropriate fractions (Rf = 0.3 in 1:4 v/v ethyl acetate/40−60
petroleum ether), compound 46 (251 mg, 77%) as a pale-yellow oil:
[α]D = +213.0 (c 1.0, CHCl3);
1H NMR (400 MHz, CDCl3) δ 6.06 (d,
J = 8.0 Hz, 1H), 5.90 (t, J = 8.0 Hz, 1H), 5.03 (d, J = 6.7 Hz, 2H), 4.59
(d, J = 6.7 Hz, 1H), 3.38 (s, 3H), 3.31 (s, 1H), 3.04 (d, J = 6.3 Hz,
1H), 2.61 (m, 1H), 2.46 (dd, J = 10.6 and 6.1 Hz, 1H), 2.03 (s, 3H),
1.46 (dd, J = 12.1 and 7.4 Hz, 1H), 1.35 (t, J = 12.1 Hz, 1H), 1.14 (s,
3H), 0.95 (s, 3H), 0.82 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
209.3, 170.1, 141.0, 121.5, 97.5, 81.1, 77.1, 56.3, 51.0, 50.7, 44.8, 43.2,
41.5, 40.2, 25.3, 22.1, 21.5, 18.4; IR νmax 2966, 1731, 1372, 1239, 1150,
1035, 710 cm−1; MS (ESI, + ve) m/z 667 [(2M + Na)+, 5], 345 [(M +
Na)+, 100]; HRMS m/z (M + Na)+ calcd for C18H26O5Na 345.1678,
found 345.1665.
(3S,3aR,4R,7S,7aS,9R)-9-((tert-Butyldimethylsilyl)oxy)-2,2,4-tri-
methyl-8-oxo-2,3,3a,4,7,7a-hexahydro-1H-4,7-ethanoinden-3-yl
Acetate (47). A magnetically stirred solution of compound 44 (400
mg, 1.44 mmol), tert-butyldimethylsilyl chloride (1.73 g, 11.48 mmol),
and imidazole (980 mg, 14.39 mmol) in 1,2-dichloroethane (20 mL)
kept under a nitrogen atmosphere was heated at reﬂux for 65 h and
then cooled, quenched with NH4Cl (10 mL of a saturated aqueous
solution), and extracted with dichloromethane (2 × 40 mL). The
combined organic phases were washed with water (2 × 40 mL) and
brine (1 × 40 mL) before being dried (Na2SO4), ﬁltered, and
concentrated under reduced pressure. The residue thus obtained was
subjected to ﬂash column chromatography (silica, 2:5:100 v/v/v ethyl
acetate/dichloromethane/40−60 petroleum ether elution) and gave,
after concentration of the appropriate fractions (Rf = 0.6 in 3:7 v/v
ethyl acetate/40−60 petroleum ether), compound 47 (465 mg, 82%)
as a white, crystalline solid: mp = 71−72 °C; [α]D = +121.0 (c 1.0,
CHCl3);
1H NMR (400 MHz, CDCl3) δ 6.03 (d, J = 8.0 Hz, 1H), 5.87
(t, J = 8.0 Hz, 1H), 5.06 (d, J = 6.0 Hz, 1H), 3.27 (s, 1H), 3.02 (dd, J =
6.0 and 1.8 Hz, 1H), 2.62 (m, 1H), 2.42 (dd, J = 10.6 and 6.0 Hz, 1H),
2.06 (s, 3H), 1.51−1.37 (complex m, 2H), 1.12 (s, 3H), 0.99 (s, 3H),
0.86 (s, 12H), 0.10 (s, 3H), 0.09 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 209.5, 170.3, 141.7, 120.9, 81.4, 76.0, 51.1, 50.5, 44.9, 44.4,
41.7, 40.3, 26.0, 25.5, 22.3, 21.6, 19.0, 18.6, − 4.0, − 5.0; IR νmax 2959,
2930, 2856, 1733, 1237, 1129, 1112, 1093, 858, 837, 778, 709 cm−1;
MS m/z 415 [(M + Na)+, 100]; HRMS m/z (M + Na)+ calcd for
C22H36O4SiNa 415.2281, found 415.2275.
(3S,3aR,4R,7S,7aS,9R)-3-Acetoxy-2,2,4-trimethyl-8-oxo-
2,3,3a,4,7,7a-hexahydro-1H-4,7-ethanoinden-9-yl Benzoate (48). A
magnetically stirred solution of compound 44 (2.90 g, 10.42 mmol), 4-
(N,N-dimethylamino)pyridine (127 mg, 1.04 mmol), and triethyl-
amine (2.9 mL, 21.00 mmol) in dichloromethane (50 mL) maintained
under a nitrogen atmosphere at 0 °C was treated with benzoyl chloride
(1.50 mL, 12.50 mmol). The ensuing mixture was allowed to warm to
and then stirred at 22 °C for 16 h before being quenched with NH4Cl
(50 mL of a saturated aqueous solution) and then extracted with
dichloromethane (2 × 100 mL). The combined organic phases were
washed with water (2 × 100 mL) and then brine (1 × 100 mL) before
being dried (Na2SO4), ﬁltered, and concentrated under reduced
pressure. The residue thus obtained was subjected to ﬂash column
chromatography (silica, 2:5:100 v/v/v ethyl acetate/dichloromethane/
40−60 petroleum ether elution) and gave, after concentration of the
appropriate fractions [Rf = 0.2(5) in 1:19 v/v ethyl acetate/40−60
petroleum ether], compound 48 (3.69 g, 93%) as a white, crystalline
solid: mp = 134−136 °C; [α]D = +196.0 (c 1.1, CHCl3); 1H NMR
(400 MHz, CDCl3) δ 7.99 (d, J = 7.3 Hz, 2H), 7.54 (t, J = 7.3 Hz,
1H), 7.41 (t, J = 7.3 Hz, 2H), 6.20 (d, J = 8.1 Hz, 1H), 6.04 (t, J = 8.1
Hz, 1H), 5.12−5.10 (complex m, 2H), 3.23 (dd, J = 6.6 and 1.6 Hz,
1H), 2.80 (m, 1H), 2.72 (dd, J = 10.6 and 6.6 Hz, 1H), 2.07 (s, 3H),
1.55 (dd, J = 12.1 and 7.3 Hz, 1H), 1.43 (m, 1H), 1.11 (s, 3H), 1.02 (s,
3H), 0.87 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 205.0, 170.1,
166.2, 141.3, 133.4, 130.0, 129.5, 128.5, 122.4, 81.1, 74.4, 51.3, 50.7,
44.9, 42.9, 41.7, 39.7, 25.4, 22.2, 21.5, 18.0; IR νmax 2967, 1722, 1268,
1238, 1108, 729, 706 cm−1; MS (ESI, + ve) m/z 787 [(2M + Na)+,
100], 405 [(M + Na)+, 85]; HRMS m/z (M + Na)+ calcd for
C23H26O5Na 405.1678, found 405.1682.
(1S,3aS,4S,7R,7aR)-2,2,7-Trimethyl-9-oxo-2,3,3a,4,7,7a-hexahy-
dro-1H-4,7-ethanoinden-1-yl Acetate (49). A magnetically stirred
solution of compound 48 (3.30 g, 8.63 mmol) in deoxygenated THF/
methanol (30 mL of a 9:1 v/v mixture) maintained at −78 °C under
an argon atmosphere was treated, dropwise over 1 h, with
samarium(II) iodide (ca. 250 mL of a 0.086 M solution in THF) at
which point a dark-blue color persisted for 0.25 h. The resulting
mixture was then quenched with NH4Cl (100 mL of a saturated
aqueous solution) and the ensuing suspension extracted with diethyl
ether (2 × 100 mL). The combined organic phases were washed with
HCl (2 × 50 mL of a 1 M aqueous solution) and brine (1 × 100 mL)
before being dried (Na2SO4), ﬁltered, and concentrated under reduced
pressure. The residue thus obtained was subjected to ﬂash column
chromatography (silica, 1:9 v/v diethyl ether/n-hexane elution) and
gave, after concentration of the appropriate fractions [Rf = 0.4(5) in
1:9 v/v diethyl ether/n-hexane)], compound 49 (1.91 g, 85%) as a
clear, colorless oil: [α]D = +161.0 (c 1.0, CHCl3);
1H NMR (400
MHz, CDCl3) δ 6.10 (d, J = 8.1 Hz, 1H), 5.86 (t, J = 8.1 Hz, 1H), 4.93
(d, J = 6.0 Hz, 1H), 2.96 (dd, J = 6.0 and 1.8 Hz, 1H), 2.60 (m, 1H),
2.46 (m, 1H), 1.98 (s, 3H), 1.79 (s, 2H), 1.38 (m, 1H), 1.26 (t, J =
11.5 Hz, 1H), 1.05 (s, 3H), 0.90 (s, 3H), 0.76 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 212.3, 170.0, 142.9, 123.0, 80.4, 53.6, 52.1, 47.7, 44.8,
42.0, 41.2, 39.2, 25.4, 22.2, 22.0, 21.4; IR νmax 2965, 1726, 1373, 1239,
1069, 707 cm−1; MS (ESI, + ve) m/z 547 [(2M + Na)+, 10], 285 [(M
+ Na)+, 100], 263 [(M + H)+, 1]; HRMS m/z (M + H)+ calcd for
C16H23O3 263.1647, found 263.1649.
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(1R,2aR,4aR,7S,7aR,7bS)-1-(Methoxymethoxy)-6,6,7b-trimethyl-
2-oxo-2,2a,4a,5,6,7,7a,7b-octahydro-1H-cyclobuta[e]inden-7-yl Ac-
etate (50). A magnetically stirred solution of compound 45 (100 mg,
0.31 mmol) in dry, deoxygenated dichloromethane (30 mL)
maintained under a nitrogen atmosphere was irradiated with a
Hanovia 100 W medium-pressure mercury-vapor lamp (maintained at
5 °C) for 16 h. The reaction mixture was then cooled and
concentrated under reduced pressure and the residue thus obtained
subjected to ﬂash column chromatography (silica, 1:19 v/v ethyl
acetate/n-hexane elution) to aﬀord two fractions, A and B.
Concentration of fraction A [Rf = 0.3(5) in 1:19 v/v ethyl acetate/n-
hexane] gave compound 50 (43 mg, 43% or 99% brsm) as a clear,
colorless oil: [α]D = −157.0 (c 0.7, CHCl3); 1H NMR (400 MHz,
CDCl3) δ 5.76 (m, 1H), 5.73 (m, 1H), 5.54 (m, 1H), 4.97 (d, J = 4.2
Hz, 1H), 3.02 (m, 1H), 2.96 (m, 1H), 2.87 (dd, J = 9.3 and 4.2 Hz,
1H), 2.14 (s, 3H), 2.06 (m, 1H), 1.98 (s, 3H), 1.51 (dd, J = 13.3 and
5.0 Hz, 1H), 1.09 (s, 3H), 1.03 (s, 3H), 0.92 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 201.3, 170.6, 169.9, 134.3, 117.2, 83.4, 83.2, 59.0,
45.4, 43.5, 42.8, 34.8, 34.7, 28.8, 24.3, 21.3, 20.5, 18.4; IR νmax 2933,
2873, 1792, 1735, 1373, 1224, 1087 cm−1; MS (ESI, + ve) m/z 375
[(M + MeOH + Na)+, 20], 343 [(M + Na)+, 100]; HRMS m/z (M +
Na)+ calcd for C18H24O5Na 343.1521, found 343.1520.
Concentration of the fraction B [Rf = 0.2(5) in 1:19 v/v ethyl
acetate/n-hexane] gave compound 45 (56 mg, 56% recovery) as a
colorless, crystalline solid that was identical, in all respects, with an
authentic sample.
(1R,2aR,4aR,7S,7aR,7bS)-1-(Methoxymethoxy)-6,6,7b-trimethyl-
2-oxo-2,2a,4a,5,6,7,7a,7b-octahydro-1H-cyclobuta[e]inden-7-yl Ac-
etate (51). A magnetically stirred solution of compound 46 (100 mg,
0.31 mmol) in dry, deoxygenated dichloromethane (30 mL)
maintained under a nitrogen atmosphere was irradiated with a
Hanovia 100 W medium-pressure mercury-vapor lamp (maintained at
5 °C) for 16 h. The cooled reaction mixture was concentrated under
reduced pressure and the residue thus obtained subjected to ﬂash
column chromatography (silica, 1:9 v/v ethyl acetate/n-hexane
elution), thus aﬀording two fractions, A and B.
Concentration of the fraction A [Rf = 0.3(5) in 1:9 v/v ethyl
acetate/n-hexane] gave compound 51 (27 mg, 27% or 98% brsm) as a
clear, colorless oil: [α]D = −324.0 (c 0.2, CHCl3); 1H NMR (400
MHz, CDCl3) δ 5.70 (m, 1H), 5.55 (m, 1H), 5.00 (d, J = 4.1 Hz, 1H),
4.67 (m, 3H), 3.42 (s, 3H), 2.90 (m, 1H), 2.85 (m, 1H), 2.76 (dd, J =
9.4 and 4.1 Hz, 1H), 2.05 (m, 1H), 1.98 (s, 3H), 1.51 (dd, J = 13.2 and
5.2 Hz, 1H), 1.11 (s, 3H), 1.06 (s, 3H), 0.93 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 204.5, 170.7, 133.4, 118.0, 97.3, 89.4, 83.2, 58.5, 56.1,
45.4, 43.5, 43.2, 34.7, 34.4, 28.7, 24.2, 21.4, 18.5; IR νmax 2962, 2933,
1787, 1733, 1373, 1240, 1110, 1067, 1012 cm−1; MS (ESI, + ve) m/z
345 [(M + Na)+, 100]; HRMS m/z (M + Na)+ calcd for C18H26O5Na
345.1678, found 345.1672.
Concentration of the fraction B [Rf = 0.2(5) in 1:9 v/v ethyl
acetate/n-hexane] gave compound 46 (71 mg, 71% recovery) as a
clear, colorless oil that was identical, in all respects, with an authentic
sample.
(3S,3aR,4R,7S,7aS,9R)-9-((tert-Butyldimethylsilyl)oxy)-2,2,4-tri-
methyl-8-oxo-2,3,3a,4,7,7a-hexahydro-1H-4,7-ethanoinden-3-yl
Acetate (52). A magnetically stirred solution of compound 47 (100
mg, 0.25 mmol) in dry, deoxygenated dichloromethane (30 mL)
maintained under a nitrogen atmosphere was irradiated with a Hanovia
100 W medium-pressure mercury-vapor lamp (maintained at 5 °C) for
16 h. The cooled reaction mixture was concentrated under reduced
pressure and the residue thus obtained subjected to ﬂash column
chromatography (silica, 1:19 v/v ethyl acetate/n-hexane elution), thus
thereby aﬀording two fractions, A and B.
Concentration of the fraction A (Rf = 0.4 in 1:19 v/v ethyl acetate/
n-hexane) gave compound 52 (18 mg, 18% or 99% brsm) as a clear,
colorless oil: [α]D = −189.0 (c 2.3, CHCl3); 1H NMR (400 MHz,
CDCl3) δ 5.64 (m, 1H), 5.55 (m, 1H), 4.98 (d, J = 4.1 Hz, 1H), 4.71
(d, J = 2.8 Hz, 1H), 2.86−2.78 (complex m, 2H), 2.65 (dd, J = 9.3 and
4.1 Hz, 1H), 2.03 (m, 1H), 1.97 (s, 3H), 1.50 (dd, J = 13.2 and 5.1 Hz,
1H), 1.10 (s, 3H), 0.97 (s, 3H), 0.92 (s, 3H), 0.90 (s, 9H), 0.10 (s,
3H), 0.07 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 206.1, 170.6,
132.8, 118.7, 85.0, 83.3, 58.0, 45.5, 43.5, 43.2, 34.8, 34.5, 28.8, 25.8,
24.2, 21.3, 18.4, 18.2, − 4.6, − 4.9; IR νmax 2958, 2931, 2859, 1788,
1736, 1239, 1108, 883, 838, 780 cm−1; MS (ESI, + ve) m/z 415 [(M +
Na)+, 100], 393 [(M + H)+, 5]; HRMS m/z (M + Na)+ calcd for
C22H36O4SiNa 415.2281, found 415.2284.
Concentration of the fraction B (Rf = 0.3 in 1:19 v/v ethyl acetate/
n-hexane) gave compound 47 (81 mg, 81% recovery) as a colorless,
crystalline solid that was identical, in all respects, with an authentic
sample.
(1R,2aR,4aR,7S,7aR,7bS)-7-Acetoxy-6,6,7b-trimethyl-2-oxo-
2,2a,4a,5,6,7,7a,7b-octahydro-1H-cyclobuta[e]inden-1-yl Benzoate
(53). A magnetically stirred solution of compound 48 (100 mg, 0.26
mmol) in dry, deoxygenated dichloromethane (30 mL) maintained
under a nitrogen atmosphere was irradiated with a Hanovia 100 W
medium-pressure mercury-vapor lamp (maintained at 5 °C) for 16 h.
The reaction mixture was then cooled and concentrated under reduced
pressure and the residue so obtained subjected to ﬂash column
chromatography (silica, 1:19 v/v ethyl acetate/n-hexane elution), thus
aﬀording two fractions, A and B.
Concentration of the fraction A [Rf = 0.3(5) in 1:19 v/v ethyl
acetate/n-hexane] gave compound 53 (17 mg, 17% or 100% brsm) as
a colorless, crystalline solid: mp = 180−181 °C; [α]D = −672.0 (c 1.5,
CHCl3);
1H NMR (400 MHz, CDCl3) δ 8.06 (m, 2H), 7.59 (t, J = 7.4
Hz, 1H), 7.45 (t, J = 7.4 Hz, 2H), 5.97 (d, J = 2.8 Hz, 1H), 5.80 (m,
1H), 5.59 (m, 1H), 4.98 (d, J = 4.2 Hz, 1H), 3.10 (m, 1H), 3.04 (m,
1H), 2.97 (dd, J = 9.3 and 4.2 Hz, 1H), 2.08 (dd, J = 13.3 and 9.8 Hz,
1H), 1.99 (s, 3H), 1.53 (dd, J = 13.3 and 5.0 Hz, 1H), 1.12 (s, 3H),
1.10 (s, 3H), 0.92 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 201.1,
170.6, 165.3, 134.3, 133.8, 130.1, 128.8, 128.7, 117.3, 83.6, 83.2, 59.2,
45.4, 43.5, 42.9, 35.1, 34.8, 28.8, 24.3, 21.3, 18.5; IR νmax 2963, 2934,
2872, 1790, 1724, 1372, 1237, 1104, 709 cm−1; MS (ESI, + ve) m/z
787 [(2M + Na)+, 10], 437 [(M + MeOH + Na)+, 50], 405 [(M +
Na)+, 100]; HRMS m/z (M + Na)+ calcd for C23H26O5Na 405.1678,
found 405.1670.
Concentration of the fraction B [Rf = 0.2(5) in 1:19 v/v ethyl
acetate/n-hexane] gave compound 48 (83 mg, 83% recovery) as a
colorless, crystalline solid that was identical, in all respects, with an
authentic sample.
( 2 a R , 4 a R , 7 S , 7 a R , 7 b S ) - 6 , 6 , 7 b - T r i m e t h y l - 2 - o x o -
2,2a,4a,5,6,7,7a,7b-octahydro-1H-cyclobuta[e]inden-7-yl Acetate
(54). A magnetically stirred solution of compound 49 (100 mg, 0.38
mmol) in dry, deoxygenated dichloromethane (30 mL) maintained
under a nitrogen atmosphere was irradiated with a Hanovia 100 W
medium-pressure mercury-vapor lamp (maintained at 5 °C) for 16 h.
The reaction mixture was then cooled and concentrated under reduced
pressure and the ensuing residue subjected to ﬂash column
chromatography (silica, 1:19 v/v ethyl acetate/n-hexane elution),
thus aﬀording two fractions, A and B.
Concentration of the fraction A [Rf = 0.3(5) in 1:19 v/v ethyl
acetate/n-hexane] gave compound 54 (23 mg, 23% or 92% brsm) as a
clear, colorless oil, [α]D = −254.0 (c 3.4, CHCl3). 1H NMR (400
MHz, CDCl3) δ 5.73 (m, 1H), 5.48 (m, 1H), 4.97 (d, J = 4.2 Hz, 1H),
3.12 (dd, J = 16.2 and 2.1 Hz, 1H), 3.05 (m, 1H), 2.84 (m, 1H), 2.59
(dd, J = 9.2 and 4.3 Hz, 1H), 2.51 (dd, J = 16.2 and 6.0 Hz, 1H), 2.01
(dd, J = 13.2 and 9.7 Hz, 1H), 1.95 (s, 3H), 1.50 (dd, J = 13.2 and 4.8
Hz, 1H), 1.19 (s, 3H), 1.08 (s, 3H), 0.90 (s, 3H); 13C NMR (100
MHz, CDCl3) δ 206.4, 170.7, 133.7, 118.2, 83.5, 64.1, 56.7, 45.7, 44.3,
43.4, 34.9, 29.0, 28.1, 25.5, 24.3, 21.3; IR νmax 3020, 2966, 2871, 1778,
1731, 1373, 1239, 1020, 711 cm−1; MS (ESI, + ve) m/z 285 [(M +
Na)+, 100]; HRMS m/z (M + Na)+ calcd for C16H22O3Na 285.1467,
found 285.1472.
Concentration of the fraction B (Rf = 0.3 in 1:19 v/v ethyl acetate/
n-hexane) gave compound 49 (69 mg, 69% recovery) as a colorless,
crystalline solid that was identical, in all respects, with an authentic
sample.
(1S,1aR,3aR,6S,6aR,6bR)-5,5,6b-Trimethyl-1,1a,3a,4,5,6,6a,6b-
octahydrocyclopropa[e]indene-1,6-diyl Diacetate (55). A magneti-
cally stirred solution of compound 50 (40 mg, 0.12 mmol) in dry,
deoxygenated dichloromethane (10 mL) maintained under a nitrogen
atmosphere was irradiated with a Hanovia 450 W medium-pressure
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mercury-vapor lamp for 0.5 h. The reaction mixture was then cooled
and concentrated under reduced pressure and the residue thus
obtained subjected to ﬂash column chromatography (silica, 1:9 v/v
ethyl acetate/n-hexane elution). Concentration of the appropriate
fractions [Rf = 0.6(5) in 1:9 v/v ethyl acetate/n-hexane] gave
compound 55 (39 mg, 98%) as a clear, colorless oil: [α]D = +167.0 (c
0.5, CHCl3);
1H NMR (400 MHz, CDCl3) δ 5.90 (m, 1H), 5.22 (dd, J
= 10.0 and 1.9 Hz, 1H), 5.04 (d, J = 3.9 Hz, 1H), 3.77 (d, J = 2.3 Hz,
1H), 2.82 (dd, J = 10.1 and 3.9 Hz, 1H), 2.64 (m, 1H), 2.05 (s, 3H),
2.00 (s, 3H), 1.90 (dd, J = 13.1 and 9.6 Hz, 1H), 1.33 (dd, J = 13.1 and
5.2 Hz, 1H), 1.22 (dd, J = 11.1 and 2.3 Hz, 1H), 1.06 (s, 6H), 0.90 (s,
3H); 13C NMR (100 MHz, CDCl3) δ 171.8, 171.1, 129.9, 123.1, 84.0,
63.4, 46.6, 42.8, 40.8, 35.4, 28.6, 24.3, 24.2, 22.1, 21.3, 20.9, 15.9; IR
νmax 3026, 2966, 2933, 2872, 1733, 1371, 1227 cm
−1; MS (ESI, + ve)
m/z 347 [(M + MeOH + Na)+, 100%], 331 [(M + K)+, 20], 329 (50),
315 [(M + Na)+, 60]; HRMS m/z (M + Na)+ calcd for C17H24O4Na
315.1572, found 315.1570.
(1S,1aR,3aR,6S,6aR,6bS)-1-((tert-Butyldimethylsilyl)oxy)-5,5,6b-
trimethyl-1,1a,-3a,4,5,6,6a,6b-octahydrocyclopropa[e]inden-6-yl
Acetate (56). A magnetically stirred solution of compound 47 (100
mg, 0.25 mmol) in dry, deoxygenated dichloromethane (30 mL)
maintained under a nitrogen atmosphere was irradiated with a Hanovia
450 W medium-pressure mercury-vapor lamp for 1.67 h. The reaction
mixture was then cooled, concentrated under reduced pressure and the
residue thus obtained subjected to ﬂash column chromatography
(silica, 1:19 v/v ethyl acetate/40−60 petroleum ether) to aﬀord two
fractions, A and B.
Concentration of the fraction A (Rf = 0.6 in 1:4 v/v ethyl acetate/
40−60 petroleum ether) gave compound 56 (74 mg, 80% or 87%
brsm) as a clear, colorless oil: [α]D = −65.5 (c 1.0, CHCl3); 1H NMR
[400 MHz, (CD3)2CO] δ 5.92 (m, 1H), 5.11 (dd, J = 10.0 and 2.1 Hz,
1H), 5.01 (d, J = 4.1 Hz, 1H), 3.14 (d, J = 2.2 Hz, 1H), 2.78 (m, 1H),
2.63 (m, 1H), 1.95 (s, 3H), 1.89 (m, 1H), 1.30 (dd, J = 13.0 and 5.2
Hz, 1H), 1.09 (s, 3H), 1.06 (s, 3H), 0.97 (dd, J = 5.5 and 2.4 Hz, 1H),
0.90 (s, 9H), 0.87 (s, 3H), 0.10(1) (s, 3H), 0.09(8) (s, 3H); 13C NMR
[100 MHz, (CD3)2CO] δ 170.7, 128.9, 125.2, 84.4, 63.9, 47.3, 43.3,
41.9, 36.2, 28.9, 27.7, 26.2, 24.7, 23.1, 21.1, 18.6, 15.9, − 4.9 (one
signal obscured or overlapping); IR νmax 3021, 2958, 2930, 2859, 1734,
1240, 1153, 859, 835, 776 cm−1; MS (ESI, + ve) m/z 387 [(M + Na)+,
100]; HRMS m/z (M + Na)+ calcd for C21H36O3SiNa 387.2331,
found 387.2331.
Concentration of the fraction B (Rf = 0.5 in 1:4 v/v ethyl acetate/
40−60 petroleum ether) gave compound 47 (8 mg, 8% recovery) as a
white, crystalline solid that was identical, in all respects, with an
authentic sample.
(3S,3aR,4R,7S,7aS,9R)-2,2,4-Trimethyl-9-((methylsulfonyl)oxy)-8-
oxo-2,3,3a,4,-7,7a-hexahydro-1H-4,7-ethanoinden-3-yl Acetate
(57). A magnetically stirred solution of compound 44 (280 mg, 1.01
mmol), methanesulfonyl chloride (94 μL, 1.21 mmol) and triethyl-
amine (212 μL, 1.52 mmol) in dichloromethane (5 mL) maintained
under a nitrogen atmosphere was stirred at 22 °C for 48 h and then
quenched with NH4Cl (10 mL of a saturated aqueous solution) before
being extracted with dichloromethane (2 × 50 mL). The combined
organic fractions were washed with water (2 × 50 mL) and brine (1 ×
50 mL) and then dried (MgSO4), ﬁltered, and concentrated under
reduced pressure. The residue thus obtained was subjected to ﬂash
column chromatography (silica, 1:9 v/v ethyl acetate/40−60
petroleum ether elution) to give, after concentration of the appropriate
fractions (Rf = 0.3 in 1:9 v/v ethyl acetate/40−60 petroleum ether),
compound 57 (198 mg, 56%) as a light-yellow oil: [α]D = +114.0 (c
4.3, CHCl3);
1H NMR (400 MHz, CDCl3) δ 6.08 (d, J = 8.1 Hz, 1H),
5.95 (t, J = 8.1 Hz, 1H), 5.08 (d, J = 5.9 Hz, 1H), 4.31 (s, 1H), 3.19
(m, 1H), 3.17 (s, 3H), 2.69 (m, 1H), 2.58 (dd, J = 10.6 and 6.0 Hz,
1H), 2.05 (s, 3H), 1.53 (m, 1H), 1.39 (t, J = 12.0 Hz, 1H), 1.20 (s,
3H), 0.98 (s, 3H), 0.85 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
204.1, 170.0, 140.9, 121.9, 81.3, 81.0, 50.7, 50.2, 44.9, 42.7, 41.6,
39.5(1), 39.4(8), 25.3, 22.1, 21.5, 18.1; IR νmax 2968, 1730, 1358,
1238, 1173, 965, 841 cm−1; MS (ESI, + ve) m/z 735 [(2M + Na)+,
15], 379 [(M + Na)+, 100]; HRMS m/z (M + Na)+ calcd for
C17H24O6SNa 379.1191, found 379.1193.
(1R,2a1S,2cR,5S,5aR,5bR)-4,4,5b-Trimethyl-1-((methylsulfonyl)-
oxy)-2-oxodeca-hydro-1H-cyclopenta[a]cyclopropa[cd]pentalen-5-
yl Acetate (58). A magnetically stirred solution of compound 57 (100
mg, 0.28 mmol) in dry, deoxygenated dichloromethane (30 mL)
maintained under a nitrogen atmosphere was irradiated with a Hanovia
100 W medium-pressure mercury-vapor lamp (maintained at 5 °C) for
12 h. The reaction mixture was then cooled and concentrated under
reduced pressure and the residue thus obtained subjected to ﬂash
column chromatography (silica, 1:9 v/v ethyl acetate/n-hexane
elution) to aﬀord two fractions, A and B.
Concentration of the fraction A [Rf = 0.4(5) in 1:9 v/v ethyl
acetate/n-hexane] gave compound 58 (48 mg, 48% or 98% brsm) as a
clear, colorless oil: [α]D = +161.0 (c 1.0, CHCl3).
1H NMR (400 MHz,
CDCl3) δ 5.54 (s, 1H), 5.09 (d, J = 4.8 Hz, 1H), 3.05 (s, 3H), 2.85−
2.72 (complex m, 2H), 2.50 (d, J = 4.8 Hz, 1H), 2.23 (s, 3H), 2.18 (s,
1H), 1.71 (d, J = 4.8 Hz, 1H), 1.59 (dd, J = 8.7 and 2.3 Hz, 2H), 1.07
(s, 3H), 0.97(2) (s, 3H), 0.96(7) (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 211.1, 170.2, 80.9, 78.8, 50.4, 45.2, 42.5, 42.4, 41.1, 39.3,
37.6, 36.1, 32.9, 25.1, 22.7, 22.5, 21.2; IR νmax 2966, 2936, 2875, 1729,
1356, 1236, 1172, 917, 842 cm−1; MS m/z 735 [(2M + Na)+, 5], 379
[(M + Na)+, 100]; HRMS m/z (M + Na)+ calcd for C17H24O6SNa
379.1191, found 379.1189.
Concentration of the fraction B (Rf = 0.3 in 1:9 v/v ethyl acetate/n-
hexane) gave compound 57 (50 mg, 50% recovery) as a clear, colorless
oil that was identical, in all respects, with an authentic sample.
X-ray Crystallographic Studies. Crystallographic Data. Com-
pound 8: C9H12O3, M = 168.19, T = 150 K, orthorhombic, space
group P212121, Z = 4, a = 7.3238(1) Å, b = 7.5553(1) Å, c =
14.5389(2) Å; V = 804.49(2) Å3, Dx = 1.389 g cm
−3, 1585 unique data
(2θmax = 144.6°), R = 0.023 [for 1569 reﬂections with I > 2.0σ(I)]; Rw
= 0.057 (all data), S = 1.00.
Compound 9: C15H26O3Si, M = 282.46, T = 150 K, monoclinic,
space group C2, Z = 4, a = 18.9377(5) Å, b = 6.2442(1) Å, c =
14.6275(5) Å; β = 105.950(3)°; V = 1663.12(8) Å3, Dx = 1.128 g
cm−3, 3042 unique data (2θmax = 144.8°), R = 0.032 [for 2889
reﬂections with I > 2.0σ(I)]; Rw = 0.080 (all data), S = 0.99.
Compound 10: C9H12O3, M = 168.19, T = 150 K, orthorhombic,
space group P212121, Z = 8, a = 8.23350(7) Å, b = 8.68949(8) Å, c =
23.6396(2) Å; V = 1691.29(3) Å3, Dx = 1.321 g cm
−3, 3334 unique
data (2θmax = 144.6°), R = 0.04 [for 3257 reﬂections with I > 2.0σ(I)];
Rw = 0.112 (all data), S = 1.01.
Compound 13: C14H26O2Si, M = 254.45, T = 150 K, orthorhombic,
space group P21212, Z = 8, a = 18.3637(1) Å, b = 14.1093(1) Å, c =
12.0122(1) Å; V = 3112.35(4) Å3, Dx = 1.086 g cm
−3, 6159 unique
data (2θmax = 145.0°), R = 0.025 [for 6101 reﬂections with I >
2.0σ(I)]; Rw = 0.067 (all data), S = 1.01.
Compound 23: C13H16O3, M = 220.27, T = 150 K, orthorhombic,
space group P212121, Z = 4, a = 7.27015(5) Å, b = 11.05109(8) Å, c =
13.78627(9) Å; V = 1107.63(1) Å3, Dx = 1.321 g cm
−3, 2186 unique
data (2θmax = 144.8°), R = 0.022 [for 2152 reﬂections with I >
2.0σ(I)]; Rw = 0.057 (all data), S = 1.01.
Compound 27: C13H16O3, M = 220.27, T = 200 K, monoclinic,
space group P21, Z = 2, a = 7.2003(2) Å, b = 8.4682(2) Å, c =
9.4258(3) Å; β = 91.1279(17)°; V = 574.61(3) Å3, Dx = 1.273 g cm
−3,
1778 unique data (2θmax = 60.0°), R = 0.048 [for 1655 reﬂections with
I > 2.0σ(I)]; Rw = 0.156 (all data), S = 1.03.
Compound 30: C11H12O3, M = 192.21, T = 150 K, monoclinic,
space group P21, Z = 2, a = 8.4949(4) Å, b = 5.9702(2) Å, c =
9.3840(4) Å; β = 95.383(4)°; V = 473.82(3) Å3, Dx = 1.347 g cm
−3,
1032 unique data (2θmax = 144.8°), R = 0.045 [for 998 reﬂections with
I > 2.0σ(I)]; Rw = 0.130 (all data), S = 1.03.
Compound 32: C10H12O2, M = 164.20, T = 150 K, orthorhombic,
space group P212121, Z = 4, a = 7.8054(1) Å, b = 9.7920(1) Å, c =
11.0580(1) Å; V = 845.17(2) Å3, Dx = 1.290 g cm
−3, 1677 unique data
(2θmax = 144.6°), R = 0.022 [for 1645 reﬂections with I > 2.0σ(I)]; Rw
= 0.057 (all data), S = 1.01.
Compound 34: C11H12O3, M = 192.21, T = 150 K, monoclinic,
space group P21, Z = 2, a = 6.9303(2) Å, b = 7.7696(2) Å, c =
8.6272(2) Å; β = 92.403(2)°; V = 464.13(2) Å3, Dx = 1.375 g cm
−3,
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993 unique data (2θmax = 145.2°), R = 0.037 [for 980 reﬂections with I
> 2.0σ(I)]; Rw = 0.117 (all data), S = 1.04.
Compound 35: C13H16O3, M = 220.27, T = 150 K, orthorhombic,
space group P212121, Z = 4, a = 7.3877(1) Å, b = 7.8178(1) Å, c =
19.8494(2) Å; V = 1146.41(2) Å3, Dx = 1.276 g cm
−3, 2267 unique
data (2θmax = 144.8°), R = 0.030 [for 2238 reﬂections with I >
2.0σ(I)]; Rw = 0.056 (all data), S = 1.00.
Compound 36: C11H12O3, M = 192.21, T = 150 K, orthorhombic,
space group P212121, Z = 4, a = 7.4666(2) Å, b = 12.0831(5) Å, c =
10.8645(4) Å; V = 980.19(6) Å3, Dx = 1.302 g cm
−3, 1491 unique data
(2θmax = 58.4°), R = 0.047 [for 1303 reﬂections with I > 2.0σ(I)]; Rw =
0.108 (all data), S = 1.00.
Compound 38: C10H12O2, M = 164.20, T = 150 K, hexagonal,
space group P65, Z = 6, a = 14.7787(4) Å, c = 7.6213(2) Å; V =
1441.56(7) Å3, Dx = 1.135 g cm
−3, 1379 unique data (2θmax = 58.8°),
R = 0.045 [for 1283 reﬂections with I > 2.0σ(I)]; Rw = 0.111 (all data),
S = 1.03.
Compound 41: C17H26O3, M = 278.39, T = 150 K, orthorhombic,
space group P212121, Z = 4, a = 6.26451(4) Å, b = 12.09608(9) Å, c =
20.26568(14) Å; V = 1535.65(2) Å3, Dx = 1.204 g cm
−3, 3025 unique
data (2θmax = 144.6°), R = 0.024 [for 2974 reﬂections with I >
2.0σ(I)]; Rw = 0.062 (all data), S = 1.00.
Compound 44: C16H22O4, M = 278.35, T = 150 K, orthorhombic,
space group P212121, Z = 4, a = 6.4307(1) Å, b = 8.7685(1) Å, c =
26.1929(2) Å; V = 1476.95(3) Å3, Dx = 1.252 g cm
−3, 2913 unique
data (2θmax = 144.8°), R = 0.024 [for 2859 reﬂections with I >
2.0σ(I)]; Rw = 0.063 (all data), S = 1.00.
Compound 45: C18H24O5, M = 320.39, T = 150 K, monoclinic,
space group P21, Z = 2, a = 7.4300(3) Å, b = 9.7667(3) Å, c =
12.1277(3) Å; β = 92.279(3)°; V = 879.37(5) Å3, Dx = 1.210 g cm
−3,
2377 unique data (2θmax = 58.6°), R = 0.038 [for 2242 reﬂections with
I > 2.0σ(I)]; Rw = 0.093 (all data), S = 1.02.
Compound 47: C22H36O4Si, M = 392.61, T = 150 K, orthorhombic,
space group P212121, Z = 4, a = 25.6494(7) Å, b = 14.1949(4) Å, c =
6.2343(2) Å; V = 2269.85(11) Å3, Dx = 1.149 g cm
−3, 5914 unique
data (2θmax = 58.8°), R = 0.045 [for 5443 reﬂections with I > 2.0σ(I)];
Rw = 0.102 (all data), S = 1.04.
Compound 48: C23H26O5, M = 382.46, T = 150 K, orthorhombic,
space group P212121, Z = 4, a = 19.9195(6) Å, b = 11.6626(3) Å, c =
8.7386(2) Å; V = 2030.09(9) Å3, Dx = 1.251 g cm
−3, 2980 unique data
(2θmax = 58.6°), R = 0.041 [for 2759 reﬂections with I > 2.0σ(I)]; Rw =
0.101 (all data), S = 1.03.
Compound 53: C23H26O5, M = 382.46, T = 150 K, orthorhombic,
space group P212121, Z = 4, a = 8.9344(2) Å, b = 15.4099(3) Å, c =
14.9268(3) Å; V = 2055.09(7) Å3, Dx = 1.236 g cm
−3, 3065 unique
data (2θmax = 59.0°), R = 0.042 [for 2868 reﬂections with I > 2.0σ(I)];
Rw = 0.112 (all data), S = 1.04.
Structure Determination. Images for compound 27, 36, 38, 45, 47,
48, and 53 were measured on a diﬀractometer (Mo Kα, graphite
monochromator, λ = 0.71073 Å) ﬁtted with an area detector and the
data extracted using the DENZO/Scalepack or CrysAlis package.15
Images for compounds 8, 9, 10, 13, 23, 30, 32, 34, 35, 41, and 44 were
measured on a diﬀractometer (Cu Kα, mirror monochromator, λ=
1.54184 Å) ﬁtted with an area detector and the data extracted using
the CrysAlis package.16 The structure solutions for all six compounds
were solved by direct methods (SIR92)17 then reﬁned using the
CRYSTALS program package.18 Atomic coordinates, bond lengths
and angles, and displacement parameters have been deposited at the
Cambridge Crystallographic Data Centre (CCDC nos. 1545223,
154224, 1545225, 1545226, 1545227, 1545228, 1545229, 1545230,
1545231, 1545232, 1545233, 1545234, 1545235, 1545236, 1545237,
1545238, 1545239 and 1545240). These data can be obtained free of
charge via www.ccdc.cam.ac.uk/data_request/cif, by emailing data_
request@ccdc.cam.ac.uk, or by contacting the Cambridge Crystallo-
graphic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +
44 1223 336033.
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ABSTRACT: The title natural products 2−7 have been prepared by
reductive cyclization of the relevant 2-arylcyclohex-2-en-1-one (e.g.
20) to the corresponding tetrahydrocarbazole and dehydrogenation
(aromatization) of this to give the target carbazole (e.g. 4).
Compounds such as 20 were prepared using a palladium-catalyzed
Ullmann cross-coupling reaction between the appropriate 2-
iodocyclohex-2-en-1-one and o-halonitrobenzene.
■ INTRODUCTION
9H-Carbazole (1) (Figure 1) was ﬁrst isolated from coal tar
more than 100 years ago,1 and since that time this aromatic
heterocycle and its various derivatives have fascinated organic
chemists because of their value in both medicine and materials
science.2 Many biologically active natural products embodying
this framework have also been isolated, particularly from higher
plants.2d,e,3 As such, the development of methods for the
synthesis of the carbazoles has been an ongoing ﬁeld of
research. A suite of approaches to these compounds has been
reported, ranging from the classical Fischer−Borsche4 and
Graebe−Ullmann5 routes to more contemporary ones such as
the cyclization of biarylnitrenes (Cadogan synthesis)6 or
variants thereof and the annulation of indoles,7 including
through electrocyclization processes. Despite the demonstrated
utility of these and other approaches,8 perhaps the most
eﬀective route to carbazoles involves the cyclization of
diarylamines, especially under oxidative conditions.9 Variations
on this last approach have been used to great eﬀect in
developing total syntheses of a plethora of carbazole-containing
natural products, with particularly notable contributions having
being made, especially in recent times, by the Knölker
group.2,9e−i,k,m
Sometime ago we reported10 that 1,2,3,4-tetrahydro-9H-
carbazoles (formally 2,3,4,9-tetrahydro-1H-carbazoles) can be
formed by a two-step process involving an initial the palladium-
catalyzed Ullmann cross-coupling of 2-halocyclohex-2-en-1-
ones with o-halonitrobenzenes and then subjecting the resulting
2-arylcyclohex-2-en-1-ones to a reductive cyclization reaction.11
Since various methods are available for or could be applied to
the oxidation of tetrahydrocarbazoles to carbazoles,12 we
sought to establish if the reaction sequence just mentioned
could provide a useful means for obtaining natural products
embodying the latter ring system. Herein we report the
outcomes of such studies and by which means we have been
able to realize syntheses of the parent carbazole (1) as well as
the natural products 3-methyl-9H-carbazole (2),13 glycoborine
(3, aka glycrophylamine),3a,14 glycozoline (4),3a,15 clauszoline K
(5),16 mukonine (6),17 and karapinchamine A (7)18 together
with their monomethoxylated congener 8 (Figure 2).
■ RESULTS AND DISCUSSION
Our initial studies focused on acquiring targets 1 and 2, and this
involved (Scheme 1) the initial palladium-catalyzed Ullmann
cross-coupling of 2-iodocyclohex-2-en-1-one (9)19 or its C4-
methylated counterpart 1011 with commercially available o-
bromonitrobenzene (11) under conditions deﬁned earlier,10
and thereby aﬀording the anticipated and previously reported
2-arylcyclohex-2-en-1-ones 1210,11 (85%) and 1311 (86%),
respectively. A methanolic solution of each of compounds 12
and 13 was then subjected to reaction with hydrogen in the
presence of commercially available W-2 Raney nickel at room
temperature, and so aﬀording the tetrahydrocarbazoles
1410,11,12b (64%) and 1511,12b (58%), respectively. Various
Received: January 8, 2017
Published: February 22, 2017
Figure 1. Structure of parent 9H-carbazole (1) and the associated ring
labeling and atom numbering.
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attempts to modify these reductive cyclization conditions in an
eﬀort to obtain dihydrocarbazoles (or perhaps even the
carbazoles themselves as a result of conducting the workup
under aerobic conditions) were unsuccessful. In the ﬁnal step of
the reaction sequence, then, mesitylene solutions of com-
pounds 14 and 15 were each heated to 150 °C with an equal
weight of 10% palladium on carbon, and thus aﬀording
carbazoles 1 (55%) and 212b (57%), respectively. All of the
spectroscopic and physical data acquired on these reaction
products were in complete accord with the assigned structures
and matched those derived from a commercially available
sample (in the former case) or reported6h,12b in the literature
(in the latter case). Furthermore, each was subjected to single-
crystal X-ray analysis.20
The preparation of glycoborine (3), a synthetic target
pursued by others,6e,g,k,9h,k,14 was readily accomplished as
shown in Scheme 2 by coupling 2-iodo-4-methylcyclohex-2-en-
1-one (10)11 with nitroarene 1621 and thereby producing the
arylated cyclohexenone 17 (88%), the structure of which was
secured by a single-crystal X-ray analysis.20 The appearance of
28 signals in the 13C NMR spectrum of this C14 compound
suggested that it existed as diastereoisomeric atropisomers
under ambient conditions. Reductive cyclization of compound
17 using hydrogen in the presence of W-2 Raney nickel gave
the tetrahydrocarbazole 1811a (72%), and dehydrogenation of
this compound under the same conditions as employed before
then aﬀorded the target natural product 3, that was obtained in
75% yield. Once again, all of the appropriate spectral
comparisons left no doubt that the glycoborine had been
obtained but ﬁnal conﬁrmation of this followed from a single-
crystal X-ray analysis.20
A reaction sequence essentially analogous to that described
above was used to synthesize glycozoline (4), a compound that
has also been the target of previous studies.3c,4c,6i,12b,22 Thus, as
shown in Scheme 3, reaction of 2-iodo-4-methylcyclohex-2-en-
1-one (10) with commercially available nitroarene 19 under the
by now standard palladium-catalyzed Ullmann cross-coupling
conditions gave the anticipated product 20 (87%), which was
reductively cyclized with hydrogen in the presence of W-2
Figure 2. Structures of natural products 2-7 and the monosubstituted congener 8.
Scheme 1. Reaction Sequences Leading to Carbazoles 1 and
2
Scheme 2. Synthesis of Glycoborine (3)
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Raney nickel and so providing the tetrahydrocarbazole
2112b,d,22b in 72% yield. Dehydrogenation of compound 21
through brief treatment with 10% Pd on C in diphenyl ether at
210 °C then gave glycozoline (4) in 89% yield, the structure of
which was conﬁrmed by single-crystal X-ray analysis.20
The reaction sequence leading to clauszoline K (5) (Scheme
4), another popular target,22d,23 provided some insights into the
propensity of 2,3,4,9-tetrahydro-1H-carbazoles to engage in
alternate oxidation reactions.12a Thus, the palladium-catalyzed
Ullmann cross-coupling of the iodinated cyclohexenone 10
with the commercially available 2-iodonitroarene 22 proceeded
as anticipated to give the required arylated cyclohexenone 23
(80%), and this in turn engaged in the same type of reductive
cyclization reaction as seen before to give tetrahydrocarbazole
2411a,14 (65%). However, compound 24 proved rather prone to
oxidation, with the hydroperoxide 25 being formed in
increasing quantities when its precursor was allow to stand at
22 °C as a solution (in various solvents) left open to the
atmosphere. Compound 25, the structure of which was
established by single-crystal X-ray analysis,20 may arise through
a facially selective ene reaction between indole 24 and singlet
oxygen, the latter reactant (most likely) being produced
through the other (24) serving as a sensitizer. Despite the
ease of the conversion 24 → 25, the tetrahydrocarbazole was
readily dehydrogenated in the same manner as described in the
other instances reported herein, producing carbazole
269c,h,22d,23a,b in 88% yield. Unlike isomer 4, compound 26 is
not a naturally occurring material but is readily converted into
one, namely aldehyde 5 (clauszoline K) (66%), on treatment
with DDQ in aqueous methanol9h,23a,b at ambient temperature
for 4 h. The structure of compound 5 was conﬁrmed by single-
crystal X-ray analysis.20
The carbazole natural product mukonine (6), another
popular target compound,9a,12d,17a,24 carries both the methoxy
and carbomethoxy substituents in the same ring and so
requiring, as the ﬁrst step in the present synthesis, the
palladium-catalyzed Ullmann cross-coupling of the “parent” 2-
iodocyclohexeneone 9 with the readily obtained (see below)
tetrasubstituted arene 27 (Scheme 5), aﬀording the required 2-
arylated cyclohexenone 28, albeit in just 39% yield. Reductive
cyclization of compound 28 under standard conditions gave
tetrahydrocarbazole 29 (79%), which upon dehydrogenation
under the usual conditions aﬀorded mukonine (6) (66%) as a
white, crystalline solid. Once again, all of the derived spectral
Scheme 3. Synthesis of Glycozoline (4)
Scheme 4. Synthesis of Clauszoline K (5)
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data were fully consistent with the assigned structure as well as
those reported for the natural product, but ﬁnal conﬁrmation of
this followed from a single-crystal X-ray analysis.20 The arene
27 used in this sequence was prepared by ﬁrst brominating
commercially available methyl 4-amino-3-methoxybenzoate
with N-bromosuccinimide (NBS) and then oxidizing the
previously reported25 bromide to the corresponding nitro
compound (viz. 27) using m-chloroperbenzoic acid (mCPBA)
(see the Experimental Section for details).
The trisubstituted carbazole natural product karapinchamine
A (7), the subject of just one previous synthetic study,7e was
readily obtained (Scheme 6) by treating compound 26 with
boron tribromide so as to eﬀect cleavage of the methyl ether
moiety and then treating the product hydroxycarbazole 309h
(84%), as a solution in THF, with an excess of n-butyllithium
and then ca. 1.5 equiv of geranyl bromide. By such means
karapinchamine A (7) was obtained in 50% yield after column
chromatography. Interestingly, there was no evidence for the
formation of the isomeric O-geranylated product during the
course of this reaction. All of the spectral data acquired on
product 7 matched those recorded for the natural product (see
the Supporting Information for relevant spectral comparisons).
Monosubstituted carbazoles wherein the single substituent
derives from the arene coupling partner are also readily
available by the procedures reported here. Thus, as shown in
Scheme 7, cross-coupling of compounds 9 and 22 under the
usual conditions aﬀorded enone 3110,11b (91%), which on
subjection to reductive cyclization using hydrogen in the
presence of Raney nickel aﬀorded the tetrahydrocarazole
3210,11b,26 (76%). Dehydrogenation of compound 32 using
10% Pd on C in hot mesitylene then aﬀorded carbazole 86f,k,l,9j
(64%), the spectral data for which matched those reported
previously.
■ CONCLUSIONS
The procedures detailed here allow for the straightforward
preparation, in a fully regiocontrolled manner, of a range of
carbazoles carrying various combinations of substituents in
both the A and the C rings as well as on the nitrogen of the B
ring. Substitution patterns encountered in naturally occurring
and biologically active carbazoles appear to be completely
accessible using the methods described here. As a further
indication of the utility of the title protocol, it is worth noting
that carbazole 30 is an established precursor to the pyrano[3,2-
a]carbazole alkaloids isogirinimbine and mahanimbicine.9h In a
related vein, clauszoline K (5) is an established synthetic
precursor to the alkaloids clauszoline M and N (the
corresponding methyl ester and acid, respectively).22d,23a The
present study also serves to highlight the continued utility of
the palladium-catalyzed Ullmann cross-coupling reaction,27
especially when it is used in combination with reductive
cyclization protocols.28
■ EXPERIMENTAL SECTION
General Experimental Procedures. Unless otherwise speciﬁed,
proton (1H) and carbon (13C) NMR spectra were recorded at 18 °C
in base-ﬁltered CDCl3 on a spectrometer operating at 400 MHz for
proton and 100 MHz for carbon nuclei. 1H NMR data are recorded as
follows: chemical shift (δ) [multiplicity, coupling constant(s) J (Hz),
relative integral], where multiplicity is deﬁned as s = singlet, d =
doublet, t = triplet, q = quartet, and m = multiplet, or combinations of
the above. In relevant cases, the signal due to residual CHCl3
appearing at δH 7.26 and the central resonance of the CDCl3 “triplet”
Scheme 5. Synthesis of Mukonine (6)
Scheme 6. Synthesis of Karapinchamine A (7)
Scheme 7. Synthesis of 2-Methoxy-9H-carbazole (8)
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appearing at δC 77.0 were used to reference
1H and 13C NMR spectra,
respectively. Samples were analyzed by infrared spectroscopy (νmax) as
thin ﬁlms on KBr plates. Low- and high-resolution electron impact
(EI) mass spectra were recorded on a double-focusing, triple-sector
machine. Low- and high-resolution ESI mass spectra were recorded on
a triple-quadrupole mass spectrometer operating in either positive or
negative ion mode. Melting points are uncorrected. Analytical thin-
layer chromatography (TLC) was performed on aluminum-backed 0.2
mm thick silica gel 60 F254 plates. Eluted plates were visualized using a
254 nm UV lamp and/or by treatment with a suitable dip followed by
heating. These dips included phosphomolybdic acid/ceric sulfate/
sulfuric acid (concentrated)/water (37.5 g/7.5 g/37.5 g/720 mL),
potassium permanganate/potassium carbonate/5% sodium hydroxide
aqueous solution/water (3 g/20 g/5 mL/300 mL), and p-anisaldehyde
or vanillin/sulfuric acid (concentrated)/ethanol (15 g/2.5 mL/250
mL). Flash chromatographic separations were carried out following
protocols deﬁned by Still et al.29 with silica gel 60 (40−63 μm) as the
stationary phase and using the AR- or HPLC-grade solvents indicated.
The melting points of solids puriﬁed by such means were recorded
directly (i.e. after they had crystallized from the concentrated
chromatographic fractions). Starting materials, reagents, drying agents,
and other inorganic salts were generally commercially available and
were used as supplied. The copper powder used in the palladium-
catalyzed Ullmann cross-coupling reactions had a particle size of <75
μm. Tetrahydrofuran (THF), methanol, and dichloromethane were
dried using a solvent puriﬁcation system that is based upon a
technology originally described by Grubbs et al.30 Where necessary,
reactions were performed under a nitrogen atmosphere.
Speciﬁc Chemical Transformations. 2-Iodocyclohex-2-en-1-
one (9). Following a procedure reported by Johnson et al.,31 a
magnetically stirred solution of cyclohex-2-en-1-one (2.00 g, 20.8
mmol) in chloroform/pyridine (80 mL of a 1/1 v/v mixture)
maintained at 0 °C under a nitrogen atmosphere was treated, dropwise
over 2 h, with a solution of molecular iodine (18.5 g, 72.8 mmol) in
chloroform/pyridine (80 mL of a 1/1 v/v mixture). The ensuing
mixture was warmed to 22 °C, stirred at this temperature for 16 h then
diluted with diethyl ether (200 mL) and washed with water (1 × 100
mL), Na2S2O3 (2 × 100 mL of a 20% w/v aqueous solution), HCl (2
× 100 mL of a 1 M aqueous solution), water (2 × 100 mL) and brine
(1 × 100 mL) before being dried (MgSO4), ﬁltered, and concentrated
under reduced pressure to give a yellow oil. This was subjected to ﬂash
column chromatography (silica, 2/5/70 v/v/v ethyl acetate/dichloro-
methane/40−60 petroleum ether elution) to give, after concentration
of the appropriate fractions (Rf = 0.6 in 2/5/11 v/v/v ethyl acetate/
dichloromethane/40−60 petroleum ether), 2-iodocyclohex-2-en-1-one
919 (3.85 g, 83%) as a light yellow solid, mp 47−50 °C (lit.19 mp 47−
49 °C): 1H NMR (400 MHz, CDCl3) δ 7.77 (t, J = 4.4 Hz, 1H), 2.67
(m, 2H), 2.44 (m, 2H), 2.09 (m, 2H); 13C NMR (100 MHz, CDCl3) δ
192.3, 159.6, 104.0, 37.4, 30.1, 23.0; IR νmax 2949, 2939, 1675, 1585,
1421, 1314, 1120, 966, 914, 803, 703 cm−1; MS (EI, 70 eV) m/z 222
(M+•, 100%), 194 (75), 67 (40); HRMS M+• calcd for C6H7
127IO
221.9542, found 221.9540.
2-Iodo-4-methylcyclohex-2-en-1-one (10). A magnetically stirred
solution of 4-methylcyclohex-2-en-1-one32 (2.29 g, 20.8 mmol) in
chloroform/pyridine (80 mL of a 1/1 v/v mixture) maintained at 0 °C
under a nitrogen atmosphere was treated, dropwise over 2 h, with a
solution of molecular iodine (18.5 g, 72.8 mmol) in chloroform/
pyridine (80 mL of a 1/1 v/v mixture). The ensuing mixture was
warmed to 22 °C, stirred at this temperature for 16 h, and then diluted
with diethyl ether (200 mL) and washed with water (1 × 100 mL),
Na2S2O3 (2 × 100 mL of a 20% w/v aqueous solution), HCl (2 × 100
mL of a 1 M aqueous solution), water (2 × 100 mL), and brine (1 ×
100 mL) before being dried (MgSO4), ﬁltered, and concentrated
under reduced pressure to give a yellow oil. Subjection of this material
to ﬂash column chromatography (silica, 1/19 v/v ethyl acetate/40−60
petroleum ether elution) gave, after concentration of the appropriate
fractions (Rf = 0.5 in 1/5 v/v ethyl acetate/40−60 petroleum ether),
compound 1011b (3.98 g, 81%) as a light yellow oil: 1H NMR (400
MHz, CDCl3) δ 7.50 (d, J = 2.6 Hz, 1H), 2.66−2.56 (complex m, 2H),
2.48−2.39 (complex m, 1H), 2.07 (m, 1H), 1.64 (m, 1H), 1.08 (d, J =
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 191.8, 164.7, 102.9, 35.6,
35.5, 30.6, 19.7; IR νmax 2959, 2930, 2870, 1686, 1585, 1454, 1318,
1109, 790 cm−1; MS (EI, 70 eV) m/z 236 (M+•, 100%), 208 (25), 109
(75), 81 (50), 53 (60); HRMS M+• calcd for C7H9
127IO 235.9698,
found 235.9691.
2′-Nitro-4,5-dihydro-[1,1′-biphenyl]-2(3H)-one (12). A magneti-
cally stirred mixture of o-bromonitrobenzene (11) (941 mg, 4.7
mmol), 2-iodocyclohex-2-en-1-one (9) (470 mg, 2.1 mmol), copper
powder (673 mg, 10.6 g atom), CuI (605 mg, 3.2 mmol), and
Pd(dppf)Cl2·CH2Cl2 (87 mg, 0.1 mmol) in deoxygenated DMSO (21
mL) maintained under nitrogen was heated to 50 °C for 10 h. The
reaction mixture was then cooled to room temperature, quenched with
water (1 × 20 mL), diluted with ethyl acetate (1 × 40 mL), and
ﬁltered through a pad of diatomaceous earth and silica gel. The pad
and the solids thus retained were washed with ethyl acetate (2 × 50
mL), and the ﬁltrate was washed with water (2 × 100 mL) and then
brine (2 × 100 mL). The separated organic phase was dried (Na2SO4),
ﬁltered, and concentrated under reduced pressure to give a brown oil,
and subjection of this material to ﬂash chromatography (silica, 1/9 v/v
ethyl acetate/40−60 petroleum ether elution) gave, after concen-
tration of the appropriate fractions (Rf = 0.4 in 1/1 v/v ethyl acetate/
40−60 petroleum ether), compound 1210,11 (390 mg, 85%) as a light
yellow crystal, mp 96−99 °C (lit.10 mp 92−95 °C): 1H NMR (400
MHz, CDCl3) δ 7.99 (m, 1H), 7.58 (m, 1H), 7.46 (m, 1H), 7.25 (m,
1H), 7.00 (t, J = 4.2 Hz, 1H), 2.56 (m, 4H), 2.13 (m, 2H); 13C NMR
(100 MHz, CDCl3) δ 196.6, 148.7, 146.8, 139.4, 133.4, 132.2, 131.8,
128.8, 124.2, 38.4, 26.4, 22.7; IR νmax 2949, 2868, 1679, 1523, 1353,
1158, 859, 788, 751, 709 cm−1; MS (ESI, +ve) m/z 240 [(M + Na)+,
100%], 218 [(M + H)+, 10]; HRMS (M + H)+ calcd for C12H12NO3
218.0817, found 218.0825.
5-Methyl-2′-nitro-4,5-dihydro-[1,1′-biphenyl]-2(3H)-one (13). A
magnetically stirred mixture of o-bromonitrobenzene (11) (960 mg,
4.75 mmol), 2-iodo-4-methylcyclohex-2-en-1-one (10) (510 mg, 2.16
mmol), copper powder (687 mg, 10.80 g atom), CuI (617 mg, 3.24
mmol), and Pd(dppf)Cl2·CH2Cl2 (88 mg, 0.11 mmol) in
deoxygenated DMSO (22 mL) was heated to 50 °C under a nitrogen
atmosphere for 8 h. The reaction mixture was then cooled to room
temperature, quenched with water (20 mL), diluted with ethyl acetate
(40 mL), and then ﬁltered through a pad of diatomaceous earth and
silica gel. The pad and the solids thus retained were washed with ethyl
acetate (2 × 50 mL), and the organic phase associated with the ﬁltrate
was then washed with water (2 × 100 mL) and brine (2 × 100 mL)
before being dried (Na2SO4), ﬁltered, and concentrated under reduced
pressure to give a brown oil. Subjection of this material to ﬂash
chromatography (silica, 1/9 v/v ethyl acetate/40−60 petroleum ether
elution) gave, after concentration of the appropriate fractions (Rf = 0.5
in 1/1 v/v ethyl acetate/40−60 petroleum ether), compound 1311
(430 mg, 86%) as a light yellow oil: 1H NMR (400 MHz, CDCl3) δ
7.99 (m, 1H), 7.58 (m, 1H), 7.45 (m, 1H), 7.40 (d, J = 7.6 Hz, 1H),
6.80 (d, J = 1.6 Hz, 1H), 2.79 (broad s, 1H), 2.65−2.47 (complex m,
2H), 2.20 (m, 1H), 1.86−1.76 (complex m, 1H), 1.24 (m, 3H); 13C
NMR (100 MHz, CDCl3) δ 196.6, 152.3, 148.7, 138.4, 133.4, 132.1,
131.8, 128.9, 124.3, 37.2, 31.8, 30.7, 20.4; IR νmax 2960, 2872, 1681,
1525, 1354, 1159, 788, 750 cm−1; MS (ESI, +ve) m/z 254 [(M +
Na)+, 100%], 232 [(M + H)+, 10]; HRMS (M + Na)+ calcd for
C13H13NNaO3 254.0793, found 254.0799.
2,3,4,9-Tetrahydro-1H-carbazole (14). A magnetically stirred
mixture of compound 12 (100 mg, 0.46 mmol) and commercially
available W-2 Raney nickel (200 mg, washed twice with absolute
ethanol) in methanol (23 mL) was deoxygenated and then stirred
under an atmosphere of hydrogen at 22 °C for 18 h. After this time
and using an externally applied magnet to hold the solid associated
with the reaction mixture within the ﬂask, the supernatant liquid was
decanted and the retained solid washed with methanol (2 × 30 mL)
(Caution! Af ter these washings water should be added to the residual solid
so as to prevent a f ire.). The methanolic solutions were combined and
then concentrated under reduced pressure to give a white solid.
Subjection of this material to ﬂash column chromatography (silica, 1/9
v/v ethyl acetate/40−60 petroleum ether elution) gave, after
concentration of the appropriate fractions (Rf = 0.6 in 1/5 v/v ethyl
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acetate/40−60 petroleum ether), compound 1410,11,12b (50 mg, 64%)
as a white solid, mp 104−106 °C (lit.12b mp 104−106 °C): 1H NMR
[400 MHz, (CD3)2CO] δ 9.70 (broad s, 1H), 7.36 (d, J = 7.8 Hz, 1H),
7.26 (d, J = 7.8 Hz, 1H), 7.02−6.92 (complex m, 2H), 2.73 (t, J = 5.9
Hz, 2H), 2.68−2.65 (complex m, 2H), 1.92−1.81 (complex m, 4H);
13C NMR [100 MHz, (CD3)2CO] δ 137.1, 135.1, 128.8, 121.1, 119.1,
118.0, 111.3, 109.7, 24.2, 24.0, 23.8, 21.7; IR νmax 3396, 2926, 2849,
1467, 1450, 1439, 1325, 1304, 1233, 736, 635 cm−1; MS (ESI, +ve) m/
z 226 [(M + MeOH + Na)+, 100%], 188 (56), 172 [(M + H)+, 70];
HRMS (M + H)+ calcd for C12H14N 172.1126, found 172.1121.
3-Methyl-2,3,4,9-tetrahydro-1H-carbazole (15). A magnetically
stirred mixture of compound 13 (320 mg, 1.38 mmol) and
commercially available W-2 Raney nickel (640 mg, washed twice
with absolute ethanol) in methanol (69 mL) was deoxygenated and
then stirred under an atmosphere of hydrogen at 22 °C for 18 h. After
this time and using an externally applied magnet to hold the solid
associated with the reaction mixture within the ﬂask, the supernatant
liquid was decanted and the retained solid washed with methanol (2 ×
30 mL) (Caution! Af ter these washings water should be added to the
residual solid so as to prevent a f ire.). The methanolic solutions were
combined and then concentrated under reduced pressure to give a
white solid. Subjection of this material to ﬂash column chromatog-
raphy (silica, 1/9 v/v ethyl acetate/40−60 petroleum ether elution) to
give, after concentration of the appropriate fractions (Rf = 0.6 in 1/5
v/v ethyl acetate/40−60 petroleum ether), compound 1511,12b (148
mg, 58%) as a white solid, mp 98−100 °C (lit.12b mp 98−100 °C): 1H
NMR [400 MHz, (CD3)2CO] δ 9.70 (broad s, 1H), 7.36 (d, J = 7.6
Hz, 1H), 7.26 (d, J = 7.6 Hz, 1H), 7.02−6.92 (complex m, 2H), 2.83−
2.75 (complex m, 3H), 2.24 (m, 1H), 1.98−1.86 (complex m, 2H),
1.53 (m, 1H), 1.13 (d, J = 6.6 Hz, 3H); 13C NMR [100 MHz,
(CD3)2CO] δ 137.4, 134.9, 128.7, 121.1, 119.1, 118.0, 111.3, 109.7,
32.3, 30.6, 30.2, 23.4, 22.1; IR νmax 3405, 2949, 2923, 1620, 1467,
1326, 1232, 1009, 740 cm−1; MS (ESI, +ve) m/z 240 [(M + MeOH +
Na)+, 100%], 202 (45), 186 [(M + H)+, 30]; HRMS (M + H)+ calcd
for C13H16N 186.1283, found 186.1286.
9H-Carbazole (1). A magnetically stirred mixture of compound 14
(46 mg, 0.27 mmol) and 10 wt % Pd/C (46 mg) in mesitylene (5 mL)
was stirred at 150 °C under an atmosphere of nitrogen for 24 h. The
cooled reaction mixture was ﬁltered through ﬁlter paper, and the solids
thus retained were washed with ethyl acetate (2 × 15 mL). The ﬁltrate
was concentrated under reduced pressure, and the ensuing mixture of
product 1 and mesitylene was then subjected to ﬂash column
chromatography (silica, 1/19 v/v ethyl acetate/40−60 petroleum ether
elution). Concentration of the appropriate fractions (Rf = 0.6 in 1/5 v/
v ethyl acetate/40−60 petroleum ether) then gave compound 1 (25
mg, 55%) as a white, crystalline solid, mp 237−238 °C (lit.33 mp 245
°C): 1H NMR [400 MHz, (CD3)2CO] δ 10.32 (broad s, 1H), 8.11 (d,
J = 7.8 Hz, 2H), 7.51 (d, J = 8.1 Hz, 2H), 7.39 (m, 2H), 7.18 (m, 2H);
13C NMR [100 MHz, (CD3)2CO] δ 141.0, 126.4, 124.0, 120.9, 119.6,
111.7; IR νmax 3416, 3049, 1597, 1449, 1233, 928, 745, 722 cm
−1; MS
(ESI, − ve) m/z 166 [(M − H)−, 100%]; HRMS (M − H)− calcd for
C12H8N 166.0657, found 166.0656.
3-Methyl-9H-carbazole (2). A magnetically stirred mixture of
compound 15 (145 mg, 0.78 mmol) and 10 wt % Pd/C (145 mg) in
mesitylene (15 mL) was stirred at 150 °C under an atmosphere of
nitrogen for 24 h. The cooled reaction mixture was ﬁltered through
ﬁlter paper, and the solids thus retained were washed with ethyl acetate
(2 × 15 mL). The ﬁltrate was concentrated under reduced pressure,
and the ensuing mixture of product 2 and mesitylene was then
subjected to ﬂash column chromatography (silica, 1/19 v/v ethyl
acetate/40−60 petroleum ether elution) to give, after concentration of
the appropriate fractions (Rf = 0.6 in 1/3 v/v ethyl acetate/40−60
petroleum ether), compound 212b (80 mg, 57%) as a white solid, mp
200−202 °C (lit.12b mp 205−210 °C): 1H NMR [400 MHz,
(CD3)2CO] δ 10.17 (broad s, 1H), 8.07 (d, J = 7.8 Hz, 1H), 7.90
(s, 1H), 7.47 (d, J = 8.1 Hz, 1H), 7.39 (d, J = 8.2 Hz, 1H), 7.37−7.33
(complex m, 1H), 7.22 (dd, J = 8.2 and 1.2 Hz, 1H), 7.15 (m, 1H),
2.48 (s, 3H); 13C NMR [100 MHz, (CD3)2CO] δ 141.3, 139.2, 128.6,
127.7, 126.2, 124.2, 123.8, 120.8, 120.7, 119.4, 111.6, 111.4, 21.5; IR
νmax 3403, 3050, 2914, 2853, 1605, 1459, 1333, 1238, 805, 746, 726
cm−1; MS (ESI, −ve) m/z 180 [(M − H)−, 100%]; HRMS (M − H)−
calcd for C13H10N 180.0813, found 180.0804.
2′-Methoxy-5-methyl-6′-nitro-4,5-dihydro-[1,1′-biphenyl]-2(3H)-
one (17). A magnetically stirred mixture of 2-iodo-1-methoxy-3-
nitrobenzene (16)21 (341 mg, 1.22 mmol), 2-iodo-4-methylcyclohex-
2-en-1-one (10) (519 mg, 2.20 mmol), copper powder (311 mg, 4.89
g atom), CuI (349 mg, 1.83 mmol), and Pd(dppf)Cl2·CH2Cl2 (100
mg, 0.12 mmol) in deoxygenated DMSO (24 mL) was heated to 50
°C under a nitrogen atmosphere for 4 h. The reaction mixture was
then cooled to room temperature, quenched with water (10 mL),
diluted with ethyl acetate (20 mL), and then ﬁltered through a pad of
diatomaceous earth and silica gel. The pad and the solids thus retained
were washed with ethyl acetate (2 × 25 mL) and the organic phase
associated with the ﬁltrate then washed with water (2 × 50 mL) and
brine (2 × 50 mL) before being dried (Na2SO4), ﬁltered, and
concentrated under reduced pressure to give a brown oil. Subjection of
this material to ﬂash chromatography (silica, 2/5/40 v/v/v ethyl
acetate/dichloromethane/40−60 petroleum ether elution) gave, after
concentration of the appropriate fractions (Rf = 0.3 in 2/5/11 v/v/v
ethyl acetate/dichloromethane/40−60 petroleum ether), compound
17 (281 mg, 88%) as a light yellow solid, mp 94−96 °C: 1H NMR
(400 MHz, CDCl3) δ 7.53 (m, 1H), 7.40−7.10 (complex m, 2H), 6.63
(m, 1H), 3.78 (m, 3H), 2.76−2.48 (complex m, 3H), 2.24−2.14
(complex m, 1H), 1.90−1.76 (complex m, 1H), 1.20 (m, 3H); 13C
NMR (100 MHz, CDCl3) δ 196.9, 196.7, 158.1, 158.0, 153.7, 153.5,
150.3, 150.0, 133.0, 132.6, 129.1, 129.2, 121.5, 121.4, 116.1, 116.0,
115.6, 115.4, 56.7, 56.6, 37.3, 37.1, 32.0, 31.6, 30.9, 30.5, 20.4, 20.1; IR
νmax 2959, 1674, 1524, 1461, 1351, 1263, 1052, 794, 736 cm
−1; MS
(ESI, +ve) m/z 284 [(M + Na)+, 100%], 262 [(M + H)+, 15]; HRMS
(M + Na)+ calcd for C14H15NNaO4 284.0899, found 284.0896.
5-Methoxy-3-methyl-2,3,4,9-tetrahydro-1H-carbazole (18). A
magnetically stirred mixture of compound 17 (211 mg, 0.81 mmol)
and commercially available W-2 Raney nickel (422 mg, washed twice
with absolute ethanol) in methanol (40 mL) was deoxygenated and
then stirred under an atmosphere of hydrogen at 22 °C for 10 h. After
this time and using an externally applied magnet to hold the solid
associated with the reaction mixture within the ﬂask, the supernatant
liquid was decanted and the retained solid washed with methanol (2 ×
15 mL) (Caution! Af ter these washings water should be added to the
residual solid so as to prevent a f ire.). The methanolic solutions were
combined and then concentrated under reduced pressure to give a
white solid. Subjection of this material to ﬂash column chromatog-
raphy (silica, 1/3/30 v/v/v acetone/dichloromethane/40−60 petro-
leum ether elution) gave, after concentration of the appropriate
fractions (Rf = 0.5 in 1/3/6 v/v/v acetone/dichloromethane/40−60
petroleum ether), compound 1811a (125 mg, 72%) as a white solid,
mp 126−128 °C: 1H NMR [400 MHz, (CD3)2CO] δ 9.63 (broad s,
1H), 6.91−6.85 (complex m, 2H), 6.41 (dd, J = 6.5 and 1.9 Hz, 1H),
3.84 (s, 3H), 3.11 (dd, J = 16.0 and 4.7 Hz, 1H), 2.72 (m, 2H), 2.41
(m, 1H), 1.92−1.79 (complex m, 2H), 1.48 (m, 1H), 1.10 (d, J = 6.6
Hz, 3H); 13C NMR [100 MHz, (CD3)2CO] δ 155.1, 138.8, 132.8,
121.8, 118.6, 109.6, 105.1, 99.7, 55.3, 32.7, 32.1, 30.8, 23.4, 22.2; IR
νmax 3397, 2948, 2923, 2836, 1565, 1505, 1349, 1253, 1244, 1104, 775,
729 cm−1; MS (ESI, +ve) m/z 232 (100%), 216 [(M + H)+, 90];
HRMS (M + H)+ calcd for C14H18NO 216.1388, found 216.1393.
Glycoborine (3). A magnetically stirred mixture of compound 18
(50 mg, 0.23 mmol) and 10 wt % Pd/C (50 mg) in mesitylene (5 mL)
was stirred at 150 °C under an atmosphere of nitrogen for 24 h. The
cooled reaction mixture was ﬁltered through ﬁlter paper, and the solids
thus retained were washed with ethyl acetate (2 × 10 mL). The
combined ﬁltrates were concentrated under reduced pressure, and the
ensuing mixture of product 3 and mesitylene was then subjected to
ﬂash column chromatography (silica, 2/5/62 v/v/v ethyl acetate/
dichloromethane/40−60 petroleum ether elution) to give, after
concentration of the appropriate fractions (Rf = 0.4(5) in 2/5/11 v/
v/v ethyl acetate/dichloromethane/40−60 petroleum ether), com-
pound 33a (35 mg, 75%) as a white solid, mp 130−132 °C (lit.3a mp
132.0−134.6 °C): 1H NMR [400 MHz, (CD3)2CO] δ 10.17 (broad s,
1H), 8.07 (s, 1H), 7.36 (d, J = 8.2 Hz, 1H), 7.28 (t, J = 8.0 Hz, 1H),
7.17 (dd, J = 8.2 and 1.2 Hz, 1H), 7.08 (d, J = 8.2 Hz, 1H), 6.68 (d, J =
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8.0 Hz, 1H), 4.06 (s, 3H), 2.48 (s, 3H); 13C NMR [100 MHz,
(CD3)2CO] δ 157.1, 142.7, 138.4, 128.5, 127.2, 126.7, 123.6, 123.5,
113.0, 110.8, 104.7, 100.5, 55.6, 21.6; IR νmax 3402, 2917, 2838, 1608,
1585, 1506, 1459, 1347, 1260, 1098, 750, 723 cm−1; MS (ESI, +ve) m/
z 234 [(M + Na)+, 10%], 212 [(M + H)+, 100]; HRMS (M + H)+
calcd for C14H14NO 212.1075, found 212.1078.
5′-Methoxy-5-methyl-2′-nitro-4,5-dihydro-[1,1′-biphenyl]-2(3H)-
one (20). A magnetically stirred mixture of commercially available 2-
iodo-4-methoxynitrobenzene (19) (150 mg, 0.54 mmol), 2-iodo-4-
methylcyclohex-2-en-1-one (10) (229 mg, 0.97 mmol), copper
powder (137 mg, 2.15 g atom), CuI (154 mg, 0.81 mmol), and
Pd(dppf)Cl2·CH2Cl2 (44 mg, 0.05 mmol) in deoxygenated DMSO
(12 mL) was heated to 50 °C under a nitrogen atmosphere for 4 h.
The reaction mixture was then cooled to room temperature, quenched
with water (5 mL), diluted with ethyl acetate (10 mL), and then
ﬁltered through a pad of diatomaceous earth and silica gel. The pad
and the solids thus retained were washed with ethyl acetate (2 × 15
mL), and the separated organic phase associated with the ﬁltrate was
then washed with water (2 × 25 mL) and brine (2 × 25 mL) before
being dried (Na2SO4), ﬁltered, and concentrated under reduced
pressure to give a brown oil. Subjection of this material to ﬂash
chromatography (silica, 1/3/25 v/v/v acetone/dichloromethane/40−
60 petroleum ether elution) gave, after concentration of the
appropriate fractions [Rf = 0.5(5) in 1/3/6 v/v/v acetone/dichloro-
methane/40−60 petroleum ether], compound 20 (125 mg, 87%) as a
light yellow oil: 1H NMR (400 MHz, CDCl3) δ 8.09 (d, J = 9.1 Hz,
1H), 6.90 (dd, J = 9.1 and 2.6 Hz, 1H), 6.70 (m, 2H), 3.88 (s, 3H),
2.76−2.51 (complex m, 3H), 2.21 (m, 1H), 1.84 (m, 1H), 1.25 (d, J =
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 196.8, 163.4, 151.2,
141.7, 139.1, 135.2, 127.2, 117.2, 113.2, 56.1, 37.3, 31.8, 30.8, 20.5; IR
νmax 2953, 1681, 1578, 1512, 1340, 1298, 1238, 1026, 844 cm
−1; MS
(ESI, +ve) m/z 284 [(M + Na)+, 100%], 262 [(M + H)+, 10]; HRMS
(M + Na)+ calcd for C14H15NNaO4 284.0899, found 284.0890.
6-Methoxy-3-methyl-2,3,4,9-tetrahydro-1H-carbazole (21). A
magnetically stirred mixture of compound 20 (100 mg, 0.38 mmol)
and commercially available W-2 Raney nickel (200 mg, washed twice
with absolute ethanol) in methanol (19 mL) was deoxygenated and
then stirred under an atmosphere of hydrogen at 22 °C for 16 h. After
this time and using an externally applied magnet to hold the solid
associated with the reaction mixture within the ﬂask, the supernatant
liquid was decanted and the retained solid washed with methanol (2 ×
10 mL) (Caution! Af ter these washings water should be added to the
residual solid so as to prevent a f ire.). The methanolic solutions were
combined and then concentrated under reduced pressure to give a
white solid. Subjection of this material to ﬂash column chromatog-
raphy (silica, 1/3/20 v/v/v acetone/dichloromethane/40−60 petro-
leum ether elution) gave, after concentration of the appropriate
fractions (Rf = 0.6 in 1/3/6 v/v/v acetone/dichloromethane/40−60
petroleum ether), compound 2112b,d,22b (50 mg, 61%) as a white solid,
mp 108−109 °C: 1H NMR [400 MHz, (CD3)2CO] δ 9.52 (broad s,
1H), 7.14 (d, J = 8.6 Hz, 1H), 6.88 (s, 1H), 6.65 (d, J = 8.6 Hz, 1H),
3.78 (s, 3H), 2.80−2.73 (complex m, 3H), 2.20 (m, 1H), 1.95−1.85
(complex m, 2H), 1.52 (m, 1H), 1.12 (d, J = 6.5 Hz, 3H); 13C NMR
[100 MHz, (CD3)2CO] δ 154.6, 135.7, 132.5, 129.1, 111.8, 110.7,
109.6, 100.6, 55.8, 32.4, 30.6, 30.4, 23.6, 22.1; IR νmax 3401, 2947,
2909, 2830, 1591, 1481, 1454, 1431, 1210, 1137, 1030, 831, 796 cm−1;
MS (ESI, −ve) m/z 214 [(M − H)−, 100%]; HRMS (M − H)− calcd
for C14H16NO 214.1232, found 214.1235.
Glycozoline (4). A magnetically stirred mixture of compound 21
(44 mg, 0.20 mmol) and 10 wt % Pd/C (44 mg) in diphenyl ether (5
mL) was stirred at 210 °C under an atmosphere of nitrogen for 0.33 h.
The cooled reaction mixture was ﬁltered through ﬁlter paper, and the
solids thus retained were washed with ethyl acetate (2 × 5 mL). The
combined ﬁltrates were concentrated under reduced pressure, and the
ensuing mixture of product 4 and diphenyl ether was then subjected to
ﬂash column chromatography (silica, 1/9 v/v ethyl acetate/40−60
petroleum ether elution) to give, after concentration of the appropriate
fractions (Rf = 0.4 in 3/7 v/v ethyl acetate/40−60 petroleum ether),
compound 43a,15 (39 mg, 89%) as a white, crystalline solid, mp 180−
181 °C (lit.22b mp. = 177−178 °C): 1H NMR [400 MHz, (CD3)2CO]
δ 9.96 (broad s, 1H), 7.87 (s, 1H), 7.63 (d, J = 2.2 Hz, 1H), 7.36 (t, J =
8.5 Hz, 2H), 7.18 (d, J = 8.2 Hz, 1H), 7.00 (dd, J = 8.5 and 2.2 Hz,
1H), 3.88 (s, 3H), 2.47 (s, 3H); 13C NMR [100 MHz, (CD3)2CO] δ
154.5, 140.0, 136.1, 128.1, 127.7, 124.2(2), 124.2(0), 120.8, 115.6,
112.3, 111.5, 103.5, 56.1, 21.5; IR νmax 3398, 2928, 1493, 1470, 1457,
1208, 1148, 1033, 806 cm−1; MS (ESI, −ve) m/z 210 [(M − H)−,
60%], 195 (100); HRMS (M − H)− calcd for C14H12NO 210.0919,
found 210.0912.
4′-Methoxy-5-methyl-2′-nitro-4,5-dihydro-[1,1′-biphenyl]-2(3H)-
one (23). A magnetically stirred mixture of commercially available 1-
iodo-4-methoxy-2-nitrobenzene (22) (341 mg, 1.22 mmol), 2-iodo-4-
methylcyclohex-2-en-1-one (10) (519 mg, 2.20 mmol), copper
powder (311 mg, 4.89 g atom), CuI (349 mg, 1.83 mmol), and
Pd(dppf)Cl2·CH2Cl2 (100 mg, 0.12 mmol) in deoxygenated DMSO
(24 mL) was heated to 50 °C under a nitrogen atmosphere for 6 h.
The ensuing mixture was cooled to room temperature, quenched with
water (10 mL), diluted with ethyl acetate (20 mL), and then ﬁltered
through a pad of diatomaceous earth and silica gel. The pad and the
solids thus retained were washed with ethyl acetate (2 × 30 mL), and
the separated organic phase associated with the ﬁltrate was washed
with water (2 × 50 mL) and brine (2 × 50 mL) before being dried
(Na2SO4), ﬁltered, and concentrated under reduced pressure to give a
brown oil. Subjection of this material to ﬂash column chromatography
(silica, 2/5/64 v/v/v ethyl acetate/dichloromethane/40−60 petro-
leum ether elution) gave, after concentration of the appropriate
fractions (Rf = 0.4 in 2/5/11 v/v/v ethyl acetate/dichloromethane/
40−60 petroleum ether), compound 23 (256 mg, 80%) as a light
yellow oil: 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 2.3 Hz, 1H),
7.15−7.09 (complex m, 2H), 6.75 (dd, J = 2.7 and 1.1 Hz, 1H), 3.85
(s, 3H), 2.75 (m, 1H), 2.65−2.40 (complex m, 2H), 2.19 (m, 1H),
1.80 (m, 1H), 1.24 (d, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3)
δ 196.9, 159.7, 151.8, 149.2, 138.1, 132.7, 124.2, 119.7, 109.3, 56.0,
37.3, 31.8, 30.8, 20.5; IR νmax 2960, 1681, 1529, 1353, 1302, 1266,
1236, 1032, 800 cm−1; MS (ESI, +ve) m/z 284 [(M + Na)+, 100%],
262 [(M + H)+, 15]; HRMS (M + Na)+ calcd for C14H15NNaO4
284.0899, found 284.0901.
7-Methoxy-3-methyl-2,3,4,9-tetrahydro-1H-carbazole (24) and
trans-4a-Hydroperoxy-7-methoxy-3-methyl-2,3,4,4a-tetrahydro-
1H-carbazole (25). A magnetically stirred mixture of compound 23
(202 mg, 0.77 mmol) and commercially available W-2 Raney nickel
(404 mg, washed twice with absolute ethanol) in methanol (38 mL)
was deoxygenated and then stirred under an atmosphere of hydrogen
at 22 °C for 16 h. After this time and using an externally applied
magnet to hold the solid associated with the reaction mixture within
the ﬂask, the supernatant liquid was decanted and the retained solid
washed with methanol (2 × 20 mL) (Caution! Af ter these washings
water should be added to the residual solid so as to prevent a f ire.). The
methanolic solutions were combined and then concentrated under
reduced pressure to give a white solid. Subjection of this material to
ﬂash column chromatography (silica, 1/3/20 v/v/v acetone/dichloro-
methane/40−60 petroleum ether elution) gave two fractions, A and B.
Concentration of fraction A (Rf = 0.5 in 1/3/6 v/v/v acetone/
dichloromethane/40−60 petroleum ether) aﬀorded compound
2411a,14 (109 mg, 65%) as a white, crystalline solid, mp 130−132
°C: 1H NMR [400 MHz, (CD3)2CO] δ 9.50 (broad s, 1H), 7.22 (d, J
= 8.5 Hz, 1H), 6.83 (d, J = 2.2 Hz, 1H), 6.63 (dd, J = 8.5 and 2.2 Hz,
1H), 3.76 (s, 3H), 2.83−2.71 (complex m, 3H), 2.19 (m, 1H), 1.90
(m, 2H), 1.50 (m, 1H), 1.11 (d, J = 6.5 Hz, 3H); 13C NMR [100
MHz, (CD3)2CO] δ 156.6, 138.2, 133.4, 123.2, 118.5, 109.5, 108.6,
95.4, 55.7, 32.3, 30.6, 30.3, 23.5, 22.1; IR νmax 3390, 2909, 2835, 1630,
1570, 1496, 1459, 1335, 1291, 1203, 1157, 1029, 826, 805 cm−1; MS
(ESI, +ve) m/z 238 [(M + Na)+, 20%], 218 (100), 216 [(M + H)+,
90]; HRMS (M + H)+ calcd for C14H18NO 216.1388, found 216.1386.
Concentration of fraction B (Rf = 0.1 in 1/3/6 v/v/v acetone/
dichloromethane/40−60 petroleum ether) aﬀorded hydroperoxide 25
(15 mg, 8%) as a white, crystalline solid, mp 106−108 °C: 1H NMR
[700 MHz, (CD3)2CO] δ δ 10.81 (s, 1H), 7.26 (d, J = 8.0 Hz, 1H),
6.97 (d, J = 2.3 Hz, 1H), 6.71 (dd, J = 8.0 and 2.3 Hz, 1H), 3.82 (s,
3H), 2.82−2.76 (complex m, 1H), 2.68 (m, 1H), 2.43 (m, 1H), 2.14
(m, 2H), 1.13 (m, 1H), 0.95 (m, 1H), 0.92 (d, J = 6.6 Hz, 3H); 13C
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NMR [175 MHz, (CD3)2CO] δ 186.1, 162.2, 157.4, 131.5, 123.8,
110.8, 107.4, 92.3, 55.8, 44.4, 37.4, 30.3, 28.1, 21.0; IR νmax 3100, 2954,
2836, 1607, 1484, 1347, 1276, 1144, 1130, 1028, 845, 815 cm−1; MS
(ESI, +ve) m/z 270 [(M + Na)+, 100%], 248 [(M + H)+, 10]; HRMS
(ESI) (M + Na)+ calcd for C14H17NNaO3 270.1106, found 270.1107.
2-Methoxy-6-methyl-9H-carbazole (26). A magnetically stirred
mixture of compound 24 (100 mg, 0.46 mmol) and 10 wt % Pd/C
(100 mg) in diphenyl ether (10 mL) was stirred at 210 °C under an
atmosphere of nitrogen for 0.5 h. The cooled reaction mixture was
ﬁltered through ﬁlter paper, and the solids thus retained were washed
with ethyl acetate (2 × 10 mL). The combined ﬁltrates were
concentrated under reduced pressure, and the ensuing mixture of
product 269c,h,22d,23a,b and diphenyl ether was then subjected to ﬂash
column chromatography (silica, 2/5/60 v/v/v ethyl acetate/dichloro-
methane/40−60 petroleum ether elution) to give, after concentration
of the appropriate fractions (Rf = 0.4 in 2/5/11 v/v/v ethyl acetate/
dichloromethane/40−60 petroleum ether), compound 26 (87 mg,
88%) as a white solid, mp 229−231 °C (lit.9c mp 228−229 °C): 1H
NMR [400 MHz, (CD3)2CO] δ 10.03 (braod s, 1H), 7.92 (d, J = 8.6
Hz, 1H), 7.78 (s, 1H), 7.32 (d, J = 8.2 Hz, 1H), 7.11 (d, J = 8.2 Hz,
1H), 6.99 (d, J = 2.2 Hz, 1H), 6.77 (dd, J = 8.6 and 2.2 Hz, 1H), 3.85
(s, 3H), 2.46 (s, 3H); 13C NMR [100 MHz, (CD3)2CO] δ 160.0,
142.7, 139.3, 128.6, 126.3, 124.4, 121.5, 120.0, 117.6, 111.1, 108.6,
95.3, 55.7, 21.5; IR νmax 3391, 2962, 1615, 1460, 1310, 1261, 1164,
1035, 811 cm−1; MS (ESI, +ve) m/z 212 [(M + H)+, 100%]; HRMS
(M + H)+ calcd for C14H14NO 212.1075, found 212.1077.
Clauszoline K (5). A magnetically stirred solution of 2-methoxy-6-
methyl-9H-carbazole (26) (50 mg, 0.24 mmol) in methanol/water (16
mL of 10/1 v/v mixture) was treated with DDQ (226 mg, 0.99 mmol).
The ensuing mixture was stirred at room temperature for 4 h and then
diluted with ethyl acetate (30 mL). The separated organic phase was
washed with NaHCO3 (2 × 15 mL of a saturated aqueous solution),
water (1 × 30 mL), and brine (1 × 30 mL) before being dried
(Na2SO4), ﬁltered, and concentrated under reduced pressure. The
residue thus obtained was subjected to ﬂash chromatography (silica, 1/
3 v/v ethyl acetate/40−60 petroleum ether elution) to give, after
concentration of the appropriate fractions (Rf = 0.5 in 1/1 v/v ethyl
acetate/40−60 petroleum ether), compound 5 (35 mg, 66%) as a
yellow solid, mp 170−171 °C (lit.22d mp 184−185 °C): 1H NMR
[400 MHz, (CD3)2CO] δ 10.72 (broad s, 1H), 10.07 (s, 1H), 8.58 (s,
1H), 8.12 (d, J = 8.6 Hz, 1H), 7.88 (broadened d, J = 8.4 Hz, 1H),
7.59 (d, J = 8.4 Hz, 1H), 7.11 (d, J = 2.3 Hz, 1H), 6.91 (dd, J = 8.6 and
2.3 Hz, 1H), 3.89 (s, 3H); 13C NMR [100 MHz, (CD3)2CO] δ 192.0,
160.8, 144.8, 143.1, 130.1, 126.3, 124.4, 123.5, 122.2, 117.6, 111.8,
110.1, 96.0, 55.8; IR νmax 3306, 2923, 2849, 1667, 1604, 1569, 1456,
1317, 1159, 817, 807 cm−1; MS (ESI, −ve) m/z 224 [(M − H)−,
100%], 209 (54); HRMS (M − H)− calcd for C14H10NO2 224.0712,
found 224.0705.
Methyl 3-Bromo-5-methoxy-4-nitrobenzoate (27). Step i. A
magnetically stirred and ice-cold solution of methyl 4-amino-3-
methoxybenzoate (3.00 mg, 16.56 mmol) in chloroform (33 mL)
was treated, in portions over 1 h, with N-bromosuccinimide (NBS)
(2.95, 16.6 mmol). The ensuing mixture was stirred at 5−10 °C for 2 h
before being diluted with dichloromethane (1 × 200 mL) then washed
with Na2S2O3 (2 × 100 mL of a 20% w/v aqueous solution), water (2
× 100 mL), and brine (1 × 100 mL). The separated organic phase was
then dried (Na2SO4), ﬁltered, and concentrated under reduced
pressure. The residue thus obtained was subjected to ﬂash column
chromatography (silica, 3/17 v/v ethyl acetate/40−60 petroleum ether
elution) to give, after concentration of the appropriate fractions (Rf =
0.6 in 1/3 v/v ethyl acetate/40−60 petroleum ether), methyl 4-amino-
3-bromo-5-methoxybenzoate25 (3.70 g, 86%) as a yellow solid, mp
90−91 °C: 1H NMR (CDCl3, 400 MHz) δ 7.81 (s, 1H), 7.38 (s, 1H),
4.65 (broad s, 2H), 3.91 (s, 3H), 3.87 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 166.5, 146.3, 139.4, 127.1, 119.5, 109.9, 106.8, 56.2, 52.1; IR
νmax 3503, 3399, 1692, 1603, 1566, 1502, 1435, 1270, 1209, 1041, 995,
759 cm−1; MS (EI, 70 eV) m/z 261 and 259 (M+•, 98 and 100%,
respectively), 246 and 244 (both 65 and 63, respectively), 230 and 228
(both 54); HRMS M+• calcd for C9H10
79BrNO3 258.9844, found
258.9846.
Step ii. A magnetically stirred solution of methyl 4-amino-3-bromo-
5-methoxybenzoate (4.24 g, 16.31 mmol), obtained as described
immediately above, in 1,2-dichloroethane (163 mL) was treated with
m-chloroperbenzoic acid (mCPBA) (11.26 g of ca. 77% technical
grade material, 65.3 mmol). The resulting mixture was heated to 70 °C
for 14 h before being cooled, diluted with dichloromethane (150 mL),
washed with NaOH (2 × 150 mL of a 1 M aqueous solution) followed
by brine (1 × 100 mL), and then dried (MgSO4), ﬁltered, and
concentrated under reduced pressure. The residue thus obtained was
subjected to ﬂash column chromatography (silica, 1/8 v/v ethyl
acetate/40−60 petroleum ether elution) to give, after concentration of
the appropriate fractions (Rf = 0.5 in 1/2 v/v ethyl acetate/40−60
petroleum ether), methyl 3-bromo-5-methoxy-4-nitrobenzoate (27)
(4.13 g, 87%) as a yellow solid, mp 103−104 °C: 1H NMR (400 MHz,
CDCl3) δ 7.88 (d, J = 1.4 Hz, 1H), 7.65 (d, J = 1.4 Hz, 1H), 3.95(9)
(s, 3H), 3.95(6) (s, 3H); 13C NMR (100 MHz, CDCl3) δ 164.4, 151.8,
144.7, 133.1, 126.2, 113.8, 112.8, 57.1, 53.2; IR νmax 3097, 1730, 1540,
1406, 1289, 1248, 1037, 984, 822, 764 cm−1; MS (EI, 70 eV) m/z 291
and 289 (M+•, 98 and 100%, respectively) 259 and 257 (40 and 35,
respectively) 199 and 197 (60 and 50, respectively); HRMS M+• calcd
for C9H8
79BrNO5 288.9586, found 288.9587.
Methyl 5-Methoxy-6-nitro-2′-oxo-2′,3′,4′,5′-tetrahydro-[1,1′-bi-
phenyl]-3-carboxylate (28). A magnetically stirred mixture of methyl
3-bromo-5-methoxy-4-nitrobenzoate (28) (2.56 g, 8.82 mmol), 2-
iodocyclohex-2-en-1-one (9) (890 mg, 4.01 mmol), copper powder
(1.27 g, 20.04 g atom), CuI (1.15 g, 6.01 mmol), and Pd(dppf)Cl2·
CH2Cl2 (164 mg, 0.20 mmol) in deoxygenated DMSO (17 mL) was
heated to 50 °C under a nitrogen atmosphere for 28 h. The reaction
mixture was then cooled to room temperature, quenched with water
(20 mL), diluted with ethyl acetate (40 mL) and ﬁltered through a pad
of diatomaceous earth and silica gel. The pad and the solids thus
retained were washed with ethyl acetate (2 × 60 mL), and the organic
phase associated with the ﬁltrate was washed with water (2 × 100 mL)
and then brine (2 × 100 mL) before being dried (Na2SO4), ﬁltered,
and concentrated under reduced pressure to give a brown oil.
Subjection of this material to ﬂash column chromatography (silica, 1/9
v/v ethyl acetate/40−60 petroleum ether elution) gave, after
concentration of the appropriate fractions (Rf = 0.5 in 1/1 v/v ethyl
acetate/40−60 petroleum ether), compound 28 (478 mg, 39%) as a
yellow oil: 1H NMR (400 MHz, CDCl3) δ 7.67 (d, J = 1.3 Hz, 1H),
7.51 (d, J = 1.3 Hz, 1H), 7.05 (t, J = 4.2 Hz, 1H), 3.96 (s, 3H), 3.94 (s,
3H), 2.58−2.50 (complex m, 4H), 2.10 (m, 2H); 13C NMR (100
MHz, CDCl3) δ 196.1, 165.4, 151.2, 150.2, 143.3, 136.3, 132.4, 131.6,
124.2, 113.3, 57.0, 52.9, 38.3, 26.5, 22.7; IR νmax 2956, 2924, 1716,
1683, 1535, 1360, 1245, 1022, 838, 766 cm−1; MS (ESI, +ve) m/z 328
[(M + Na)+, 100%]; HRMS (M + Na)+ calcd for C15H15NNaO6
328.0797, found 328.0793.
Methyl 8-Methoxy-2,3,4,9-tetrahydro-1H-carbazole-6-carboxy-
late (29). A magnetically stirred mixture of compound 28 (400 mg,
1.31 mmol) and commercially available W-2 Raney nickel (800 mg,
washed twice with absolute ethanol) in methanol (65 mL) was
deoxygenated and then stirred under an atmosphere of hydrogen at 22
°C for 16 h. After this time and using an externally applied magnet to
hold the solid associated with the reaction mixture within the ﬂask, the
supernatant liquid was decanted and the retained solid washed with
methanol (2 × 40 mL) (Caution! Af ter these washings water should be
added to the residual solid so as to prevent a f ire.). The methanolic
solutions were combined and then concentrated under reduced
pressure to give a white solid. Subjection of this material to ﬂash
column chromatography (silica, 3/17 v/v ethyl acetate/40−60
petroleum ether elution) gave, after concentration of the appropriate
fractions (Rf = 0.6 in 1/2 v/v ethyl acetate/40−60 petroleum ether),
compound 29 (268 mg, 79%) as a white solid, mp 181−182 °C: 1H
NMR [400 MHz, (CD3)2CO] δ 10.15 (broad s, 1H), 7.81 (s, 1H),
7.25 (s, 1H), 3.96 (s, 3H), 3.86 (s, 3H), 2.77 (m, 2H), 2.70 (m, 2H),
1.92−1.82 (complex m, 4H); 13C NMR [100 MHz, (CD3)2CO] δ
168.5, 146.2, 136.6, 129.7, 129.4, 122.1, 114.8, 111.7, 102.5, 55.7, 51.8,
24.0, 23.9, 23.7, 21.6; IR νmax 3339, 2928, 2836, 1696, 1628, 1366,
1326, 1231, 1188, 993, 765 cm−1; MS (ESI, +ve) m/z 541 (65%), 282
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[(M + Na)+, 100]; HRMS (M + Na)+ calcd for C15H17NNaO3
282.1106, found 282.1105.
Mukonine (6). A magnetically stirred mixture of compound 29 (264
mg, 1.02 mmol) and 10 wt % Pd/C (264 mg) in mesitylene (20 mL)
was stirred at 150 °C under an atmosphere of nitrogen for 24 h. The
cooled reaction mixture was ﬁltered through ﬁlter paper, and the solids
thus retained were washed with ethyl acetate (2 × 20 mL). The ﬁltrate
was concentrated under reduced pressure and the ensuing mixture of
product 6 and mesitylene then subjected to ﬂash column
chromatography (silica, 1/19 v/v ethyl acetate/40−60 petroleum
ether elution) to give, after concentration of the appropriate fractions
(Rf = 0.5 in 1/3 v/v ethyl acetate/40−60 petroleum ether), compound
617 (171 mg, 66%) as a white solid, mp 196−198 °C (lit.17a mp 193−
195 °C): 1H NMR (400 MHz, CDCl3) δ 8.52 (broad s, 1H), 8.48 (s,
1H), 8.10 (d, J = 7.8 Hz, 1H), 7.60 (s, 1H), 7.49−7.43 (complex m,
2H), 7.28 (m, 1H), 4.05 (s, 3H), 3.98 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ 168.1, 145.2, 139.6, 133.0, 126.5, 123.9, 123.7, 122.0, 120.9,
120.4, 116.4, 111.4, 106.8, 55.9, 52.2; IR νmax 3350, 2941, 1689, 1608,
1585, 1433, 1338, 1255, 758, 732 cm−1; MS (ESI, +ve) m/z 533
(28%), 278 [(M + Na)+, 100]; HRMS (M + Na)+ calcd for
C15H13NNaO3 278.0793, found 278.0792.
6-Methyl-9H-carbazol-2-ol (30). A magnetically stirred solution of
compound 26 (50 mg, 0.24 mmol) in dichloromethane (15 mL)
maintained at −78 °C under an atmosphere of nitrogen was treated,
dropwise, with BBr3 (470 μL of a 1 M solution in dichloromethane,
0.47 mmol). The resulting mixture was stirred at −78 °C for another 2
h and then warmed to −40 °C. After 2 h the reaction mixture was
recooled to −78 °C and a further portion of BBr3 (520 μL of a 1 M
solution in dichloromethane, 0.52 mmol) added dropwise. The
reaction mixture was then warmed to 22 °C, stirred at this temperature
for 11 h, cooled to 0 °C, and then quenched by the slow addition of
NaHCO3 (30 mL of a saturated aqueous solution). The resulting
mixture was extracted with dichloromethane (1 × 20 mL), and the
combined organic phases were washed with water (1 × 20 mL) and
brine (1 × 20 mL) before being dried (Na2SO4), ﬁltered, and
concentrated under reduced pressure. The residue thus obtained was
subjected to ﬂash chromatography (silica, 3/17 v/v ethyl acetate/40−
60 petroleum ether elution) to give, after concentration of the
appropriate fractions [Rf = 0.2(5) in 3/7 v/v ethyl acetate/40−60
petroleum ether], compound 309h (39 mg, 84%) as a white, crystalline
solid, mp 259−261 °C (lit.9h mp 230−233 °C): 1H NMR [400 MHz,
(CD3)2CO] δ 9.91 (broad s, 1H), 8.25 (s, 1H), 7.84 (d, J = 8.4 Hz,
1H), 7.74 (s, 1H), 7.28 (d, J = 8.2 Hz, 1H), 7.08 (d, J = 8.2 Hz, 1H),
6.90 (d, J = 2.1 Hz, 1H), 6.71 (dd, J = 8.4 and 2.1 Hz, 1H), 2.45 (s,
3H); 13C NMR (100 MHz, (CD3)2CO) δ 157.4, 143.0, 139.2, 128.4,
126.0, 124.7, 121.5, 119.8, 117.1, 110.9, 109.1, 97.4, 21.5; IR νmax 3403,
2922, 2853, 1633, 1616, 1490, 1459, 1296, 1026, 804 cm−1; MS (ESI,
−ve) m/z 196 [(M − H)−, 100%]; HRMS (M − H)− calcd for
C13H10NO 196.0762, found 196.0767.
Karapinchamine A (7). A magnetically stirred solution of
compound 30 (27 mg, 0.14 mmol) in anhydrous THF (7 mL)
maintained at 0 °C under a nitrogen atmosphere was treated,
dropwise, with n-BuLi (340 μL of a 1.6 M solution in n-hexane, 0.55
mmol). After 0.17 h, a solution of geranyl bromide (51 mg, 0.21
mmol) in THF (7 mL) was added dropwise over 0.5 h. The resulting
mixture was warmed to 22 °C, stirred at this temperature for 1.5 h,
then cooled to 0 °C and quenched with NH4Cl (15 mL of a saturated
aqueous solution). The resulting mixture was extracted with ethyl
acetate (2 × 30 mL), and the combined organic phases were washed
with water (1 × 20 mL) and brine (1 × 20 mL) before being dried
(Na2SO4), ﬁltered, and concentrated under reduced pressure. The
residue thus obtained was subjected to ﬂash chromatography (silica, 1/
9 v/v ethyl acetate/40−60 petroleum ether elution) to give, after
concentration of the appropriate fractions (Rf = 0.6 in 3/7 v/v ethyl
acetate/40−60 petroleum ether), compound 77e,18 (23 mg, 50%) as a
white solid, mp 118−119 °C (lit.7e mp 124.3−125.6 °C): 1H NMR
(400 MHz, CDCl3) δ 7.87 (d, J = 8.3 Hz, 1H), 7.78 (s, 1H), 7.23−
7.18 (complex m, 2H), 6.78 (d, J = 1.9 Hz, 1H), 6.70 (dd, J = 8.3 and
2.0 Hz, 1H), 5.24 (m, 1H), 5.02 (m, 1H), 4.88 (s, 1H), 4.79 (d, J = 6.1
Hz, 2H), 2.52 (s, 3H), 2.09−1.98 (complex m, 4H), 1.90 (s, 3H), 1.62
(s, 3H), 1.55 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 154.6, 142.2,
138.9, 138.7, 131.9, 128.4, 125.8, 123.9, 123.4, 121.2, 120.0, 119.6,
117.1, 108.4, 107.7, 95.2, 41.3, 39.5, 26.4, 25.8, 21.5, 17.8, 16.8; IR νmax
3278, 2922, 2855, 1635, 1610, 1487, 1471, 1348, 1171, 801 cm−1; MS
(ESI, +ve) m/z 356 [(M + Na)+, 100%], 334 [(M + H)+, 20]; HRMS
(M + Na)+ calcd for C23H27NNaO 356.1990, found 356.1994.
4′-Methoxy-2′-nitro-4,5-dihydro-[1,1′-biphenyl]-2(3H)-one (31).
A magnetically stirred mixture of 1-iodo-4-methoxy-2-nitrobenzene
(22) (912 mg, 3.27 mmol), 2-iodocyclohex-2-en-1-one (9) (330 mg,
1.49 mmol), copper powder (472 mg, 7.43 g atom), CuI (425 mg, 2.23
mmol), and Pd(dppf)Cl2·CH2Cl2 (61 mg, 0.07 mmol) in
deoxygenated DMSO (15 mL) was heated to 50 °C under a nitrogen
atmosphere for 10 h. The reaction mixture was then cooled to room
temperature, quenched with water (15 mL), diluted with ethyl acetate
(30 mL), and then ﬁltered through a pad of diatomaceous earth and
silica gel. The pad and the solids thus retained were washed with ethyl
acetate (2 × 40 mL), and the separated organic phase associated with
the ﬁltrate was washed with water (2 × 80 mL) and brine (2 × 80 mL)
before being dried (Na2SO4), ﬁltered, and concentrated under reduced
pressure to give a brown oil. Subjection of this material to ﬂash column
chromatography (silica, 2/5/44 v/v/v ethyl acetate/dichloromethane/
40−60 petroleum ether elution) gave, after concentration of the
appropriate fractions (Rf = 0.3 in 2/5/11 v/v/v ethyl acetate/
dichloromethane/40−60 petroleum ether), compound 3110,11b (334
mg, 91%) as a light yellow oil: 1H NMR [400 MHz, (CD3)2CO] δ
7.51 (d, J = 2.2 Hz, 1H), 7.28 (m, 2H), 7.10 (m, 1H), 3.92 (s, 3H),
2.58 (m, 2H), 2.46 (m, 2H), 2.09 (m, 2H); 13C NMR [100 MHz,
(CD3)2CO] δ 196.5, 160.5, 150.4, 147.5, 139.5, 133.6, 125.1, 120.0,
109.9, 56.4, 39.0, 27.0, 23.5; IR νmax 2945, 1678, 1525, 1496, 1353,
1232, 1035, 913, 830, 798 cm−1; MS (ESI, +ve) m/z 270 [(M + Na)+,
100%], 248 [(M + H)+, 10]; HRMS (M + Na)+ calcd for
C13H13NNaO4 270.0742, found 270.0739.
7-Methoxy-2,3,4,9-tetrahydro-1H-carbazole (32). A magnetically
stirred mixture of compound 31 (100 mg, 0.40 mmol) and
commercially available W-2 Raney nickel (200 mg, washed twice
with absolute ethanol) in methanol (23 mL) was deoxygenated and
then stirred under an atmosphere of hydrogen at 22 °C for 16 h. After
this time and using an externally applied magnet to hold the solid
associated with the reaction mixture within the ﬂask, the supernatant
liquid was decanted and the retained solid washed with methanol (2 ×
20 mL) (Caution! Af ter these washings water should be added to the
residual solid so as to prevent a f ire.). The methanolic solutions were
combined and then concentrated under reduced pressure to give a
white solid. Subjection of this material to ﬂash column chromatog-
raphy (silica, 1/3/20 v/v/v acetone/dichloromethane/40−60 petro-
leum ether elution) gave, after concentration of the appropriate
fractions (Rf = 0.4(5) in 1/3/6 v/v/v acetone/dichloromethane/40−
60 petroleum ether), compound 3210,11b,26 (62 mg, 76%) as a white,
crystalline solid, mp 138−139 °C (lit.10 mp 136−142 °C): 1H NMR
(400 MHz, CDCl3) δ 7.54 (broad s, 1H), 7.33 (d, J = 8.5 Hz, 1H),
6.80 (d, J = 2.2 Hz, 1H), 6.75 (dd, J = 8.5 and 2.2 Hz, 1H), 3.84 (s,
3H), 2.69 (m, 4H), 1.88 (m, 4H); 13C NMR (100 MHz, CDCl3) δ
155.9, 136.5, 132.9, 122.5, 118.3, 110.1, 108.4, 95.0, 56.0, 23.4,
23.3(5), 23.3(4), 21.1; IR νmax 3405, 2919, 2842, 1628, 1464, 1307,
1213, 1156, 1029, 826, 803 cm−1; MS (ESI, +ve) m/z 202 [(M + H)+,
100%]; HRMS (M + H)+ calcd for C13H16NO 202.1232, found
202.1230.
2-Methoxy-9H-carbazole (8). A magnetically stirred mixture of
compound 32 (40 mg, 0.20 mmol) and 10 wt % Pd/C (40 mg) in
mesitylene (5 mL) was stirred at 150 °C under an atmosphere of
nitrogen for 24 h. The cooled reaction mixture was ﬁltered through
ﬁlter paper, and the solids thus retained were washed with ethyl acetate
(2 × 10 mL). The combined ﬁltrates were concentrated under reduced
pressure, and the ensuing mixture of product 6 and mesitylene was
then subjected to ﬂash column chromatography (silica, 1/19 v/v ethyl
acetate/40−60 petroleum ether elution) to give, after concentration of
the appropriate fractions (Rf = 0.3 in 1/5 v/v ethyl acetate/40−60
petroleum ether), compound 86f,k,l,9j (25 mg, 64%) as a white,
crystalline solid, mp 227−228 °C (lit.6f mp 233−235 °C): 1H NMR
[400 MHz, (CD3)2CO] δ 10.18 (broad s, 1H), 7.97 (m, 2H), 7.44 (d,
The Journal of Organic Chemistry Article
DOI: 10.1021/acs.joc.7b00044
J. Org. Chem. 2017, 82, 4148−4159
4156
310
J = 8.1 Hz, 1H), 7.28 (t, J = 7.9 Hz, 1H), 7.13 (m, 1H), 7.03 (broad s,
1H), 6.80 (m, 1H), 3.86 (s, 3H); 13C NMR [100 MHz, (CD3)2CO] δ
160.1, 142.4, 141.0, 125.0, 124.2, 121.6, 120.0, 119.7, 117.7, 111.4,
108.8, 95.4, 55.7; IR νmax 3391, 2929, 1608, 1463, 1444, 1308, 1196,
1163, 1033, 818, 727 cm−1; MS (ESI, −ve) m/z 196 [(M − H)−,
100%]; HRMS (M − H)− calcd for C13H10NO 196.0762, found
196.0753.
X-ray Crystallographic Studies. Crystallographic Data. Com-
pound 1: C12H9N, Mr = 167.21, T = 150 K, orthorhombic, space
group Pnma, Z = 4, a = 7.6589(2) Å, b = 19.0353(5) Å, c = 5.6814(1)
Å; V = 828.29(3) Å3, Dx = 1.341 g cm
−3, 864 unique data (2θmax =
147.4°), R = 0.035 [for 795 reﬂections with I > 2.0σ(I)]; Rw = 0.058
(all data), S = 1.00.
Compound 2: C13H11N, Mr = 181.24, T = 150 K, monoclinic, space
group P21/c, Z = 4, a = 20.3990(8) Å, b = 5.7846(2) Å, c = 7.8899(3)
Å; β = 98.458(4)°; V = 920.88(6) Å3, Dx = 1.307 g cm
−3, 1858 unique
data (2θmax = 147.8°), R = 0.057 [for 1748 reﬂections with I >
2.0σ(I)]; Rw = 0.096 (all data), S = 1.00.
Compound 3: C14H13NO, Mr = 211.26, T = 150 K, monoclinic,
space group P21/n, Z = 4, a = 11.4714(17) Å, b = 5.6130(6) Å, c =
16.915(2) Å; β = 95.648(12)°; V = 1083.9(2) Å3, Dx = 1.295 g cm
−3,
2160 unique data (2θmax = 151.8°), R = 0.058 [for 1763 reﬂections
with I > 2.0σ(I)]; Rw = 0.164 (all data), S = 1.00.
Compound 4: C14H13NO, Mr = 211.26, T = 150 K, orthorhombic,
space group P212121, Z = 4, a = 6.4420(1) Å, b = 7.5921(1) Å, c =
21.9422(3) Å; V = 1073.16(3) Å3, Dx = 1.308 g cm
−3, 2166 unique
data (2θmax = 147.8°), R = 0.035 [for 2114 reﬂections with I >
2.0σ(I)]; Rw = 0.064 (all data), S = 1.00.
Compound 5: C14H11NO2, Mr = 225.25, T = 150 K, orthorhombic,
space group Pbca, Z = 8, a = 7.1367(1) Å, b = 13.2390(1) Å, c =
22.5108(2) Å; V = 2126.88(4) Å3, Dx = 1.407 g cm
−3, 2152 unique
data (2θmax = 147.8°), R = 0.033 [for 2089 reﬂections with I >
2.0σ(I)]; Rw = 0.058 (all data), S = 1.00.
Compound 6: C15H13NO3, Mr = 255.27, T = 150 K, monoclinic,
space group C2/c, Z = 8, a = 15.7767(2) Å, b = 9.4629(1) Å, c =
16.1402(2) Å; β = 91.7342(13)°; V = 2408.52(5) Å3, Dx = 1.408 g
cm−3, 3284 unique data (2θmax = 59.6°), R = 0.039 [for 2869
reﬂections with I > 2.0σ(I)]; Rw = 0.077 (all data), S = 1.00.
Compound 17: C14H15NO4, Mr = 261.27, T = 150 K, monoclinic,
space group P21/c, Z = 8, a = 21.5986(4) Å, b = 6.89910(11) Å, c =
17.6362(3) Å; β = 104.596(2)°; V = 2543.16(8) Å3, Dx = 1.365 g
cm−3, 5147 unique data (2θmax = 147.6°), R = 0.084 [for 4826
reﬂections with I > 2.0σ(I)]; Rw = 0.214 (all data), S = 1.12.
Compound 25: C14H17NO3, Mr = 247.29, T = 150 K, monoclinic,
space group P21/c, Z = 4, a = 14.6135(2) Å, b = 5.8504(1) Å, c =
14.6942 (2) Å; β = 96.2796(15)°; V = 1248.74(3) Å3, Dx = 1.315 g
cm−3, 2542 unique data (2θmax = 147.6°), R = 0.036 [for 2433
reﬂections with I > 2.0σ(I)]; Rw = 0.098 (all data), S = 1.00.
Structure Determination. The image for compound 6 was
measured on a diﬀractometer (Mo Kα, graphite monochromator, λ
= 0.71073 Å) ﬁtted with an area detector, and the data were extracted
using the DENZO/Scalepack package.34 Images for compounds 1−5,
17, and 25 were measured on a diﬀractometer (Cu Kα, mirror
monochromator, λ = 1.54184 Å) ﬁtted with an area detector and the
data extracted using the CrysAlis package.35 The structure solutions
for all eight compounds were solved by direct methods (SIR92)36 then
reﬁned using the CRYSTALS program package.37 Atomic coordinates,
bond lengths and angles, and displacement parameters have been
deposited at the Cambridge Crystallographic Data Centre (CCDC
nos. 1525166, 1525163, 1525164, 1525162, 1525167, 1525160,
1525161, and 1525165 for compounds 1−6, 17, and 25, respectively).
These data can be obtained free of charge via www.ccdc.cam.ac.uk/
data_request/cif, by e-mailing data_request@ccdc.cam.ac.uk, or by
contacting The Cambridge Crystallographic Data Centre, 12 Union
Road, Cambridge CB2 1EZ, U.K. (fax: + 44 1223 336033). Single-
crystal X-ray analyses of compound 1 have been reported previously.38
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ABSTRACT: A cross-coupling/reductive cyclization protocol
has been employed in a uniﬁed approach to all four carbolines.
So, for example, the 2-nitropyridine 8, which is readily prepared
through an eﬃcient palladium-catalyzed Ullmann cross-coupling
reaction, is reductively cyclized under conventional conditions to
give 6,7,8,9-tetrahydro-α-carboline that is itself readily aromatized
to give α-carboline (1).
■ INTRODUCTION
The isomeric α-, β-, γ-, and δ-carbolines (1−4, respectively, in
Figure 1) are important heterocyclic rings systems.1 All are
found, albeit to varying extents, as key structural motifs in
natural products. They also feature in a wide range of
medicinally relevant compounds. The utility of their various
derivatives in materials science is a further focus of current
studies.2 The α-carboline framework (1) is encountered in a
limited number of naturally occurring anticancer agents and in
the neuro-protective alkaloid mescengricin.3 On the other hand,
synthetically derived α-carbolines have shown anxiolytic, anti-
inﬂammatory, central nervous system stimulating, and kinase
inhibitory properties.4 β-Carboline (2), itself a natural product
isolated from both plants and micro-organisms, is the most
well-known of the four systems and represents a key
substructure associated with, for example, the eudistomine
and manzamine classes of biologically active marine alkaloids.5
Many medicinal agents embodying this heterocyclic framework
have been identiﬁed.5,6 Derivatives of γ-carboline (3) have been
explored extensively as anticancer and anti-Alzheimer agents,7
while those associated with δ-carboline (4) have been studied,
inter alia, for their antibacterial and antitumor properties.1b,8 δ-
Carboline-containing alkaloids have been isolated from, for
example, various West and Central African plants that are
prized as sources of traditional medicines for treating malaria
and certain infectious diseases.1b
A multitude of methods has been established for the
synthesis of the carbolines, including classical ones involving
Graebe−Ullmann, Fischer indolization, Bischler−Napieralski,
and Pictet−Spengler reactions.9,10 Variations on the Cadogan
syntheses of carbazoles are also known,11 as are routes
involving the annulation of pyridines onto indoles,9,10,12
including through Diels−Alder and electrocyclization pro-
cesses. Generally speaking, though, “customized” approaches
are required for the assembly of each of the α-, β-, γ-, and δ-
carboline frameworks, thus prompting the search for more
general routes to them.13 There has been modest success in this
regard, with the most eﬀective route involving the cyclization of
anilinopyridines.13g−j Recently, Driver13i and Ray13j have each
reported variations on such methods that allow access to three
of the four frameworks. It is against this background that we
now detail a distinct, operationally simple, and likely ﬂexible
route to all four of the isomeric carbolines and highlight the
utility of this through the synthesis of the simple natural
product harman (5, Figure 2), a compound that displays anti-
HIV and antibacterial properties.14
■ RESULTS AND DISCUSSION
The pivotal steps associated with the uniﬁed approach to the
carbolines reported here are the palladium-catalyzed Ullmann
cross-coupling15 of 2-iodocyclohex-2-en-1-one16 with the
relevant halogenated nitropyridine and the reductive cyclization
of the ensuing 2-pyridylcyclohex-2-en-1-one to give the
corresponding 6,7,8,9-tetrahydrocarboline. Oxidation of these
tetrahydro compounds to their fully aromatic counterparts (viz.,
the carbolines) was readily accomplished using 10 wt %
palladium on carbon. This sequence mirrors that used in our
Received: February 10, 2017
Published: March 17, 2017
Figure 1. Isomeric α-, β-, γ-, and δ-carbolines (1−4).
Figure 2. β-Carboline alkaloid harman (5).
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recently reported syntheses of various carbazole-based natural
products, including glycoborine, glycozoline, clausazoline K,
mukonine, and karapinchamine A.17
The synthesis of α-carboline (1), as shown in Scheme 1, is
illustrative and starts with the palladium-catalyzed Ullmann
cross-coupling of the readily prepared17 2-iodocyclohex-2-en-1-
one (6) with commercially available 3-bromo-2-nitropyridine
(7), thus aﬀording the 2-pyridylcyclohex-2-en-1-one (8) in 82%
yield. In order to reduce the extent of homocoupling of the
pyridine in this reaction, the iodo enone 6 was treated with a
combination of copper metal, copper(I) iodide, and Pd(dppf)-
Cl2·CH2Cl2 in DMSO at 50 °C for 0.75 h prior the addition of
compound 7. Presumably this allows cupration of compound 6
to take place prior to a palladium-catalyzed cross-coupling
reaction with halide 7, thereby increasing the yields of product
8. The reductive cyclization of compound 8 was eﬀected using
hydrogen in the presence of catalytic amounts of 10 wt %
palladium on carbon (Pd/C) in methanol at room temperature
for 16 h, and this produced the 6,7,8,9-tetrahydrocarboline
(9)18 in 75% yield. In our hands, the oxidation19 of compound
9 to α-carboline (1)4a was best carried out by exposing the
former system to an equivalent mass of 10 wt % palladium on
carbon in diphenyl ether at 210 °C for 0.66 h. By such means
target 1 was obtained in 97% yield, and all of the spectral data
acquired on this material were in complete accord with the
assigned structure and matched those reported in the literature.
A single-crystal X-ray analysis was carried out on compound 1
and details of this are provided in the Experimental Section and
the Supporting Information (SI).
Given the use of 10 wt % palladium on carbon in both the
second and third steps of the reaction sequence, these could, in
principle, be “telescoped” to establish a one-pot process. To
date, however, we have not been able to identify conditions that
allow for this to be conducted in both an operationally superior
way and with better outcomes.
The synthesis of β-carboline (2) (Scheme 2) required 4-
iodo-3-nitropyridine (10)20 as a coupling partner, and this was
readily obtained by reacting the commercially available chloro
analogue with sodium iodide in acetonitrile (see the
Experimental Section for details). Cross-coupling of com-
pounds 6 and 10 proceeded smoothly under essentially the
same conditions as employed for the conversion 6 + 7→ 8 and
provided the anticipated coupling product 11 in 86% yield.
Reductive cyclization of compound 11 proceeded uneventfully
under the previously established conditions, and product 1221
(88%) was readily oxidized to target 2 (94%) upon brief
exposure to an equal mass of 10 wt % palladium on carbon in
hot diphenyl ether. Once again, all the spectral data acquired
for β-carboline (2) matched those reported22 previously. The
structure of compound 2 was also conﬁrmed by single-crystal
X-ray analysis.
The analogous synthesis of γ-carboline (3) is shown in
Scheme 3, and in this instance the required pyridine (13) was a
commercially available material. Reductive cyclization of the
cross-coupling product 14 (89%) produced from compound 6
and 13 proceeded as anticipated to give the tetrahydrocarboline
15,23 albeit in just 66% yield. Similarly, the oxidation of this last
compound under the previously employed conditions was less
eﬃcient than observed in the two previous cases, with
compound 324 being obtained in 77% yield. Once again, full
characterization of this product was undertaken, including by
single-crystal X-ray analysis.
The establishment of a uniﬁed approach to all the carbolines
followed from the successful synthesis of δ-carboline (4) by the
pathway shown in Scheme 4. So, as before, the palladium-
catalyzed Ullmann cross-coupling of iodo enone 6 with the
required and commercially available pyridine 16 proceeded
uneventfully to give product 17 (75%) that was reductively
cyclized in the usual manner to aﬀord the tetrahydrocarboline
1825 (65%). Oxidation of this last compound using an equal
Scheme 1. Synthesis of α-Carboline (1)
Scheme 2. Synthesis of β-Carboline (2)
Scheme 3. Synthesis of γ-Carboline (3)
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mass of 10 wt % palladium on carbon in hot diphenyl ether
then gave δ-carboline (4)26 (92%) that was subject to the usual
range of spectroscopic analyses, including a single-crystal X-ray
study.
In order to test the capacities of the above-mentioned
protocols to deliver substituted carbolines, the β-carboline-
based natural product harman (5, Figure 2) was targeted for
synthesis. The required pyridine was prepared by the route
shown in Scheme 5. Thus, commercially available 2-
methylpyridin-4-amine (19) was subjected to a Sandmeyer
reaction using water as the nucleophile, thus providing the
previously reported nitric acid salt27 20 of 2-methylpyridin-4-ol.
Aromatic nitration of this last compound could only be
achieved under rather forcing conditions, thus providing a 1:3
and inseparable mixture of pyridines 21 and 22 (70% combined
yield). Accordingly, this mixture was treated with POBr3 in
reﬂuxing toluene, thereby aﬀording what is presumed to be the
corresponding mixture of bromides 23 and 24 (92% combined
yield). These regioisomers could only be separated by HPLC
techniques but suﬃcient quantities of the pure form of the
latter could be accumulated by such means. The former
product (presumed to be compound 23) was not puriﬁed or
subject to any spectroscopic characterization.
With compound 24 in hand, the synthesis of harman (5) was
completed by the now standard pathway shown in Scheme 6.
Thus, palladium-catalyzed Ullmann cross-coupling of iodo
enone 6 with pyridine 24 delivered the required product 25 in
84% yield. Reductive cyclization of the last compound under
the usual conditions gave tetrahydroharman 2628 (83%), which
could be oxidized to the natural product 514,29 (91%) on
treatment with an equal mass of 10 wt % palladium on carbon
in hot diphenyl ether. Once again, all the spectral data,
including those derived from a single-crystal X-ray analysis,
acquired for compound 5 conﬁrmed the assigned structure, and
appropriate comparisons with those reported14 for the natural
product were entirely favorable.
■ CONCLUSIONS
The reaction sequences reported here should allow for the
rational/logical design of pathways to a wide range of α-, β-, γ-,
and δ-carbolines. This is all the more so given the increasingly
ready availability of a wide range of polysubstituted pyridines30
and 2-iodocyclohex-2-en-1-ones. For similar reasons, the
protocols deﬁned here should allow for ready access to a
wide range of azaindoles, compounds of considerable interest
from a medicinal chemistry perspective.31 Studies exploiting
such possibilities will be reported in due course.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Unless otherwise speciﬁed,
proton (1H) and carbon (13C) NMR spectra were recorded at 18 °C
in base-ﬁltered CDCl3 on a spectrometer operating at 400 MHz for
proton and 100 MHz for carbon nuclei. 1H NMR data are recorded as
follows: chemical shift (δ) [multiplicity, coupling constant(s) J (Hz),
relative integral], where multiplicity is deﬁned as s = singlet; d =
doublet; t = triplet; q = quartet; m = multiplet or combinations of the
above. In relevant cases, the signal due to residual CHCl3 appearing at
δH 7.26 and the central resonance of the CDCl3 “triplet” appearing at
δC 77.0 were used to reference
1H and 13C NMR spectra, respectively.
Samples were analyzed by infrared spectroscopy (νmax) as thin ﬁlms
on KBr plates. Low- and high-resolution electron impact (EI) mass
spectra were recorded on a double-focusing, triple-sector machine.
Low- and high-resolution ESI mass spectra were recorded on a triple-
quadrupole mass spectrometer operating in positive ion mode. Melting
points are uncorrected. Analytical thin-layer chromatography (TLC)
was performed on aluminum-backed 0.2 mm thick silica gel 60 F254
plates. Eluted plates were visualized using a 254 nm UV lamp and/or
by treatment with a suitable dip followed by heating. These dips
included phosphomolybdic acid/ceric sulfate/sulfuric acid (concd)/
water (37.5 g/7.5 g/37.5 g/720 mL), potassium permanganate/
potassium carbonate/5% sodium hydroxide aqueous solution/water (3
g/20 g/5 mL/300 mL), and p-anisaldehyde or vanillin/sulfuric acid
Scheme 4. Synthesis of δ-Carboline (4)
Scheme 5. Route to the Trisubstituted Pyridine 24 Required
for the Synthesis of the β-Carboline Alkaloid Harman (5)
Scheme 6. Completion of the Synthesis of Harman (5)
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(concd)/ethanol (15 g/2.5 mL/250 mL). Flash chromatographic
separations were carried out following protocols deﬁned by Still et al.32
with silica gel 60 (40−63 μm) as the stationary phase and using the
AR- or HPLC-grade solvents indicated. The melting points of solids
puriﬁed by such means were recorded directly (i.e., after they had
crystallized from the concentrated chromatographic fractions). Starting
materials, reagents, drying agents, and other inorganic salts were
generally commercially available and were used as supplied. The
copper powder used in the palladium-catalyzed Ullmann cross-
coupling reactions had a particle size of <75 μm. Tetrahydrofuran
(THF), methanol, and dichloromethane were dried using a solvent
puriﬁcation system that is based upon a technology originally
described by Grubbs et al.33 Where necessary, reactions were
performed under a nitrogen atmosphere by subjecting the relevant
solution to reduced pressure for several minutes and then admitting
nitrogen. This process was repeated three times.
Speciﬁc Chemical Transformations. 2-(2-Nitropyridin-3-yl)-
cyclohex-2-en-1-one (8). A magnetically stirred mixture of 2-
iodocyclohex-2-en-1-one (6)16 (2.63 g, 11.82 mmol), copper powder
(1.50 g, 23.65 mmol), CuI (1.69 g, 8.87 mmol), and Pd(dppf)Cl2·
CH2Cl2 (483 mg, 0.59 mmol) in degassed DMSO (118 mL) was
heated at 50 °C under a nitrogen atmosphere for 0.75 h. After this
time, a solution of commercially available 3-bromo-2-nitropyridine (7)
(1.20 g, 5.91 mmol) in degassed DMSO (30 mL) was added to the
reaction mixture over 1.5 h. After a further 4 h, the reaction mixture
was cooled, quenched with water (30 mL), and then diluted with ethyl
acetate (50 mL). The ensuing mixture was ﬁltered through a pad
comprised of a mixture of diatomaceous earth and silica gel. The solids
thus retained were rinsed with ethyl acetate (2 × 50 mL), and the
separated organic phase associated with the combined ﬁltrates was
washed with water (2 × 100 mL) and then brine (2 × 100 mL) before
being dried (Na2SO4), ﬁltered, and concentrated under reduced
pressure to give a brown oil. Subjection of this material to ﬂash column
chromatography (silica, 1:3:11 v/v/v acetone/dichloromethane/40−
60 petroleum ether elution) gave, after concentration of the
appropriate fractions (Rf = 0.2 in 1:1 v/v ethyl acetate/40−60
petroleum ether), compound 8 (1.06 g, 82%) as a light-brown solid:
mp = 115−116 °C; 1H NMR (400 MHz, CDCl3) δ 8.52 (dd, J = 4.7
and 1.7 Hz, 1H), 7.74 (dd, J = 7.6 and 1.7 Hz, 1H), 7.60 (dd, J = 7.6
and 4.7 Hz, 1H), 7.08 (t, J = 4.2 Hz, 1H), 2.60 (m, 4H), 2.15 (m, 2H);
13C NMR (100 MHz, CDCl3) δ 196.0, 157.0, 148.5, 147.8, 141.7,
137.2, 128.1, 126.7, 38.2, 26.5, 22.6; IR νmax 2950, 1679, 1540, 1405,
1366, 975, 864, 810, 707 cm−1; MS (ESI, +ve) m/z 241 [(M + Na)+,
100%]; HRMS m/z (M + Na)+ calcd for C11H10N2NaO3 241.0589,
found 241.0591.
6,7,8,9-Tetrahydro-5H-pyrido[2,3-b]indole (9). A magnetically
stirred mixture of compound 8 (30 mg, 0.14 mmol) and 10 wt %
Pd/C (12 mg) in degassed methanol (7 mL) was maintained under an
atmosphere of hydrogen for 16 h at 22 °C and then ﬁltered, and the
solids thus retained were washed with methanol (20 mL). The
combined ﬁltrates were concentrated under reduced pressure and the
white solid thus obtained was subjected to ﬂash column chromatog-
raphy (silica, 1:4 v/v ethyl acetate/40−60 petroleum ether elution).
Concentration of the appropriate fractions (Rf = 0.7 in ethyl acetate)
then gave compound 918 (18 mg, 75%) as a white, crystalline solid: mp
= 155−156 °C (lit.18 mp = 155−156 °C); 1H NMR (400 MHz,
CDCl3) δ 10.65 (m, 1H), 8.19 (d, J = 4.3 Hz, 1H), 7.75 (dd, J = 7.7
and 1.3 Hz, 1H), 7.01 (dd, J = 7.7 and 4.3 Hz, 1H), 2.84 (t, J = 6.0 Hz,
2H), 2.70 (m, 2H), 1.98−1.86 (complex m, 4H); 13C NMR (100
MHz, CDCl3) δ 148.9, 140.8, 135.4, 125.7, 120.8, 115.1, 108.4,
23.3(4), 23.2(8), 23.1, 20.8; IR νmax 3149, 3075, 2921, 2846, 1587,
1418, 1289, 786, 765, 677 cm−1; MS (ESI, +ve) m/z 173 [(M + H)+,
100%]; HRMS m/z (M + H)+ calcd for C11H13N2 173.1079, found
173.1078.
9H-Pyrido[2,3-b]indole (α-Carboline, 1). A magnetically stirred
mixture of compound 9 (20 mg, 0.12 mmol) and 10 wt % Pd/C (20
mg) in diphenyl ether (15 mL) maintained under a nitrogen
atmosphere was heated at 210 °C for 0.66 h. The reaction mixture
was then cooled to room temperature and ﬁltered (through ﬁlter
paper), and the solids so retained were washed with ethyl acetate (2 ×
15 mL). The combined ﬁltrates were concentrated under reduced
pressure, and the residue thus obtained was subjected to ﬂash column
chromatography (silica, 0:1→ 1:4 v/v ethyl acetate/40−60 petroleum
ether gradient elution). Concentration of the appropriate fractions (Rf
= 0.2 in 1:1 v/v ethyl acetate/40−60 petroleum ether) gave compound
14a (19 mg, 97%) as a white, crystalline solid: mp = 200−202 °C (lit.4a
mp = 215−217 °C); 1H NMR (400 MHz, CD3OD) δ 8.44 (dd, J = 7.7
and 1.5 Hz, 1H), 8.34 (dd, J = 4.9 and 1.2 Hz, 1H), 8.09 (d, J = 7.9 Hz,
1H), 7.52 (d, J = 8.1 Hz, 1H), 7.48−7.44 (complex m, 1H), 7.26−7.19
(complex m, 2H) (signal due to N−H group proton not observed);
13C NMR (100 MHz, CD3OD) δ 152.9, 146.1, 140.6, 129.9, 128.0,
122.0, 121.9, 121.0, 118.0, 116.1, 112.3; IR νmax 3048, 2984, 2906,
1600, 1587, 1572, 1455, 1411, 1274, 998, 767, 736 cm−1; MS (ESI,
+ve) m/z 169 [(M + H)+, 100%]; HRMS m/z (M + H)+ calcd for
C11H9N2 169.0766, found 169.0768.
4-Iodo-3-nitropyridine (10). A magnetically stirred solution of
commercially available 4-chloro-3-nitropyridine (1.00 g, 6.31 mmol) in
acetonitrile (126 mL) maintained at ambient temperatures was treated
with sodium iodide (17.02 g, 113.55 mmol). The ensuing mixture was
heated under reﬂux for 2 h and then cooled to 22 °C and diluted with
ethyl acetate (200 mL). The resulting solution was washed with
Na2CO3 (1 × 100 mL of a saturated aqueous solution), Na2SO3 (1 ×
50 mL of a saturated solution), water (1 × 200 mL), and brine (1 ×
100 mL) before being dried (Na2SO4,), ﬁltered, and then concentrated
under reduced pressure. The residue thus obtained was subjected to
ﬂash column chromatography (silica, 1:19 v/v ethyl acetate/40−60
petroleum ether elution) to give, after concentration of the appropriate
fractions (Rf = 0.5 twice in 1:5 v/v ethyl acetate/40−60 petroleum
ether), 4-iodo-3-nitropyridine (10)20 (1.46 g, 92%) as a light-yellow
solid: mp = 80−82 °C; 1H NMR (400 MHz, CDCl3) δ 9.04 (broad s,
1H), 8.35 (d, J = 5.1 Hz, 1H), 8.03 (d, J = 5.1 Hz, 1H); 13C NMR
(100 MHz, CDCl3) δ 152.5, 149.6, 145.9, 136.5, 98.5; IR νmax 1572,
1540, 1521, 1357, 1223, 1058, 835, 657 cm−1; MS (EI, 70 eV) m/z
250 (M+•, 100%), 204 (70), 177 (60); HRMS m/z M+• calcd for
C5H3
127IN2O2 249.9239, found 249.9236.
2-(3-Nitropyridin-4-yl)cyclohex-2-en-1-one (11). A magnetically
stirred mixture of 2-iodocyclohex-2-en-1-one (6) (888 mg, 4.00
mmol), copper powder (508 mg, 8.00 mmol), CuI (571 mg, 3.00
mmol), and Pd(dppf)Cl2·CH2Cl2 (163 mg, 0.20 mmol) in degassed
DMSO (40 mL) was heated at 50 °C under a nitrogen atmosphere for
0.75 h. After this time a solution of compound 10 (500 mg, 2.00
mmol) in degassed DMSO (10 mL) was added to the reaction mixture
over 1 h. After a further 0.75 h, the reaction mixture was cooled,
quenched with water (10 mL), and then diluted with ethyl acetate (15
mL). The ensuing mixture was ﬁltered through a pad comprised of a
mixture of diatomaceous earth and silica gel. The solids thus retained
were rinsed with ethyl acetate (2 × 15 mL), and the separated organic
phase associated with the combined ﬁltrates was washed with water (2
× 30 mL) and then brine (2 × 30 mL) before being dried (Na2SO4),
ﬁltered, and concentrated under reduced pressure to give a brown oil.
This was subjected to ﬂash column chromatography (silica, 1:3:10 v/
v/v acetone/dichloromethane/40−60 petroleum ether elution) and
gave, after concentration of the appropriate fractions [Rf = 0.1(5) in
1:1 v/v ethyl acetate/40−60 petroleum ether], compound 11 (374
mg, 86%) as a light-yellow solid: mp = 105−107 °C; 1H NMR (400
MHz, CDCl3) δ 9.18 (s, 1H), 8.78 (d, J = 4.9 Hz, 1H), 7.22 (d, J = 4.9
Hz, 1H), 7.13 (t, J = 4.2 Hz, 1H), 2.63−2.57 (complex m, 4H), 2.19−
2.13 (complex m, 2H); 13C NMR (100 MHz, CDCl3) δ 195.5, 153.9,
148.7, 145.3, 145.0, 140.0, 137.5, 125.6, 38.2, 26.5, 22.5; IR νmax 2948,
1679, 1600, 1542, 1523, 1357, 1217, 1159, 1121, 851, 716 cm−1; MS
(ESI, +ve) m/z 219 [(M + H)+, 100%]; HRMS m/z (M + H)+ calcd
for C11H11N2O3 219.0770, found 219.0768.
6,7,8,9-Tetrahydro-5H-pyrido[3,4-b]indole (12). A magnetically
stirred mixture of compound 11 (190 mg, 0.87 mmol) and 10 wt %
Pd/C (76 mg) in degassed methanol (44 mL) was maintained under
an atmosphere of hydrogen for 16 h at 22 °C and then ﬁltered, and the
solids thus retained were washed with methanol (100 mL). The
combined ﬁltrates were concentrated under reduced pressure, and the
white solid thus obtained was subjected to ﬂash column chromatog-
raphy (silica, 1:4 v/v methanol/dichloromethane elution) to give, after
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concentration of the appropriate fractions [Rf = 0.3(5) in 1:1 v/v
methanol/dichloromethane], compound 1221 (132 mg, 88%) as a
white, crystalline solid: mp = 163−164 °C (lit.21 mp = 199−200 °C);
1H NMR (700 MHz, CD3OD) δ 8.49 (broad s, 1H), 7.97 (broad s,
1H), 7.36 (d, J = 4.9 Hz, 1H), 2.77 (t, J = 6.0 Hz, 2H), 2.65 (t, J = 6.0
Hz, 2H), 1.92−1.83 (complex m, 4H) (signal due to N−H group
proton not observed); 13C NMR (175 MHz, CD3OD) δ 142.2, 136.9,
134.5, 134.2, 132.6, 113.7, 110.4, 24.2(2), 24.2(0), 24.0, 21.6; IR νmax
3143, 3040, 2926, 2850, 2839, 1569, 1471, 1442, 1359, 1142, 1030,
808 cm−1; MS (ESI, +ve) m/z 173 [(M + H)+, 100%]; HRMS m/z
(M + H)+ calcd for C11H13N2 173.1079, found 173.1078.
9H-Pyrido[3,4-b]indole (β-Carboline, 2). A magnetically stirred
mixture of compound 12 (20 mg, 0.12 mmol) and 10 wt % Pd/C (20
mg) in diphenyl ether (15 mL) maintained under a nitrogen
atmosphere was heated at 210 °C for 0.66 h. The reaction mixture
was then cooled to room temperature and ﬁltered (through ﬁlter
paper), and the solids so retained were washed with ethyl acetate (2 ×
15 mL). The combined ﬁltrates were concentrated under reduced
pressure, and the residue thus obtained was subjected to ﬂash column
chromatography (silica, 0:1→ 1:1 v/v ethyl acetate/40−60 petroleum
ether gradient elution) to give, after concentration of the appropriate
fractions (Rf = 0.5 in 1:2 v/v methanol/dichloromethane), compound
222 (18 mg, 94%) as a white, crystalline solid: mp = 210−211 °C (lit.22
mp = 199−201 °C); 1H NMR (400 MHz, CD3OD) δ 8.79 (s, 1H),
8.27 (d, J = 5.3 Hz, 1H), 8.18 (d, J = 8.0 Hz, 1H), 8.08 (d, J = 5.3 Hz,
1H), 7.56 (m, 2H), 7.29−7.23 (complex m, 1H) (signal due to N−H
group proton not observed); 13C NMR (100 MHz, CD3OD) δ 142.7,
138.4, 137.8, 134.1, 130.4, 129.7, 122.7, 122.2, 120.8, 116.1, 112.8; IR
νmax 3134, 3052, 2963, 2754, 1628, 1449, 1331, 1245, 746, 732 cm
−1;
MS (ESI, +ve) m/z 191 [(M + Na)+, 70%], 169 [(M + H)+, 100];
HRMS m/z (M + H)+ calcd for C11H9N2 169.0766, found 169.0766.
2-(4-Nitropyridin-3-yl)cyclohex-2-en-1-one (14). A magnetically
stirred mixture of 2-iodocyclohex-2-en-1-one (6) (2.19 g, 9.85 mmol),
copper powder (1.26 g, 19.70 mmol), CuI (1.41 g, 7.39 mmol), and
Pd(dppf)Cl2·CH2Cl2 (400 mg, 0.49 mmol) in degassed DMSO (98
mL) was heated at 50 °C under a nitrogen atmosphere for 0.75 h.
After this time, a solution of compound 13 (1.00 g, 4.93 mmol) in
degassed DMSO (25 mL) was added to the reaction mixture over 1.5
h. After a further 4 h, the reaction mixture was cooled, quenched with
water (20 mL), and then diluted with ethyl acetate (1 × 30 mL). The
ensuing mixture was ﬁltered through a pad comprised of a mixture of
diatomaceous earth and silica gel. The solids thus retained were rinsed
with ethyl acetate (2 × 30 mL), and the separated organic phase
associated with the combined ﬁltrates was washed with water (2 × 60
mL) and then brine (2 × 60 mL) before being dried (Na2SO4),
ﬁltered, and concentrated under reduced pressure to give a brown oil.
Subjection of this material to ﬂash column chromatography (silica,
1:3:11 v/v/v acetone/dichloromethane/40−60 petroleum ether
elution) gave, after concentration of the appropriate fractions (Rf =
0.2 in 1:3:6 v/v/v acetone/dichloromethane/40−60 petroleum ether),
compound 14 (956 mg, 89%) as a light-brown solid: mp = 94−95 °C;
1H NMR (400 MHz, CDCl3) δ 8.82 (d, J = 5.3 Hz, 1H), 8.61 (s, 1H),
7.81 (d, J = 5.3 Hz, 1H), 7.17 (t, J = 4.2 Hz, 1H), 2.66−2.58 (complex
m, 4H), 2.18 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 196.1, 154.1,
152.8, 151.4, 148.6, 136.0, 125.4, 116.6, 38.2, 26.5, 22.6; IR νmax 2945,
1677, 1557, 1529, 1401, 1358, 1222, 1159, 839, 705, 675 cm−1; MS
(ESI, +ve) m/z 241 [(M + Na)+, 100%], 219 [(M + H)+, 15]; HRMS
m/z (M + Na)+ calcd for C11H10N2NaO3 241.0589, found 241.0589.
6,7,8,9-Tetrahydro-5H-pyrido[4,3-b]indole (15). A magnetically
stirred mixture of compound 14 (50 mg, 0.23 mmol) and 10 wt %
Pd/C (20 mg) in degassed methanol (12 mL) was maintained under
an atmosphere of hydrogen at 22 °C for 16 h and then ﬁltered, and the
solids so retained were washed with methanol (25 mL). The combined
ﬁltrates were concentrated under reduced pressure, and the white solid
thus obtained was subjected to ﬂash column chromatography (silica,
1:4 v/v methanol/dichloromethane elution) to give, after concen-
tration of the appropriate fractions [Rf = 0.3(5) in 1:1 v/v methanol/
dichloromethane], compound 1523 (26 mg, 66%) as a white,
crystalline solid: mp = 223−224 °C (lit.23 mp = 269−271 °C); 1H
NMR (700 MHz, CD3OD) δ 8.58 (broad s, 1H), 8.05 (broad s, 1H),
7.28 (d, J = 5.3 Hz, 1H), 2.74 (m, 4H), 1.95−1.87 (complex m, 4H)
(signal due to N−H group proton not observed); 13C NMR (175
MHz, CD3OD) δ 141.6, 139.9, 139.1, 138.1, 126.2, 110.3, 107.5, 24.2,
24.1, 23.9, 21.6; IR νmax 2926, 2839, 2693, 1625, 1466, 1294, 1169,
1142, 989, 802, 684 cm−1; MS (ESI, +ve) m/z 173 [(M + H)+, 100%];
HRMS m/z (M + H)+ calcd for C11H13N2 173.1079, found 173.1078.
5H-Pyrido[4,3-b]indole (γ-Carboline, 3). A magnetically stirred
mixture of compound 15 (20 mg, 0.12 mmol) and 10 wt % Pd/C (20
mg) in diphenyl ether (15 mL) maintained under a nitrogen
atmosphere was heated at 210 °C for 0.66 h. The reaction mixture
was then cooled to room temperature and ﬁltered (through ﬁlter
paper), and the solids thus retained were washed with ethyl acetate (2
× 15 mL). The combined ﬁltrates were concentrated under reduced
pressure, and the residue thus obtained was subjected to ﬂash column
chromatography (silica, 40−60 petroleum ether elution → 1:3 v/v
methanol/dichloromethane gradient elution) to give, after concen-
tration of the appropriate fractions [Rf = 0.2(5) in 1:3 v/v methanol/
dichloromethane], compound 324 (15 mg, 77%) as a white, crystalline
solid: mp = 223−225 °C (lit.24 mp = 225−227 °C); 1H NMR [700
MHz, (CD3)2SO] δ 11.69 (s, 1H), 9.33 (s, 1H), 8.43 (s, 1H), 8.22 (d,
J = 7.8 Hz, 1H), 7.56 (m, 1H), 7.47 (m, 2H), 7.26 (t, J = 7.4 Hz, 1H);
13C NMR [175 MHz, (CD3)2SO] δ 144.5, 143.5, 142.7, 139.5, 126.5,
120.7, 120.6, 119.9, 119.4, 111.4, 106.4; 1H NMR (700 MHz,
CD3OD) δ 9.20 (s, 1H), 8.36 (s, 1H), 8.16 (d, J = 7.8 Hz, 1H), 7.53
(d, J = 8.1 Hz, 1H), 7.49−7.46 (m, 2H), 7.28 (t, J = 7.4 Hz, 1H)
(signal due to N−H group proton not observed); 13C NMR (175
MHz, CD3OD) δ 145.8, 144.4, 142.7, 141.5, 128.2, 122.4, 121.6(4),
121.6(0), 121.5, 112.4, 107.6; IR νmax 3062, 2956, 2806, 2679, 1607,
1582, 1467, 1239, 999, 744 cm−1; MS (ESI, +ve) m/z 169 [(M + H)+,
100%]; HRMS m/z (M + H)+ calcd for C11H9N2 169.0766, found
169.0766.
2-(3-Nitropyridin-2-yl)cyclohex-2-en-1-one (17). A magnetically
stirred mixture of 2-iodocyclohex-2-en-1-one (6) (1.09 g, 4.93 mmol),
copper powder (630 mg, 9.85 mmol), CuI (704 mg, 3.69 mmol), and
Pd(dppf)Cl2·CH2Cl2 (200 mg, 0.25 mmol) in degassed DMSO (50
mL) was heated at 50 °C under a nitrogen atmosphere for 0.75 h.
After this time, a solution of compound 16 (500 mg, 4.93 mmol) in
degassed DMSO (12 mL) was added to the reaction mixture over 1 h.
After a further 2 h, the reaction mixture was cooled, quenched with
water (10 mL), diluted with ethyl acetate (15 mL), and then ﬁltered
through a pad comprised of a mixture of diatomaceous earth and silica
gel. The solids thus retained were rinsed with ethyl acetate (2 × 15
mL), and the separated organic phase associated with the combined
ﬁltrates was washed with water (2 × 30 mL) and then brine (2 × 30
mL) before being dried (Na2SO4), ﬁltered, and concentrated under
reduced pressure to give a brown oil. Subjection of this material to
ﬂash column chromatography (silica, 1:3:12 v/v/v acetone/dichloro-
methane/40−60 petroleum ether elution) gave, after concentration of
the appropriate fractions [Rf = 0.1(5) in 1:3:6 v/v/v acetone/
dichloromethane/40−60 petroleum ether], compound 17 (403 mg,
75%) as a light-brown solid: mp = 104−106 °C; 1H NMR (400 MHz,
CDCl3) δ 8.79 (dd, J = 4.7 and 1.3 Hz, 1H), 8.29 (dd, J = 8.2 and 1.3
Hz, 1H), 7.49−7.43 (complex m, 2H), 2.65 (m, 2H), 2.58 (m, 2H),
2.20−2.13 (complex m, 2H); 13C NMR (100 MHz, CDCl3) δ 196.2,
152.9, 151.0, 149.4, 146.1, 139.2, 132.2, 123.4, 38.3, 26.6, 22.5; IR νmax
2947, 1677, 1593, 1561, 1526, 1451, 1357, 765 cm−1; MS (ESI, +ve)
m/z 241 [(M + Na)+, 100%], 219 [(M + H)+, 15]; HRMS m/z (M +
Na)+ calcd for C11H10N2NaO3 241.0589, found 241.0589.
6,7,8,9-Tetrahydro-5H-pyrido[3,2-b]indole (18). A magnetically
stirred mixture of compound 17 (213 mg, 0.98 mmol) and 10 wt %
Pd/C (86 mg) in degassed methanol (49 mL) was maintained under
an atmosphere of hydrogen for 16 h at 22 °C and then ﬁltered, and the
solids so retained were washed with methanol (100 mL). The
combined ﬁltrates were concentrated under reduced pressure, and the
white solid thus obtained was subjected to ﬂash column chromatog-
raphy (silica, 1:1 v/v ethyl acetate/40−60 petroleum ether elution) to
give, after concentration of the appropriate fractions (Rf = 0.2 in 1:1 v/
v ethyl acetate/40−60 petroleum ether), compound 1825 (109 mg,
65%) as a white, crystalline solid: mp = 183−185 °C (lit.25 mp = 200−
202 °C); 1H NMR (400 MHz, CDCl3) δ 8.86 (broad s, 1H), 8.38 (d, J
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= 4.3 Hz, 1H), 7.52 (d, J = 7.9 Hz, 1H), 7.00 (m, 1H), 2.84 (m, 2H),
2.76 (m, 2H), 1.95−1.84 (complex m, 4H); 13C NMR (100 MHz,
CDCl3) δ 145.6, 141.9, 139.2, 129.1, 117.4, 115.8, 110.8, 23.8, 23.2,
23.1, 20.1; IR νmax 3136, 3083, 3053, 2929, 2847, 1483, 1414, 1362,
1286, 1144, 904, 767, 729 cm−1; MS (ESI, +ve) m/z 173 [(M + H)+,
100%]; HRMS m/z (M + H)+ calcd for C11H13N2 173.1079, found
173.1080.
5H-Pyrido[3,2-b]indole (δ-Carboline, 4). A magnetically stirred
mixture of compound 18 (20 mg, 0.12 mmol) and 10 wt % Pd/C (20
mg) in diphenyl ether (15 mL) maintained under a nitrogen
atmosphere was heated at 210 °C for 0.66 h. The reaction mixture
was then cooled to room temperature and ﬁltered (through ﬁlter
paper), and the solids thus retained were washed with ethyl acetate (2
× 15 mL). The combined ﬁltrates were concentrated under reduced
pressure, and the residue thus obtained was subjected to ﬂash column
chromatography (silica, 0:1→ 1:4 v/v ethyl acetate/40−60 petroleum
ether gradient elution) to give, after concentration of the appropriate
fractions [Rf = 0.2(5) in 1:1 v/v ethyl acetate/40−60 petroleum
ether], compound 426 (18 mg, 92%) as a white, crystalline solid: mp =
211−212 °C (lit.26 mp = 206−207 °C); 1H NMR (400 MHz,
CD3OD) δ 8.39 (dd, J = 4.8 and 1.4 Hz, 1H), 8.28 (d, J = 7.9 Hz, 1H),
7.88 (d, J = 8.2 Hz, 1H), 7.52 (m, 2H), 7.40 (m, 1H), 7.26 (m, 1H)
(signal due to N−H group proton not observed); 13C NMR (100
MHz, CD3OD) δ 142.4, 142.3, 141.5, 135.1, 129.0, 122.4, 121.4, 121.3,
120.8, 119.9, 112.6; IR νmax 3057, 2979, 2919, 2848, 2760, 1629, 1460,
1396, 1320, 1223, 741, 724 cm−1; MS (ESI, +ve) m/z 169 [(M + H)+,
100%]; HRMS m/z (M + H)+ calcd for C11H9N2 169.0766, found
169.0766.
2-Methylpyridin-4-ol Nitrate (20). Commercially available 2-
methylpyridin-4-amine (8.00 g, 73.98 mmol) was dissolved in a
mixture of concentrated HNO3 (44.1 mL) and H2O (59.4 mL), and
the resulting solution was cooled, with vigorous magnetic stirring, to 0
°C. A chilled solution of NaNO2 (7.40 g, 107.25 mmol) in water (21.7
mL) was then added dropwise over 0.5 h, and the mixture thus formed
stirred at 0 °C for 4 h before being allowed to warm to 22 °C and then
stirred at this temperature for another 10 h and was recooled to 0 °C.
The resulting solid was removed by ﬁltration, the ﬁltrate was
concentrated to about one-third of its original volume and then
cooled to 0 °C, and a second crop of solid was removed by ﬁltration.
The combined solids were then air-dried to give the nitric acid salt27 of
compound 20 (10.49 g, 82%) as a white, crystalline solid: mp = 162−
164 °C (lit.27 mp = 164−165 °C); 1H NMR (400 MHz, CD3OD) δ
8.34 (d, J = 6.5 Hz, 1H), 7.11−7.09 (complex m, 2H), 2.62 (s, 3H)
(signals due to O−H and N−H group protons not observed); 13C
NMR (100 MHz, CD3OD) δ 173.4, 156.0, 143.2, 114.7, 113.0, 19.3;
IR νmax 3098, 2919, 2617, 1627, 1501, 1305, 1216, 830 cm
−1; MS (ESI,
+ve) m/z 110 [(M + H)+, 100%]; HRMS m/z (M + H)+ calcd for
C6H8NO 110.0606, found 110.0608.
2-Methyl-4-nitropyridin-3-ol (21) and 2-Methyl-3-nitropyridin-4-
ol (22). A magnetically stirred solution of salt 20 (3.00 g, 17.43 mmol)
in concentrated H2SO4 (6.9 mL) was cooled to 0 °C and then treated,
dropwise, with fuming HNO3 (6.9 mL). The ensuing mixture was
stirred at 0 °C for 0.17 h, heated at 130 °C for 20 h, and then cooled
to 0 °C and carefully neutralized with NaOH (25 mL of a 10 M
aqueous solution). FC-grade silica gel (20 g) was added to the ensuing
mixture, and this was then concentrated under reduced pressure. The
free-ﬂowing solid thus obtained was subjected to ﬂash column
chromatography (silica, 1:19 v/v methanol/dichloromethane elution)
to give, after concentration of the appropriate fractions (Rf = 0.6 in 1:1
v/v methanol/dichloromethane), a 1:3 mixture of 2-methyl-5-
nitropyridin-4-ol (21) and 2-methyl-3-nitropyridin-4-ol (22) (1.88 g,
70% combined yield) as a white crystalline solid: mp = 148−150 °C;
1H NMR [400 MHz, (CD3)2SO] δ (major product) 12.17 (broad s,
1H), 7.72 (d, J = 7.5 Hz, 1H), 6.33 (d, J = 7.5 Hz, 1H), 2.29 (s, 3H);
13C NMR [100 MHz, (CD3)2SO] δ (for mixture) 168.2, 151.2, 148.1,
143.5, 142.2, 139.4, 137.8, 137.3, 120.7, 118.0, 18.2, 15.3; IR νmax 3037,
2796, 1612, 1557, 1502, 1356, 1222, 836, 768 cm−1; MS (ESI, +ve) m/
z 331 (42%), 177 [(M + Na)+, 100], 155 [(M + H)+, 10]; HRMS
(ESI) m/z (M + Na)+ calcd for C6H6N2NaO3 177.0276, found
177.0278.
4-Bromo-2-methyl-3-nitropyridine (24). A magnetically stirred 1:3
mixture of 2-methyl-5-nitropyridin-4-ol (21) and 2-methyl-3-nitro-
pyridin-4-ol (22) (1.12 g, 7.27 mmol), obtained as described
immediately above, in toluene (8.0 mL) and maintained under a
nitrogen atmosphere was treated with POBr3 (2.19 g, 7.63 mmol). The
ensuing mixture was heated under reﬂux for 10 h and then cooled to 0
°C before being quenched with NaOH (30 mL of a 1 M aqueous
solution). The ensuing mixture was extracted with ethyl acetate (1 ×
150 mL) and washed with H2O (2 × 150 mL). The separated organic
phase was then dried (Na2SO4), ﬁltered, and concentrated under
reduced pressure. The solid so obtained was subjected to ﬂash column
chromatography (silica, 1:3:20 v/v/v acetone/dichloromethane/40−
60 petroleum ether elution) to give, after concentration of the
appropriate fractions (Rf = 0.4 in 1:3:6 v/v/v acetone/dichloro-
methane/40−60 petroleum ether), a 1:3 mixture of what is presumed
to be 4-bromo-2-methyl-5-nitropyridine (23) and 4-bromo-2-methyl-
3-nitropyridine (24) (1.46 g, 92% combined) as a white solid. A ca.
800 mg portion of this material was subjected to semipreparative
HPLC (silica, normal phase, 17:83 v/v ethyl acetate/n-hexane elution,
600 mL/h) to aﬀord, after concentration of the relevant fractions (Rt =
0.45 h), a pure sample of 4-bromo-2-methyl-3-nitropyridine (24) (ca.
350 mg) as a white, crystalline solid: mp = 78−79 °C; 1H NMR (400
MHz, CDCl3) δ 8.40 (d, J = 5.3 Hz, 1H), 7.50 (d, J = 5.3 Hz, 1H),
2.60 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 151.8, 150.5, 148.5,
126.3, 123.7, 20.9; IR νmax 3072, 1575, 1534, 1365, 1266, 846, 837, 714
cm−1; MS (EI, 70 eV) m/z 218 and 216 (M+•, both 90%), 201 and
199 (both 70), 172 and 170 (both 95), 93 and 91 (both 83), 62
(100%); HRMS m/z M+• calcd for C6H5
79BrN2O2 215.9534, found.
215.9533.
2-(2-Methyl-3-nitropyridin-4-yl)cyclohex-2-en-1-one (25). A mag-
netically stirred mixture of 2-iodocyclohex-2-en-1-one (6) (205 mg,
0.92 mmol), copper powder (117 mg, 1.84 mmol), CuI (132 mg, 0.69
mmol), and Pd(dppf)Cl2·CH2Cl2 (38 mg, 0.05 mmol) in degassed
DMSO (9 mL) was heated at 50 °C under a nitrogen atmosphere for
0.75 h. After this time, a solution of compound 24 (100 mg, 0.46
mmol) in degassed DMSO (3 mL) was added to the reaction mixture
over 0.66 h. After a further 6 h the reaction mixture was cooled,
quenched with water (3 mL), and then diluted with ethyl acetate (5
mL). The ensuing mixture was ﬁltered through a pad comprised of a
mixture of diatomaceous earth and silica gel, and the solids so retained
were rinsed with ethyl acetate (2 × 5 mL). The separated organic
phase associated with the combined ﬁltrates was washed with water (2
× 10 mL) and then brine (2 × 10 mL) before being dried (Na2SO4),
ﬁltered, and concentrated under reduced pressure to give a brown oil.
Subjection of this material to ﬂash column chromatography (silica,
3:9:40 v/v/v acetone/dichloromethane/40−60 petroleum ether
elution) gave, after concentration of the appropriate fractions [Rf =
0.1(5) in 1:3:6 v/v/v acetone/dichloromethane/40−60 petroleum
ether], compound 25 (90 mg, 84%) as a light-brown, crystalline solid:
mp = 80−81 °C; 1H NMR (400 MHz, CDCl3) δ 8.59 (d, J = 5.0 Hz,
1H), 7.09−7.05 (complex m, 2H), 2.66 (s, 3H), 2.58−2.54 (complex
m, 4H), 2.12 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 195.6, 151.4,
150.8, 150.1, 146.6, 139.0, 136.3, 123.4, 38.2, 26.5, 22.5, 22.0; IR νmax
2939, 1681, 1594, 1528, 1359, 1229, 860 cm−1; MS (ESI, +ve) m/z
255 [(M + Na)+, 100%], 233 [(M + H)+, 10]; HRMS m/z (M + Na)+
calcd for C12H12N2NaO3 255.0746, found 255.0734.
1-Methyl-6,7,8,9-tetrahydro-5H-pyrido[3,4-b]indole (26). A mag-
netically stirred mixture of compound 25 (103 mg, 0.44 mmol) and 10
wt % Pd/C (42 mg) in degassed methanol (22 mL) was maintained
under an atmosphere of hydrogen at 22 °C for 16 h and then ﬁltered,
and the solids thus retained were washed with methanol (50 mL). The
combined ﬁltrates were concentrated under reduced pressure, and the
white solid thus obtained was subjected to ﬂash column chromatog-
raphy (silica, 1:4 v/v methanol/dichloromethane elution) to give, after
concentration of the appropriate fractions (Rf = 0.2 in 1:1 v/v
methanol/dichloromethane), compound 2628 (69 mg, 83%) as a
white, crystalline solid: mp = 187−189 °C (lit.28 mp = 184−188 °C);
1H NMR (400 MHz, CD3OD) δ 7.84 (d, J = 5.4 Hz, 1H), 7.19 (d, J =
5.4 Hz, 1H), 2.78 (broad s, 2H), 2.63 (broad s, 5H), 1.91−1.84
(complex m, 4H) (signal due to N−H group proton not observed);
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13C NMR (100 MHz, CD3OD) δ 141.6, 141.2, 136.7, 133.7, 132.9,
111.9, 110.6, 24.3, 24.2, 24.1, 21.7, 19.1; IR νmax 3045, 2930, 2846,
1563, 1498, 1308, 1226, 809 cm−1; MS (ESI, +ve) m/z 187 [(M +
H)+, 100%]; HRMS m/z (M + H)+ calcd for C12H15N2 187.1235,
found 187.1232.
1-Methyl-9H-pyrido[3,4-b]indole (Harman, 5). A magnetically
stirred mixture of compound 26 (36 mg, 0.19 mmol) and 10 wt %
Pd/C (36 mg) in diphenyl ether (15 mL) maintained under a nitrogen
atmosphere was heated at 210 °C for 0.66 h. The reaction mixture was
then cooled to room temperature and ﬁltered (through ﬁlter paper),
and the solids so retained were washed with ethyl acetate (2 × 7 mL).
The combined ﬁltrates were concentrated under reduced pressure, and
the residue thus obtained was subjected to ﬂash column chromatog-
raphy (silica, 40−60 petroleum ether elution →1:9 v/v methanol/
dichloromethane elution) to give, after concentration of the
appropriate fractions (Rf = 0.5 in 1:3 v/v methanol/dichloromethane),
compound 529 (32 mg, 91%) as a white, crystalline solid: mp = 233−
235 °C (lit.29 mp = 235−238 °C); 1H NMR (400 MHz, CDCl3) δ
8.91 (broad s, 1H), 8.38 (d, J = 5.4 Hz, 1H), 8.12 (d, J = 7.9 Hz, 1H),
7.84 (d, J = 5.4 Hz, 1H), 7.56−7.51 (complex m, 2H), 7.29 (m, 1H),
2.84 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 141.9, 140.3, 138.7,
134.8, 128.5, 128.4, 122.2, 122.0, 120.2, 113.1, 111.7, 20.5; IR νmax
3135, 3068, 2925, 1626, 1568, 1504, 1450, 1323, 1251, 1237, 742
cm−1; MS (ESI, +ve) m/z 183 [(M + H)+, 100%]; HRMS (ESI) m/z
(M + H)+ calcd for C12H11N2 183.0922, found 183.0922.
X-ray Crystallographic Studies. Crystallographic Data. Com-
pound 1. C11H8N2, M = 168.20, T = 150 K, monoclinic, space group
P21/n, Z = 4, a = 11.1814(2) Å, b = 5.53776(8) Å, c = 13.4546(2) Å, β
= 96.2939(15)°, V = 828.09(2) Å3, Dx = 1.349 g cm
−3, 1673 unique
reﬂections (2θmax = 147.6°), R = 0.035 [for 1520 reﬂections with I >
2.0σ(I)], Rw = 0.089 (all data), S = 1.00.
Compound 2. C11H8N2, M = 168.20, T = 150 K, orthorhombic,
space group P212121, Z = 4, a = 5.8440(1) Å, b = 9.8140(1) Å, c =
14.4195(1) Å, V = 827.00(2) Å3, Dx = 1.351 g cm
−3, 1004 unique
reﬂections (2θmax = 147.8°), R = 0.027 [for 998 reﬂections with I >
2.0σ(I)], Rw = 0.073 (all data), S = 1.00.
Compound 3. C11H8N2, M = 168.20, T = 150 K, orthorhombic,
space group Pna21, Z = 4, a = 17.1576(6) Å, b = 12.2955(6) Å, c =
3.8213(2) Å, V = 806.15(6) Å3, Dx = 1.386 g cm
−3, 944 unique
reﬂections (2θmax = 147.8°), R = 0.032 [for 906 reﬂections with I >
2.0σ(I)], Rw = 0.062 (all data), S = 1.00.
Compound 4. C11H8N2, M = 168.20, T = 150 K, monoclinic, space
group Ia, Z = 4, a = 12.1155(7) Å, b = 3.9036(2) Å, c = 18.1199(13)
Å, β = 107.250(7)°, V = 818.42(9) Å3, Dx = 1.365 g cm
−3, 820 unique
reﬂections (2θmax = 146.6°), R = 0.042 [for 807 reﬂections with I >
2.0σ(I)], Rw = 0.107 (all data), S = 1.05.
Compound 5. C12H10N2, M = 182.23, T = 150 K, orthorhombic,
space group P212121, Z = 8, a = 9.5865(2) Å, b = 13.2423(4) Å, c =
15.1680(4) Å, V = 1925.54(9) Å3, Dx = 1.257 g cm
−3, 1994 unique
reﬂections (2θmax = 52.0°), R = 0.032 [for 1805 reﬂections with I >
2.0σ(I)], Rw = 0.073 (all data), S = 1.00.
Structure Determination. Images for compound 5 were collected
on a diﬀractometer (Mo Kα, graphite monochromator, λ = 0.71073 Å)
ﬁtted with an area detector, and the data were extracted using CrysAlis
PRO.34 Images for compounds 1, 2, 3, and 4 were measured on a
diﬀractometer (Cu Kα, mirror monochromator, λ = 1.54184 Å) ﬁtted
with an area detector, and the data were extracted using the CrysAlis
PRO.34 The structure solutions for all 5 compounds were solved by
direct methods (SIR92)35 and then reﬁned using the CRYSTALS
program package.36 Atomic coordinates, bond lengths and angles, and
displacement parameters have been deposited at the Cambridge
Crystallographic Data Centre (CCDC nos. 1530002, 1530003,
1530004, 1530005, 1530006). These data can be obtained free-of-
charge via www.ccdc.cam.ac.uk/data_request/cif, by e-mailing data_
request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallo-
graphic Data Centre (12 Union Road, Cambridge CB2 1EZ, UK; fax:
+ 44 1223 336033).
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Appendix 
Structure of compound 7 as shown in publication 1 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 7 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1526109). 
O
O
O
7
437
Structure of compound 8 in publication 1 with labeling of selected atoms. 
Anisotropic displacement ellipsoids show 30% probability levels. 
Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 8 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1526110). 
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Structure of compound 9 as shown in publication 1 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 9 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1526111). 
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Structure of compound 11 as shown in publication 1 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 11 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1526112). 
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Structure of compound 14 as shown in publication 1 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 14 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1526113). 
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Structure of compound 16 as shown in publication 1 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 16 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1526114). 
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Structure of compound 17 as shown in publication 1 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 17 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1526115). 
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Structure of compound 22 as shown in publication 1 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 22 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1526116). 
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Structure of compound 26 as shown in publication 1 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 26 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1526117). 
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Structure of compound 30 as shown in publication 1 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 30 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1526118). 
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Structure of compound 32 as shown in publication 1 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 32 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1526119). 
 
 
 
 
 
 
32
O
O
O
O
H
O
447
  
 
 
 
 
 
Structure of compound 8 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 8 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545223). 
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Structure of compound 9 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 9 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545224). 
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Structure of compound 10 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 10 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545225). 
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Structure of compound 13 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 13 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545226). 
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Structure of compound 23 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 23 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545227). 
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Structure of compound 27 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 27 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545228). 
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Structure of compound 30 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 30 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545229). 
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Structure of compound 32 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 32 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545230). 
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Structure of compound 34 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 34 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545231). 
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Structure of compound 35 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 35 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545232). 
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Structure of compound 36 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 36 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545233). 
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Structure of compound 38 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 38 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545234). 
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Structure of compound 41 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 41 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545235). 
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Structure of compound 44 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 44 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545236). 
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Structure of compound 45 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 45 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545237). 
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Structure of compound 47 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 47 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545238). 
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Structure of compound 48 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 48 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545239). 
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Structure of compound 53 as shown in publication 2 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 53 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1545240). 
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Structure of compound 1 as shown in publication 3 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 1 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1525166). 
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Structure of compound 2 as shown in publication 3 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 2 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1525163). 
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Structure of compound 3 as shown in publication 3 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 3 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1525164). 
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Structure of compound 4 as shown in publication 3 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 4 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1525162). 
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Structure of compound 5 as shown in publication 3 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 5 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1525167). 
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Structure of compound 6 as shown in publication 3 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 6 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1525160). 
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Structure of compound 17 as shown in publication 3 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 17 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1525161). 
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Structure of compound 25 as shown in publication 3 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 25 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1525165). 
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Structure of compound 1 as shown in publication 4 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 1 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1530002). 
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Structure of compound 2 as shown in publication 4 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 2 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1530003). 
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Structure of compound 3 as shown in publication 4 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 3 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1530004). 
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Structure of compound 4 as shown in publication 4 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 4 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1530005). 
 
 
 
 
 
 
 
 
4
N
N
H
477
  
 
 
 
 
 
Structure of compound 5 as shown in publication 4 with labeling of 
selected atoms. Anisotropic displacement ellipsoids show 30% probability 
levels. Hydrogen atoms are drawn as circles with small radii. A full X-ray 
crystallographic report for compound 5 has been deposited at the 
Cambridge Crystallographic Data Centre (CCDC 1530006). 
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